>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
bLebLebLhbLcbLcbLebLcLsmbLcbLibLcbLjbLcLsLsmmbRgbRibRibLebRgRsmbLhbLcR
sbLgbRgbRcbRhbRoRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bRgbRsbRgbRsbRgbRsRsmbRsbRhbRhbLcb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bRsLsRsbRsbLgbRsLsbsbsbsbRoRsmbRsRsmbRsRsmbRcLsLsmbRcbRibRgbRgRsLsmbRs
bRsbRgbRgRsmbRsbRibRoRsmbRibRibRgRsmbLsRsbLsRsbRhbRsbRcbRoRsmbRoRsmbRi
RsmbRcbRibRobLcbLhbRsbLcbLsbLcLsmbLcbLiRsbLcbLiLiLsbLiLsbLsbLcRsbLcLsL
smmbLcbLcLsmbLcbLcbLcbRcbRcbRcbRibLjbRhbRjbLjbLjbsbLjRsbRsRsRsmmbRsRsR
smmbLjbsbLjbLjbLjbLibRsbRsRsmbLjbLjRsbLiLsbRsRsmbRibRcbRhRsRsmmbRjRsmb
LibRsbLcLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bRhbRibLebLgbRebLsbLhbLjbLibRsbRgRsmbRjbRgbRsRsRsmmbRsRsRsmmbRsbRsRsmb
RsRsmbRsRsRsmmbRsbRsbRsbRgRsRsmmbRsRsRsmmbRsRsmbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bRobRcbRhbRcbRsLsbLoRsbLoLsmbLcbLibLobLcbLjbRsRsRsRsRsmmmmbRsRsmbRjLsb
LcbLhLsbRsRjbRcRgbRhLsbRibRcbLjbLcbLiLsRsLiLsbLsbLjRsRcRcbRsbLjbLsLsmb
LsLsLsmmbLsLsmbLsLsLsLsLsmmmmbLsLsmbLsLsLsLgmmbsbLgLsbRcRsRgLsmbRiRgRi
RsmbRiReRsmbRgRsRimbRobRebRsbLsbLsbLsLeLiLgbLgbRebRebRebReRgRsmbRsbRgb
RsRsmbRsRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bRsRsmbRsbLsLsmbLibRsbRsRsLsmbLebRsbRgbLsbLcbLjbLhbLsLsmbRsbLiLsbRsbLi
bLsbRgRsmbRjRsRsmmbRcbRsbRibRgbRgRsmbRsbRsbRgbRsRsmbRsbLobLcbLiRsbLoLs
mbRsbRgRsmbRsRsmbLobLibLibLibRsbLhbLibLhbLcLsmbLjLsmbRjbRcbRiRsmbRsbRi
bLjbLiLsbLjLsmbLhbLsLsmbRsRsmbLcLsmbLgbLiRsRsmbLhbLjLsmbRcbLcLibLhRsbL
iLsbLgbLibLgbRsbRiRsmbLjbLjLsmbLeLsbLibLiLsbLjRsbLgRsbLgLsbLjbLhLsbLjb
LjbLjbLcbLjLjbLjbLcLsmbRsbLjLsmbLsbLsbLgbLsbLgbLjLsmbLhLgbLjbLebLsLsmb
RsbLsbLiLsbLjLsmbLeLsbLcLsmbLcbLhbLiLsLsmbLibLibLjbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bRoRsmbReRsmbRhbRhbRcbLhbLcRsbRjbLobRjbLcLsmbRgbRgbRjbLsbRsLsbRoRsmbRs
LsbRsRsmbRsRgbRsRsmbRgbRsbRsLsbLsbRcbLcbLebLeLsbLcbLgbRgbLhbLhbLcbLcbR
sbRsRsmbLsbRgbLcLsLsLsmmmbLibLcLsmbLcbRsLebRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bLobLibRgbRgbRibRsbRsbRsbRcbRibRcbRcbRiRsRgmbRgbRsLsRsbRsRsRsmmbRibRib
RhbRjbRhbRcbRjLsbLcLsmbRcbRobRjRjbLsbLcbLebRgRibLjLsmbLobRsLsbLcbLibLc
bRcRsmbRobRcRsmbRcbRcbRhbRgbLobRobRcbRsbRibRibRibRibRiLsbLobRcbRibLcbR
cRsRsRsmmmbRcRgbLjLsmbRhRsmbRhbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
bsbRsbLsbRcbRobRiRsmbRcbRsbRgRsmbRgRsmbRgbRgbLobLiRsbLgbLgbLsLsmbLgbRo
bRhbRcbLoRsbLcbLjRsbLcbLobLcbLcRsbRobRcbRhLsbRjLsbLjRsbRjbLjbLhbLhbLjR
sbLcRsbLhbLjRsbLgRsLsbRsbLsbLsbLjbLiLsbLcRgbRoLsbLcbRsRsmbLiRsbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
bLsbLsbLsbLibLibLibLjLsmbRsbLcbLcbLjbLjRsbLibLibLhbLhbRcbRibRibRcbRjbR
jbLjLsmbRsbReLgbLebLsbRebLsbRebRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bRsbLsbRsbRobRhbRcbReRsmbLcbLjbLjbLcLsmbLobLcbLibRjbLjLsmbLgbLibLgbRjb
LjbRibLibRibLiLibLibLibRjbRjLsbLgRsbLgRsbLsRsRsmbRjbLsbRsRsmbRibRgRsRs
mmbRgRgbLgbLsLsmbRjbLgRsbRebRib

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
bLobLobLobLsLsmbRhbRcbRibRsbLobLjRsLsbRobRobRoRsmbRcbRoRsRsRsmmmbRibRs
bsbsbRjbRhbRhbLcbRhbRsRoRsLsmbRsRsmbRcbLcLsmbLcbLjRsbLjbRhbLjRsbRobRsb
RobRhbRhLsbLjbLcbLjbLjRsbLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
bRiLsbRsRjbRcbRcbRsbRcbRgbLcbLsbRebRhbReRsmbRibRiLsbRibRcRgbLgLsLsLsmm
bLsLsLgLsLsLsLsLsLsmmmmmmbLgbLgLgLsbLsLsLsmmbLgLsLsmbLsLgLsLsmbLsLsLsL
sLsLsLgmmmmmbLsLsLsmmbLgbLsbLgbLsLsmbLsLsmbLgbLgbLgLsbLgbLsLsLsmmbLsLs
mbLgLsbLgbLgbLgLgbLsLsLsmmbLgLsbLgbLsLsmbLgbLsLsmbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bRobRjbRibRobLcbLebLjbLjbRibRjbRhbRibRjbRjbRibLsLsmbLcbLhbRjbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bRjbRobRibRjRsmbRsRcRgRsmbRhbLsbLhbLcbLcbLiRsbRcbRhbRibLsbRcbRcbRebLcb
LjRsbRibLibRgLsbRsRsmbRsbRcbLcbLibReRsmbRibReb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bRibRjbLcRsbLjLsLsmmbLjLsmbLibLsbLhbLibLsbLsbsbLsbLgbLsbLsbsbLgbRsbLjR
sbRcbReLsbLibLibRcbRibLsRsLsbLobLibLgbLibLibLibLgbLibLhbLibLibLsLsmbLg
bLibLibLgbLiRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bRjRgbRcbRcbRjbRibRjbLjbLcbLcbLjbLjbLjbRcbRjbRcRsmbRibRibRibRcbRcbLhbL
cbRjbLibRjRsmbLibRibRsbsbLsbLgbRiRsmbLibRjRsmbLjbRhbRiRsmbRibRibRiLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bRsRsmbRcbRcbRcbLcLsmbRcbLebLhbLgbLsbLgbRibRgbLcbLsbLibLsRcbRjbRiRsLsm
bRibRgbRibRjbRjbRgbRibRsLsbLsbLsbRcbRgbRibRgbRsbRsbLhLsbLgbRcbRsRsRimb
RcbRgbRibRhbRiRsmbRibRsbRibRibRgbRcLsbLsbRibRhLsbRgbLjbLibLiLsbLiLsbLg
LsLsmbLebLebRgRsmbRebRgLsbRsbRsbRsbRiLgbLhbLibLgRsbLibLibLgbLsbRjbRcbR
ibRibRibRibRibRgbLsbLsbRgbRgbRsbRcbLsLsmbLgbRcbRibRibRgbRgLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 19; Drug: Control Apo 50 然
bLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 20; Drug: Control Apo 50 然
bRsbLsbRjbLsbLjbRsbLgbLsbRjbRibLsRsLsRsbLcbLeRsbRsRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 21; Drug: Control Apo 50 然
bRhLsbLoRsbReRsRsmmbRebLcbRcbRcbLjRsbLjbRsRhRsmbLjbLibRcRsmbLibRibRoRs
mbLjRsbRgbRcRsmbLhbRsRgbReRgRsRsRsmmmbRgRsRsmmbRcbRsRsRsmmbRgbReRsRsRe
RiRsmmmbRgRsRsmmbRebRsRsRsRsmmmbRsbRgbRsbRgbRiRsmbLibRebRjbRcRsRsRgmmb
LcLsLsmmbLjRsbRjbLiLsLsmbRsRsmbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 22; Drug: Control Apo 50 然
bLgbLibLibLsbLgbRoLsbLgbLiLsbLibLibLgbLibLhbRhbRcbLibRcbLhbLibRcbLjbRi
bLibRcbLhbLhbRjbReRsmbRobLgbLgbLibRcRsmbReLsbReRsmbRibRhLsbRhbLiLsbLib
RcbLjLsmbRebLjbLibRebRiLsbRcRsmbRcbRebLcbLiLsbRgRsmbLebLibRhbReRsmbRcb
LcbLibRoRsmbRibRebRibRebRcbLibLibLibRcLsbRebRhbLsbRobReRsmbRiRsmbRibLe
bLibLibLgbRebRsRcbRhbRibLebLgbLibRjbRebLobLcbLeLsbRcbRgbLebLibRjbRjbRe
bLcbLibRjbRjRsmbRibRgbRsbRebRgbRcbRebRcbRgbLcbLcbLgRsbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 23; Drug: Control Apo 50 然
bRgbRcbRiLsbLibLsLsmbRobRjbRiRsmbRjRsmbLsbRsLsbRibRsRsmbRhbRjRsLsmbRjb
RjbRibRjbRjbRjbRgbRjbRjbRsRsRsLsLsLsmmmmbRibRcRsmbRsbRsLsbsbLsRsRsRsRs
mmmbRsbRsRsmbsbRsRgbRsbRsRgbRsRsRsmmbRsRsmbRsRsRsLsRsRsRsRsRsRsRsLsmmm
mmmmmbRsbRsbRsbRsLsbLsbLsbRsbRsbRgLsbRsRsmbRsbRsRsLsmbRsLsRsbsbRsRsmbL
sRsbRsRsmbRsRsRgmbRsRsRsmmbRsRsmbRsRsmbRsRsmbRgbLsbRibRiLsbRjbRgbsbRsb
RsRsRsRsmmmbRsRsRsRgmmbRsRsmbRgRsRsRsmmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 24; Drug: Control Apo 50 然
bLebLcLsmbRhbRhbRhbRsbRjbRjbRiRsmbRhbLsbRcbsbRibRjbLgbRibLsRsRsmbRgbRh
RsmbRsRgbRsRsRsmmbRgRsmbLsRsbRiRsmbRibRhbRibLibRcbRibRibRibRhbLebRsLcb
LeLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bRsbRobRibLsbLcbLgbLsbLgbLebLebLsRsbRgbRhbRcbRibRjbRcbRhbRcbLebRobLobR
obRobRobLebLjbLobLobLobRsbLebRjbRsbRebRcbLgLsbLsRsbLsLgLcbLsLsmbLsbRgb
RoRsLsRsLsmbRsbRgLgbLhbLcbRcbRcbRibLibLebLsbLsbLsbLsbRibRjbLsbLgLsbLib
LgbLgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
bRcbRobRcbRcbRhbRjbRcbRcbRibRcLsbRcbRebLibRjbRobRjbLjbLcbRcbRcbRcRsmbL
jbLcLsmbLibLhbLjLsmbLjLsmbRebRcbRcbRsRsmbLgLsbRjRsmbRiRsLsmbRibRgbRibR
jRsRgmbRgbRibRgbRibRebRjbRcRsmbRcbRebRebRgbRjRsmbRibRgbRibRebRhbRjbRcR
smbRibRibRjRsmbRjRsRgRsmmbRhbRhbRhbRobLiLsbLibLibRcLsbRsbRgbLcbRjbRsRj
RsmbRcbRhbRibLjbLibLibLibLibLibLgLsbLsbRhbRoLgLsbLgbRsRgbRsRsmbRibRibR
gbLsbLiLsbLibLibLibLibLibLgbLgbLgbLibLgbLgbLgLsbLgbLibLgbLgbLgbLebRebR
cbRibRibRgbRsRsmbRsRgbLgbRsbRhbRibRcbRsRsmbLsLsmbRibRibRsbLsbRgbRibRhR
smbLibLhRsbLibLgbLiLsbLgbLibLgbLiLibLibLsbLgbLgbLsbLibLgbLgbLibLcbLgbL
gbLibLibLibRibRoLsbLsbLgLsbLibLgbLibLibLgbLgbLhbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bLcbLjbLcbLcbLhbLjbRcbRcbLobLibRsbLjLsmbRgbLsLsRsmbLsbLsLsmbsbRsRsmbRs
RsRsmmbRsRsRsmmbRcLsbRebRcbLhLjbLiLsLsLimbLiRsbRgRsmbRsbRcRsRsmmbRsbRg
bRsbRsbRsbRsRsLsmbRsbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bRjLsbRcbLcbLhbLjLgbLsLsmbLjLsmbLgLsbLsLsmbLgbRiRobRib

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
bRcbRibLcbLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bLcbRsLsbRjbRcbRobRjbRcbLiLsbRjbRjbLjbRjbRjbRgRsmbRsRsmbLsLsLgLsLsLsmm
mbLsLsmbLsLsmbLsLgLgbLsRsbLsLsLsmmbsbLcbLobLsLsmbLsLsmbLsLsLsLsLsLsLsm
mmmmmbLsLsLsmmbLsLsLsLsmmmbLsLsmbLsbRobLsbLsLsLsLsmmmbRsLsbLgLsLsLsmmb
LgbLsLsmbLgLsbLsLsLsmmbLsLsmbRsLsLgRsbLsLsmbsbLsLsLgmbLsbLgLsbLsLgbLgL
sLsmbLsbLsbLgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bLcbLcRsbLobRobRibRcbRibRjbRcbRsbRjRsmbLcbRjbRhbLcbRjLsbRiRsmbLjbLcLsm
bLcbRjbLcLsmbRjRsmbRcbRgbReLsLsmbRsRiLsbRcRibRcRiRebRebRebRcbRebRebReb
RhbReRsmbRsRebRsbLsRhbRibRgbRiLsLsmbRcbRebRsbRsRsmbRsLsbsbsbsbsbsbRsbs
bsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
bsbLsLsmbLgbRebRiRgLsbRsbRgbRsbRsbLgbLobLibLsbLgbRcbRibRsbRsbLcbLibLgb
LsRsbRjbRjLsbRcbLiLsbRcbRcbLiLsbLsRgRsmbRiLsbRsbRibRsLsbRgLsLsLsmmbRsR
iRsRsRsmmmbRgRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bLsLsLsLsmmmbLsRsbLhLsbLhbLhbLsLsmbLsbLeLsbLgRsbLhbLsLsLsmmbLgbLibLiLs
bLsbLibLiLsbRsRsRsmmbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bRibLebLhbLcbLebRcbRjbRebRibRjbRibLcbRibRsbLjbLibLgLsbLgbRjLsbRibRobRg
bRjRsmbRcbRebRcRsmbRibRgbRcbLibLgbLibLibLsLhbRgbRibLcbRgbLcbLibRibRibR
ibRibRgbRhbLibLhbRgbLebRibRgbRibRib

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bLobRjbRcbRcbRibRcbRhbRhRsmbRhLsbRibRcbRibRhbRibRsbRsbRsRsmbRsbRibRsRs
RsmmbRgbRgRsRsmmbRsbRsRsmbRsRsmbRgbRsRsmbRsRsRsmmbRiRsmbRsRsRsLsmmbRib
LsLsmbRsRsmbRibLsLsmbRsbRcbLsbRibRiLsbRsbRibRsbRebRsbRcbLhLsbRcbRcRsmb
RgbRsbRcbRgbLsbLibRebsbLcLsmbLibRsbLgLsbLibLsbLsbLgbLibLgbLsbLhbLibRib
RiRsmbRsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bLgLsbLsLsmbLgbLcbLibLebLgbLibLiLsbLsbRoRsmbRgRsmbLjbRobRsbRgbLebLgbLh
LsbLobRsbRcbLsbRcbLcbLgbLibLcbLibLcbRebRcRsmbRsbLcbLcbRibReLsLsLsmmbRs
bLsbLob

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bLgbRgbRsbRiLsbLsbRcbRiRsRsmmbRiLsbRhbRibRibRibRsbRiRhbRiRsmbRhbRsLsbR
gbRiRsmbRibRcbRcbRcbRiLsRgbRcbLiRsbRibLcbRcRsRimbRibRgbLcLsmbRjbRibRiR
iLsbRgLsbRibLjRsbLcLgbLiRgbRcbRgRsmbRgbRsRsLsmbRgLsbLsbLjbLcbRjRgbRiRs
mbRiRsmbLsReRiRsRgRsRiRsRsmmmmbRgRibRgRsmbRebRiLsbLgbLsRiRibRgbRgbRgbR
gbRibRibRhbLibRiLsbLjbLjbLibLcLsmbRhbRhbRjbRibRoLsbRcb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bRcbReRsRhRsmmbReRsRsRiRsmmmbLcRsbRcRsmbLsLsmbRsRsRsmmbRgRsLimbLibRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bLcbRcbRibRhRsmbRcRsmbLcRsbLiLsbLgbLjbRsbRhRsmbRhbLsRsbRiLsbLgbLjbRsRs
mb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
bLgRgbLhbLiLsbLsbLcLsmbLibLcbLcbRcRsmbRibLsRsbRhRsmbRsbLcbReLsbRhbRgbR
ibLsbRsbRobLobLobLcbRcbRibRebRcbRcbLcRsbRgRsmbRcbLcbLcbRgbRibRgRsmbRjb
RiRsmbReRibRibRcbLebLcbRsRsmbRsLsbRcbLhbLiRsLsbLiLsbRsLsbLsLsLsmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bLgLsbLgRsbLsLsmbLhbLgbRibLsLsmbRiRsmbRebRsRsLsmbRgRsmbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
bsbRhRsmbRibLebLibLcbLgbLsbLjbLibLsbLsbLgbLgbLgLsbLgbLsbLgbLgbLgbLgbLs
bLgbLibLsLsmbLibLebLsLsmbLgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 43; Drug: Control Apo 50 然
bRjbLcbRjbLjbLoRsbRibRjbRhbRhbRiLsbRjLsbLsbRsbsbLsRsbRsRsmbRjRsRsmmbLs
LsLsmmbLibsbLsRsLsbLsLsmbLsLsmbsbLsbLsLsmbLsbLsRsbRsbLsbLgbLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 44; Drug: Control Apo 50 然
bLhbLebLeLsbLiLsLsmbRsbRcRsmbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 45; Drug: Control Apo 50 然
bRobRcbRgbLcbLibRsbRsbLgbLcRsbLibRsbRcbRibRcbRcbRhbLcbRjRsLsmbRjbRjRsm
bLibRsRsLsmbRsbLcRsbRjbRcRsRsmmbRibRsbRiRsmbRiRsmbLgLsLsmbRsbRsRsRsmmb
RgbLsRsbRgLsbRsbRgbRgRsRsRsmmmbLsbRgRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 46; Drug: Control Apo 50 然
bRcbLibRcbRhbRebRcbRibRgbRiLsbRjRsLsLsmmbRjLsbRebRiRsRsmmbRgbRjLgRgbRi
LsbRibRsRgbRibRgLsbRibRsRsRsmmbRiLsbRibRibRibLibRibRhbRhbRgbRibRjRgbRi
LsLsmbLhbRibRebLsRgbRiRsmbRibRibRibRgbRibRjbLgLsbLibLibLibRibRgbRjbRgR
gbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 47; Drug: Control Apo 50 然
bLhLsLsLsmmbLgbLgbLsLgbLiLsbRsbLsbLsbLsbLgbLsLgLsbLsbLsLsLsmmbLsLebReL
sbRebLcbRjbRcRsmbRhRsmbRgLsbLeLsbsb

>ZF Recording 2016-03-22; tW: 300s; Start: 114915; End: 115415;
Recording: 1-1; Individual: 48; Drug: Control Apo 50 然
bRobRcbRsbRgLsbRsbLjbLibLibLcbLjbLjRsbLjbLibRjbLhLsbLhbLjbLebLebLiLsbL
jbLgLsbLgbLeLsLsmbLsbLebRsbRsbLibLebRsbLjbLhbLibLeLsbLebRsLsbRsbRjbLsb
LebLib

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
bRhbLhbLibRcLsbLgLsbReRhbRcLsbRcbRcbLcbLcbLcbLhbLobRobRibLcLsLsmmbLgbL
hbLcbLcbLiLibLgLsbLiLsbLibLcbLibLhLsLiLiLsbLeLgLebLebLobLcbLcbLhbLibLi
bLebLebLcbLobLcLibLcbLhbLebLhbLibLibLcbRgRsmbRibRcbRiRibRgbRebRhbLjbLi
LsbLibLebLgbLeRsbLcbRcRgbRobLcbLcbLcbLiRsbLeRsbLibLgbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bLsLjLsmbRsRsmbLebLgbRibLebRibRcbRibRjLsbRobRjbRcbRcbLebRjbRebLcbLibLe
bLibLgbLcbLebLibLibRsbLibRsbRibLibLgbLiLsbLcbLcbLibLgbLcbRibRibRiRsmbR
ibRsRsmbRhbRibRhbRgbRcbRibLebLibLhbLebLibLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bLsbsbLiRsRsLsmbLsLsmbLsLsLsmmbLsLsmbRsLsbLsLsLsmmbLsLsLsLsmmmbLsLsLsm
mbLsbsbLsLgLgLsbRsbLibLsRsRsmbLcbLcLsmbLiRsbLebLgLsbLcbLsLgRsbLcbRsbLc
bRhbRcbRcRsmbRcbRebReRsRsmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bRsbRsbsbRebLsbRgbRcbLsRsbRjbRsbRsRsmbRcbRsbLibLsbLsLsmbLgbLjbLsbLibLg
bRebRsbLcbRgbRibLcbLibLibLibLgbLibLibLgbRebRibRgbLsbRgbRhbLsbRgbLcbLsb
LiLsbLgbLibLgbLibLibRsbRsbLcbLsbLsRsRsmbLsbRjbRcbRsbRibRibRibRibLjbLgL
sbLibLgbRgbRsbLsbLgbLsLsLsLsLsmmmmbRsLsLsLsmmbLsbLgbLsbLgbRsbRjbRsbLib
LgbLsbLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bRsbsbRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bLibLiLsbLgLsbLgLsbsbLgLsbRsRsmbRsbRsRsmbRsbLjRsbLsLsmbLgLsbRsbLgbLgLs
bLjLsLsmmbRsbLsbLsbRsRsRsmmbLibLsbLgbLsRsbRsbLgbLgLsLsmbLibLgbLsLsmbLi
bLsbLibLsLsmbLeLsLsmbRsbRsbRebReRgbRibLsbLjbLcbRcbLjbLcLsmbLibLgbLhbRs
RsmbRsbRsLsbRsbRoLsbRgbRgRgRsLsRimbRsRiRsmbRgRgbRibRgbRibRsbRsbRgbLjRs
bLhLsbLibLgRsbRsbRsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bRibRebLebLcbRsbRgbLebRgbLebRibRjLsbRobRcRsmbLcbRhRsmbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bRgLgbRsbLsLsmbRjbRsRsRsmmbRsRsmbRgRsmbRgbRgRsLsRsmbRsbRiRsRsmmbRgbRgL
sbRgbRsRsRsmmbRsRsRsmmbRgLsbRiLsbLibRiRsmbRsRsmbRgRgRsRsmmbRsRsRsRsRgm
mmbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bRcLsbLibRibLgRsbRebRibLsbRhRsmbLgbRgRgbLibLsRsbRibLgbRhbRobLsbLgbLsbL
gbLgbLibLcbLcbLjbRcbLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
bLjbLjbLcRsbsbRjbLjbLibLjbLsLsmbLsLsmbLgRsbLcbLcbRjbLcbRjbLjRsLsbRjbLj
bRjb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
bRebRsbRebRobLsRsRsmbRibRsRsmbRgbReRsRsmmbRsbRcLsRsbRiLsbRiLsbRhbLibRs
RsmbRsRibRgbRsbRsRgbRgbRgRsRsmmbRgRgbRsRsRsRgmmbRgLsbRgbRgRsmbRsRsmbRg
bRsbRgbRgbRsRsRgmbRsRsRsmmbRsReRsmbLsbRcbRcbRhbRebRhRsmbLsbRcbRebRcbRs
bRibRibLjbLebLgbRsbRjbRhbRibRsbRhbRsRsRsRsRsmmmmbRgbRgbRgbRsRsRgmbRgRs
mbRgbRgbRsbRsbRsbRsLsbRgRsmbRsbRibRibRsbLcbLhbLibLibLibLgLsbLsLsmbLibL
ibLebLibLhbLgbLiLebLibLeLsbRjbRebRibRgbRibRhbRcbRcRsmbRebRgLsbRsRsmbRs
bRebRgbRsRsmbLsRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bRsLsbLsLsLsLsmmmbLibLsLsLsLsLsLgmmmmbLsLsLgmbLgLsLsmbLgLsLsLsmmbLgbLs
LsLsmmbLibLgbLgbLsLgLsLsLsmmbLgLsLsLsLsmmmbLgbLgLsbLsLsReRcmbRsbLsRsRs
RsmmbRsbRsbRsbRsbRgbLjbLhbLibLiLsbLibLibLgbLiLsLsmbLgbLibLibLgbLibLibL
gLsbLibLebLgbLibLibLgbLgRsRsmbLibLsbLibLibLibLibLgbLibLsLgbLibLsbLgbLs
bLibLibLgbLibLibLgbLgbLgbLgbLibLgbLibRgbRjRiRsmbRhRsmbRibRibRiRsmbRiRs
mbRgbLgbLobLibLgbLgbLgLibLebLibLhbRsbLebLgbLgbLgbLgbLibLgbLgbLsbLgbLgb
LibLgRsbLgbLgbLibLgbLiLsLibLibLgbLsbLibLibRibLibLjbLsbRjbLsbRhbRibRibR
gbRibRibRgbRibRiRsmbRibRibRibRgbRgbRgbRebRibRibRibRgbRgbRibRibRibLibLc
bLibLibLgbLibLibLibLgbLgbLgbLibLebLgbLibLgbLgbLgbLibLgLsbLibLhbLgbLibR
ibRiRsmbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bRiRsmbRebRiRsmbRhbLjbRsRsmbRibReRsmbRsbLsbLcbLgbLhbLsLsLsLgmmbLgLsbLg
LgLsLsmbLibLgbLebLibLoLsmbLeLsLsLsmmbLibLibRcbRebRcLsbLsbLsbLobLebLebL
iLgbLgLgbRgbRsRibRibRcRsRembRgbLhbLgbRob

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bLsbLibLgLsbLsbLibRsRsmbLjbLjbLibLjRsbReRsmbRsbRsRsRsmmbRsRsmbRsbRsbRs
RsmbLsRsbRgbRsbRsbLsbRgbRgRsmbLjRsbLibLhbLhbLcbLibLhbLeLgRsbLgbLibRgbR
cbLjbLhbLebLgbLibLgbLhbRgbLcbLiRsbLibLcbLebLiLsbLhbLebLgbLgbLgbLcbRibR
ibRebLhbLiLgRsLsbLibLsbRjbLgbLsbLgbRsLsbLgbLgLsbLibLsbLsbLsbLgLsbLsbRc
bRgbRibRgbRgbLcbLgRsbLibLibLgRsbLibLibLhbLhbLibLibLibLeLsbLsbRsRsmbRsb
Lgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bRhbLibLcbRgRsmbRibLibLhbRhRsmbRhbRiRsmbRibRcbRibRibRcbRcbRibLcbLibLob
LjRsbLhRsbLcbLeLsbLgbLibLibLsbLibLgbLgbLibLibLebRsLsbsbLgbLibRsbRsbLcb
LhbLhbLibLibLgLibLibLjLsmbLiRsbLibLibLeLsbLibLgbLibLibLibLibLibLgbLiLs
bLibLgLsbLgLgLibLgRsbLeLsbLebRsLebRiRjbRebReRsmbLiRsbLibRhRsmbRhbRiRsm
bRhbRebRibRhbRiRgbRibRjRsmbRcRiRsmbRiRgbRiRebRsRgbRgbRibLsLjbLjLhbLiLs
LsmbLgLsbLiLsbLibLibLibLiLsLsmbLibLiLsbLcbRsbRebRcbRcLsRsbRibRhRsmbRiR
smbRiRsmbRcReb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bRibLgbLgbLiLgbLibLibLgbLsLibRsLsLsmbLibLsLsmbLhLsbLgbLgbRjbLcbLibRjbR
hbRiRsmbRgRsmbRibRsbLcbLgLsbLhbLgLsLsmbLsLsmbRsbRsbLsLsLsLgmmbLgbLeLsb
LsbLsbLsbsbsbLsLgbLsbLgbLiLsbLgLgLsLsmbLgbLibLibLibLibLgLsLsLgmbLiLsbL
sLsmbLibLgLibRsbLjbLsLsLsmmbLibLsLsmbLiLebLgbRsbRebLebRcbRcbRibRsbLhbL
iLsbLebRsbRibRebLcLsmbRsRgbLhbLibLsRsbLgbLsbLsbLgbLgbRjRsmbRcbRhRsmbRs
bRibRibLcbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 19; Drug: Control Apo 50 然
bLobLobRebRebLobLebRsbLsbRibRebRjbRobLgbLjbLobRebLobLsRebRobLobLgbRobL
ebLebRcbLibRgbLibRebLebRobLgbLobLobRsbLebLcbRibRebRobRobRobLsbRgbLobRe
bLebLobLobRgbLobLobRibLebLcbLebLobRhbLobLebRebLobRobRebRjbLobLobLibRob
LebRebLebLgbLebLcbLobRebLebRobRsbRsbLsbRobLobRcbLobRobLebRibLjbRebRobL
cbLcbRcbRobLobLobRcbRebRobLgbRjbRcbRebLcbRobLebRibLsbLebRgbRgbLebRcbRg
bRebRhbLsbLcbRobLobRibRhbLebRobLobRobLobLcbLebRcbRebLobLcbLgbLgbRcbRgb
LebLobRcbRobLobLibRobLobLobLobLgbRcbLgbLebLobLibLcbLgbLobLobRobRsbRobL
ibLobRobLgbLobLibLcbLebRcbLebRobLjbLobLebRebLebRobRobRebRgbRobLobRobLo
bLebLobRobRobLobRobRebRobRebLobLobLobRcbLobLobRebRobLjbRobLsbRobRobLob
LcbLcbRcbLebLobLsbRsbLsbLhbRsbLcbRobRobLobLcbLobRgbRgbLebRcbLebLobLebR
obLobLobRobLcbLebLebLebRebLsbLobLcbRobRobLebLjbLebLsbLhbRebRobLhbRobRc
bRgbLebLobLebRobRobLebLcbLobRobRobLobLebRobLobLobRebRcbRebRebRcbLebLeb
LobRebLebLobRebLobRobLebRebRcbRgbRsbRebRcbLebRibRcbLcbLebRobLebRobRobL
obRsbRebLsbRobRobLobRcbRcbRobRibLobRgbLebLcbRobLobRobRhbRebRobLobRobRo
bLebRobLobRcbLobLcbLobRebRobLobRcbRibRcbRebLsbLebLebLcbLjbRobRobRebLsb
RgbRebRsbRebLobLibLebRobLobRobRobRibRebRobLobLcbRobLebLobRebLcbLebRobL
ebLcbRobLsbRcbLsbRebLjbLebRebLobRcbLjbLobLobRobLobLjbLobRgbLcbRcbRebLj
bLebLgbRcbLcbRobRebRebLobRobLcbLobRcbRobRobRcbLobLobLjbRebLebLebRobRob
RcbLobLebRsbRebLsbLsbRobRobRcLebLebLobRebLobLsbLobRobRsbLsbLebLsbRebRc
bLobLiRsbRsbRsbLsbRebLobRsbLsbLebLsbRsbRcbLjbReLsbRsbRsbRsbLjbLsbRcbRe
bRsbRsbRsbLobRsbLobRsbRobRsbRsbRobRsbLsLsmbRsLsbRsbRsbRsbLsbRsbRebRobL
obLsbLsbLsbRsbLsbRsbRsbLsbLsbLsbLobRsbRsbRsbRsbRsbRsLsLcbLsbRoLsbRsbLe
bRsbRebLobRsbRsbRoLsbLsbLsbLsbLebLsbRoLsbRebRsbRsbLsbLsbRsbLjbLsbRsbLs
bLsLsmbRsbRebRobLsbRsbRebLsbRsbLjbLsbLobRsLsbRsbLsbLsbRobRsbRsbRsbRsbL
sbLsbLsbRsbRsbLsbRsbRebLsbRsbLsLsmbRsbLsbLobRsbRsbLsbsbRsbRsbLsbLsbLsb
LsbLsbRsbRsbLobRsbLebLsbRsbLobLsLsmbRsbRsbLsbRsbRsbLsbLsbRsbLoRsbRsbLs
bLsbLsbRsbLobRsbRsbRsbRsbRobRsbLsbLsLsmbLsbRsbRsbRsbRsbLsbLsbRsbRsbLsb
RsbRsbLsbLebLebLsbRebRsRgbRsbRobRebLobRsbLobRcbRsbRsbRobRsbLsbRsbRsbLs
bRsbLjbLsbRsbRsbLsbLsbRsbRsbLsbRsbRsRsmbLobLsbRsbLsbLsbRsbLsbLsbRsbLsb
LsbRsbLsbRobRobLebLebLebLebLebLgbLgbRobRebRsbRobLcbLebRgbLcbLebRobLobR
jbLjbRobRcbLobRobRobLobRsbRsbRobLsbLjbLobLsbRebLsbLobLobLsbRcbLebLebRs
bRobRjbLobLobLsbLebRebLcbRobLjbLebLebRcbRcbLobRobLibRibRebRgbRobRebRob
LobRebRobRibLobLobLjbLgbLebRobRcbLobLobRobLobRebRcbLebLobRobLebLgbLcbR
ibRobLobLibRcbLebLebRobRobRebLgbRibRhbLobRebRobLobRobRobLobRobRebRgbLe
bLebLibLcbLebRgbRsbLsbRhbLobLsbLsbLgbLebLcbLebLcbRebRebRebLobRgbRgbLsb
RobLgbLobLebLcbLjbRsbRobLgbLsbRebLobLsRebLgbRebLebRebLebRsbRebLobRebRo
RebRsRsmbRebRebLobLebRcbRsbLebRebRobRsbRebLcbRebRobRobLebRobRsbLobRobR
sRebRebRib

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 20; Drug: Control Apo 50 然
bRebRoRsmbRcbRcbRcbLobLhbReRsmbRibRebRjRsmbLcbLiLsLsmbLgbLcLsmbRebRibR
ibRcbRibRebRebLcbLsRsbRjbRiRsmbRhbRibRsbLjbLiLsbLibRiRsmbRgbRcbRibRhRs
mbRibRebLcbLhbLibRcbRibRibRibRgbLjbLcbLebLibRjbRhbRcbLcbLebRjbLcLsmbLe
bRiRsRsRsmmmbRiLsbLjbLebRjb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 21; Drug: Control Apo 50 然
bLsbLsLsLsmmbLgbLsbLsLsmbLsLsLsRsmmbLsbLsbLsLsmbLsbLsLsLsmmbLgbRsbRsLs
bLsRsbLsLsLsRsmmbRsRsmbLsRsbRsRsmbRsRsRsmmbLsLsRsmbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 22; Drug: Control Apo 50 然
bLibLcbRebLebLhbLibRjbLcLsmbLibLhbRibRebRhLsbRebRcRsmbRiRgbRebLcbLibLi
bRibRcbRebLjbLjbLebRsbLibLsbRsbLcLsmbRjbReRsmbRgbLcbLhbLobRebRebRibReb
RhbRhbLcbLibLibLibLibLcbLibRsbRebRibRibRiLsbRibRgbRhbLgbLjbLcbLibLibRe
bRebRibLoRsbLgLsbRjbRibLcbRsbLcbLibRcbRiRsmbRibRebLcRsbLhbRcbRibRgbLcb
RebRibLebRhbRibRebRhRsRsmmbRgbRebRebRcRsmbRibRibLobLibLhbLcbLibLobRibR
ibRcbLebLibRebRgbRibRgbLcbRebRgbRibRibRebRebRibRibRebRobLcbLibLgbLibRe
bRcbRibRiRsmbLjbLibLibLcbLhbRobRhbRcbRibLcbRjbRgRsRsmmbRjbRgbLcbLibReb
RhbRsRibRcbRcbRibLobLhbLebLiRsbLcbRhbLsRibRibRebLeLsbRgbLibRebRebRsbLe
bLgbRgbRhbRibRibReb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 23; Drug: Control Apo 50 然
bRsRsmbRsRsRsmmbRsRsRsRsmmmbRsLsbRsbsbRsbRsRsRsRsRsmmmmbRsRsmbRsbRsRsR
sLsmmbRgLsbRsLsbRsRsRsRsmmmbRsLsbRsRsmbRsRgbRsRsRsmmbRsRsmbRsbRsRsRsRs
RsmmmmbRsRsRsRsRsmmmmbRsbRsRsRsmmbRsLsbRsRsRsmmbRsRsRsRsmmmbRsRsmbRsRg
RsRsmmbRsRsRsmmbRsbRsRsmbRgRsmbRsbRsbRgRsRsRsmmmbRsbRsRsmbLsRsRgbRgRsR
smmbRsbRsbRsbRsRsRsRsRsRsmmmmmbRsbLsRsbRsbLsbRsRsRsmmbRsbRgbRgRsmbRgRs
RsRsmmmbRgbRsbRsbRsRsRsmmbRsRsRsmmbRgbRsRsRsmmbRsRsmbsbRsRsRsmmbRgRsmb
RsRsmbRsRsRsmmbsbRsbsbRsRsmbRsRsRhmbLcRsbLibRebLobLebRsLsbRsbLcbLobRsb
RcbLhLobLhbLiLsLsmbLibLgLsbLsLsmbLgbLsLsmbLibLsLsLsLsLsmmmmbLiLgbLiLsb
Lib

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 24; Drug: Control Apo 50 然
bLsbRibRgbRibLcbLibLebLebLibLhbLhLsbLgbLhLsbLcbRsbRebRibLgbLeLsbLiRsbL
iLsbLibLcbLibRgbRcbRhbRgbRibRgbRibRgbLsbRhbRiRsmbRibLsRsbLibRcRsRsmmbR
ibRgbRsbRgbRsbRgbRiRsmbRiRsmbRgRsRimbRgbReRsmbRiRsRsmmbRgbRgbRibRgbRib
RsbRgRsmbRgbRibRsRsmbRgbRibRgRsLsmbRgRsmbRgbRibRsbRgbRibRgRgRsmbRgbRsb
RibRgRsmbRsbRibRgbRsbRgbReLsbRgRsmbRiRibRgbRgbRgbRiRgbRsbRgbRgbRsbRgbR
sbRsRgRgbRgRhbRebRgbRhbRiRebRhbRebRhbReRsRsRemmbLsbRgbRcRsmbLcbLebLgbR
hRsmbRiRgRsmbRiRsmbRebLibLgbLiLsLsmbLgbLibLgLsbLibLibRgbRibRibRsbLibLi
LsbLibLiLsbLgbRhbRibRsbRgLsbRgbRgbRgRsmbRibLibLcbLibLibLibLiLsLgbLsbLs
bLebLgLsbLiLibLebLibLsbLibLeLebLeLhLgbLebLgLsLsmbLgbLsbLsLsmbRsbLsbLgb
LibLhbRsbLgbLsbLsbLsbLsLsmbLibLgbLgLsbLgbLibLgbLgbLebLibLibLgbLeLgLsbL
iLsbLiLgbLibLgbLiLsLibLibLsbLhbLebRsbLgbLsbLeLsbRsbLebLgbLgbLgLsLsmbLe
bLebLebLebLibLsbLgLsbLgbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bRebLsbLgbLgbRsbLsbLgbLgbLsbLcbRibRibLgbLgbLebRhbLcbLhLsbLhbLsbRebLebR
ebRsbRcLsbRsbLibLcbLebRsbRhbRsbRoRsmbRgbLhbLebRsRibRebRgbRsbLgbLcbLebR
ibLebLobRcbRhbRhbLhbLebLgbRibRibRiLsbRsbRibRiRsmbRibRgbRibRgbRhbRibReR
sRsmmbLsbLgbLgLgbLgLsbLgbLgbRiLsbLsbLiLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
bLgbLgbRsbLhbLhLsbLgbLgbLibLibLibLibRgbRhbRibRgbRgbRibRibRibRobLcbLebL
gbRsLsbRjbRebRibRcbLsbLgbLibLgLsLsLsmmbLibLgbLiRsbRsbRsbRhbRobLgbLsbLs
bLiLsbLibLgbLgbLibLgbLgbLibLibLibLiLsLsLsmmbLibLgbLjRsbLsbRsbLibLibLgR
sbRcbRibRsbRiRsmbRsbRsbRibRibRcRsmbRibRibRgbRibRcbRhbRgbRibRgbLgbLibLi
bRjbRiRsmbRibRgbLsbLjbLhbLiLsbRsLsbLhbLiLsbLebLiLsbLibLgbRsbRibRjRsmbL
sLsRsmbRibRsbRiRsmbRhbRsbRhbRibRgbRebRgbRgbRsbRsRsmbRibRsbRgbRgbRgRsmb
RgbRgbRibLjbLibLsLsmbLibLgbLibLgbLgbLgLsbLiLsbLiLsbLibLgbLgbRiRsRsRsRs
mmmmbRibLgLsbRibRibRibRibRibRgbRsbRibRgRsmbRibRiRsmbRgbRibRgbRgbRgRsmb
RgbRgbRgbRsRsRsmmbRibLgbLjbLhbLgbLiLsbLgLsRsbRsLsLsmbLiLsLgbLiLsLsmbLi
bLgbLibLgbLjLgbLgLsbLibLgLsbLibLgbRsbLibLiLsLsmbLsLsmbRsbRjbRibRgLsbRg
RsmbRhbRsLsRsbRibRgbRgbRgbRgbRgbRgbRgbLjLsmbLibLgbLgbLibLibRsRsmbLibLs
LsmbLeLsLsmbLebLeRsbLcLsmbLcLsmbLhbRhbRcbRiRsmbRhbRobLgbLgbLsbReLsRsbR
ibRgbReRsmbRhRgbRsRsmbRhbLsbRiRsmbRhbRgbReRsmbRibRhRsmbRsbReRsmbRiRsRs
mmbRibRibRgRsmbRibRgbLsbLjLeLibLsbLgbLibLgbLiLsbLgbLibLgRsbLiLgbLgRsbL
sLgLsLsLsmmbLibLsbLiLsLsmbLgbLibLgbRcbRibRgRsmbRsbRiRcbLgLsbLebLebLgbL
gbLeLsbLgLsbLiLgLgLsbLgbLibRsbLiLsbLsLgLsbLsbRjbRsRjbRibRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bRsRsRgRsRsRsRsRsRgmmmmmmbRgRsmbRgbsbRgbRsRsmbRsRsmbRgRsRsmmbRgRsmbRsR
smbRsRsRsmmbRsRsRsmmbRsRsRsRsRsmmmmbRsRsmbRsRsRsRsmmmbRsbRgbRsRsmbRgbR
sRsmbRsRsmbRsbRsRsRsRsmmmbRsRsRsRsmmmbRsRsLsmbRsbRsRsRsmmbRsbRgbRgRsRs
mmbRsRsRsLsmmbRgbRsRsRsRsmmmbRibRsbRsbRsRsmbRsRsmbRsRsRsmmbRsRsmbRgRsm
bRsRsmbRsRsRsRsmmmbRgRsmbRsRsRsRsRsmmmmbRsRsRsRsRsmmmmbRsbRgbRgRsRsmmb
RsRgRsmbRsbRsRsmbRsRsRsmmbRsRgRsmbRgbRgRsmbRsRsRsRsmmmbRgbRgRsRsRsRsRs
mmmmmbRgRsmbRsRsmbRsRsRsmmbRsbRgRsmbRsbRsRsRsmmbRgRsmbRgbRgbLsRsRsRgRs
mmbRgbRgRsRsRsRsRsRsmmmmmmbRgRsRsmmbRgbRsRsRsmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bRjbRgbRgbRsbRsbRsbRsbRsRsmbRgLsLsmbRsLgbLibLibLgbLsRsbRsLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bLgLsbsbsbRsLsLsLsmmbLsbLsLsmbLsLsmbLgLsbLgbLsRsbLiLsbLsLsLsmmbLsLsLgm
bRsLsLsmbLgLsbLgbRsbLsLgbLsbLgLsbLsbsbsbsbRsbLgbLsLsLsmmbLgLsbRsLsbLsL
sLsLsLsmmmmbLsLsmbLgLsbLsLgbLsbLgLsbLgbLgLsbLgLsbLgLsbLgbLsLgbLgLgRsbL
sLsmbLgLsLsmbRsLsLsLsmmbLgbRsbLibLcRsbLibLoLsmbLhbRjbRobRebRobRcbLjbLc
bLoRsbRiLsbRibRhLsbRcbLobRjbLibLgLgbsbLibLgLsRsbLiLsbLgbLgbLsLsLsmmbLs
LsLsmmbLgbLsLgLsbLsLgbLiLgbLsLsmbLgLsLsmbLsbRsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bRcbLibLcLsmbLcbRibRjbRibRjRsmbRsRsmbRsbsbLsbRsRsLsmbLsbRibRjb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bLcLsmbLiLsRsbLobLibLcLsmbLiRsbLhbLeLsbLibLgbLibRgbLobLsLsmbLcbLibRibR
hbRobLsbLsbLcLsmbLibRebRcbLsbRebRiRgRsmbReRgRsmbRoRsmbRhbLcbLibLcbLgbL
iLsbLibLsbLibLgbLibLsbLebLiLhbLgRsbsbLsRsbRsLgRsbLiLsbLgbLiLsbLgLsbLgb
LgbLgbsbLgbLgbLgbLgLsbLgbLibLgbLgbLibLgLibRsLsLcLsmbLiLsLiLsbLcbLibLeb
LibLgbLcbLcbLgbRcbRibLcRsbRibRibRgbRiRgbRobRhbLobLibLibLgLhLsbLhbLiLsb
LgbLiLgLsLibLgLsbLgLsbLgbLeLsbLgRcbLeLsLsmbLgbLhLsbLeLsbLgbLhbLibLgLsb
LeLsbLhLsbLiLgbLebLgbLgRsLsbRsRsmbRsbRsLsbLsbLsbRsbLiLsLsRgmbLgbLiRibR
eRsmbRgbRsbLhLsbRjRsRemb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bLhbRibRgbRgbRgbRsbRgbRebLibLibLgbRsbLibRsbRgbLjbLgbRgbRibRgbRibLibRib
RibRibLsbRibRgbRgbRibRgbRibRibRgbRsRsmbRgbRgbRgbRibLgbLsRiLsbRgRibLsbR
gbRibRgbRjRsmbRgbRhbRibRgbRgbLcbRibLgbLgbLibLibLibLibRibRjbRibRgbRsLsb
RibLsbRibRibRibRebRjbRiLsLsmbLgbLibLibLibLibLgLsbLsLgbLibRgbRjbRibRiRs
mbRgRsRsmmbLjbLjbLiLsbRjbLgLhbLjbLibLgbLiLgbLibLgbLgbLibLgbRibLgbLibRg
bRjbRebRgbRgbRibLsbLgbLjLsmbLebRibLhbRgbRgbRibRibRgbRgbRgbRgbRgbRibRib
RgbRibRgbRibRibRibRgbRiLsbRibRibRibLgbLjbLibLibLibRgRsmbLsbRibRibRebLh
bRcbRibRibRgbRgbRibRiRsmbRgLsbLebLiRsbLiLsbLcbLibRjRjbRibRibLsbRibRgbL
cbLibLgbLgbLgbLibLgbLgbLjLsmbLgLsbRobLsLgbLibLgbLibLibLebLibLjLsmbRcbR
ibRibRgbRgbRibLgbRsRiRsmbRgbRgbRgbLjbLcbRgbLiLsbLiLgLgbLiLsbLsbLgbLgbL
gbLhLsbLebLgbLgbRjbRhLsbLjbRjRsmbRhbRhbRibRibRibRgbLebRgbRibRibRgbRibR
gbRgbLibLibLhbLgbLgLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bRgbRibLsbRibRibRcbRgbRibRcbRibRgbRebRibRgbRibRibRgbRsbRgbRibRgbLsReRs
mbRibRgbRibRgbRgRsmbRibLjbLibLsbLgLsbLebRjbRibRibRsbRibRsbRgbRibRgbRgb
RsbLgbRsbRibRgbRgbRibRibRibRgbRibLoLsmbLibLgbLhbLebLhbRsbLibRjbRebRgbL
jbLcbLgLsbRobRibRgRsmbRsbRgbRgbRsbRgbRgbRsbRsRsLsmbLobRgbRsbRgbRsbRgbR
sbRgbRgbRsbRsLsbRsbRsbRgbRibRgbRgbLsbLobLebLibLsbRcbLibRjbRjLsbRebRgbL
jbLjbLibLibLgbLibLibLsbLebLgLsbRsbLgLsbLgbRsLsbRsbRibRgbRgbRgbLsbRgbRg
bRsbRsRsmbRgbRgbRibRsbRibRgbRgbRcbRgbRibRibRiRsRsmmbRgbRgbRibRgbRobRiL
sbLcbLibLgLebLgbLibLeLsbLebRobRibRgRgRsLsmbRibRibRgbRsRsmbRebRgbRiRsmb
RgbRgbRebRgRsRimbRebRgbRhRibRgLsbRgbRgbRebRibRiRsmbRebRsRgReRhRsmbRibR
gbRibRgbRgbLjbLibLgbLgbLgbLgbLgbRsbLgbLgbLgbLgbLgbLgbLgbLibRgbLibLibLg
bLibLibLibLgbRsbLcbLgbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bRsbLsRsbLebLsbLsRobReRsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bLjbRhbRhbRiRgRsmbRibRhRsLsRsmbLcbLibRobRibRiRsmbRiRsmbRobRibRcbRibRib
RiLsRsbRibRcbRhRsmbRibRiRsmbRebRiRibRebLsRsbRgbRibRibRhbLiLibRjbRhbRib
RiRsmbLcbLhRsbLiRsbLsbLgbRcbRibRhbRhRgRsLsmbRgbRibRgbRgbRibRibLcLsRsmb
LibLiLhbLiLiLgLsLiLeLhLebLcLsmbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bRsRgRsRsmmbRsbRsbRsRsmbReRsmbRgbRgRsmbRgbRgRsRsmmbRsRsmbRgRsmbRsbRgbR
hRsmbRebRgRsmbRsbRsLsbRibRgbRsbRiRsmbRsbRgbRsbRsbRebRgbRcbRgbReRsmbRgb
RgRsmbRebRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bRgRsmbLjbLgbRibLjbRibLgbRsRsmbRibRcbLibRjbRibRibRcbRsLibLobRjRsmbRjbR
ibRgbLsLsmbRibRebRibRhbRsbRiRsmbRcbRgbRibRibRgbRcbRsLiLsbLibLibRjbRiRi
bRibRcbRgbLsbLibLhLsbLiLibLhbLiRsbLhbLgLibRcbRibRibRibRibRgbRiLsbRcbRh
bRebRiRsmbRiRsmbRhbRiRsmbRgbRcbReRiRsmbRibRibRiRsmbRsbsbLsbRgbRiRsmbRg
RsmbRibRgbRgRsmbRsRsRsmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
bRebLsbRsbRcLsbRiRsRsmmbRgRsmbRsbRsbRgbRibLhbRibRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
bLcbLebLibLebLebLebLcbLgbLcRsbLebLebLebLhbLobRsbRibRibLgbLjbLcbLibLcbL
hbLibLibLsbLsbLibLebLibLibLibLibLsbLibLgbLebLibRsLebLhbLibLsbLcbLhbLib
LibLhbLiLsbLgbLhbLgbLibRgbRgbLibLgbLiRsbLibLebLgbRsRcRsmbRibRgbRgbLibL
ebLgbLgbLcLsmbLgbLiRsbLebLebLhbLibLsbRgbLibLibLsLgbRjRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 43; Drug: Control Apo 50 然
bsbLsLsLsmmbRsRsLsLsmmbLsLgbLsLsLsLsLsmmmmbLgLsbLsLsmbLsbLsLsmbLgLsbLs
LgbRsLsLsmbLsLsmbsbLsLgLsbLgLsbLgLsLsmbLsbLsbLsLsLsLgLsLsLsLsmmmmmbLsR
sbLsLsmbLsbLsbLsLsLsmmbLsLsLsLsLsmmmmbLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 44; Drug: Control Apo 50 然
bLsbsbLsbLsbRsbRobRsLsbRsbLsbsbRsbRsbLsbRsbRsbRsRsLsmbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 45; Drug: Control Apo 50 然
bRsbRsbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 46; Drug: Control Apo 50 然
bLebLiLsbRcbRgbLjbLgLgbLgbLibRgbRgbRibLjbRebRibLebLsRsbRibRiLsbLiLsbLg
LsbLgbLgbLgbLibLgbLibLgbRjbRiRsRsmmbRiLsbRhLsbRsbRibRgbRiRgbRgbRibRibR
ibRgbRsbLiRsbLsLsLsmmbLgbLgbLibLgbLgbLgbLibLibLgbRjbRibRgbRibRjbRibLjb
RiRgbRgbRiRsmbRhbRebRebRgRsmbLgbRsbRsRebRgRebRebRcReRgRsRsRgRiRiRsRsmm
mmbRebRgbReRsmbRiRsmbLsbRsRsmbRgbRibRsRsmbRsbRiRsmbRiLsbRhRsmbRgbRibRi
RgRsmbRsbRgbRsbRiRiRsmbRibRsbRgRibRiRgbRhbRgRgbRibRgbRiRsmbRsbRsbRgRsm
bRgbRsRsmbRgbRgbRgRsmbRgbRgbRsbRgbRgRsmbLsbRibRiRsmbRsRsmbRebRgbRgRsmb
RgbRgbRgRsmbRiRsmbRibRgRsmbRibRsbRgbRgbRibRgRsmbRiRsmbReRsRsmmbRibLsbR
ebRsbLsbRibRobLsLiLsbRjbRjRsmbRebRgbRibRiRsmbRgbRibRgbRsbRgbRgLsbLsLsm
bReRgRhbRibRsRiRsmbRsbRibRgRsmbRgRsRsmmbRgbRgRsmbRiRsRsmmbRgbRgbRgbRgR
sRsmmbRsbRgbRgbRebLgbLgbLibRjbRjRsRsmmbLjbLjbRhbRgRsRgmbReRsRsmmbRgbRg
bRibLjLsmbLibLgbLibLibRsbRjbRibRsRsmbRiRsRsRsmmmbRsbRgbRsRgRsmbRgbRibR
ibRibRhbRibRgbRgbRgbRgRsRsmmbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 47; Drug: Control Apo 50 然
bRgbRsbRsbRsbRsbsbRsbLsRsbRsLsbRsLsbRsRsmbRgbRsRsRsRgmmbRiRsRsRsLsmmmb
RiRgbRibLoLsLsLsmmmbLcbLhbLeLsbLhLsbLsbLibLgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115417; End: 115917;
Recording: 2-1; Individual: 48; Drug: Control Apo 50 然
bLebLcbLgbLgbLibLebLsbRjbLibLeLsbLsbLebLebLcbRgbLebLhRsbLebLcbLhbLcbLg
bLeLsbLgbLeLsbLebLebLebLebLcbRjbRibRibRobLebLebLebLgbLeLsbLeLsbLcbLibL
hRsbLebLhLsbLsbLgLsbLeLsbLsbLcbLcbLeRsbLeLsbLeLsbLcbRhRsmbRjRsmbRsRibR
sbLcbLcbLhbLibLiLsbLcbRibLhLsbLibLibLebLeRsbLebLebLcbLiLsbLebLgLhbRjbR
jbRjRsmbRgRsRsmmbLiLsbLibRjbLjbLeLsbLebLgLsbLebLibLibLeLsbLgLsbLiLsbLh
LsbLhLsLsmbLgbLibLhbLebLibLgLsbLgbRibLcb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
bLibLibLcbLhLsbLsbRibLcLcbLhbLcbLcbLiLsLsLhmbLebLcLsmbLgbLcbLibLgRsbRc
RsmbRsbRhbLebLgbLiLsRsbLiLsbLiRsbRhbReRsmbRiRsmbRiRsRsRsRsmmmmbRgLsbRi
bRsbRgRsmbRcbLhbRebRcbRiLsLsmbRhbRhbLcbLibLibLibLiLsbLibLiLsLebLebLebL
iRsbLebLebLgbRhbRgbLgbLgbLsbLibLsbLcbLgbLhbLiLsbLibLgLgbLgLsLgbLiLsbLe
LhLsbLibLiLsLiLsbLgRsbLobRhbRebRiRgbRhRsmbRiRsRsmmbRibRibRibRibRgbLjbL
cbLibLgbRsbRhbRcRsmbRsbRebRgRsmbLibLiLsbLibLeRsbLgbLsLeRsbLsLsmbLgLebL
gLgbRcRsRembRgbRiRsmbLibLeLebLibLibLgbLebLibLibLiLibLiRsbLgbLiLsbLiLeb
LibLiLeLebRsRsmbLsRsbLsRsbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bLebLibLgbLgbLcbLibRjbLibRibRibRibRcbRcbRgbLeLsbLebLibLebLcbLhbRgRsmbL
iLsbLebLiLsbRgbLcbLcbLebLibLcbRhbRibRjbRibRcRgbRibLjbLhbLibLibLsbLibRi
bRibRhbRebRebLebLebLiRsbLibLibLcbRsbLjbLibRcbRiRsmbRibRhbRiRsmbRibRhbR
gbLcbLibLibLibLcbLibLcbLgbLgbLhbLjbLgbLibLiLsbLsLsmbLibLebLibRcbRibRib
RiRsmbRgbRgbRibRebLoLsLsmmbLcbReRsmbLibLsRsbRcbRjRsmbLibLhbLebLgRgbReR
smbReReRsRsmmbLcbLcbRhbRjbRibRgbRibRgbRiRsmbLibLjbLibLgbRibRhbRiRsmbRi
RsmbRiLsRsbRgbRsLsbRibRcLsRsbRgbLibLhbLibLibLibLcbLsbLibLobLhbLhbRhbRc
bRhbRgbRibRgbRgRsmbLiLibLgbRjbRhbRibRibRsLebLhbLibLibLgbLibLibLhbRcbRi
bRibLgbLhbLibLhbRibLiLsbLhLsbLcbRjbRcbRibRsbRibRsRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bLebLcbLoLsLsmmbRjbLgLsbLgbLgbLgLsLsmbLibLgbLsbLsbLsbRiLsbRcbLjbLiLsbL
gbLiLsLsLgLsmbLhLsbLibLibLiRsLsbLoLibLcbRhbRcRsRsmmbRhLsRsbRoRsmbRhRsR
smmbRiRsRsmmbRjbRibLibLiLsbLcbLebRgLsbLebRsbLibLsbLsLeLsLsmbRsbLeRgbLg
bLsbLeLsLsLsLhLimmbLebRsbLibLebLiLeLgbLiLgLsLsLsLsmmmbLgLsLsmbLgbLsLsm
bLgLeLebLibLiRsbLsbLjLsmbLsbLsLsmbRjLsRsbRebRibRsbRsbRgbRsbRhbLcbLcbRs
bRsbLsbsbsbRobRhbRibRsbsbLsbLsbRsbLsRsRsmbLcbRgbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bLsLsmbLjRsbRgbRcbRibRgbRgbRgbRgbRibRsbLjbRjbLgLsLsRsmbLsbLsLsmbLgbLsR
sbLsLsmbLgbLsLsmbLgLsbLsLsLsmmbLgRsbLgbLgbRsbLsbLgRsbLgbLgbLsbLsLsmbLg
bLsLsmbLsLsmbLgLsbLgbRgbRebLibLgbLgbLgbLsbLgRsbRgbLgbLsLsmbLgbLgLgbLsL
smbLsLsLsLsmmmbLgbRsLsLsLsmmbLgbRsLsbLgbLgbLgLsLsmbLgLsbLgLsLsmbLsbLgb
LsbLgbLgbLgbLgRsbRsRsmbLgbLsLsmbLgbRsLsbRsLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bLsbLsLsRsmbRcRgRibRsRsmbRiRsmbRhRsRiRsmmbRibRibRibReRiRibRcRsRsmmbReR
smbReRsRsRsmmmbRebRebRebRebRgbLgbLibLibLibLcRsbLgbLhLsbRsbLhbLsbLibLcb
LibLcbLibLibLhbLhbLiLsbLibLibLibLgbLgbLcbLgbLsbLcbLgbLibLibLibLgLgLhLs
bLgbLgLsbLibLibLsbLsLsmbLsbRsbLsbLsbLsLsmbLsbLsbLsbLibRsRsmbLebLgLsbLi
LsbLgbLgLsbLsbLiLsbLibLsbLgbLebLsbLsLgLsbLsbLsbLsbLsbLgbLgbLsbLgbLsbLs
bLgLsbLsbLgLsbLsLsmbLsbLsLsmbLsbLsbLsbLsbLsbLgbLgRsbLgbLsbLebLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bLgbLsLsmbLsLsmbRsbLsbLsbsbLgbLsLsLsmmbLgLsbLiLibLibLiLsLsmbLsLsmbLhRs
LsbLsRsbLsLsmbLhbLsbLibLsbLgRsbLjRsbLibLgLsLsmbLgLsLsmbLgRsbLsLsmbLsbL
sRsbLhbLibLsLsmbRsbsbLsbLgbLgRsbLeLsLsmbLsbLsbLeLsbLsbRsLibLsbLibLgbLs
bLgLgbLeLsbLsRsLsbLsRsbLgbLgLsRsLsLsmbRsLsRsbLsLsLsLsmmmbLgbLsLsLsmmbL
sLsmbRsLsbLgLsbLsbLsLsmbLgbLgbLgLsbLsbLgLsbLgbLjLgLsbLsbLgbLgbLgbLsLsL
smmbLsLsmbLgbLgLsbLgLsbLsLsLsmmbLsLsmbLgLsbLgbLgLsbLgLsbLgbLiLsbLgbLib
LgbLiLsbLibLgbLhLgbLhLsbLibLcbLgbLcbLiLsbLsbLsLsmbLiLsLsmbLsbLsbLsbLgR
sLsbLsRsbLsbLgLsLsmbLsbLsbLsbLgbLgbLsbLsbLgLsbLgbLsbLgbLsLsmbLsbLsLsmb
LgbLsLsmbLgbLgbLgLsLsmbLgRsLsbLgLsbLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bRebLcLsLsmmbRgLsbLcbRgbLeLsbLebLcbLebRibRibRgbRsbRgbRgbRsLsRsbRsLsbRg
bLsbRgRsmbLobLsbRgbLebLcbLsLsmbRiRibRsRsRsmmbLjLsmbLsRcbLeRsbRhRsmbRib
RsRgbLibLcbRsRsmbRgbRgbRsRsmbRibRgbLcbLcRsbRjbRgbRgRsmbRgbLebLebLebRob
RibRcbRebRebRebRebRcbLeLsbRgbLeLsbLcbRhbLjbLebRgbLsbLebLsLsRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bRgbRgLsbLeLcbLgLiLgLsLsLsmmbLgbRibRiRsmbRiRsmbRiRsmbLsbLjbLcbLibLgbRj
bLcLsmbLcLsmbLhbLobLibLibLcbLebLgbLgLsbLiLgbLiLhbRsRcbRcbRsRhbRgLsbLcb
LcbLgbLgLsbRsbRjRgbRhRgbRhbRcbRcbRiRsmbRebRhRsRsmmbRebRcbReRsmbRhRibRh
bRsbRhbRgbRibRebRgbRoRsmbRebLcLsmbLiLsLsmbLhLsLsLsmmbLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
bRjbsbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
bLobLsbRjbRsRsmbRebRobRobLebLobLobLebLsbLebRcbRcbRebRsbRobRcbLobRsbLjb
RebLsbRebLebLcbLebLobRibLobRsbLcbLebLobRobLcbLibLebRobLgbLibRobRobLobR
ebRebLobLcbLobLgbRebLobLcbLebLobLsbRgbRobLobLobLcbRobRobRobRibRcbRgbLc
bRibLgbLobLcbLhbLobRobRibLobLobRobLobLobLcbLebLcbRsbLobRobRobLobLobRob
LcbRsbLobRobRobLobRobLcbRobRebRobRcbRibRobRobLibRibLobRebLebLobLobLobL
ibLebRgbRgbRebLobLobRcbLcbRgbLobRcbRhbRibRgbRibRobLebLcbRobRebLobRcbRg
bRgbRibRcbRjbLebRebLobRcbRgbRhbLebLobLebRebRobRobLibRobLebLobLibLobReb
RobLebRebLsbRebRgbLibLebLebRcbLobRcbRobLibRcbLebLobLobLebRebLobRgbRhbL
ebLobRobRobLobRobLcbLobLobRobLebRobLobRebLibRcbLebRobRobLobLobRebLebRo
bLibLebRobRsbLsbRebRobRobRobLibLobLcbLobRobRibRhbRebRobLcbRobRobRobRcb
RobRobLebLcbRcbRgbRcbRobLsbRobRobRobLcbRjbRebLobRcbLobRobRobLibLgbLobL
cbRcbRebLebLibRgbRebRobRcbRebRobLebLobRibRobLcbRobLobRebLcbLibLsbRobLo
bRgbRsbRobRhbRobLobLebRcbLcbLobLobRebLobLcbRobRsbRobLobLobLobRsbLobReb
LobRobRcbRjbLcbLibRibLcbLebRibRobRcbLobRgbLibLobRobLobLibLibRebRcbLobL
hbLcbRobLebRsbLobLobRcbLcbLobRobRobLebLebLebLcbRgbRhbRcbLobLsbLobRcbLg
bLebRobLobLebRobRobLobRcbLibRibLobLobLebRcbLcbRebLibRcbRobLsbLsbRsbRob
RebLsbRobRcbLgbLebLebRcLebRobRobLobRobRcbRgbLgbLobLjbRebLebLobLjbRcbRe
bRobRobLobLgbRebLsbRsbLobRsbLobRsbRsbLobLsbRebLebRobRebLsbRobRobRsbRsb
RobLsbLsbLhbRebRobLobRibLebLebRobLebRobRgbRsbLobLjbLebRcbLibRgbLhbLobR
gbLcbRebLebRjbRobRgbRjbRcbLobRcbLcbRobRobRcbLobRobRobRibLobLibRsbRobLe
bRobRobRebRsbRobLcbRebRobLibLsbRobLibLobLibRcbRobRcbRobLebLobRobRcbRob
LgbLebRobRsbRebLobLebRibRebRobLobLibLobRobLcbLobLobLebRobLgbRebRebLobL
obLobRobRibLgbLgbRsbLobRsbRobRobLsbRibRcbRobRobLoLsRsLsmbRobLobRsbLobL
obLobRobRsbLjbLobRobLebLibLobRsbRobRibRibRebLebLebLebLhbRobLibRcbLibLo
bLcbRsbRobRhbRebRcbRgbLobLcbRobLobLcbLibLobLebRsbRsbRobLcbRibLibRgbLeb
LobRibRobLobRibRobLobRsbLsbLebLcbRsbRobRobRebLebRobLsbRobRibRsbLsbRebL
ebLobRobRjbLjbRcbRjbLobLobRobLcbLobLgbLsbRsbRsbRobLebLsbLebLebLsbLsbLj
bLebRcbLobLsbRsbRcbRjbLcbRobRsbRebLobRsbRobRsbRsbLcbLobLobRsbRjbRobLhb
RobLsbRcbRobRsbLebRsbLobLcbRebRobLjbRsbLsbRsRebRobLobRebLobLobRsbLebLj
bRebRebLcbLsbLjbLebLebLobLebRebLebLsbRebRobRgbRobRsbLobLobRobRsbLsbRhb
LjbLcbRebLgbRjbRobLobRgbRobRobLcbLcbRsbRobLebLebRebLobRobLebRobLjbRsbR
obRebLsbLobLcbRsbLobRgbLobLobLebRcbRobLcbLobRobRebRobRebRobLcbRobRebLo
RsbLgbRgbRobLsbRsbReLsbLsbLsbRobRobRebLobRsbLebLsbLsbLobLobRobLebRsbRo
bLobLcbRcbLobLebLobLgbRebLobRobRebLobLjbRebLsbRsLsRsLsLsRsLsLsmmbLsLsR
sLsmbLsRsLsRsLsRsLsRsLsbRsRsmbLsRsLsRsRsLsmbLoLsRsRsRemmbLebLcbLobLobR
sbLsbRobLgbRobRebRgbRobLebLobLcbLobRobRcbLobLcbRgbLobRobLebRgbRobRibLc
bLobLcbRebLgbRcbRebLcbRobRobLgbLobRsbLgbLgbRsbLgbLibLebRebRobLob

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bLcbLibLobLibLjLjbLsbLsLjbLhbLibRcRsmbRcbRobRiLsRsbRibRobLsbReRgbRgbLe
RsbLibLibLsbLebLibRhbReRsmbLcbLcbRcbRhbLhbLjbLibLgbLhbLsbLgbLibLobRibR
jRgbRcbRibRibRcbLsbRebRcbRibRibRcbRibRhbRhbRhbReRiRibRobLebRjbRebRibRg
bRibLgbRibLsbRibRiRsmbRsbRcbRgLsbRgbRgbRgbRebRibRjbRcbLjbLcbLibLibLibL
gbLobLibLhbLibLhbLiLsbRcbLeRsbLebLibLsbLsLsmbLgLsbLgbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
bLjbLcRsbRoLsbLebLcbRobLeLsbLjbRcbReRsmbRcbRcbLoLsmbLcbLcbLgbLcbLiLsbL
gbLsLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bRgRsmbRibRiRibRiRsmbRibRgRsmbRgbRgbRgLsbRibRgbLobRiRsmbRibRgbRgbRgbRg
bRhbRebRebLsbLsbLsbRgbRsbRsbRsbRsRsmbRsRsmbRgbRsbRsbRgbRsbRsRsmbRgbRsR
smbLgRsbRsRgbRgbLibLcbLibLiLsbLibLibLgbLgbLibLsbLhbLiLsbLhbLibLgbLgbLh
bLiLsbLgbLeLsbLebLgbRjbLibRjbLsLgbLcbLibLibLibLgbLebLebLibLgLsbLsbLebL
gbLibLebRsRjbRcLsbLhbLibLgbLhbLiLsbLebLibLebLibLgbLgbLgbLeLsbLebLiLsbL
ibLhbLgLsbRjbLjbLobLjRsbLebLcbLsbLgLsbRjRjbRcRsmbRiRsmbRgRsmbRgbRgRsmb
RibRgbRebLiLsRsbLibLsbRiLsbLebLibLibLebLebLsbLebLebRjbRiRsmbRgbRgRsmbR
jLsbRiRsmbRsbRiRsmbLsbLjbLiLibLiRsbRibRgbRgbRibRgbRgbRibRsRsmbRibRsbRi
bRibRgbRgbRgRsmbRhbRgRsmbRgbRgbRgRsmbRgbRibRgLsbRiRsmbRiRsmbRiRsmbRgRs
mbRjLsbLjbRibRhbRhRsmbLgbLgLibLgbLibLibLgbLgbLgbLibLgbLhbLhbLebLibLgLs
bLibLebLiLsbLgbLgLsbLibLgbLhbLibLebLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bLgLgbLibLhbLhbLobLibLebLibLibLsbLcbLebLebLgbLgbRcbRcbRobRgbRsRcbRcbRg
bReRsRembRgReRsmbRebRgRgbRebReRgbRjbRsbLibRgbReRhRsmbRebRibRsRsRgmbRiL
sbRsbRibReRgbLobLebLiLibLgbLhLsbLgLsLsmbLgbLibLgbLsbLebRgbLgLsbRgbRgbR
gRsmbRebRebRsLsLsmbRsbRebLobLiLibLiLhbLiLsbReReRgRsmbRcRsmbLcbLcbRsbLc
bLebLibLgLgLebRhbRebRebRsbRebRebRebLcbRebRebRebRibRebRiRsmbRsbLsbRobRg
bRibRiRsRiRsRsRsmmmmbRiRsmbRhRsmbRiRsmbRgbRibRgbRibRibRibLcLcbLibLgbLg
bLcbLiRsbRibRgReReRibRebRiRsmbRhbRibRebRhbRibRhbRibLibLsbLoLsmbLiLsbLi
bLibLgRsbRibRibRiRsRembRgbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bRjbRsbLsRsbLibRsbLjbLiLsbLgbRsbRsbLsbLcbLebLibLgLsLgbLeLsbLgbRcbRjRsm
bRebLsbLsLsLsmmbRsRsmbLsbRjbRhLsLsmbRhbLibRcbRibRebRiRsLsLsmmbRhRsmbRe
RsRsRsmmmbReRsRhRsmmbRgbRibRiRiRsmbRgRsmbRgbRiRsmbRiRsmbRhRsmbReReRsmb
RibRibRgRsmbLhbLgbLgLsbLsbLibLibRsReReRibLsbRjRsmbRgbRgbRgLsbRsbRibRib
RsbRgRsmbRgbLgbLibLgLsbLgbLgbLgbLgbLgbLgbLgbLgbLgLsLsmbLgbLibLgbLgLsbL
gbLgbLgbLsbLgbLgbLsbRsRsmbLsbLsbLgbLibLgbLibLsbLsbLsLsmbLsbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bLgLsLsmbLeLsbLcRsLgbLhRsLsbLiRsbLibLibLgbLibLibLiLsbLiLebLgbLsbRibLcb
LibLgbLgbLgbLgbLgbLgbLiRsbLgbLhbLjbLibLibLiLsLiLebLebLiLsbLsbReRsmbReR
smbRgbRjbRjRsRsRsRimmmbRjLsLsmbRibRibRgbRhbRibRibRhbRibRibRiRsmbRcbRib
LjbLibLiLsbLgbLgRsbLgbLgbRjbRibRebRebRcbRibRjbRibRhbRibRhbRebRibRibReR
ebRhReRsmbRiRsmbRhbRsbLcLsmbLcLsmbLsLcRsLgbLibLibLgbLgbLgbLibLhLeLsbLs
LebLeLsbRsbLsbRjbRsbRebRibRibRcbRibRhbLjbLjbLibLgbLgbLhbLibLiLcbLcbLgL
sbRcLsRsbRhbRibRibRhbRebRibLjLcbLibLhbLgbLgLibLeLsbLgbLebLhLsbRiRsmbRi
RsmbRebLgRsbLibLibLgbLgbLibLgbLibLiLibLibLgLsLsmbLiRsbLgLsbRibRibRhRsR
hmbRibRebRhbRibRgbLjbLcbLgbLgLsbLiLgbLiLsbLiRsbLsbRsbRibRjRgRgRsmbRgbR
ibRhbRibRjRjbRibRibRibRibRibRhRgbRhbRhbRiReRgbLgbLcbLgbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bRebRiRiRebRebRobLiLsbLcRsbLibRoLsbLebRhbRgRsmbRgbRibRsRsmbRebLgLsbLgb
RibRsRsmbRsbRsRsRsLsmmbLsbRcbRcRsmbRgbRcLsbRiRsRimbRibRobRsbRobLgbRsRs
mbLeLjbLsbLebLgbLibLsLsLgmbLgLsLsRsmbLgbRsbRsbLgLsLsmbLiLsLsmbLibLibLg
bLcbLebLibRgbRoLsbRhbRibRcbRibRibLcbRhbRiRsmbRcRibRibReRgbRgbRobRibRob
LsbLoLibLebLebLebLcbLibLgLsbLsLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 19; Drug: Control Apo 50 然
bLiLibRcbLcLsmbLibLsbLcbLgbLcbLhbLibLibLcbLhLibLibLibLebLgRsbRjbRjbRgb
LsbRcRsRimbRcbRibRgbRhbRcRsmbRiRgbRgbRjbRibLhbLibLibLiLibLgLsbLgbLsLeb
LgLsLsmbLiLsRsbLgbRcbRiRsmbRiLsbRibRiRsmbRcbRibRgbLjbLcbLgbLibLibLebLg
bLiLgbLiLsbLgbLibRgbRebRiRgRsmbRgRsmbRgRebRibRiRibRiLsbRsRjbLebRcbRibR
ibRgRsLsmbRibRibRibLibLibLgbLibLibLeLsbLebLgbLibLeLeLiLgLsbRcbRibRcbRi
LsbLgRcbRibRibLgbLjbRibRibRibLjbLibRcbRibRibRsLsbRgbRgbRebLgbLjbLibLib
LgbLgRsbLsbLibRjbRcbRibRibRgbRibRibRgbRhbRgbRibRibLjbRcbLgbRiRsmbRiRsm
bLcbLibLgbLgbLibLiRsLsbRibRcbRiRsmbLibLhLibLgbLgbLgbRjbRibRibLhbLibLib
LgRsbLibRjbRiRsmbRibRibRiRsmbRibRhRsRsmmbRgbRibRibRcbLibRjbRhbRibLsbRi
bRebRibRiRsmbRgbRoRsmbLjLibLebLgbLiRsbLcbRiRsRsmmbRiRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 20; Drug: Control Apo 50 然
bLcLhLsbLebLcbRebRebRgbLsLsmbLebReLsbRhbLhbLcbLcbLibRcbRibRibLebLibLiL
sbRibRjbRiRsmbLjbLcbLcLsmbLibLgbLsLsmbLibRibRcbRhbLjbRoRsmbReRebRebRsb
RebRobLcbRcbRebRebRibRebRebRhbLsbRsRsmbRsRsmbReRsmbRhbRibLjbLhbLcbLiLs
bLcbLhLsbRiLsbLhLsbLsLsmbLjLsmbRgbLgbLhLsbLcbRgbRibRgbRibRibRiRsmbRsbL
cbRibRcbRibRiRsmbRibLsLsmbReRsmbRebLgbRibRibRibLcLsLsmmbLibLhbRgbLcbRj
bLeLsbLibRhbLjbReRsmbLjbLebLiLsLsmbLeLsLsmbLoRsbRhbRibLcLsLsmmbLhLsLsm
bRgbLsbLiLsbRgLsbRjbRebLcbLiLsbLcbRgbRcbRibRib

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 21; Drug: Control Apo 50 然
bLsbLsLsmbLsbLcbRoRsmbRcbRsRsmbLobRoRcbLgbLhLsbLcbLcbRcbRcRsmbLcbLebRe
bRcbLjLsmbLhLsLsmbLgbLsRsLsLsmbLgbLsbLsRsbLsbLsbRsRsLsmbsbLsRsbRsRsmbL
sLsLsmmbRsRsRsmmbLsLsmbRsRsmbLsLsLsmmbLsbLsbLsbLsLsmbRsbLiLsbRobRcbLiL
sbLibLgLsLsLsmmbLibLobRobRebRhbRiRsmbLcbLibLibLgbLebLgLsbLiRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 22; Drug: Control Apo 50 然
bLjbLcbRsRgbLsbRebRibLgbRjRsmbLjbRgbRebRibRgbRcbRobLcLsmbLeLsbLhbRcbLi
bRsbLibLobRebRiRcbLcbLibRjbRhRsmbRcbLibLibLibLobRgbRcbRcbRibLhbLebLgbR
cbRibRiRsmbRcbLibLibRebRibRcbRcRcLsbRebRhRsmbLobRsLiLsbRcRsmbRgbRebRjR
gRsmbRgbRsLsbRhbRebRsbLjbReLsbLsRibRebRhbLcbRebRcbRcbRibRsbRebLsRsbRhb
RebLebLibRcRibLcbLibLgbLebRcbRsRsmbRibRibLibLibLebLobRebRobLibRebRgRsm
bLcbLsLibLgbLsRjbRsbRebRebRgbRcbRjbLjLsmbLobLcbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 23; Drug: Control Apo 50 然
bLcbLiLiLsLsLsLsLsLsmmmmmbsbLiLsbLcRsbLsbLcLsLsLsmmmbLgLsLsLgLgmbLsbLs
bLsLsLsmmbLsLsLsLsLsmmmmbLsLgbLgLgLsLsLsmmbLsLsLsLsmmmbLgLsRsbLgbLsLgL
sbLsbLsLsmbLsRsbLsLsmbLsLsLsmmbLsbLsLsmbLgLsLsmbLsLsmbLgbLsbLsLsmbLibL
sLsmbLeLgLsLsLgmbLiLsbLobLibLibLiLiLibLsbLgbLibLibLgLgbLsLsmbsbLcbLcbL
hbLibLiLsbLgbLgbRsbRgbLsbLsLsmbLgbLgbLgbRsbLsbLsbLiLsbLibRobRhRsmbRibR
gLsbRgRibRhbRcbLsLibRobRiRgRebRsbRibRibRhbRiRsmbRgbLjbLibLibLiLgbLiLgL
gbLhbLsLgbLgbRsLsbLiLsLsmbLcbLhbLcLsLsmmbLebLsbLsbRsbLsbLsLsLsmmbLsLsL
smmbLsLsmbLsLsmbLibRoLsbLibLibLsRsbLgbLiLsbLsbRjbRcbLsRgRsRsRsmmmbLobL
oRsbRjbRsbRgRgbRgbRibRcbRiRsRgmbRgRgRsRgRsRsRimmmbRcbRibRhbRgRgbsbRsbL
cLsmbLgbLiLsLsLsmmbLhbLibLebLebLiLsbLgbLibLsbLsbRsLsbsbLsbRhbRsRsmbRhL
sbReRsmbRibRibRibRibRibRgbRibRgRsmbRiRsmbRhbRgbRebRgLsbRgbRgbRgRsRsmmb
RsRsmbRgbRsRsmbsbLsRsbsbRsbRsbRsRsmbRsbRjLsbRsRsmbRiLsbRibRhbRhb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 24; Drug: Control Apo 50 然
bLgbLgbRjbRjbRjbLjbLjLsmbLjbRhbRibRgbLsbRgbRibLsbLibLcLsmbLebLeLsbLgbL
iRsLsbLsbRjbLjLgbLiLsbRsRsmbLiLsbRgbRjbRibRgbRsbRibRgbRgbRibRgRsRsmmbR
gbRgRsmbRgRsmbRgbRibRgbLiLsbLiLsLsmbRjbRibRgRsRsmmbRgbRgbRsbRgbRgbLsbR
sbRgLsbLjbLeLsLsmbLgbLibLibLgbLibLibLsbRsbLibLsLsRsmbLibLsbLiRsbLgbLsL
gbLiLsLsmbLebLibLibLgbLsbLibLsLsLsmmbLgLgbLhbLgbLebLebLgLsbRsRsmbRsbLi
bRjLsbLsLsmbLgbLebLgbLgbLsbLgbLgbLeLsbLibLibRibRibRgRgRsmbRibRgRebRibR
gbRibRiRsRgmbRgbLgbRjLsbLjLsmbRhbLsLsmbRjbRibRsLsbRibRgRsmbRgbRibRgRgR
smbRgbRiRsmbRebRsRsmbRibRgRsmbReRibRsbRgbRsRsmbRgbRibLgRsbRibRsbRibRgR
smbRgbRgbRibRsbRgLsbLsbLjbLcLsmbLibLibRsRsmbRsLsbLibRgbLibLebLebLebLeR
sLsLsmbLgbLgbRgLsbRcbLiLsbRibRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bLibLsbLibRcLsbRiLsbLgbRhbRhbLhbLgbLgbLcbRibRsbRcbRgRibRgbRebLsbLhbLhb
LibLebLebRebRhbLeLsbLgbLsbLibRcbLsbRjbRhbLhbRobLiLsbLgbRgbRhbLsbRibRjb
RcbRgbRhbRgbLebLsbLibLebLibLhbLgLsRsbLgbLgbLgbLgbLgbLsbRgbRcbRibRhbReb
ReRsmbRgbRsbRgbRebReRsRgmbLsbRibLebLiLsbLsbLibLibLibLsbRgbLsRibRibLsbR
cbRcbRebRibLgbRjbRhbRibLgbRsbRhbLjbRcbRiLsbLsbLgbLoRsbLsbRebRcbLsbLgbL
iLgbRibRgbLsbRsbRgbLsbRjRobLibLgbLgbLgbLgbLsbsbLgbLsbLsbLgbLibLgbLibRs
LsbLsbRsbRgLsbLgbLsLsLsmmbRjbLgbLgbLgbRsRsmbLsLsmbLgbLgbLgLsbRsbLgbLgb
LgbLgbRsbLgbLibLsRsbRebRibRibRgbRsbRsbRhbLsLsRsmbLsRsbRgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
bLsbLibRjbRibRgbRgLsLsmbRsRsmbRiRsmbRgbRsbRsRsmbRgRsmbRsbRgbLsbLibLibL
gLsbLgbLsLsLsmmbRgbRibRjRsRsRsmmmbRgbLsbRibRgRsmbRsRsmbRiRsRsmmbRgbRsb
RgRsmbLsbRiRsmbRgbRgRsRsRsmmmbRgRsRsRsmmmbRiRsRsmmbRgbRgRsRgmbRsbRibRg
bLebLibLsbLgbLgbLgbRgbRjbRibRiRsmbLsLsRsmbRgbRgbRgbRsRsmbRsbRgbRgRsmbR
gRsmbRgRsmbRgRsmbRsbRgbRgbRgRsmbLsbRgbRgbRhRsmbRgbRgbRsbRgRsmbRibRgbRg
bRgbRjLsbLibLgbLiLsbLgbRsbLiLsLsmbLibLgLsLsLsmmbLgLsbLgLsbRsbLsbLibLgL
sLsmbLgLsbLgbLibRgbRibRgbRsbLsRsbRgbRgRsRsRsmmmbRibRibRsRgbRibRgbRgbRi
bRgbRibRiRsmbRiRsmbLsbLibLibLgLsbLgLsbLsbLsLsmbLiLsLsRsmbRsRsmbLibLsRs
LsLsmbLsbLcbLgbLibRibRsRsLsmbRibRgbRibRgRgbRgbRgbRibRgRsmbRgbRsbLjbLgL
hLsbLibLgbLgLsbLibLsLsmbLgLsLgLsbLgbLgbRjbLibLgLsLsmbLgbLsLgLgRsbLibRs
LsbLgLsLsmbLgbRsbRcbLjLibLiLsbLsLsLsLsmmmbLiLsbLgLgbLsbLsLsmbLiLsLsmbL
sLsmbRsRsmbLibLibLgbLibLsbRjbRgLsbRhbRibRgbRibRsRsmbRgRsRimbRgRsmbRibR
gRsmbRiRsmbLsbRibRsbRhbRgRsmbRgRsmbRgRsmbRsbRiRsmbRibRsRgbRibRgbRibRgR
smbRibReRgRgbRibRhRsmbRsbRibRibRibRgbRsbRhRsmbRibRibLsbRhbRgbRsbRgbRib
LsLsmbLcbLiLsbRsLsbRjbRibLibLebLsLsmbLgLsLsLsLsLsLsmmmmmbLibLibLiLsbLg
bLibRsbRcbRibRgRsmbRgbRibRgbRsbRsbRgbRgbRgbRiRsRsRsRsRsmmmmmbRebRibRgb
RgbRsbRgbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bRsbRgRsRsmmbRgRsmbRgRsLsmbLsRsbLsbRsLcbLcbLsbRcbLebLgLgLsbLebLgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bLsLsmbRsbLobsbLsbsbRsbsbLsbLobLcLsmbRobLeLsbLibRoLsLgbLhbLgLsbRibLsRo
bReb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
bLsbRobLcbLobLobLebLebLebRjbLjbRebRebLebLcbLebLcbLobLobRobLjbRsbRsbLeb
RobLjbRsbRsbRjbLobLebRsbRsbLebLjbLobLsbRebLebLsbRjbLobLobLsbLobRobLebR
ebLobRobLsbLebRobRebLebLsbLjbLebLobRcbLobRobRobRsbRobRjbRsbLjbRobLobLo
bLebRebRebLsbLsbLebRcbRebLcbRobLobRsbLobLsbLsbLebRcbLobRebRobLjbLjbLeb
RsbLcbLobRobLebRsbRebLsbRjbRobLsbRobLobRebRebLobLcbRobRcbRsbRobLsLobRo
bLebLsbLobRobRjbLobRjbRobLjbLebRebRcbLcbRobLebLebRcbRobLebLjbLcbLobRjb
RobLebRobRebRobLobRobLobLjbRobLobLcbLsbRjbRebRobRsbRebLjbLobRsbLebRobR
obLjbRobRebRcbLobRobRebRebLebLebLobLobRobLsbRcbLobRjbRgbRebLjbRobLobLe
bRjbLcbRsbRebRobRjbLobRsbLsbRebLcbLebRcbLobRobLobRsbLebLjbLobLobRobLsb
RsbRobRjbLebRjbLebRjbRebLjbRebLsbLcbLebLsbLebRsbLebRobRobRebRsbRjbLebR
sbLcbLsRjbLsbLebRjbRebLsRebRcbRebsbReLjbLcbRcbRjbRsbLsbRjbLsbLobLjbRsR
jbLsbRsbRsLsbRsbLebLsbLobLobLjbRsbLebLobLjbLsbRobRebRsbRobLebLebRebLjb
LsbLjbLjbLcbRsbRsbLcbLsbRjbRebLobRobRebLsbLgbLobRobLjbRjbLebLsbLobLsbR
obRsbLjbRjbRjbLcbLobRebRsbLsbLsbRebLjbRjbRsbRobLjbRsbRjbRjbRebRjbRobLj
bLjbLsbLsbLjbLobRjbRebLjRsbRsbLsbRebLsbRsLsbRsRsmbRsbRebRsbLjLsmbRobRs
RjbLebLjbLcbReLjbLsLsmbLoRsbRjbRobRjbReRsmbLsbLobRebLsbLjbLjRebLsbLcbR
jbLsRsbReLsbLjbLgRebRobRcbLsRsbRsbLsbLsbRebRsRjbLsLcbLebRjbRsbRsbRsbRs
bRcbLcbRebRjbLebRebLebLjbLobLebRcbLsbRsbLobRobRobRobRsbLebLsbLsbRobRjb
RjbRsbLebRsbLebRsbLebLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bLgLsbLsLsmbLsLsLsmmbLgLsbLgLsbLiLsLsmbLgbLsLsLsmmbLsLsLsmmbLsLgLsbLgb
LgbLgbLsLsLsmmbLgLsbLsLsLsRsmmbLgLsbLgLsLsLsLsmmmbLgbLgbLgbRibLgbLibLs
LgLsbLgbRgbLjbLibLobLjLsLhLsmbLsbRcRsmbRibRibRgbRibRhbRgbRcbRjbRhRgbRe
RsRsmmbLcbLgbLgLsbLsLsmbLgbLgLibLoRsbRgbRibRibRobRibRsbRebLobLsbLgbLgb
LibLeLhbLobRibRibRhRsmbRgRsmbRebRgbRibRebRibRebRgRgbRibRebRibRoLsbRebR
jbRgbLebRsbRebLobRhbRsRsmbRobRsRiRsmbRgReRebRcbRibLcbLibLhbLgRsbLobRsb
RibRhbRjbLsbLobRgbRebRebRcbRhbRobsbLsbLgbLgLsbLiLsbLgLsbLgbLgLsbLcLsmb
LgLsLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bRcRsRsRsmmmbLsRsbRsbRsRsmbRgLsbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bLjbRjRiRgRsmbRgRgbLcbLgLsbLibLsbLsbLgLiLsbLgbLiLgLhLiLibLgLsbLgbLsLsm
bLiLsLibLibLebLiLiLsLsLiLsLsLsmmmbLibLgbLgbLibLgbLibLiLsbLgbLibLgbLsbL
eLsLsmbLibLiLsbLgRsbLhLebLebLeLibLebLgLeLsLgLsbLgbLoLsmbLgbLeLebLeLiLs
LiLsbLeLiLsbLebLiLebLhLhLebLgRsbRgbRibRiRsmbRgbLgbRebLsbLjbLjbLhbLibLi
bLsbLibLibLiLsLgLsbLibRsbLibLgbLgLsbLgLsRsbLsLsmbLiLgLsbLgRgRgRsmbLiLs
bLsbLsLsLsmmbLgbRjbLiLsLsmbLgRsbLgbLsbLiRsRsmbLebLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bLgbLgbLgbLgbRjbLibLibLebRibRgbLgbRibRgbRgbRgbRibRibRibLgbLhbLibLgbLhb
RgbRjbRibRcbLgbLjbLibLibLgbLgbLgbLgLsbLhbRebReLsbRiRsmbRibRibRibRgRsmb
LgLsbLhbLibRjbRibRibRibRhbLgbLgbRibRcbRibRgRsmbRibRgbRgbRgbRgbRibRgbLc
bLibLiLsbLgRsbLgbLcbLibLgbLibLgLsbLhLebLibLibLibRgbRjbRcbRibRibRibRsbR
ibRibRibRiRsmbRgbLsbRibRgbLsbRibRgbLsbRibRibRgRsmbLjbRsbRgLsbLjbLibLiL
sbLibLibLibRcbRiLsbLsbRiRsmbLsbRiLsbRgbLjbLjbLibLibRjbLiLsbLibRgbLibLg
bLgbLibLibLibLgbLgbLsLibRibLsbLibLgbLgbRcbRjRsmbRibRgbRibRibLgbRhbRgbR
ibRibRgbRibRibRgbRgbLjbRibRgbLsbLcbLibLgbLibLgLsbLibLiLsbLcbLgbLibLgbL
sLsmbLibLibLsbLhbLibLgbLiLsbLiLsbLibLgbLibLibRibRcbLsbRibRibRibLsRgbRi
bRibRiRsmbRsbRibRiRsmbRcbRjbLgbLebLsbLibLibLgbLibLsbLgbLgbLgbLgbLgbLgL
sbLgbLibLgbLgbLibLibRgbRibLjbRhbRibRibLiLsbLgbLgbLsbRjbRsRibRibRibRibR
ibRibRhbLgbRhbRgbLibRcbRiLsbRsbRibRgbRsbRibLcbLgbLiLsbLibLgbRibRibRgbR
ibRgbLsbRgRsmbRibRgbRebReb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bLibRjbRibLgbRgbLsLsmbRibRgbRsbRgbRgbLsbLgbRiRsmbRgbRiRsmbRcRsmbRibRiR
smbRgbRgRsmbRgbRgbLjbRobRgbLcbRcbRibRsbRibRgbRgbLgbRjbRgbRibLhbRibRibR
gbRibRibLibRibRibRgbLgbRiRsmbRibRgbLibRibRibRgbRsbRgbLgbRgRsRsmmbRgbRg
bRgbRgbLjbRiRsmbRgbRiRsmbRsLsbLjbRebRgbLibRibRsLsbRibLsbRgbRgbRsbRgbRs
RsmbRgbLsbRhRsmbsbRhRsmbRiRsmbRhbRibRibRiRsmbRgbRibLsbRibRgRsRsmmbRgbR
gbRibRoLsbLsbRjbRibRgbRgbRgbRgbRgLsRsbRgbLcbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bRgbRsLsbRgRsmbLsbRcRsmbRhbLcbLibLhbLibLibLibLiLsbLgLsbLibLeLgLebRgbRo
bRibRibRgbRhRsmbRiRsmbRiRsmbRgRsRgmbRgRsmbRgbRsbReRgbRibRibRiRsmbLibLi
bLgLsbLiLgRsbLgbLiLsbLeLsbLgLsRsbLiLsLsmbLiLsbLgRsLsRsbLgLsbLgLsbLibRs
LsbLiLsbRgRsmbLiLsLsLsmmbRibRiLsbLhbLibLgbLiLsbLibLibLhbLibLebLgLsbLiL
ibLibLgLeLeLsLebRjbRibRgRsmbLibLgLsLsmbLsbLibRjbLhbRgbLcbRiLsRsLsRsbLc
LsmbLhbLibLhLsLsmbLibLibLgbLsLsRsmbRsbLebLgbLgbRebRcRsmbRgRsLsmbRibRiR
smbRiRsmbRsRibRibRibLoLsmbLhbLiLgbLibLibLgLsbLgLsbLibLgbLiLsbLebRibRib
RgbRgRsmbRgRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bRgbRibRsbRsbRgbRgbRebRjbRsbRibRsbRsbRsbRsbRebRsbRgbRsbRsbReRsmbRgbRsR
smbRgbRsRsLsmbRebRgbRibRgbRgRsmbRsbRsbRsbLsbRsRsmbRsRsmbRsbRcbRsbRibRh
RsRsmmbRgbLiRsbRebRebRhRsmbRibRgbRsbRjRsmbRibRsRgbRsbRsRsRsmmbRjbLsbRi
bRhbRsbLjbRcbRibRsRsmbRibRsbRgbRebRsRsmbRgRsmbRiRsmbRsbRgRsmbRcRsRsmmb
LoRsbReRsmbRcRsRimbRcRsmbRgRsmbRebRebRcLsbRiRsmbRiRsmbLsLsmbRibRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bRgRsRimbRgbLsbRgbRgLsbRgbRibRibRgbRibRibRjLsRsbRibLobLebRcbRibRibRiRs
mbRsbRgbRibRgbRcbRobRhRsmbRgbRibLjbReRsmbRibRgbRebRgbRgbRsRsmbRsbRsbRg
bRiLsRibLsbRgbRsLsbRiRsRsmmbRgbRibRibRcbRsbRebLibLgbLiLsLiRsbLcbLgbLsL
gbLibLhbLsbLobLiRsbLiLsLsmbLcbLhLsbLibLibLebLebLeLsLsmbLeLhbLibLgbLgLs
bLebLsLsmbLsbLgbLgbRsLsLsmbLsbLgbLgbLibLgRsbLhbLgLsbRhbRcbRiRsmbRibRhb
RgbRibRebRiRsmbRibRhbRsbRjbRibRiRsmbRibRiRsmbRibRgLsbRobRgbRibRibRibRc
bRgbLsLsmbRcbRgbRgLsbRgbRgbRgbRsbRgbRsRsmbLsRsbRsbRgbRgbRgRsmbRiRsmbRi
bRgbRgbRgbRgbLgLsbRibRibRgbRibRibRibRgbRgbLibLibLiRsbRjbRibRiRsmbRsRsm
bRibRsbRsRsmbRsRsmbRsbRibRibRgbRibRiLsbRibRgRsmbRgbRibRgbRgbRibLsbRgbR
gbLsbRibRgbRiRsmbRgbRibRhRsmbRgbLiRsbRibRsRsmbRsRsmbRgRgRsmbRgbRgbRgbR
gbRsbRgbRhbRibRcbLsbRibRgbRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bRgbRebRhRsmbRibRsLsbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
bLebLibLebLhbLibLjLsLgLsmbLhbLiLsbLibLhbLhbLhbsbLebLibLhbLibLiLsLsmbLg
bLcbLgLsbLibLibLebLgRsbLhbLhbLibRgbRibRibRiRsmbRgbRcbRgbRibRiLsbRgbRcR
sRsmmbRgbRobRsbLjLibLibLibRsbRjbRsRcbRgbRgbRsbRsRgRsRimbRgRgbRsbRibRgb
RgbLgbLjbLhbLcbLibLiLsbLgLebLibLgbLiLgbLgbLgbLcbLiLsbLibLibLgbLhLsbLiR
sbLibLhbLebLgbLibLsLibLibLgbLsbLcbLiLsbLgbLebLibLgbLebLebLsbLsbLsLsmbL
hLsRsbRgbLebLhbLhbLibLebLibLebRsbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 43; Drug: Control Apo 50 然
bRsLsLsmbLsbLgLsLsLsLsLsmmmmbLgLsbLsLsLsLsLsLsLsmmmmmmbLsLsLsLsLsLsLsL
sLsmmmmmmmmbLgLsLsmbLsbLgLsLsmbRsbLsbLgLgbLsLsLsmmbLgbLhbLiLsbLcbLcbLg
bLgLgLcbLsbLgLsbRsRcbRiLsbRibRiRgbRgRsmbRebReRsRsmmbRebRsRgRsRsmmbRsRg
bRsRsRsmmbRsRsmbRgLsbRsbRsLsbRsLsbRsRsRsmmbRsRsmbRsbRsbRsRsmbRhLsbRobR
ibRgRsmbRgbRgbRibRcbLjbLjbLibLsLhbLsbLiRsbLiLsLsLgLsLsmmbLiLsbLibLibLi
bRjbRhRsmbRibRgbRgbRsRsLsmbRibRgbRjbLibLiRsbLgRsbLiLsbLgbLgLgbLibLeLsL
smb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 44; Drug: Control Apo 50 然
bsbRsbRsbLsbRsbRsbLsbRsLsbLsbRsbLsbRsbLsbRsbRsbRsbLsbRsbRsbRsLsbLsRsLs
bRsRsmbLsbRsRsmbRsbLsbLsbLsbRsbRsbRsLsbsbLsbLsbLsRsbRsRsmbRsRsLsmbsbLs
bRsbRsbsbRsRsLsmbLsRsbLsbsbRsbLsbRsbLsbsbLsbLsbLsbRsbsbRsbLsbRsbsbRsbL
sbLsbLsbsbRsLsbLsbLsbRsRsmbRsbsbRsbLsRsbsbLsLsmbRsbLsRsRsRsmmbRsbLsbsb
LsLsLsmmbLsRsbLsRsLsRsbLsRsLsbLsLsmbRsbRsRsmbRsbRsbRsbLsbsbLsbLsbRsbsb
LsRsbsbRsbLsLsRsmbRsLsbLsbRsRsmbLsbRsbRsbRsbRsLsRsRsLsmbLsbLsRsLsbLsbL
sRsLsLsmbRsbLsbLsbLsRsLsRsbRsbRsLsbLsbLsbLsRsbLsbLsRsRsmbLsRsbLsbRsbLs
RsbRsbRsRsmbLsbLsRsbLsRsLsbRsbLsRsLsbRsbLsLsmbRsLsbRsLsRsbRsbRsbLsRsbL
sbLsbRsbRsLsbRsbRsbRsLsRsLsLsmbRsLsbLsLsLsmmbLsbRsLsRsLsbLsbsbRsbRsRsm
bLsbRsbRsbRsRsmbRsbsbLsbsbLsbRsbRsbRsbLsRsbRsbLsLsmbLsbRsbLsRsbLsbRsLs
LsmbLsbRsRsLsmbRsLsLsLsmmbRsLsbLsLsLsmmbRsLsbLsbRsLsbRsbRsbLsbRsbLsRsb
sbRsbsbLsbsbLsRsbsbRsbRsbLsLsmbLsbsbsbLsbRsbLsbRsbRsRsmbLsbsbLsbRsbsbR
sbsbsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 45; Drug: Control Apo 50 然
bLsLsmbRjRgbLobLebRebRebRcbLsRsbRsbRsRsLsRsmbRobLsbRobLsbRobLobRsbLsbR
sbRsbLsbLsRsbRsbLjbRsbRsbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 46; Drug: Control Apo 50 然
bLjLsmbLjbRibReRsmbRibRgRsmbRibLibLhbLiLsLsmbLsbLgLsbLsbLgbReRsRsRgmmb
ReLsbRebRebRebRebRebRgbRgRsmbRgbRsbRgbRgbRgRsmbRgbRgLsbRiRsRsmmbRgbRgb
LgbRibRgRsRgRgmbRgbRiLsRsbRiRsmbRgbLsbRhbRgbRibRibRiLsbRgbRgRgbRgLsbRg
bRgbRibRsRsmbLsbRgRsmbRgbRebLgbRibRgbRgbRibRgRsmbRiRsmbRgbRgLsbRibRgbR
sbRibLsbRiRsLsmbRjLsbLgbRsLsbRgbRibRgbRiRsmbRibRgRsmbLiRsbRibRibRibRib
RgRsmbRgbRibRgRsmbRebReRsmbRgbRgRsRsmmbRiRsmbReRsmbRgbRgbRsbRgbLsbLjbL
ibLibLgbLibLibLsbLsbRjbRibRiRsmbRebRiRsLsmbLibLibLibRjbRhLsbLjLsmbRebR
ibRgRsmbRibRiRsmbRebReRsmbRibRibRebRgbRgbRgbRibLjbLcRsbLiLsbLiLsbLgLsb
LsbLiLsbLsbRebRibRibRsRiRsmbRiRsReRsmmbRebRgbRgbRibRsbRiRsRsmmbRibRebR
gbRsbLcbLgbLgbLiLsbLsLsmbLsRsLsRsbLsLgLsbLsbLibLgLsbLgLsbLgLsbLsbLgLsb
LsRsbLibLgLsLsmbLsLsRsmbLgbLsbLgbLibLiLibLebRsbLgLsbLsLsmbLgLgbLsLiLsb
RgbRhRebReb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 47; Drug: Control Apo 50 然
bLgLsLsLgLsLsLsmmmbRiLsbLgbLgLsLsLsmmbLgbLgLsbLebLgbLsRsbLhbLcbRiRsmbR
sbRcbLsbLeLsbLebLgbLsbsbRsLsbLgRsbLsbLgbLsbLgLsbLebLibLeRsbsbsbLsLsmbL
sbRsbLsbLsLsmbRsbLsbLgLgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 115918; End: 120418;
Recording: 3-1; Individual: 48; Drug: Control Apo 50 然
bLeLsbLibLibLebLgLsbLebRgbLhbLebRebRgbRcbRgbRgLsbRibRsRgbRsbRibRgbLeLs
bLcbReLsbRhbRibRgbRebRhRsmbRibRsbLcbLebLhbLeLsbLibLgbLeLsbLhLsLsmbLhbL
ebLeRjbLoLjbRgLgbLgbLhLsLebLgbLebLgbLebLeLeLeLgbLeLibLeLgRsbLebLebLhbL
ibLhbLiLsbLibLiLsbRsbLiLsbLibLebLhLsLsLgmbLibLebLgbLebLibLebLibLgbLibL
iLsbLebLibLsbRgbLjbLcbLibRibRgbRsRsmbRgbRjLsbRgbLebLhLsbLibLhbRjbRjLsb
RibRhbRgbRibRgbRibRgbRgbRgbRgbRsbRibRibRgLsbRjbLibLebLiRsbLgbLibLibLcb
LebLgbLgbLgbRsbRgbLibLibLibLibRjbRibRjbRibRhbLjRsbRibRgbLjbLibLibRjbLe
bRgbRibRgbRgbRibRgbRgbLjbLibLibRjbLebLebLhbLiLsbLibLibLibRjbLebRjLsbLi
bLibLcLsmbRibRgbLebLhbLcbRibLibLgbLcbRhbRgbLjbRibRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bRiRsmbLgLgbRgbRibLsbRibRcRsmbRhRsmbRgbRebLiLsbRiRsmbRebRibRhbRibRibRi
bRibRobLhbLeLsLeLebLeLsLsmbRebRibRcbRcbRebRcbLcbLibLebLibLiLsbLibLiLsb
LgbLsbLsbRjbRibRcbRcbRibRcbRibRibRibLgbLibLiLsbLibLibLcbLebLibLibRsRsm
bRibRibRgbRcbRibRibLsbLebRjbRgRsRsmmbLjbLibLiLsbLibLeLgLsbRgbRiRsmbReb
RiRibRiRsmbRgbRiRsmbRiLsbRibRibRibRgbRcbRgbLebLhbLibLebLibLhbLgbRhLsbR
sRibRibRibRibRcbLjbRgbRibLsRsbRibLibLgLsbLibLibLgbLgbLsLgbLibLibLcbRjb
RibRgLsLsmbRibRibRib

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bLsbLsbLsbLgRsbRsLsRsbLsbLgbRsLsbLgbLiLsbLeRsbLhbRibRibRgbRibRgRsmbRib
RiRsmbRiRgRibRgRsRsmmbRhbRgRsmbRgRebRhRsmbRcbLebRsbLjLsmbLsRsbRsbRsbLi
LsbLgbLhLsbLibLcLsmbLcLiLsbLgbRcRgbRibRcbRgbLoLsmbLiLsbLiLiRsbRjbRibRg
bRgbRgLsbRsRsmbRiRsRsmmbRibRibRgbRsbRgbRibRibRcRibRcbRcbReRsmbRgbRsReb
LobRcbRcbRsbLsbRsbLsRsbRgbRiRsmbRjRsmbRibRiRsmbRibRgbRgRsmbRibRgbRgbRi
bRhbRhbLjbLhbLibLhbLibLsLsmbLcbLgbLcbRcRgbRgbRgbRebRgbLgLsbRibRgbLcbLi
bLcbLibLibLiLsLsmbLebLgbRgbRjLsbRgbRgRsmbRsbRsRibRsRibRsRsmbRsbsbRsRsm
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bLgLsbLgbLgLsbLgbLgbLjbRibRgRsmbRcbRebRiRsmbRiRsRsmmbLgbRsRsRsRsRsmmmm
bRgbRsRsmbRebLgbRebRebLgbLgbLibLibLgbRibRibRcbRgLsbRgRibRhbRibRibLsbLi
bLgbLgbRebRebRsbRibRibRibLebLibLibRjbLibLgbLibLsLsmbLibLgbLgbRibLhbLib
LsbLhbRgbRhbRgbRibLgbRhbLgbLibLhLsbLibLgRsbLgLsbRjbLibLibLgLsbLgbLgLsb
LiLsLsmbLgLsbLgbRgRsmbLibRebRibRsbRiRsmbRsRsmbRhbRsbLgbRibRsbRgbRhRsmb
LgbLobLibRcbRibRgRsmbRsRsmbRebLjbLgbLibLibRgbRjbRcbRibRgRgbRgbLsLsmbRs
RgbLibLgbLgbLibLsbLgbLibLgbRcbRibRibRsbRibLsbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bLgbLgbLiLsbLgbLhbLiLsbRoRsmbRhbRibRsRibRgbRgbRibRiRibRsRgLsbRgbRibRgb
RibRibLcbLcbLibLibLeRsbLeLebLgLsLsmbLsbLsbLsbLsbLsLsmbLsbLsbLsbLgbLgbL
sLsRsmbLsRsbLsbLsRsbLsbLsbLsbLsLsmbLgRsRsmbLsbLebLgbLsbLhbLcbLobLibLgL
sLsmbLibLgbLsLsmbLsbLsLsmbLsLsmbLsbLibLgbLsRsbLsbLgLsbLsLsLsLsLsmmmmbL
sbLsbLeLsbRsLgLsbLebLgbRsbLgLsbLibLcbLebLhbLibLsbLiLgbLibLgbLcbLgbRebR
hbRgRibRcbLsReRsRembRgRsRiRimbLcbLebRsbLsLsmbLsLsmbLsbLsbLsLsmbLsLsmbL
sLsmbLsbLsLsmbLsLsmbLsLibLjLsLsmmbRibRoRsRiRsmmbRgRsmbRiRsRsmmbRibRibR
gbRhbRibRibRibRibRibRcbRgRsmbRiLsbRobRcbRsRcbRcbRcbRhbRhbRgbRiRibRgRsR
smmbRgRebRgbRobRsbRcbLsRcbReRhRsmbRgbRsbRsRsmbRsbRsRsmbRsbRsbRsbRsRsRs
RsmmmbLsbRsbRsbRsRsmbRgRsmbsbRgbRsbRsbRiRsRsRgmmbRgRsmbRgLsbRsRsmbRsbR
sRsmbRgbRsbRiRhRiRibRibRibRgbRebRhbRgRiRibRibRgbReRhReRsReRembRsRsmbRi
RgRsRimbRsRsmbRgbRgRgbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bLgLsbLgbRsLsbLgRsbLgRsbLgbLgbLsLsLsmmbLjLsLgLsmbLgLsbLibLgRsbLgLsbLgb
LsbLgbLgbLsLsmbLgbLsLsLsmmbLibLibLgbLgbLgbLgbLgbLgbLsLgbLiLsbLhLsbLeLs
bLgbLiLcbLgbLibLibLsbLsbLgbLsLsmbLgbLiLsbLsbLoLgbLcbLiLsLsmbLgbLsbLsRs
LsbRsbLibRsbLgbLgLeLsbLibLgLgbLhbLcbLiLsLgbLcbLebLiLgLsbLgLsbLebLiLsbL
gbLgLsbLgbLcbLcLsmbLhLeLsLsmbLgbLgLebLgbLcbLsLgbLsbLsLsmbLsbRsbLsLsmbs
bsbLsbLsLgLsLsmbLsLsmbLsbLsLsmbLsLsmbLsbLsLsLsmmbLsLsmbLgbLsbLsbLsLsLs
LsLsmmmmbLsbRsbRsRsmbRsbLsLsmbLsLgbLsbLgbLsLsRsmbLsbLgbLsLsLsmmbLgbLgL
sLsLsmmbLgbLsbLsLsmbLsbLsbLsbLsLsRsmbLsLsmbLsbLgLsbLsRsbLgbLsbLgbRsbRs
bLgbLgbLsLsmbLsbLsbLsbLsbRsbsbLibLgbLgbLsbLgbLgbLgbLgbLjLiLibLsbLeLsbL
cbLebLhbLiLsbLgbLsbLgLsLsmbLsLsmbLsbLgbLgLsbLsbLgbLsbLsbLsbLgbLsRsbLgb
LgbLsbLgbLsbLhbLsbLhLsbLhLgbLcLsmbsbRsbRsbLjLsLsmmbLgbRsLsbLsbLgRsbLgb
LhbLobLgLsbLeLsbLgbLgbLsbRsbLgbLebLeLsbLiRsbRsRsmbRcReRsRembRibRobRibR
ibLebRcb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bLcbLebRhbRgRsRsRsmmmbRgbRibRgbRibRibRibRibLgbRgbRgbReRsmbRibRibRgbRib
LsbReLsRsbRobRgbLobLcbLcbLcbLcbLebLcLsmbLcbRgbRcbRgbRhbRgbLhLsbLebLibL
ibLibRobRjbRibRibRgbRhbRibRibLsbLsRgRsmbRgbRgbRgbLsbRsbRsbRgbRsbLgbLeb
LcbLobLcbRibRcbReRsmbRhbLebLobLcbLobRiRsmbLsLsmbRgRsmbRgbRebLsLsmbRsbR
gbRgRsRsmmbRhbRsRsmbRibRsRsmbRsbRsbRsbRebRgRsmbRgbRsbRsbRsbRgbRibRibRg
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bLsLsLiLgmbLgbLhbRcbRgRiRsRgmbRsbRcRsmbRcRsmbRhRiRsRsmmbRgRsLsmbRiRsmb
RjRsmbRibRibRgbRsbRsRsmbRebLcbLebLgbRjbRebRhRibRiRsmbRgbRebRebReRsmbRi
RiRsmbRhRhbRebRsRiRsmbRebRibRibRsbRgbRobRoLsbRcbRhbRebLcbLibLiLsbLgLsL
smbLibLiLsbLobLjLgbRebRiRsmbRibRibRiRsRsRhRsmmmbRiRsmbRgRsReRimbRhRsRi
mbRibRiRebLsbRsbLobLsLibLgbLiLsbLgbLsbLcRsLsbLsbLcbLgRsbLibLgLgLgbLgbL
ibLhbLgLsbLgbLgbLgbLsbLgbLhLgLgRsbLgLsbLgLsRsbLsbRjLsbRsRibRcRsRsmmbsb
ReRsmbRgbRebRcRsmbRebRebRgbRcRibRebRsbRobRcbRibLgbRiRsRsmmbRiRsLsmbRgb
RebLhbLibLebLgbLebRcRsmbRcRsRsmmbLsbRibRhbRibRebRiRsmbRiRsmbRgRiRsRgRs
RsRsmmmmbRibRebRibRiRsmbLgbRgRgbRgbRsRsmbRgbLsbRgRsmbRgbLsLsmbRgRsRsmm
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
bRsbReRsmbLgbRcRsRsmmbRgRsmbRibRgbLgbRhbRsbRobRiRsmbRhbRgbRgRsLsmbLcRs
bLibLgbLsbLgbLgLsLiRsbLiLsbLsbLibLcbLgbLjLsmbLgbLsbLsbLgbLhbLjLsmbLibL
jRsbLjRsLsbLeLsbLsbRjRjbRibRibLibLibRjLsbRjbLibLcbRjbLgbLjbLcbLibLebLg
bRsbLsRsLsbLsbLgLsbLsLibLibLsbLcbLiRsbLhbLsbLsbRibRhLsbRgbRhbLcbLgLsbL
hbLiLsbLibLgLsbLsbLcRsbLcRsLsLsmbLebLcbLibLibLibLhbLiLibLgbLgbLibLhbLi
RsbRiRibRgRsRgRsmmbRgbRgbRsRsmbRsbRobLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bLibLibLgbLgbRjbRcbRhbRsRcbRhbRhbRhbRibLjbLcbLgbLibLibLsbLhbLibLcbLjbL
ibLhbRhbRibRibRcbRcbRcbLjLsmbLhbLjRsbLgRsbLibLibLcbRgbLcbLibLiRsbLsbRj
RhRsmbRobLgbLsbRoRsLsmbRgbRibLibRibRcRsmbRgbRgbRibRibRibRjbRibLgbLibLi
LsbLibLiLsbLibLhbRcbLibLibLibLgLsLebRgbLgbLibLgbLhbLsbRjbRhRsmbRsRsmbR
sbRibRibRcbRsRcbRobRhbRobLsbLgRsbRobRobLiLsbLibLibLibLiLsbLiLsbLhbLibL
iLsbLibRobRhbRgbReLsbLsbRiRsmbRibRhbRibRcRsmbLgbRibRsRsmbRibLgbLjbLibL
hLsbLibLibLgbLgRsbRibRsReRsmbReRsmbLsbRibRobLiRsbLobLibLibLgbLiLibLibL
ibRhbLjbLibLgbLibLiRsbLgbRhbLsRsbRiRsmbRibRiLsbLgLsbLgLsbLiRsbLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
bsbsbsbsbLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
bsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bLgLsbRsbLibRiRsmbRhRsmbRibRhbRibLsbRhbRsbRiRsmbRgRsmbRgRsmbRibRgbLcLi
bLgbLibLgbLibLebRebRiLsbRibRibRsLsRsbRibRgbRgRsmbRgRsmbRgbRibRibRiRsmb
RgbRgRsmbRgbRgRsmbRgRsmbRgbRgRsmbRgRsmbRibRibRiRsmbRibRibRiRibRgRsmbRg
bRiRsRsmmbRcbRsbRibLgbLhbLiLebLebLibLhbLgLsbLebLgLsbLgbLgbLiRsbLsbLgbL
gLsbLibLgbLgbLibLgbLgLsbRgbLibLebLeLibLgbLebLibRsbLibRjbLibLibRgbRjRsm
bLgbLcbLibLeLibLibLibLgLsLiLsbRsbRsRibLgbRjbRgLsbLibLsbLiLsbLhbLgbLibL
gbLebLebLsbLsbLgbLibLibLibLibLibLibLgbRibLibLsbLibLebLsLsmbLibRsbLibLg
bRsbLibLhbRibLiRsbLibLibLibLhbLgbLsbLibLibLebLibLsbLgbLsLsmbLibLgbRgbL
jRsbLsbLgbLibLgbLgbLgbLgbLibLiLsbLibLgbLebLgbLgbLgbRibRibRgbRgbLsbRgbR
gLsbRgbRgbRgbRibRibRgbRgbRgRsmbRgbRgbRgbRgbLjbLjRsbRibRjbLjbRgbLgbRgbL
jbLibLgLsbsbLgLsbLgbLsbLgbLgbLgbLsbLgbLgbLgbLgbLgbsbLgLsbLibLgbLgbLgbL
gbLgbLgbLsbLgbLgbLgbLgbLgbLsbLgLsbLibLsLsmbLgbRsbLibLsLsmbLsbLgLsbLgLs
bLgbRsLsbLgbLsbLibLsbLgbLgbLibLgbLgbLgLsbRgbLibLgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bLsbLiLsbLgbLsbLsbLsbLsbLsbLsbLsbLsbRjRebRgbRgbRebLsbLibLgbRsbRiRcbRib
RgbRibRgbRgbRibRebRibRibRgbRsRsmbLjbLhbLibLibLgbLgbLibLiRsbLgbLcbLibLg
bLgbLebLibLiLsbLgbLibLgbLgbLgbLgbLgbLsbRsLsLsmbLgbLsbLsbRjbLibLsbLsbLi
bLsbLsbLsbLsbRsbRebRgRsmbReRebRebRiReRgbRgbLsbRibRibRcRsmbRhbRibRsbLib
LibLgLgbLgbLeLsbLebLgbLiLsbLsbLgbLsbLsbLsbLgbLgbLsbLsbRiRsmbLjbLibRibR
sRsmbRgbRsRsmbRsbRsRsmbRsbRgbLcLibLgLsbLibLgbLibLcLsmbLgbRsbRjRsmbLcbL
ib

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bRsbRsbRsbLsbLibRsbLibLiRsbLibLgbLiLhbLibLeLhRsbLsLgbLcbLsbRibRibRjbRs
RibRiRsmbRibLcbLibLeLgbLgbLhLeLebRjbLgbRcRsmbRgbRibRcbRibRhbLjbLibLgbL
iLibLcbLebLgbLibRcbLjbLsLibLjbLibLebLibLgRsbLebRjLsbRebRibRibRiRsmbRib
LjbLiLgbLeLsbLebLebRsRjbReRsmbRibRibRibRibRhbRjbRcbRcbRhbReRsRimbRibRi
ReRsRembRgbLgRsbLhbLsLgbLiLsbLibLgbLgbLgbLiLsbLibLiLsbLibLiLsbLibLgbLi
bLgbLibLsLsmbLgLsbLsLibLebLsLsmbLebRebLhbLgRsLsbLibLjbLebLibLibLiLsbLi
bLiLebLeLebLgLsbLjLsmbLsLsRsLsmbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bRsbRsbRhbRcbRhbRibLibLcbLcbLcRsbLoRsbRsRsmbLsbLoLsmbLsbLsbLsLsmbRsbRs
bLeLgLsbLibRgbRjRibLcbLibLebLeLsbLibRsbRobRhbRcbRgbRhbLjbRsbRsReRsmbRh
bRsRsmbRsbRgbLobLgbRsbRgRsmbsbLgbLsbRgbRibLjRsbLjbLjbLibLgbRsbRebRibRg
bRebRsbRhRebRiRsLsmbRgbRgRsmbLhbLjbLsbLgbLibLibLibLibLibLobLsbLhbLgLib
LibRgbRgLsbLsRobLibRjRsmbRgRibLgbLsLsLsLsLsmmmmbLibLgbLibLsbLibLjbRsbR
sRobLjbRiLsbRibRibRgbRebLsbLcbLibLjbLsbRcbRhRsmbRiRsLsRsmbsbRsRsRsmmbL
sReLsbLsbLjbRibLsbRsRsmbRsbRgbRsbRgbRsbsbRsRsmbLgbLjbLsbLsbLgbLsLsLiLs
mbLsLsmbLsLsmbLsLsLsRsmmbLsLsmbLibLgbLhbLcbLsbLjbLgbLibLibLjbReRsmbRib
RiRibRibRibLgbRjbRhbRgbRibRgRiRgbRgbRibRcbLsRobRibLjbRobRibRibLgbRibRi
bLibLhbLibLgbLebLiRsbLgbLibLsLsLembLgLsRsbLsLiLsbLgbRgbRhbRiRsmbRibRib
RibLobLjLibLgLsbLgbLhLsbLibLobRgbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 19; Drug: Control Apo 50 然
bRebRgbRhLsbLibLibLhbLsLgRsbLgLgbLgbLgbLgbLgbLhbLgbLgbLibLgRsbLibRjbRi
RsmbRiRsmbRibRiRsmbRibRibRgbRibRgbRibLgbRibRibLibLjbLibLhLsbRebRgRsmbR
ibRgbRibRibRibRiRsmbRsbRgbLibLibLgbLgbLgbLiLgLsbLgLsbLgbLibLibLsbLgbRi
bRibRibRibRibRgRgbRjbRibRibRhbRgbLjbLibLgLsbLiLibRjbRibRgRsmbRgbRibRib
RsbRhbRhbLsbRiRsmbRibRgbRgRsRsmmbRhRsmbRgbRibRgRsmbLjbLjbLibLgbLgRsbLg
bLibLibLebLebRsbLibLiLsbLgRsbLibRjbRiRsmbRibRiRgbRgbRgbRgbRgbRgbRgbRgb
RibRsbLgbLcLsmbLiLgLsbLebLiRsbLibLibLgRsbLebLebLsLhbLhRibLebLgLsbRjbRj
bRiRsmbRgbRiLsLsmbRobLgbLibLgbLsbLiLgbLibLgbLhbRcLsLsmbRcRibRibRibRibR
gbLibRgbRibRgbRgbRebsbLcLsmbRibLibLcbLsbLjRsbLibLgbLibLgbRibLgbLibLibL
gbLibLiLsbLgbLgbLibLiLsbLiLgbLibLhbRibReLsbRiLsbRibRgRsmbRgRibRgbRebRs
bLgbRgbRiRsLsmbRibLgbRibRibRgbRgbRgbRibLibLibLibLgbLgLsbLgbLgbLcLsmbLg
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 20; Drug: Control Apo 50 然
bRiRsRsmmbLsRsRsmbRgRgRgRsRsRsRsmmmmbLobRjbReRsmbRsRsRsmmbRiRsmbRibReR
ebLsbLoLsRsmbLcbLibRcRsmbRgbReRsmbRhRsmbLibLibLhLsbRsbRebLcbLoRsbRebRi
bRiLsbLebRjbRhRsRsRsRsmmmmbRgLsbRgRsRsRgRsmmmbRsRsmbLcbRjbRjbRibLebLeb
RebRgbRiLsbRiLsbRobRibRcbRgbRhbLjbLcLsLsmmbLsbRcbLcbRsbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 21; Drug: Control Apo 50 然
bLgLsbLsbRsRsmbLsbLsbRgRsRsmmbLsbLsRsbLsbRsbRsRsRsmmbRsbLebRsbLeRsbLsL
ibRcbRhRsmbRsbReRebLibRebRebLgbLhLgLsbLiLhbLobLebLibLiRsbLhbLiLsbLiLsb
LibLibLebRhRgRebRebRebRebRebRebRsbRgbRebRebRebRsRibRebRcRebRsRsRsRsmmm
bRebRsbReRsmbRsbRsRebRgLsbRiRsmbRsRsRsRsmmmbRebRebRgbRgbRibRcbRebRcbRc
bRcbRcRsRsmmbRgbRhbRibRgbReRsmbRibLjbLcRsbLhbLgbLibLgbLibLgbLgbLsbRsbR
sbLsbRsbRgbLsRsbRsRsRsRsRsmmmmbRsRsmbRgbRibLcLhLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 22; Drug: Control Apo 50 然
bRiLsbRibRebRibRcbLobLebLebLobRoLsbRgbLebRsbLiLsbLiLsbRgbRjbLebLibLibL
jbLsbLobRiRcbRcbRcbLebLjbLgbLibLebRobRebRibRiRibLsbLcbLcbLibLhLsbLibLi
bLebLibLebLibLhRsbRjbRhbRgbRibRgbLobLibLibLjbLgbLobRebRibRibLjbLhbRibR
cbRebLibLcbRcbRibLebLjbRsbLibLcbRobRsbLiLsbRsbRgbRebLcbLibLobRsbRobRib
RebRibRgbRebRgRebRebRebRebRcbRebLsRsbLcbLsLsmbLgbLgbLjbRsbRcbRgbLcbLib
LgLsbLibLcbLibRibRibRcbLgbLgbLibLibRjbRebRgbRjbRebRebRiRsmbRibRsbRgbRg
bRgbLjbRebRgbLgbLcRsbLgbLibLhbRcbRhRsmbRebRhbRhbRibRebLibRibRhbRgbLibR
obLcbLgbLgbLgLsLsLsmmbLsbLibRhbRcbRobLgLsRsbLgbRsbLcbRsLsbLibLhbRcbLhb
LhbRibRcbRiRsmbRibLjbLebRobRsRgRsRsmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 23; Drug: Control Apo 50 然
bRgbRiRgbRgRsmbRebLcbReRsmbRebLsbLobRiRsmbRgbRgRsRsRsRsLsmmmmbRgbRibRi
bRgbRcbRiRibRebRgRsRgmbRjbRgbRiRgRsmbRgRsmbRiRgbRibLhLjLsmbLgbLiLsLiLs
bLiLeLibLibLsbRgbRgbRebRebRebRebRebRgRsLsmbLjbLibLsbRcbRibRgbRibRiRsmb
RgbRibRibRgbRiRibRebLhbLiLsbLiLsLgbLsbLgbLiLsbLiLsLgbLsLsLiLsLsmmbLgbL
ibLsRsbLhbLeLsbLgbLgbLebRibRcbRjbRsLsbRgbRcbRjbRsbRibRiRsmbRjbRiRsmbRe
bLgRsbRjbLsbLibLiLsLgLgbLcbLgbLgRsbLhbLibLiLgbLiLsbLhLsbLgLgbLcLsmbLsb
LcbLsLsmbLsLgLsbLiLsbLgLsRsbLgRsbRsbLsLsmbRibRibRsRibRjbRibRcbRjbRsbRi
bRcbRgbRsbRebRebRebRhLsRobLcbLhbLcRsLsbLibLjbLibLjLsRsmbLhbLgbLhRsbRhL
sbRjLsbRgbLjbRsRsmbRibRgbRgbRgbRgbRgRsRsmmbRgbRsRgbRgbRibRgbRsbLcbLibL
ibLiRsbLibLibLibLibLgbLibLgRsbLgbRgbLsbRgRsmbRgbRibRibLibLjbLibLgbLgLs
bLibLibLiLsbLgLsbLgbLgbLgLsbLgbLiRsbLibRgbRsLsRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 24; Drug: Control Apo 50 然
bRibLjbRibLsbRiRsmbRgbRsbRgbRgbRgRsmbRgRsRsmmbRsRsmbRgbRgRsRsmmbRsLsbR
sRsmbRsRsmbRgbLsbRjLsbLjbRibRgRsmbRsbRibLsbRibRsbRgRsmbRsbRgbRibRgbLsR
sbRsRsRgRsmmbRsbLjbLhLsbLiLsbRjbLibLebRsbLibRsbRjbLsbRjbLiRsbRcLsbRibR
ibRgRsmbRgbRgRsmbRsbRgRgbRgbRgbLsbRgbRibsbRhbLibRibRibRsRsRgmbRibRgLsb
LjbLibLjLsmbLsLsmbRibRiRsmbLibLcbLgbLgbRjbRgbRgRsRgRsRsRsReRimmmmbRebR
gbRibRibRsbRgbRgRsmbRibLsbRgbLhLsbLibLibRgbLiLsbLgbLgLsbLiLsbLibLgbRib
RibRiRsmbRgbRjLsbRgRsmbLsLsLsmmbRgRsmbRibRgbRgbLsRsbRgbRiRsmbLjbRiLsbR
ibRgbRgbRgRebRibRiRsmbRibRibRgbRgbRiRsmbRgbRgRsLsmbRgbRgbRgRsmbRgbRgbL
sRsRsmbRgbLsLgbRibLsbRgbRgbLjbRiRsmbRsLsbRibRibRibRebRebRiRsLsmbRiRsRs
mmbRgbRgRibRgLsbLcbLibLibLibLgbLgbLibRjRgRsmbRsbRgRiRsmbRgbRgbRgbRsRsR
sRsmmmbRgbRgbLsRsbLsRsbRgbRgbRsbRgbRgbRgRgRsRsRsmmmbRgRsmbRibRibRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bRsbRsRsmbRiLsbLsbRgbRgbRsRsmbRibLgbLsbLgbRgRsmbRgbRgbLebLebRgRsmbRjbR
ebLjbRsbRjbLsbRgbRibLebRgbRgLsbRhbLgbRgRsmbRsRgbLsbRgRsmbRgbLsbRiRsmbR
gLsbRgbLibRiRsmbRibRgbLgbRgRsmbRgRgbRibLsRsbRsbRgbLsbRsRsmbRgbRgbRgbLj
bRebReRsmbLgbRsbLhbRsbRjbRiRsmbRebRsbRcRsmbRsbRibLsbRibLgRsbRibRgbLsRs
bRsRsmbLsbRibLibRsbRhbLsbRsbLjbReRsmbRgbRibLsbLsbRibRsbLsbRsbRgRgbRgRs
RsmmbRgbRgbRgbRjbRgbRgbRgRsmbLgbRiRsmbRibRibRgRsRsRsRsRsmmmmmbLsbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
bLsbRibRsbRgbLsbRgRsRsRsmmmbRgbRsRsmbRsbRsRgbRsbLibLsLsmbLibLsRsRsmbLg
bLsLsmbLgLsbLgLsLsmbLsLsmbLeLsLsmbLiLsbLiLsbLibRibRhbLsLgbLhbLhbLgbLgL
gbLsbRibRibRgbRibRsbRibLgbLjbLibRebRsRsmbRebLeLsbLebLgLgLsbLgLgbLiLgbL
hbLsLsLsmmbLibLhbLgLgbLgbLiLsLsmbLibLgbRebRibRhRsmbRebRgbRgbRibRsRsmbR
gbRibLgbRibRhbLsbRiRsmbLsRsbLebLiLsbLibLgLsRsbLsLsmbLgbLgLsLsLsLgmmbLi
bLiLsbLgbLiLsbLsRsbLsbRjbRobRibRibRgRsmbLsbRibRibRgbRiRsmbRibRibRgRsmb
LgbLcbLibLiLsbRgbLhbLiLsbLeLgbLgLsbLsbRgbLsbLibRgRsRsmmbRjRgbRibRhRsmb
RiLsbLgbLjbLibLiLsbLsbLibLsbLibLiLsbLsLsmbLibsbLgbLibLebRjbRibRsbRgRsm
bRgbReRgRsmbRibLsbRobLsbRgbRibRibRgbRgLsbRebLgbLiLsbLsLsLsmmbRsbLgLsbL
gbLgbLiLsbLgbRebLcbLobRgbRcLsbLsbRiRibRhbRiRgRgbRebRibRibRobRjRsmbRiRs
mbRgRsmbRsRgbRibRibRgbRgbRgRsRsmmbRgbLsRsRsmbRgbRsRibLjbLibLiLsbLgLsLs
LsLsmmmbLiLibLgbLgbLsbLgbLgbLgbLsbLibLgLsLsmbLiLsLsmbLiLsbLeLsLsmbLeLs
bLebLibLibLiLsbLgbLgbLsLsmbLgLgLsbLgbLsReb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bRsLsbsbRsbRsbRsbsbLobRjbRcbRcbRjbsbRjbRhRsmbRibRibRibRgRsmbRhbRgbRcRs
mbLhLsRsbLibRobsbsbRobRsbLsRsbLhbLgbLhbLgbLhbLcLsmbLsbLiLibLibLcbLsbRs
bLibLiLgLibLgbRibRibRgbRibRgbLsLsmbRsLsbRsRsmbRibRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
bRsbRgbLoLsmbRcbRcbReRsRsmmbRgRsRembRgbRgbRcRsLsmbRgRsmbRebRibRibRibLg
bLhbLgbLcbRcbRhbRiRsRgmbRjbLgLsbLibRcRsmbRhRsmbLibLjbLjbRsbRjbRcRsmbRs
RsmbRobRhbLiLsbLsLsmbRjbRjbRsbRebRibRgbRgbRhbLcbLcbLibLcbRibRcbRebRgLs
bRebRgbLjbLjLhLsbLebLibRjbRcbRgRsmbsbRsbRibRibRgbRibRcRsmbRobLcLeLiLhR
sLsbLeLcbLibLhLsbLibLcbLcbRgRsmbLcbLibLcbLibLcbLsbRcbReRebLjbRcbRhbRib
RgRsmbRebRebLsbLgbLcbLgbLgbRcbLgRsRsmbLibLhbRcbRhbRibRhLsbRgbLiLsbLgbL
gbLibLebLobRibLcbLcbLcbLeLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bRsbLjLsRsLgLimbLiLsbLsbRsbLgbLgbLsLsLsLsmmmbLgbLgbLsLsmbLiLgbLiLsbLib
LiLsbLcbLiRsbRgRsmbRobRgbRcbRcbRebRebRgbRgbLobLcbLgbRibRobRibRibRsbReb
RgbRiRiRibRhLsRsbLsbRibRibLsbLibLibRhbRebRgbLjbRibRsRjbRhRsmbRhRsmbRsb
RibRebRhRgbLgRsbLjbLibLgbLibLibLebLgbLgbLsbLibLcRsbLcbLgbRcbRiRsmbRgbR
ibRgbRiRgbLibLibLibRsbRhbRibRibRgbRsbRgbLjbLibLibRsbLhbLsbLcbLgbLsbLiL
ibLgbLgbRsbRibRgbRgbRiLsbRgbLgbRsbRgbRgbRgRsmbRgbRgbRgbRgbLgbLhbLibRgb
LgbLibLgbLgLsbLgLsbLiLsbLibLibLgbLsbLsLjbLibLgLsLsmbLibLibLgbLebLsLsmb
LgbLsbRebRiLsbRjbLhbLgbLgbRgbLjbRsbLibRsbLeLsbLhbLsbLebLsbLgbLgbLibLsb
LeLgbLgbLgbLgbLibLibLiLsbLgLgLibLgbRgbLgbLgbLgbLsLibLgbLgRsbLgbLgbLeLs
LhbLibLgbLgLsLsmbLhLeLsbLsbLgLgLsbLsbLgbLgbLebLcbLebLcbLeLebLgLibLsbLc
bLgbLgLsLebLsbLibLiLsbLebLobLsbRibRgbRjbRsbRgLsbRgbLsLsLgmb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bLiRgbLgbLibRcbRibRsbRcRsmbLgbRebRcbRebLsbLcbRsLibLgbLgRsLgbLiLsbRsbsb
sbLsLsLsmmbLgLsLgbLgLsbLiRsLsbLibLibLgbLiRsbLebLiLsbLiLsLebLeLsLsmbReL
sbRcbLjbLibLibLibLgLsbLgbLsbLgbLgbLibLibLgbLibLgbLibLgbLeLiLsbLgLsbLib
LsbLgbLhbLhLiLsLibLebLgLsbRebRcbRhbRsbRcbRibRcRhbRhRsmbRcbRebRiRsLsRsR
embRibRibReRsmbRiRsmbLgbRibRiReRsmbRibRibLsbRoRsmbRibRiRsmbRebRebLjLsm
bLgLsLsmbLgLsbLiLsbLibLibLebLiLsbLgbLgLsbLhLsbLiLsbLhbLiLsLebLebLibLeb
LibLgbLgbLiLsbLcLsLsmmbLibLibLebLib

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bRebLsbRhbRgbRibRibRgbRibRibRibRhbRibRibRibLgbLgbLhRsbLibLgbLgbLgbLibL
gRsbLgbLgbLibLsbRibRibRibRibRibLgbRibLjbLibLobRobLgbRcbRgbRgRsmbRibLgb
RhbRhbRjLsbRibRibRiLsbLgbLibLibLgbLgbLgbLgbLsLgbLgbLibLgLsbLgbRcbLgbRi
bRibRibRgRsmbRibLsbRibLobRsbRgbRgbRiLsLsmbLjbLhbRibRcbLibLgLsbLgbLgbLi
bLgLsbLgbRsbLgbLibRsRsmbLibLibLgbRgbLibLsRsbLibLibLibLibRsRjbRiRsmbRgb
RgbRibRibLibLgbRcbRibRgRsmbRgbRibRibLgbLiLsbLibLgbLsbLiLsbLgbLgbLgbLgb
LgLsbLgbLgbLgbLgbLgbLibLgbLibRjbRcbRgbRibRibRgRsmbRgbRgbRgRsmbRgbRgbLg
bLjLjbRibRgbRibRgbRgbRibRsRsmbRibRibRgbRcbRsbRibRsbRibRgbRcbRibRgbLgbL
jbLgbLibLiLsbLgbLiLsbLgbLgbRjbReRsRsmmbRibRgbRgbRgbRibRgbRgRsmbRiRsmbR
gbRibRgRsmbRibRgbRibRibRgbLjRsbLibLibLgbLgbLgLsbLibLgbLgbLgbLgbLgbLobL
gbRgbRibRgbRibRibRibRiLsbRibRgbRibLsbRibRgbLgbRhbLsLsLsmmbRjRgRsmbRgbR
ibRgbRgRsmbRibRgbRgRsmbLcbLiLsbLgbRgbRcLsbRibRibRgbRsbRgbLsbRibRgbRhbR
iLsbLebLibRsbLiLsbLgLsbLgLsbLgLsbLibLgbLgbLgbRhRsmbRibRgRsmbRibRgbRiRs
mbRiLsbRhbRiLsbRibLgRsRsmbLjbRsbLibRsLgbLgbRsbRhbRibRibRgbLsRsRsRsRgRs
RsRsmmmmmbRgRsmbRiRsmbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bLjbRgLsbRiLsbRibRgRsmbRgbRibRgbRsbRgbRsRsmbRibRgbRibRgbRiLsbRibRgbRgb
RgbRgLsbRibRgbRgbRgbRgbRsbRibRgbRgbRsbRsbRibRgbLjbRjbRhbRsbRibRsbRsbRi
bRgbRgbRsbRgRsRsmmbRgbRgbLgbRsbRhRibRsbRgbRgbRgbRibRgRsmbRibRsbRgbRsbL
cbLibLgbLgbRsbLgLsbLgbLgbLgRsbLibLcbLibRibRcbRgbRibRsbRobRsbRebRibRibR
iRsRsmmbRgbRsRsRsmmbRgbRibRibRsbLjbLjbLcLsmbLgbRsbLibLgLsbRjbRcRsmbRib
RgbLsbRibRgbRibRcbRsbRgbLjLsmbRiRsmbRgbRgRsmbRgbRiRsRsRgRsmmmbRgRsmbRi
RsmbLjbRhbRibRsbRgRsmbLjbLjbLcbLsbLcbLibRsbRibRgRsmbRibRgbLibRibRsbRib
RgRsLsmbLgbRobRsbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bLsbsbRsbRibRhbLobLgbRsbLsbLobRsbLibLibLoLsmbLsRobRibRsbLobRsbLobRsbLs
LibRgbRcRsmbRiRsmbRhbRcbLibRcbLjbLobLhbRobRibRcRsLsmbRgRsRembRebRgbRib
RsbLibLgLeLgbLibLsLsmbsbRobReRsmbReRsmbRgbRibRgRgbRibRobReRgRgbRsbRoRs
RsmmbLiLsbLiLsbLibRsbLgbRebLcRsbRsbRsbRcRsRsmmbRibRibRgbRoLgLebRsLsRsb
LiLsLsmbRsbLgLsbLebLcbLibLjbLsLiLebLgbLeLsLgLiRsbLiRgbLobLcRgLsLgbRibR
hbRcbRhbLhLsbLibRsRsmbRgbLjbLhbLibLgLiLgLiLsLgLgbLsbLsbLibLibRsbRcbRcb
RsbLgbRcbRgbRiRgbRcbRiRsmbRobRcbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bRibLjbLjbRcbRiLsbRibRhbLibLibLibLibLibLibLibLibLhbReRebLsRsbLjbLcbLiL
sbRcRsmbRibRibRibRibRibLjLsLsmmbLiLsbLgbsbLgLsbLsbLgbLsLsLsRsRsRsLsLsL
sLimmmmmmbLgbRjbRhbRiRsRgmbRibRgbRibLjbLcbLiLsbLibLiLsbLibsbsbLibLsLsm
bRibRhbRhbRgRsRgRsRsmmmbRgbRgbLsLsRsRsmmbRcbRibRcbRibRebRcbLgbLhLsRsbL
ibLgLsbLgbLgLsbLgbLgbRjbLjbRcbRhRsmbRibRhbRibRibLibLhLsbLiLsLsLhmbLiLs
LgLeLsbLsLsLsRsmmbLsLjbRgbLcbRiRsmbRcbRiRiRsmbRiRiRibRibRiRsmbRibRhbRi
bLibLcLibLgLiRsbLgLsLsLsLsLeLeLeLgLsmmmbLgbLoLsmbLibLcbLibLgbLibRhbRib
RcbRgbRsbRjLsRsbRiRsmbRgbRibRgLsbRibLibLiLsbLibLsLsmbLiLgbLgLsbLeLebRg
bRcbRibRibRiRsmbRgRsmbRibRibLgbLibLgbLhLgLsLiLgLgbLgbLebLgbLgbLgbRobRi
LsbRibRgbRgbRgbRhbRgbRgbRhbRibRsbRgRsmbRgRsmbRiRiReRsRsRemmbRjLsbReRsR
sRsRgmmmbRebLsRsRsRgRsRgRiRgLsRsLsmmbReRsmbRebLjbRiRsRsRgmmbRgRgRsmbRs
RsRsmmbRsbRhb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bRgbRgRsmbRsRsmbRgbRiRsmbRibRgbRiRsmbRgRsmbRgbReRsmbRgbRibRhbRiRsRsmmb
RhRsRsmmbRgbReRsmbRebRgRsmbRgRsmbRgLsbRibRebRebRhRsmbRhbRgRsmbsbRsbRsb
LsbsbLsbReRsmbRebRibRebRiRsRimbRibRiLsbRgbRibRiRsmbLsRsbRsbRiRsRsLsRiR
smmmbLgbRsRsmbRiRsmbRiRsmbRsRsmbLjbLhbLibLgLsbLeLgbLibLhLsbLiLsbLgbLgL
sbLibLibLiLeLsLiLsbLgRsbLgRsbRcbRcRsmbRsbRsbRgRsmbRgbRsbRgRsRsmmbRsbRe
bRebRgRsmbRgbRiRsmbRibRsbRgbRibRgbRibRgRsmbRgbRgbRhRsRsRsmmmbRebLebLib
LgLsRsbLiRsLsbLebLiLebLgbLsbLsLsLsRsmmbLgLsLsmbLgRsbRsbRsLsbLibLgbLcbL
ebLgbLgbLibLibLgLsbLgbLebLgbLibLibLgbLibLebLiLsLgbLhbLiRsbRgbLiLsbLsbL
gbLsbLgbLsRsbLhbLebLgbLgRsbLebLiLsbLsbLgbLsLsLsmmbLsbRsbLsLsmbLsLsRsmb
LgbLiLsbLsLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bRsbRgbRgRsmbRibRgbLgLsRsbRgRsmbRgRgbRiRsmbRhbRgRsmbRsRgbRgbRiReRsmbRg
bRgbLsRsbRgRgRsRsmmbRgRsmbRgbReRsmbRhbRibRibRibRibRibLgbRibRgbRibRgbRi
RsmbLgbLjbLibLibLobLgbRgbRibRgbRgbRgbRgbLgRsbRibRibRibRibRgRsmbRgbRgRs
mbRgbRsbRhRsmbRibRibRiRsmbRgbRibRibRibRibRsbRsbRsbRgbRgbRiRsmbRgLsbRgb
LsbRibRgRsmbRibRgbRsbRgRsmbLgbRibRgbRgRsRsRsmmmbRgRgRsRsmmbRgRsmbRibRg
RsmbRibRgbRgRsmbLgRsRsmbRibRsbRsRsRsRsRsRsRgmmmmmbRgRsmbRsRsmbRgRsmbRg
bRsbRgbRibRgLsRsbRgRsmbRgbRibRibLsbRibRgbRgbRgbRibRhbRgbLgbRgbRgbRgbRi
bRibRcbRgbLsbLgLsLsLsLsLsmmmmbLibLgLsbLgLgbLgLsbLibLsLsLsRsmmbLiLsRsLs
bLgLsLgbRsbRsRsmbLgLgLsbLgbLhRsbLgRsRsmbLgLsbLhRsbRsRsmbLsbRibRjRsmbRg
bRgbRiLsRsLsLsmbRibRcbRobRiRsmbRoRsRsmmbLgbLhbLgbRhbRibLjbRebRibRiRsmb
RibRhbRgRsmbRibRibLgbRgbRgbRobRcbRgbRhbRsbRiRsmbRibRiRsRsRsmmmbRiRsmbR
iRsmbRibRhbRhbRgbLibLibLibLibLsLsmbLibLibLobRgbRgbLgbLobLibLsLibLgbLgb
LsbLob

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
bLibLoRsbRsbLhLsbRibRgbRcbRcbsbRcRsLsmbLcbLibLibRibLjbRcbLsbLeLgLsbLhb
LoRsLsbRsbLibLibLgbLsbLgbLobRgRsmbLjLsmbLob

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bRebLgbRobRibRibRebLjbLcbLibLsbRhbLeRsbLhLsbLiLsbRcbRiRsmbRcRsRsmmbRhR
smbRebLsbLsbRsRsmbReRsmbRcLcbLiRsbLibRibLcbLcLibLgbLibRsbRebRiRsmbRcbL
hbLeLsbLcbLcbLsbsbLgLsbLgbRjbRebRgbRsRcbLgbLhbLcbLcbRebReRsmbRibReRsmb
RsbLebLeLsbRsbLgLsLsmbLiLsLsmbLsbLebLcLsmbRebRgbRhbRcbLeLsbLgLsbRcbLjb
LcbRgbRgLibLhLsbLgbLcbLgbRcbRcLsbReRsRsmmbRgRsmbRgbRcbRcbRsRgbRibRibLg
RsbRcbRcbLcbLgbRjbRcbLsbRgbRibRiRebRcbRcbRiRsmbRsRgRhbLgbLjbLibLebRsbL
gbLcbLsbLsbLsLsmbLgLsbLibLibLibLgLcbLgbLgbLsbRsRsRsRhmmbRgRsmbRsbLhLgb
LebRsLgbLibLgbLibLcbLebLsLsmbRobRcRebRebRcbRgbLiLsbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
bRgbLgbsbRgRgRsmbRsRsRsLsmmbRgRgbLsRsbRibRgbLcbLjbLcbLsbLhbLibLebLcbLe
bRibRibRibRibRgRsmbsbRibRibRibRsbRibRibRgbRibRjRsmbLsbRhbRgRgbRibRgbRg
bRibLibRsbLibLcbLibLibLiLsLsLsmmbLgbLibLgbLsLsmbLibLibRgbLeLsbLebLgLsL
smbLhbLhbLibRgRsmbLsbRjbLcbLibLsLibLibLibLhLsbLibLibLcbLcbRibLebLibLib
LebLebRsRsmbRgbLcbLibLibLhbLiLibRsbLcbLibRibRibLibRgbLgbLeLsbLhbLibLeb
LgRsbLobLebLebLibRgbRcRibRibRibRgbRgbRgbLgbLcbLibLibLgbRsbRiRsmbRebRsR
ebRibRebRiRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 43; Drug: Control Apo 50 然
bLeLsbLsLsLsLgmmbRsbLsbLsLsmbLsLsLsmmbLibRsbRhRibRibRcbRgbLgbRobRiRgbR
ibRhbRgbRibRgbRibLcbRibRibLebLiLiLsbLibLiLsbLibLiLsbLibLgbLsLsmbLibLib
RsbRcbRsRgbRgLsbRgbRibRibRgRsmbLibRcbRhRibRibLgbRhbRsbRibRibRgbLsbRgbR
gbRiRgbRibRgbRgbRiRsmbLebLibLiLebLgbLgbLgbLgLsLsmbRjbRibRgbRibLgbRibRi
bRsRsmbRgbRiLsbRgbLsbRibRgLsbRgRsmbRgbRsbRgRsmbRgbRhbRibRibRiLcbLobRsb
RiRsmbRhbRibRsbRhbRiRebRgbRgbRcbLhLhbLsbLsbLgbRsLsbLibRibLgbLsbLsbLgbR
jbRebRibRgbRibRgbRibRgbRsbRgbRebRibRibRibRgbLjbLibLgRsbRibRibRgbRgbRib
LgbRibRcbRhbRsbRibRgbRibRibRebRgbRibRgbLgbRiRibRgRsmbRebRsRsmbRibRibRi
bRibRcbRiLsbLibLiLsbLgbRcbRiRsmbRibRgRsmbLsbRibRibRib

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 44; Drug: Control Apo 50 然
bRcbLsLcRsLsbLcRsbLhbLjLibLcbLebRsLebLgbLgbRsRsmbRcRsmbLhbLeLsbLsbLgbL
iRsbLcbRebRiRsmbLsbLebLgbLgLgLsbLhLsbLcbRcbRibRibRgRebRebRibRsbRgRsmbR
ebRebRcbLgLsbRjbLebLebRsRsLsmbLgbLibLibLgbRibRhbRibLgbLhbLcbLibLcbLibL
oLsmbLobLcLgbLibLgbLiLsbLgbLgLsLsmbRebReRsmbRcbLhbLeLsbLibLhbRgbRibRib
RibRsbLoLeLsbLiLeLsbLibLcbLibRsRhRgRiRsmbRgbRobLgbLiLsLsmbLsbLgLebLsbR
ibRebRcbRebLibLhbRhbRebRcRiRsRembRiLsbRoLsbLsbLebLiLsbLibLibLebLobLeLs
LsmbLebLoRsbLibLgbLobRcRsmbRebRibRiRsmbRgbRiRsmbRibRhbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 45; Drug: Control Apo 50 然
bLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 46; Drug: Control Apo 50 然
bRibLcbLibLhLsbLibLgbRsRsmbLgbLgLgbLsbLgbLgLsbLgbLgbLsbRjbReRcbRsbRiRs
mbRsbRgbRgRsmbRiRsmbRgRsmbReRsmbLibRebLobLgbLibRsbLgbRsbLsbRsbLsbLsbRs
bsbLsLsLsLsLsRsmmmmbLsbRsbRibRebReRsmbRibRgbRgbRgRsmbRgbRiRgbRsbLsbLcb
RibLjbLhRsbLibLibLgbLiLsbRjbRibRcbRhbRebRibRiRsmbRibRgRsmbRibRgLsbRiRs
mbRibRebLgbLcbLibLibLibLgLsLiLsbLiLsbLgbLhLsbLgbLgLsLsmbRsbLsLsmbRsRsm
bLsbLsbReRsmbRibRebRhbRhbRibRebRgbLhbLibLgbLgbLibLibLgbLgRsbLgbLgbLibR
gbRsbLiRsbLibLgbLgbLgLsbLgbLgLsbLgLsbLgbLgbLgLsbLgbLsbLgLsLsLimbLgbLsL
smbLgLhbRgbLgbRsRobRhRsmbRhbRibRiRsmbRibRibRgRsRsmmbRibRgLsbRibRgbRiRe
RsmbRgRsmbLhbLibLiLsbLibLibLgLgLsRsbLgbLiLsbLgbLibLgbLgbLgbLgbLiLsbLgb
LibLibLgbLgLsbLiLsbLiLsbLgbLgbLcbLgbLsbLibRsbLsRsbLgbLsbLiLsLsmbLsLsmb
LsLsLsmmbLsLsLsmmbRsbsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 47; Drug: Control Apo 50 然
bLiLsbLebRgbLsbLibRjbRibLjLsmbLeLsbRsbLgRsbLiLsLsmbLgLsbLsLsmbsbLgLsLs
mbLgbLgbLiLsbLsbLgbLsbLgbLgLsbLibRsbLhLibLeLsRsbLgLiLsbLebLebLibLeLsLs
mbRsLiLsbLiLsLsmbLgbLgbLgbLibLgbLsbLibLsbLsbLgbLgbLsbRibLgLsbRcbRgbRib
LebLibLsLsmbLibLsbLgbLgbLsRsbLgbLgbLsbLgLsbLgbLgLsbLsbLibRibLebLgbLgLs
bLiLgLsbLibLgbRsbRsbLsRsbLibLsLsLsRsmmbsbLsbLgbLsbRsRsmbLgbRsLsbLgbLiL
sbLgLsbLgbLiLsbLsLsmbLgLsbLsbLsbRsbLhLsbLgbLgbLgbLgbLsbLibLibLsbLibLgb
LgbLgbLsbLsRsbRsbLiLsLsmbLgLsLsmbRsbLgbLgbLibRgbLiLsbLibLhLsbLeLsbLiRs
bLhbLiLsbLgbLgbLsbLsbLgbLgbLsbLgbRsLsbLsbLgLsLgLsbLgLsLsmbLsbLgbLsbRsb
LjbLgLsbLiLibLgbLcbLiRsLiLsbLgbLhLsbLeLcbLebLiLsbRcbRibRsbRibRsLsbRcbR
sbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120420; End: 120920;
Recording: 4-1; Individual: 48; Drug: Control Apo 50 然
bRhbRgbRgbRibLibRibLcbLiLsbRgbLsLgbLibLcbLebLibLhbLibLhbRsbLhbLcbLhLsb
RibLcbLebLsbLibRgbLeLsbLhbLebLebLebLsLsmbLeLibLgbLcbRibRibRibRibRgbRib
RgLsbRgbRgbRsRsmbRgLsbRgbRgbRjbLcbRhbLjbLibRjbRibLcbRjbLcbLsLsmbLsLsLs
LimmbLcbLebRsLgLebLcbRjbRibRgLsbRibRgbRibRgbReRiLsbRebRgbRiRhbRgRsmbRe
RhbRiRebRibLsbRiRsmbRebRibRebRibReRsmbRgbRsbRgbLobLibLsbLibRsbLibLgbLg
LibLsbLibRcbLoLgbLgbLibLsLcbLibLhLebLcbRsbLebLibLgbLibLibLgbLibLibLebR
ebRibRhbRgbLibLhbLebLiLsbLebLebLhbLebLiLebLebLibLcbLibLibLcbRgbRgbLjbL
ibLsbLibLeLsLebLibLsLsmbLhLsbRgbLiLebLgbLhbLsbRgbLebLsbLibLgbRsbLebLgb
RsbLhLsbLgbLcbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bLjLsmbRgbLhLsLsmbLibRcRsmbRgbLebRibRcbRibRhbRgLsbRibLibRgRsmbRibRibRg
bRibRcbLibLibLibLibLibLibLcbLiLsbLibRcbRibRibRgbRibRibRibRcbRibRgbLjbL
ibLhbLiLsbRibLsRibRcbRibRhbRhRsmbRibRobRsbRjbLcbLibLgbRgbLibRjbRcbRibL
sLjbLhbRjbLibLibLgbRsbLibLibLgbLcbLsbLibLibLgLsbRsbRiRgbRgLsbRibRiRsRs
mmbLhbLiLsbLibLebLsbRibRibRibRibRgbRgbRibRsbRibRiLsbRhbLjbRsbLibRgbLhb
LibLgbLiRsbRjbRjRsmbRgbLgLsbLebLgbLgbLjbLgbRcbLibRjbLeLsbLebLibLoRsbRi
LsbRibRgbRgRsmbRibLcbLhbLgbLgbLcbRgbRcbRiRsmbRibLjbRcbRiRsmbLcbLiLsbLj
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bRcRsmbRhRsmbRcbRsbLibRcbRcbRibLgbLhLhLgbLiRsbLgbLcbLhbLibLibLhbLhbLib
LhLsbLibLiLcbLoRsbLjbLibRjbRhRsmbRibRibRiRibRibRibRibRiRsmbRebRiRsRimb
RgbRsRiRsmbRibRcbRhRsmbRgbRiRsmbRgbRgRiRcbLcLeLsbLibLcbLibLgLgbRcbLibL
sbRjbsbRsbRsbsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bReRsmbLgLsbRsbRcRsmbRiRsmbLsLsmbRsbRgbRgbRgLsbLjbRgbLsRsbLcbReRsmbsbR
sRsRsmmbRiRgbLebLibLgbLgbLgLsbRsbLibLsLsmbLsLsmbLgLgLsbLgbLiRsbRibRebR
ibRgbRibRibRibRhbLgbLjbLibLgbLhbLgbRgbLsLsmbRsRebRsbRcbRgLsbRiRsmbRgbR
cbLgbLibLgbLgbRsbLgbLibLgbLsLsLsmmbLsbLjbRcbLgbLgbRsbLsLgbRgRsmbLgLsLs
mbLsLsLsmmbRgbLcbRebRgRsmbLsbLsbLjbRibLsbRsbLsRsbRsRsRsRsRsmmmmbRsRsRs
mmbsbLsbRgRgRsRsLsmmbLsbRsbRsRgLsbLgbRsbRsLsbLebLobLsLsmbLgLsLsmbLgLsL
smbLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bRhLsbRgLsbRsbRsbRsRsRgmbRsRsRsmmbRsLsbRsbRibRibRiLsbRsRibRgbRibRsbRgb
RgbRgbRsbRsRsmbRsbRiRsmbRebRibRgbRibRgRsmbLjbLhLsbLibLgLgbLsbRiRiRgbRs
bRsRsmbLhbLcRsbLibLibLebLebRsLsLsLsmmbLeLsLebRsLsRsbLsbRjbRsRgbRsbRgRs
RsRsmmmbLsbRsRgbRgbRsLsbRsLsbLgbRhbRibRibRsbLhbLibLgRsbLiLsbLhbLibLcbR
sRcRcRhRibRcbRibRibRibRibRebLcbLiLsbLiLgLsLsLsmmbLsbLsbLsRsbsbLsbLsLsL
sLsLsLsLsmmmmmmbLsRsLsLsLsmmbLsbRsbRsbRibLcbLhbLibLiLibLibLibLebLcbLib
LcbLebLhLsbLibRcbRibRibRebRhbRibRhbRgbRibRgbRgRgRibRgRsmbRebRiRsRsRiRe
RsmmmbRibRsRsmbRibRgRsRsmmbRsRsRsRsRsRimmmmbRsbRsbRibRgbLibLcbLhbLebLi
bLibLeLhbRiRsmbRiRsmbRcbRibRcbRibRibRgbRgbReRgbRgbRhbRiRgRsRsmmbRibRgR
smbRibLsbLsbRsLgbLsLjbLibLgbLibLgbLgbLgRsbLgbLgRsbLgbRgbRgbRibRibRgbRg
bRsbRsRgbRgbRsRibRgbRgbRsbRsbRgbRibRgRgbRgbRgbRgbRibRcbLsRibRgbRibRgRg
RsRgRsRsmmmbRgbRsRsmbRhRhRebRgRsmbRgbRsRsRgmbRsRsmbRgbRgRsRgRsRgRsRsRs
RgRsRsmmmmmmmbRsbRgbRgbRgRsmbRgRsmbRgbReRgbRiRsRgRsmmbRibRgbRibRgbRgbL
ibRhRibRibRsbRgbRgbRibRiLsbRibLsbRcRsmbRibRgbRgbRgbRhbRhbRiRsmbRjb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bRibLjbLsbLiLsbRobLeLsbLhbLsbLsbLsRsbLsbLebLcbLcbLibLsbLsbRsbRcRsRsmmb
RibRhbRgbRgRsmbRhbRibRibRibRibRcbRhbRebRibRibRgbRcbRcRsRiReRembRibLhbR
cRsmbLibRibRjbRibRibRgbLsRhbRiRsmbRgRsmbRcRsmbRibRsReRsmbRebRoLsLsRsmb
RibRhbRjRsmbLjbRhbLcbLibLcRsLgbLebLebLgbLiLsLsmbLgLiLgbLcbLcLoRsbLeLsb
LhbLgbLibLibLiLgLsLiLcLiLsbLgLsRsRsmbLiLsbLiRsLsbLsLsmbLsLebLsLgbLsbLs
bLsbLgLsbLsbLebLsLsmbLgbLsLsmbLsbLsLgbLsLgbLgLsLsmbLibLsLsLsLimmbLibLg
bLgLsbLgLsLgbLhLsLibLiLsbRsbLgLsbRsbLsbLsbLgbLsbLgRsbLgbLsbLsbLsLsmbLg
LsbLgLsLsLgmbLsLsmbLsbLgbLgbLgbLgbLsbLsbLgLsbLsbLsbLsRsRsmbLsLsmbLgbLg
bLgLsbLsLsmbLgbLgLsLsLsmmbLhbLgLsbLgbLgbLcLsmbLgbLsLsLsmmbLeLsbLeRsbLh
LsbLhLhLsbLgbLgbLibLgLsbLsbLgRsbLibLcbLgRsLibLhLebLeLsLsmbLibLeLsbLibL
eLsLsLiLeLsmbLibLsbLgbLgbLsLsmbLsbLibLgbLiLsbLibLgLsLgbLgbLcbLiLsLhbLi
LibLiLgLsLeLgLebLiLsbLhbLibLobLgbLobLibLiLhLibLeLiLsLiLeLsLebLeLeRebLe
LsbLhbLebLibLibLibLiLsbLibLhbLiRsLiLsbRsLcbRgbLhRsbLgbLgLsbLgbLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bRsbLebLcbLsbReRsRsmmbRibRsbRgRsmbRhbRibRhbRgbLcbLcbLcLsmbLibLiLsbLebL
gLiLgbLiLsLobReRsRsRsmmmbLhLsbLgbLhbRgbRjbRgbRibRgRsmbRgbRobLgbLibLgbL
gLsbRsLsbRhbRsbLsbLiLsbLiLsbLgbLsRgbRebRsbLjbLcbRsbRobRhbRgRgbRibRebRi
bRibLgbLcbLcbLiLsbLibRibRoRsmbRsLsbRibRgbRibRiRsLsmbRiRsmbLgbLcbLcbLeb
RcbRhRsmbRgbRcbRibLsbRgbLcbLibLibLibLgLsbLjbRsbLsbLsbRsbRsbRgbRiRsLsmb
RgbRibReRhbRsLsbRsbRebLsRgbRibLibLobLibLcbLhbLibLibLhRsbLcbRibRibRgbRs
RgLsbRgbRsbLsbLhbLcbLebLsLsmbLhLsbRibRgbRgbRibRgbRgbRsbRiLsbRgbRebRsbR
gbRsbRgRsRsmmbRibRebRsLsbLsbRsLsLsLsRsmmbLsbRgbRibRsbRiRsmbRsbRebRhbRe
bRebRebLcbLgbLibLibLibLjbLcbLibLoLsmbLibRiLsbRhRsmbRgbRgbRgRsmbRgbRgbR
gbRibLhbLhbRgbRcbLjbLibRjLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bRcbRebReRibRcbRgRibRcbReRibRibRgRsmbLobLgRsbLiLsbLiLsbLibLgbLibLiLsLs
mbLgLsbLiLsbLhLsbLiLsbLiLsbLibLibLibLibRcbRgbLebRiLsRsbLebRcbRibRgbRiR
smbRsbRiLsbRsRgbRgbRsbRsRgbRsbRsbRebRgLsbRsbRgRsmbLhbLcbLibLiRsRsmbLiR
sbLibLibLgbRibRhRsmbLibLcbLiLsbLiLgLiLsLsmbLiLsbLgRsbLiLgbLibLcLsmbLib
LiLsbLeLgLibLiLibLgbLgbLiRsbLsbLibLiRsbLiRsbLiLsbLgbLgLsbLibLibLibLebL
gLgLgRsbLeRsbRcbLjbLiLsLsmbLgLsbLibRjbRcbRebRgbRiRsmbRiReRsmbRibRgbRiR
sRsmmbRibRibLhLsbLibLiLsLhLsbLgbLsLsmbLgbLiRsbLsbLiLsbLoRsbLgbLgbLibLi
LsbLibLiLsbLeLsbLibLgLgbLsbLiLsbLibRibRgbRibLgbLsbRgbLjbRcbRiRsmbRiLsb
LgbRhbRibRibRgRsRgmbRgRsmbReRsmbRgRgbReRsmbRgbRiRsmbRgbRgbRgLsbRsbRgbR
sRsmbLsbRsRsmbRsLsbRsbRibLibLcbLgLgbRsbRjbRsbRcRibRgbRobRsbRhRsmbReRgb
RsbLsRsbRhbLsbLoLjLsLimbLiLibLiLsbLibRgRibRhbRibRgbRsRiRsmbRsbRibRsRsm
bRsRsmbRiRsmbRsRsmbRgRgRsRsmmbReLjbRgbLibLgbRjbRhRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
bLgbRsRcbRiRgbRcbReRiRibRibRibRgRsRsmmbRgbRhLsbRgbLgLsbLgbLsLgLsbLobRs
bRibRgRsmbRhbRgbRiRgbRgbRgRiRsmbRcbRiRibRhRsRimbRiRiLsbRhbRsRsReRgmbRi
RsmbRibRibRcLsReRsReRembRebRcbRiRsmbRibRobLgLsLsmbLgRsbLhLebLebLgRsLsb
RhRsmbLibLgbLibLibLsbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
bRebLebRcbRiRsmbRiRsmbLiLhbLgbRebLebLhbRcRsmbLoLgbLeLsLsmbLeLeLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bLsLgbLibLibLgbLiRsbLibRcRsmbRcbLcbLhbRcbRcbRibRibLsLobLsbLobRsLcbLobL
ibLiRsbRcRsmbLjbLcbRjRhbRibRiRsRsRsmmmbRiRsmbRiRsmbRibLjbRibRgbRiRsmbR
ibRibRiRsmbRsbLjbRibRsRgRsmbRsRsmbRgbRgRsmbRgRsmbRsRsRsRsRsRsRsRsmmmmm
mmbRjbRibRiRsmbRebRobLcbLcLsmbLcbLcbLhbLhbLhbLobLhRsbLhbLhbRiRsmbReRsm
bRsRobRibRsRobRcbRibLjbLgbLibLgbRiLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bLgbLgbLsLgLsRsbLsLsmbLiLsbLiLsbLsbLiLsbLgbLgLsbLsLsLsmmbLibLgLsbLgbLg
bLgbLgLsbLgLsbLibLibLibLgbLibLcbLibRibLsLibLsbLibLgbLgbLsbLgbLibLibLgb
LhbLhbLebLibLibLibLgbRsbLibRjbRjbRibRgbRgbRgbLjbRsbLhbLibLgbLgbLibLibL
ebRjbRcbLhbLsbLibRjbRhbRiRsmbRibRibRibRgbRibLgbRibRibRibRibRgbLjbRibRi
bLsLsmbLibLgbRsbLibLibLibLibLsLsmbLgbLibLgbLibLibLibLebLebLeLsbLibRebR
ibRibRhbRgbLsbLibLiLhbLgbLebLgbLgbLgbLgbLibLibLibLibLibLgbLebLhbLgbLeb
LsbLiLsLsmbLibRjbRibRibRgbRgbRgbRgbRgbRgRsmbRcLsbRibLgbLibLiLsbLebLgbL
ebLsbLebLsbLgRsbLibRgbRibRibRibRgbRibRgbRgRsmbRgbRgbRibRibRgRsmbRgbRgb
RebRgbRgRsRsmmbRsbRsbRsbLsbRhbRiRsmbLsRsbRcbRgbLiLhbLgbLgbLibLsbLgbLiL
sbRsbLibLiLibLgLsLhbLiLsbLeLsbLeLebRcRsmbRiRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bRgReReRsmbRebRebRsRjbLibRibRgRibRsbLcbLgbRjbRsRcbRebRsbLibLibLsLhbLsb
LcLsmbLhLsRsRsmbRibRoRsmbRebRjbRibRebLgbRsRsmbRsbsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bRsbLibLibLgRsbLibLcbLcLsLhmbLgLeLsbLgbLgbLgLsbLebLiLebLgbRsbLcbLcbLiL
sbLhbLibLgbLebRjbLcbLibLiLiLsbRsbLcLsmbLgbLibLgbLgbLgbLsbLgLsbLsbLgbLs
bLebLsbLgbLiLsbLsbLsRsbRsbRibReRsRimbRibRibRsbLgRsbLgbRsbLsbLsbLgLsbLs
LsmbLsbRsbLgbLsRsLsbRsbRsRsmbRsbLsbRebRebRgbRgbRsRsmbRiRsmbRsbRgRsmbRg
bRgbRsLsbRsbRsbRgbRgbRgLsbRgbRsbRgbRgbRsbRsRsmbRsbRsRsRgmbRsbRsRsmbRsb
RgbRgbRgRsmbRsLsbRsbRgbRsRsmbRsRsmbRsbRgbRgRsmbRgRsmbRsbRgbRgbRgbRsRsm
bRgbRgRsRsmmbRgbRgbRgbRgRsmbRsbRsRsmbRgbRgbRgRsmbLsbLsbRibLhbLiLsbLibL
ibLgbLgbLgbLgbLgRsbLgbLiLcbLgLeRsRsmbLibLgbLgbLgLsbLgbLsbLsbLgbLgLibLi
bRgbLibLgbLgbLgLsbLgbLiLsbLiLcLsLsmmbLgbLibLiRsbLjbRibRcbRcbRsbLhLsLib
LebLeLsbLibLcbLhbLiLsbLibLgbLcRsLeLsbLeLsbRebRiRibRgRsReRsRsmmmbRibRsb
LsbRiRsmbRhRsmbRsbRibLibLgbLgbLgbLsbLibRgRsmbLibLiLsbLgbLgbLibLgbLgbLg
bLgbLgbLsbLsRebRibRgbRgbRsbLsbReRsmbRiRsRgmbRgbRsRsmbRgbRebRiRsmbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bLcb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bLsbRjbRsbRsbRibRgbRsRebRsRsmbRsbRsRsRimbRiRsmbRgRsRembRgbLjbLhbLiLsRs
bLgLsbLgLsbLgbLebLibLibLibLibLgbLibLibLiLsLgLibRjbRiLsbRibRibRgRibRgLs
bRiLsbRibRgbRibRibRsRsmbRobRibLgbLgbLgbLibLgbLibLsbLgbLsLsRsmbRcbRebRh
RsmbRgbLjbRibRgbRsbRiLsbLgbRgbRibRgbRhbLsbLiRsbLebLibLhRsbLgbLgbLibLgb
LibRsbLiLsbLgbLjRsbRgbRsRsRgRsmmbRgLsLsmbLgbLobLgbRibRibRgbRibRsbLsLsm
bLjbRibRibRgLsbRibRgbLjbLibLsbLsLsLsmmbLsbLgRsbRobRsbRsRsRsRsmmmbRsRiL
sbRsRibRsbRsRsRsLsRsRsRgRemmmbRhbRsbLobLjbLibLgbLgbLibLgLibLiLsbRsLsbL
iLsbLsLsmbLgbLibLibLiLgLsbLsbLgLsbLebLgbLgbLgbLgLsbLibLsbLibLibLsLsmbL
ibLsbLibLgbLibRsLsbLsbRjbRhbRsbRibRgbRibRsbRsbRsRgbRgbRgbRgbRgbRgbRsbR
gRsmbLjRsbLjbLjbRsRibRgbRsbRgRsmbLsbRsbRsbRiRsRembLsbRgbLgbRibRsRsmbRs
RgbLsRsbRsRsRsRgRsmmmbRgbLgbRibRibRiRsmbRgbLgbRgbRgbRgbRsbRgRsmbRsbLsb
RsbRgbRsbRsbRsbRgbLsbRgRsRsRsRsRsRsRgRgRgRsRgmmmmmmmbRgbLsbRibRgbRgbRg
bLsbRgbRsRgbRgRsRsRsRiRsmmmmbRgbRgRsRgmbRgbRgRsmbRibRibRiRsRsRgRemmbRs
bLgbRjbRsbLobLsbLibLgLgLsLsmbLgbLsbsbLsLsLsmmbLgLsbLgbLgbRsbLiLsLsmbLs
LsmbLgbLsbLsbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 19; Drug: Control Apo 50 然
bLgbLgbRibRjbRgRgbRsbRibRgbRgbRgRsmbRibRibRsbRcbRiRgbLsbRiRsmbRgRsmbRg
RsmbRgLsbRibRgbLgRsRsmbRiRsmbLebLgbLibLsbLibLiLsLsmbRsbLibRhRsmbRibRiR
smbRibRibRgbLjRsbLgbLgbLiLsbLiLsbLgbLgbLiLibLsbLibLibLeLsbRsbLgbRcbRsR
ibRgLjbRibRgRsmbRsRibRibRibRgbRibRibLgRsbRobRgbRgbRsRiRsmbRgbLjbRebRhb
RgbRgbRgbLibLjbLibLgbLgbLebLgLsbLibLsbRebRsRibRgbRgbRgbLjbLibLgbLgbLgb
LiLsbLebLsLsmbRsbRjbRibRibRgbRgbRibRgRsRsmmbRsRsRsmmbLsbRibRgbRgRsmbRi
RsmbRibRgRsmbRgbRibRgbRibLcbLjbLcbLebLebLgbRcbRjbRibRgbRiRgbRibRibRsRs
mbRgbRgbRgbRobLgbLgbLcbLgbRibLcLgbLebRiRsRsmmbRibRgbRhLsbRgbLgbLcbLgbL
gbLibLibLgbLgLsbLibLgbLiLsbLgbLgbLibRsbLebLsbRibRebRiLsbRgbRgbRgbRgbRi
LsbRibRgbRgbRibRgbRgbRibRebRiRsmbLiRsbLibLgLsbLgbLgbLiLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 20; Drug: Control Apo 50 然
bRhbRhbLcbRibsbsbLcbLgbLeLgbLcbRgbRcRsRgmbRebRebRebReRsmbRhbRgbRsbRgRe
bRebRgRsmbRgRsmbRobLsbLsbLiLsRsbLcbLsbRibLjbRoRsmbRjbRsbLibRsLsbLiLsLs
RsmbLgbLcbRiRsmbRiRsmbLgbRiRsRsmmbRgbRsRsmbLiLsLsmbLhbLgLsbRibRhRsmbRe
bRibRcbRjbLsbLebLobRhRsRsRsmmmbRiRsmbRcbLiLsbLebRgLsbLjbLibLibLibLibLo
bLsbRibRibLcbLsLsmbLcLsmbLebLibLib

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 21; Drug: Control Apo 50 然
bLiLibLebLibLebLhbLgbLsbLibLcLsmbLibLhbLibLibLhbLiLsbLibLgbLoLsmbLibLe
bLiLgLsbLgbLhLsbLibLgbLhbLibLgbLobRhbRibRiRsmbRcbRoLsbRgLsbRcRsmbLgbRj
bRgRsmbRsRsmbRibLsbRhRsRsmmbRebRcbRebRebRhbRhbRhbLjbRobRibRobRgbRebRcb
LibLhbLibLgLibLgLsbLgLsbLgbRgbRjbRjbRhbLibLebLibLibLgLsbLibLibLiLsRsbL
gLsbLsRsbRsLsbLiLsLsmbRsLsbLibLsbRebRgbRgbRgbRgRsRsRimmbRibRcbRebLeLsb
LgbLibRgRsRsmmbRhbLgRsbRibReRsRsmmbLiLsbLhbLibRcRsmbRhbRcbLibLebRjbLeb
LsLsmbLeRsLsbRsbRcbLibLcbLgbLgbLgLsbLsbLgRsbRsLsbLiLsLsmbLgLgbRsLsRsbL
iLsbLibLibReRsmbLjbLhRsbRgLgbLiLsbLibLgbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 22; Drug: Control Apo 50 然
bLsRsbRebReRebRebRebLjbLhLsbLgbLgbLjbLebLhbLgLibLsbLsbRgbLjbLcbRiRsmbR
gbRibLobRsLhbRcbRibRobRibRhLsbLcbRibLobLibLgbRcbRibLibLcbLibRcbRibLobL
ibLsLsmbRobRibLobRsbRobRgbLgbRiRsmbRgbLjbLebRobLjbRobLjbLjbLibLcbRibLc
bLoRsbRibLobLsbRobRobRibLcbReLsbRebLsbLobLsbLsbLiLsbLjLgbLibRebRibRibR
obLhbRiRsmbLgbLhbLebLibRjbLiLsbRcbRhbRebRiRsmbRgbLhbLeLsbLgbRcbReRsmbR
obRcRsmbRgbLcbLjbLibRjbLjbRhbReRsmbRcbLgbRcbRebLibLjbLibRjbRebRibLsReb
LsbRcbRhbRcbLibRibLcLsLsmmbLibLhbRhbRibLcLsmbLibRobRibRebRgbLcbRgbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 23; Drug: Control Apo 50 然
bLsbLiRsbLgLsbLgLsLsmbLibRibRibRgbRcbRibRibRgbRgbRiRsmbRebRibRibRgbRib
RgbRibRgbLgbLobLibLiLgLgbLgLsbLiLsLeLsLebLeLsbRcbLcbLobRsRcbLiRsbLoLsL
smmbLebLsbLgLsbLgbRjRjbLjRsbLjbLsRsbLsLsmbLgbLibLibRibRibRibRibRibRgbR
gbRgbRgbRsbRiRsRsmmbRsRsRsmmbRjLsbLibLibLgbRsLsbLgLgLsbLgLsbLgbLgbLgbL
gbLibLiLebLsbRsLgLgLsLsmbLgLsbLhbLhbLgbLibLjbLibLgbLibLiLsbLibLiRsbRsb
RjbRcbRibRgbRhbRibRibRgbRgbRgRsmbRiLsbRhbRibRgbRibRgRsmbLsbRsRgbRsRsmb
RsRsRsRsmmmbRgRgbRhRsmbRibRibRsbLhbLibLibLiLsbLibLibLiRsLsbRsRsRsmmbRg
bRgRsRsmmbRsRsRsmmbRsRsmbRsRsmbRgLsbLjbRgbRjbRgbLjbLsbLibLibLsbLgbLsbL
gbLgLsbRcb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 24; Drug: Control Apo 50 然
bRgbLsRsbRibRgRsLsmbLsRgbRibRiRgbRgbRgbRiRsmbRiRgbRsbRgbLjLsmbLibLsbLe
bLebLgLsbLibLsbLibRjbRjbRjbRgbRgRsRsRgmmbRsbRgbReRsmbRgRsRsmmbRiRsmbRi
bRibRiRsmbRsbRgRgRsRsmmbRgbLjbLjbLibLgLsLsmbLgbRsbRjbLsLsmbLjLsLsLsLsm
mmmbLgLsLsmbLibLhRsbRgbRibRibLjbLgbLibLiLsbLgbLsLsLsmmbLiLgLsbLgbRsbRj
bLeLsbLgbLhbLgbRibRgRsmbRgRsRgmbRgLsRsLsbLjbRibRibRcbLgbRjbRjRsmbRgRsm
bRibLsRsRsRsRsRimmmbRgRsmbRgLsbLjRsbRsRsmbRiRsmbLjbLebRcRsmbLsRsbRibRs
bRsRsmbRsRgRgbRsRsRsmmbRhRsmbRgbReRsmbRhbRebRiRgbRgbRgLsbRiRsmbLsbRsbR
ibRibLjbRjRhbLibLjbRcRsmbRgRsRsRsmmmbRibRgRsRsmmbRibRgRebRgRsRsmmbReRs
mbRsbRgbRibRgRsmbRsbRsRsmbLsRibRgRsmbRgbRsRsRgmbRsRsmbRgLsbRsRibRgbRgb
RibRsbRgbRhbRsbRiRsRsmmbRhbRibRebLsRebRgRsmbRgbRsbRgbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bRgRsmbRgRsmbLsbRsbRgRsmbRgbLgbRgRsmbRgbRsbRsRsmbRibRgbRgRsRsRgRsmmmbR
gbRgbRgRsmbRibRgbRiRsmbRibRgbRgRsmbLgbRgbRsRsmbLgbRgRsmbRsRgbRsbRibRib
RgbLgbRibLsbRgbRgbRgbRgbLsbRgRsmbRgRgbLsRsRsRsmmbRgLsbRgRgbRgRsRsmmbRg
RsRimbLsLsmbRgbRsbRgRsmbLgLsbRjbRebRgbLgbRibLsbRsbRsbRgRsRgRsmmbRgRsmb
LsRsbLsbRiRsmbRgbRgbRibLgbRgbRibRgbRgbLsbRsRsRembLgbLibLgbRsbLibLgbLgb
LsbLsLsLsmmbLsLsmbLsbLgbRebLsbRiRsmbLsbRsbLsbRebRibRgbLgbRsbLobLobRgbR
sbLsRsbReRsmbLgbRebRgbRebLgbRsbLgLsbLibRsLsbLsbLsbLgbLgbLibLgbRgbRsbRs
bRibRgbRgbRibRgbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
bRgbRgbRhRsmbLsLsmbLgbRibRibRgbRgRsmbRgRsmbRibRiRsmbRibRsbRibRibRgbRgb
RibRiRsmbRibLsbLjbLjbLiLgLsbLgbLiLsRsbLgLsbLgLsbLgLsbLgbLgLsbLhbLsbRjb
RibRsRsmbRibLsbRgbRgbRibRgbRgRgbRgbRgbRibRgbLsbRibLgbRsLjbLgbLgbRibRib
RibRibRhLsbRibRhRsRgmbRibRgRsmbRhbRgRgbLsbRibLibLiLiLsLsLsLsLsmmmmbLib
LgLsbLhbRgbRibRibRsbRsbRgRsmbRibReRsmbRsRsRsRsmmmbReRgbRgbRgbRsbRsbRsb
LsbRibRgRsmbRgbLjLibLgbLgbRgbRjRsmbRgbRgbRibRibRgRsRimbRsbRgRsmbRsRsmb
RgbLsbRhbRhbRiLsbRibRebRhbLsbRibRibRibRibRibRsRsmbRsRsRsRsRsRsmmmmmbRi
bRgbRgbRibRibRgRsmbRsLsbRgRsRsmmbRibRibLsRsbRsRsmbRibLgRsbRibRiRsmbReR
smbRgRsmbRsbRgRgbRsbRibRibLgbLjbLgbLebLsLsLsmmbLsbRcbRibRgbRsbRebRsbRg
bRibRsRsRgmbRiRsmbRgRsmbRiRsmbRibRebRebRhbRgbRsbRibLsbLhbLsbRsbRcbRiRs
mbRhRsmbRcbReRsmbRcbRcbRhRsmbLsbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bLiRsRsRsmmbRcbLobLcbLiLsbLibLsLsmbLibLgbLhbLibLebLiLebLeLsLsmbLeLiLsb
LebRcbRcbRgbReRsmbRibLsbLsbLsbRcbRcbRebRibRebRibRgRsmbRhbRiRsRhRgRsRim
mbRebRjRgbLob

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bRsRjbRebRgbRiRsmbRibRiRsmbRgbRibRiRsmbRgbRgbLsbRobRgLibLsbLgbLsbLsLeb
LebLiLebLeLgbLiLhLsLgLsLebLgbLibLibLiLsLibLsRsRsmbRjbRsbRhbRibRgbRiLsb
RsbRibLcbLiLsbRjbLsbLhbLibLibLjbLcbLgbRjbsbLsRsbLsbRsbsbLsbsbLsbsbsbLs
bLsbLsbRsbRsbRsbsbRsLsbLsbRsRsmbRsRsmbsbsbRebRebLeRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
bRebRsbLhbRiLsbRebRibRibRgbReRsmbRibRebLgbRhbRiRsmbRgbRgRsRsmmbRibLsRs
bRsRsmbRiRsRsmmbRibRebLsRsbRhbRibReRcbRgbRibLcLsmbRebReRsRsmmbRcbRcbRh
LsbRcbRobRcRsRembRsbRibRjLsbRcbRcRsmbRhbRiRsmbRiRobLiLsLsmbLiLsbLebLeb
LgbLgLsbRebRcbRibRibRibRebRebRibRebRibRhbRgbRcbRibRibLibLibLibLhLsbLcb
RsRebRgbRebRhbRhbLjbRjbLibRjRsmbRibRsbRibLgbRgbRiLsbRibRgbRhbRsbRgbsbR
gRgbRgbLgRsbRibRiRsRsmmbRsbRebRsbRsbRsbRibRgbRgRsmbRiRsmbReRsmbRibLsbL
ibRcbRebLjbLibLobRgbRcRsmbRcbRobRgbRebRjbLjbLcbLibLibLibLgbLibLeLsbLsb
RhRsRsmmbRsRsmbRibLsbRsRebLsbRgbRgbRibRibRhbRhbRobLhbLcbLhbLibLhbRsbRi
RsmbRebRibRgbRgbRibRibRcbRibRibRgbRibLjbRobReLsbRgbRibRsbRgbRibRgbRcbR
hbLibLibLibRsbLgbLibLibLgbLgbLgbLgLsbLhbRibLcbLibLgbLsbRebRibRgRsmbRgb
RibRibLsbRibRibLgbLgbLgbLgbRsLsLsLsmmbRsbRiRsmbRgRsRsRsRsmmmmbRibRsRsm
bRsbLsLsmbRibRibLsbRibRibRibRib

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bLgLiLgLgLsbLgbLsbLebLibLgLgbLebLcLsmbRibLiLgbLgbLgbLhLsLsmbLibsbLgbLg
bLibRgbLibLibLgbLsbLgbRgbLhbLibLobRsbRgbRgLsbRgRsRsmmbRgbRgRsmbRgRsRsm
mbRgLsbRibRiLsRsbsbLjbLobLsLsmbRobLibRsbLgbLiLsbLgbLgbLgbRcbRgbRgRsmbL
sRgRsmbRgbLsRsRsRsmmbRgbRgbRsbRsRsmbRsbLibLgbLgLiLsbLibLibLgbLibLsbLhL
sbLsbLgbLiLsbLsbLgbLibRsbLibLibLgbLebLibLhbLgLsbRjbRgbRgbRgbRgbLgbRgbL
gbRgRiRsRsmmbRgbRebRcbRibRgbRhbRebRebRsbRsbRhbLibRgLsbRgbRebRebRgbRebR
ibRobLsLiRsbLibLibLgRsbLgbLgbRebRsRsRsmmbRiRsmbRebRgbRsbRsRgRebRgbRsbR
iRibRiRsmbLjbLcbLgbLibLibLjbRsbLibLgbLiLsbLgbLsbLsbLsLsLsmmbLebRgbLgbs
bLebLeLsbLiLebRsbLgbRsbLgbLgLsLgLibLibLgbLgbRhRsmbRgRsmbRebRgRibRibRsb
ReRgbRibRobLgbRibLibLiLgbLsbRsbLiRsbLgbRgbLibLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
bLsbRsbRsbRjbRsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bRjbLeRsbsbRsLsbLsbsbLsLsmbRsbLebsbLibRsLsbLiLiLsbLhbLebLsbLgbLgLsbRsb
LsbLibLiLebLibRsbLiLsLsLgLsmbLibLgbLiLgLibLgbLeLgLsLebLibLeLsbLgLgLsbL
ebRebLgbLibLebLeLebLhbLgbLobRhbRhRsmbRcRsRsmmbRgbLsbLeLsbRsbRsRebRoReb
RiRsRsmmbRsRebLebsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bRibRiRsmbRgbRibLgbLjbLcbLibLgbLgLsbLiRsbLoRsbRibRibRgRibRibRgbRibLsbR
gbRibRibRiRsmbRibRgLsLsmbLhbLgbLgLsbLgbLgbRjbLsRibLhLsbLibLgRsbLgbLgbL
gbLibLgLsLsmbLgbLgbRjbRibRibRibLsbRiRsmbRibRibRgRsRsRsmmmbRibRiLsbRibR
gbRgbRgbRibRiRsmbRgbRgbRgbRgbLgbLjbLibLibLgbRsbRhbRgbRibRgbRgbLsbRiRsm
bLsRgRsmbRgbRibRgbRiRsmbRibRgRsmbLgbLsbRibLgbLcbLibLibLibLibLgbLibLibL
gbLgLsbLgLsbRcbRgbRibRiRsLsmbRibRgbRiRsmbRsRsmbRibRsRsmbRibRibRibLibLg
bLgbLibRcbRibLebLibRibRibRiLsbRgbRibLsbLhbLibLhbLsbLgbLibLibLiLsbLgbLs
bLiLsbLibLibLgbLiLsbLgbLobLgbRibRibRgbRgbRgRsmbRgbRibRhbRibRgbRiRgbRib
RhbRibRibLiRsbLgbLhbLsbRibRgRhbRgbRgbRibLcbLgLsbRibLgbRgbRibRibRibRgbR
iRsmbRgbRibRibRibRibRibRgbRibLsbLjbLibLiLsbRcLsbReRibRsbRibRibRsbRibRi
bRebReRsmbRibRiRsmbRiLsbLsbLibLibLsbLgRsbLibLgLsbLgLibLibLiLsbLgbLgbLg
LsbLgbLgbLsbLibLiLsbRjbRibRibRgbRgbRgbRiRsmbRgbRgbRibRgbRibRgbLsbRgbRg
bRibRibRiLsbLsbRibLgbLcbLibLgbLgbLgbLiLsRsbLgbLgbLgRsbLibLibLgbLibLgbL
sbRcbRibRiRsmbRibRibRibRgbRhbRibRibRgbRgbRibRgbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bRgbRgRsmbRibRgRsRsmmbRgbLjbRebRgRsRsmmbRgRsRsmmbRgbRgbLibLibLibLsbLib
LiLsbRobLgLsbRgbRhRsRsmmbRibRibRgbRibRgbLibLgbLibLgbLibRsbRiRsmbRgRsRs
mmbRgbRsRsRsmmbLsLcbLgbLebLsbLsbLsbRibRibRsbLsLsmbLsbLsLsmbRiRsmbRgRsR
smmbLjbRjbLjbLibRgbLsbRjLsbLibLgbLgbLgLsLsLsmmbLsLsmbLgLsLsmbLgbLsLsmb
LsLsLsmmbRibLibLsLsLsLsmmmbLgbLgbLhbLiLsbLibLsLsmbLsbLgbLsbRgbLgbLgbRj
bRibRgbRgbRsRsRsRgRsmmmbRgbRiRsmbLsbRibRgbRsbRibLsbRibRgRsmbRgbRgbRgbR
gbRgbRgbRibRibRgRsmbRibRgbRgbLgbRibRsbRibRgbRsRsmbRiRsmbRgbRgbLgLsbRhb
LibRgbRgbLsLsmbRhRsmbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bLibLhbLibRcbRoRsmbRhbRcRsRsmmbRhLsbRgRsmbRibRoRsmbLsbLibLcbLibLcbLibL
gLsbLgbLgbLibLgbLgbRsbLgbRebLsbRgbReRsmbRcRsmbRhbRobRhbRsRibRibRiRsmbR
gbRhbRsbLcbLiLsbLhbLgbLgbRgbRsbRgbRgbLibRgbLcbRsRsmbLibRibRgbRgbRibRib
RibLibLgbLsbLsbLobLgbReLsbRibLcbLhLibLgLsRsbLgbLgbLibLsbLgbRcbRhbRsRsm
bRibRcbRsbRcbRiRsmbRhbRebRhbRebRgbRibRcbRgbRgbRhbRgLsLsmbRsbRiRsmbRgRs
mbLobLhLsLsmbLgbLgbLgbLsLsmbRebRobRsbLibLsbLcbLsbRsbRibRsbLjbRsbLgbReb
LibLibRebLibRjbLhbRcbRibRhbLhbLgbLgbLjbLobRiRsmbRgbsbRgbRibLobRgbRibRi
bRcbLibLibLcbRgbRcbRcbLsbLibLibRhbRobRgbRsbLsbRibRgbLibRibRibRiRsmbRcb
LibLsbLibLibLibLsbLibLibLibLsbLsbLibLsbRjbRgbRhbRibRcbRobRcRsmbRgbRibR
gbRibRibRcbRcbRibRgbRgbRgbLsbRhbRcbRibLgbLgbLibLibLgbLgbRjbRhbLsbRcbRg
bLsbLhbLiRsbLibRsbLiRsbLgbsbLgbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bRsbRsbRjLsbRcbRcbRhRsmbRgbRgRsmbRibRiRsmbRcbLjbLibLgbLibLgLiLsbLgbLib
LiLsbRsRsmbLgbRjbRibRibRgbRibLiRsbRibRebLjbRhRsmbRgbLgbRibLcbRibLcbRjb
RjLsbRiRsmbRsRsRsmmbRiRsmbRibRiRsmbRgbLsbRiRsmbLsLsRsmbRibLjbLhbRjbLsR
sLibRhRsmbRgbRgbRibLeLsbRhbRhbLebRhbLcLsmbLibRjLsbsbRjRjRsRsmmbLjLsLsm
mbRiRsmbLjbRiRsRsRsmmmbRjLsbRiRsmbLibRoRsmbRobLsbLibLiLsbRcbRcbRiRsmbR
cbRhLsbRibLcLsmbLibLibLibLibLiLsbLiLiLebLcbRhRsmbReRcb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bLobRebRsRsmbRgbRibRgRsmbsbRsbRsbRiRsmbRsbReRsRsmmbRhRsRsmmbRsbRgbRgbL
sbRgbRhbRgbRgbRgbRgbRibRhbRsLsbRgbRibRgbRibRibRibRgbRibRiLsbRsbRgRsmbR
ibLsbRsbRibRibRgbRgRsmbReRcRsmbRiRsReReRiRembRibRhLsbRgbReRsmbRgbRibRg
LsbRibRsbRiRsmbRgbRiLsbRiRsRsRsmmmbRiRsLsLsmmbRgbRibRibRsRgbRsbRiRsmbR
gRsmbRibRibRsbRcRsmbRibLsbRiLsRsbRiLsbRgbRiRsmbRsbRiRsmbRsRgbRgbRgRsmb
RibRgRsmbRsRgbRiRsLsmbRgbRgbRibRsRgRsmbRgbRgbRebRsbRhbRibRgbRibRgRsmbR
ibRgbRgbRgbRiRsmbRsbRibRgRsLsRsmbRibRgRsmbRiRsmbRibRgbRiRsmbRgRsmbRgbR
gbRgRsRsmmbRgRsmbRgbRsbRgbReRsmbRibRgbRgbRgbRgRsRsmmbRibRsLsbRgbRibRgb
RsRibsbRgbRiRsRsRsmmmbRgbRgRsmbRgRsmbRgbRgbRgbRibRgbRibRgRsRsmmbRgbRib
RgbRgbRiRsmbRgbRgbRgRsmbRibRgRsLsmbRgbRgbRgbRgbRgbRgbLsRsbRsbRibRgbRgb
RiRsmbRgbRsRsmbRgbRsbRgbRibRsbRgbRgbRibRibRgRhRsmbRsRsmbRgRsmbRgLsbLsb
RsRsRgRgRsmmbRiRsmbRgbRiRsmbRgRsRsmmbRibRgRsRsmmbRibRiRsmbRsbRgbRibRib
RibRiRsmbRiRsmbRibRibRgbRgLsbRibRgbRibRgbRgbRgbRgRsmbRiRsmbRgbRibRcRsm
bRsbRgbRibLsbRgbRiRsmbRgRsmbRibRgRsRsmmbRsbReRsRsRsRsmmmmbRgRsmbRibLsb
RgRsmbRgbRgbRsRsRsmmbRgRsmbRgRsmbRgbRiRsmbRsbRgRsmbRgRsmbRgbRgbRgbRgRs
mbRgbRgbRiRsmbRgbRiRsmbRgbReRsmbRsbRsbRgbRhbLsRsbLiLsbLgRsbLiLsbLhbLhL
sbLiLsbLiLcbLibLgbLsRsbLgbLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bRiRsmbRgbRgbRiRsmbRgbRhbLiRsbRgbRgLsbRgRsRsmmbRsbRgLsbRsRsmbRgRsmbRgb
RibRibRibRibRgbRibRibRiRsmbRgbRiRsmbRgRsmbRgbLeLsbLiRsbLibLibLibLgbLiR
sbLsbLgLsLsmbLibLsLiLsbLsRsbLibLgbLiLsbLibLibLibLgbLsbRsLsRsLsbLsLsmbL
sLsLsmmbLsLsmbLgRsbRhRgbRsbRgLsbRsRsmbRsbRgbRsRsmbRsRsmbRgbRsRsmbRgRgb
RgbRgbRibRgRsmbRgRsRsRsmmmbRgbRgRsRgmbRgRsmbLsRsRsmbRgbRgRsmbRgbRgbRsb
RgbRsLsbRgbRgbLsRsbRsRsRsRsmmmbRsbRgbRgRsmbRgRsmbRsbRsbRsRsmbRsRsmbRgR
smbLsLsmbRiRsmbLsLsLsmmbRgLsbRgbRsRsmbRcbRgbRhRsmbRibRoLsbRgRcbRgbLobR
sRsmbLoLsmbLeLsbRsLebRsRsmbRsbLeLsbLsbLibRibRhbLgbRibLibRgbRibRibRibRh
RsmbRibLjbRsRgbRgbRibRgbRgbRgbRgLsbRgbRiRcbLibLibLibLgLsbLibLgbRjbRhbL
oRsRgbRibLsbRgRsRsmmbRgbRibRhbRsRsmbRgbRsbRgbLsbRgLsRsbRsbRgbRgRsmbRiR
smbRgbRibRgbRgbRiLsbRgbRgbRgbRcbLgbRibRgbLiRsbLgLsbLgLsbLgLsbLiLsbLsLh
bLcbLgLsbLsLsmbLiLgbLsLsLsmmbLgbLgbRiRsmbRgbRgbRgRsmbRiRsRsmmbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
bLebLeLsbLgbLsLsmbLgbLgRsLsbLgbLgRsbLebLsbLsbRjbLgbLebsbLobRgbLibLjbLg
bLiLsbLgbLgbLgbLhbLiLsbLgbLcRgbLcLsmbLeLsbLjbLibLibReRsmbRgbRhRsmbRgbR
ibRibRibRgbLjbLibLgbRjbReRsmbRhbLiRsbRibRoRsmbLgbLiLsbLibLiLsbLobLibLi
bLsLebLsbLgRsbRibRibLobLiLgLsbLibLhLsbLsbRhbRiRsmbRgbRiRsRgmbReRgbRobR
gbRgbRhbRgbLgLsbLibLgLibLibLgbLibLgbLgbLiLsLsmbLiLsbsbRjbLhLsbLibLibRs
LgLebLgbLgLsbLibLibLebLebRsbLgbLgbLsbLsbRjbLibLgbRibRhbRebRiLsbRiRsmbR
gbRibRiLsbRhRsmbRibRibRibRibLjbLcbLibRgLsLsLeLsmbLgLsLsLsmmbLibLibLgbL
cbLibLhbLgbRhRgbReRsRembLsbRibLjbLiLgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bRcbRgbRibLebLibLobLebRgbLsLiLibLebRgbLgbRoRsLsmbRebRcbRibRcRebRiRsmbR
ibLjbRgLsbLcbLgLsbLcbRhbLibLebLebLiLsbLebLcbLsbLibLgbLibRgLsbRhbRiRsmb
LsbRsbRgbRgbRiRgRsRsmmbRebRgbRgbLhbRcbLjbLeLsbLeLsbLibRcbRhRibRiRsmbRh
bLjbRobLjbRebRsRsmbLsbRsbRibRgRgbRsRgRgbRibLibRjbLjbLibLgbLgLsbLsbLsLg
bLsLsmbLsLsmbLsbLjLsLgLsLgmbLgbRsLsLsLgLgLsLsmmbLhbLgLsbLsLgLgbLsLsmbL
gRsbLsLsLgLgmbLgbLcbLeLsbLebLgbLgbLsbLgbLsbLsLsmbLsLsmbLgbLsLsLsLsLgLe
mmmbRsLsLgLsLgLsbLsRsbLsLgLsLsLsmmbLsLsmbLgLebLgbRibLhbLibLobRebRhbReb
LsbRibRsRsLsmbRebRgRgbRsbRibRebRsbReb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
bLsLebLeLsbLsRsbLibLcbLibLibLibLibRgbRoLsbRibRibRgLsbRgbLjbLgLibLibLgL
sbLiLsbLibLjbRebRgbRgbRibLgbRsRgbRgbRgbRibReRsmbRibLebLibLibLibLibLgbL
eLsbRjbRibRgbRjbRibRgbRgbRgbRgbRgbRibRsbLjbLibLibLibLcbLgbLebLgbRgbLsb
RsbRibRgbRibRhbRsRsmbRibRgbRgbRsRsmbRgbRgbRgbRcbLsbLjLebLibLgbLibLsbLh
bLibLibLibLcbLcbLeLsbRsLsLsmbLiLsbLgLsbRsLsLsmbLgbLgbRsLibLgbLgbLhbLgL
sbLgbLibLgLsbRibRhbRgbRsLsbRgbRebRsbRgbRgbLibLibLibLgbLgbLsLibRgbRebRo
LsbLsbLebLibLebRibLebLcbRgbLebLsbLibLgbLgbLhbLsbRsbRibRiRsmbRgbRibRiRs
mbRibLsbRibRgbRgbRsbRibRiRsmbRgbRibRgbLibLebLiLcbRsbLebLgLsbLibLebRsbL
ibLiLsbLgbLibLgLgbLebRsbLgLhbLibLiLsbLgLgbLgbRgbLsbLibLibLgLsbLgbLgbLi
b

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 43; Drug: Control Apo 50 然
bRsbRibRibRibRgbRhbRgbRhbRibRibRhbRibRgbLjbLibLgbLibLibLgbLgbLsRsbLgbL
ibLgbLsbLgbRibRsbRsbRgbRiRsRsmmbRibRsRibRgbRibRgbRgbLsbRsLsbRgbRibLsbR
ibRebRhbRgbRibRgbRgbRgbLsRsbRgRsmbRgbRibRgbRgbRibRgbRgRsmbLebLibLibRsb
LgbLgbLibRibRiRsmbRiRsmbRgbRibRibRibRhbRibRibRibRiRsmbLsbLjbLhbLgbLibL
ibLgbLgbLgbLsbLgbRgbLgbLgRsbLsbLgbLiLsbLgRsbLibLgbLibRhbRibRibRibRcbRi
bRibRibRibRsRgRsmbRibLgbLcbRibRsbLsbRsbRibRgbRebRibRsbRibRgbRgbRgbRgbL
sbRgbRgRsmbRgRsmbRgbLsLsmbRibRsRgbLgbRgbRebLjLsmbRiRsmbRgbRibLgLjbLiLs
bLibLgRsbLgbLibLsbLgbLsbLgbLsbLgbLibLibLgbLgbLebLsbLgLgLibLsbLgbLjbRjb
LibLgbLibLsbRjbLhbLibLiLsbLibLgLsbLgbLibRhbRiRsmbRgbRebRsbRebRiRgbRgbR
gbRjbRgbRhbRhbLebLibLgbLgbLgLsbLibLgbLsbLibLgbLsbLgbLgbLsbLgbLibLebLgb
LsbLgbRgbRiRsmbRcb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 44; Drug: Control Apo 50 然
bLibLiLsbLgLsbLgbLeLsbLhbLebLhbLcLsmbLibLoLsmbLsLsmbRhbRebReRsRsLsRsmm
bRibRcbRgRsmbRgbRibLhbLcbLibLcbLibLcbLhbLiLsbLiLsbLiLeLsLgLsbLibLcLsLg
mbLcbLobLhRsbLiRsbLibRhRsmbRiRsmbRibRibRgbRgbRhbRcbRiRsmbRibRgbRibLjbL
ibLiLsbLgbLebLibLiLsbLhLsbLiLsbLgLgbLgLsbLibLgbRiRgbLebRcLobRsbRjRsmbR
gRsmbLjbLcbLgbLsLsmbLgLsLgbLibLgLsbLiLsbLgLsLsLgLsLsmmbsbRebRebLjbLsbL
ebLibLebLiLgbLibLebRcbRiRiRsmbRsbRibRibRgbLjLgbLcbLsLsLiLeLsmbLsLgbRsR
smbRgbRiRsmbRiLsbRiRsmbRsRhbLibLibLsLsLsmmbLiLsbLgLsbLgLsLsLsLsLsLsmmm
mmbLsLsLsmmbLsLsmbLhbLgLsbRsRsRsRsmmmbLibLjbLcbLibLsbLgbLhbLhbReRsmbRj
bRsbRebRsLsbLibLsLgbLiLsLsLsmmbLgLsbLgbLgLsLsmbLcbLibLebLebLebLebLgbRh
bRibRhbLgLsLiLsbLibLiRsbLgbLibLebLcbRgbLebLibLibRjbRcb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 45; Drug: Control Apo 50 然
bRgbsbRjb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 46; Drug: Control Apo 50 然
bLgbLsLsLsmmbsbRsbsbRsLsbLsLsmbLgbRgRsmbLiRsbRgbRibRebRibLobLhLibLiLsb
LgbLiLsbLeLsbLibLibLgbLibLhLsbLgbLiLsbLhLsbLgbLibLibLsbLgLsLgLsLebLibL
ebLibLibRsbLhbLiRsbLiRsLsbLgbsbLsbsbLsRjRsmbRgbRsbRsLsbLsbRsRsmbLsRsbR
sbRsLsLsmbsbLsbsbRsbsbLsbLgLsbLsLsLsLgLsLsmmmbLgLsbLgbRsbLgbLsbLgbLsbL
gLsbLgbLgLsbsbLsbRsLsbRsRsLsmbLsLsmbLgbLgbLgbLsLsmbLgLsbRgbLsbRjbLhbLi
bLibLsRsbLibLsbLhbLiLsLsmbLgLsbLibLgbRgbRibLjbLibLibLiLsbLiLsbLebLhLeb
LebLibLhbRsbRcLsbRibRiLsbRcRsmbRibRhbLgbLibLgLsLgLebLgbLibLgbLgLsbLsLs
LsLsLsLsLiLsmmmmmbLeLgbLgLsbLgbLgbRsLsbRsbReRsmbReRsmbRsbRhbRiRsmbRiRs
mbLhbLibLibLiRsbLibLgbLibLibLibRjbLcbRiRsmbRgbRibRgbRibRgRsmbRiLsbRibR
ibRibRibRibRgRsmbLgbRgbRgbRgLsbRsRhRsReRgRsmmbReReRiRsRsRsRhmmmbRiRsmb
RoLsbRobRhbRiRsmbRiRsmbLiRsbRibRiRsmbReRgRsmbRibRebRibRibRgbRgbLjbLibL
ibLsbLiRsbLgbLgLsbLgLsbLsbLibRsbLibLsbLibLgbRsLsbLgLsbLgbRibRibRgbRgbR
gbRibRiRsmbRgRsRsmmbRsbRibRgRsmbRibRibRgbRebRgbRgRsmbRibRgbRgbRgbRgbLs
bLgbLibLgRsbLgLsbLgbLibLgLsLsmbLsLsmbLhbLibLgLsLeLgbRgbRcbLhLgLeLsRsbL
gbLgLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 47; Drug: Control Apo 50 然
bRgRsRsRsmmmbRgLsLsLsmmbRsRsmbRsbRsbRgbRsbRgbRsLsRsbRgbRgLsRsRsmbRgbRs
bRgbRsbRibRsRsmbRgRsRsmmbRsbRsbRibRgRsmbRgbRsbRsbRgLsLsRsmbRgbRsbRgbRi
bRhbRebRgRsmbRsbRsbRsbRgLsRsbLsbRiRsmbRgRsmbRiRiRgbRcbRibRobReRsmbReRs
RsmmbRgbRoLsbRgbLebLsbLsLhLeLsbLebLoLibRcbRoRsmbRgLsbRibRiLsbRsLjbRsRc
bLhLsbLsbLiLsbLiLhbLhLibLeRsbsbLjbRjbLiRsbLibLgbLgbLebLibLeLebRsbRgbRg
bRgRsmbRgbRhbRgbRsRsmbRgbRsbRiLsbRsLsbRsbRgRsRsLsRsmmbRgLsbLsbRgRsRsmm
bRgbRsbRgbRsRsmbRsbRsbRgbRgbRsbRsbRgLsbRsRsLsmbRgbRgbLsbRsLsbsbRgRsRsm
mbLsRsbRsbRsbRgLsbRgbRsbRsbRgRsmbRsbRsRsmbRsbRsRsmbRsRsLsmbRgbRsRsmbRs
bRsbRsLsRsLsbRgbRebRsRsRsmmbRsRgRsmbRsRsmbRgbRgbRsbRgbRsLsbRsRsRsmmbRg
RsmbRgbRgLsbRsbRgbRsRsmbRgRsmbRsRsRsRemmbRsLsbRsbRgRsmbRgbRsbRsbRibLgb
RcRsRsmmbRibLhLeLsLebLebsb

>ZF Recording 2016-03-22; tW: 300s; Start: 120922; End: 121422;
Recording: 5-1; Individual: 48; Drug: Control Apo 50 然
bLebRcLsbLjLsmbLebRjbLebRsbLibLibLgbLgbLhbRjbRgbRibLsbRgbRjLsbLjbLhbRj
bLcbLgbLibLibLgbLibLibRibLcbLebLgbRjRsmbLcbLibLcbRebLeLsbLiLsbRgbLebRs
bLiLibLsbLebLibLcRsbLsbLibRjbLhbLcbRgbLebLibLibRibLebLeLsLebLibRgbLebL
ebLebLebLibRgLsbLebRhLsbLiLsbLibLebLgbLebRibLeLsbLsLsmbLcbLibLebRgbRib
LjbLebLhbLgbRsbLcbLcbRjRsmbRgbLcbLhbLibLebLiLsbLeLsbLhbLebRgbRgbLsLibL
ibLiLsbLhbRibRgbRsbLgbLcLibLibLcbRsbLebLebLebLgbLeLsbLcbRibRibRjbLebLi
bLebRcbLebLebRibRgLsbLebLebLhbLgbLibLibRgbLibLcbLhbLcbLsbLcbRibLcbLgbR
gbLebRsbLebRgLsbLhbRsbLgbRgLsbLhbRgbLcbLcbRoLsbLhbRjbRgbLhRsbLebRgbRjb
RibRgRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
bLcbLobLobLgbRobLobLebRobLobRobRibLebRobRobRobRcbRobLsbRebLcbRcbRobLgb
LobLgbRobRobRgbRibLobLobLobRobRobRebRcbLobRcbLobLsbLobRebLcbRobLgbLobR
ebLobLobLebRobRibLobRobLobRobRobLobLjbLcbLobRcbLebLobRgbLebLobRcbLcbLo
bRibRobRcbLsbLebRobRobLsbLobRebRobRobLobRibLcbRobLebRobRcbLebLgbRsbLjb
RcbRobRebLibLobRcbRobRobLebRcbRobRobRcbRcbRcbRibLcbLsbRebRcbRebRebLebL
sbLobLobLobRgbRobRobLsbRibRcbRobLcbRobLebLebLebRebLebLibLcbLjbRobLebRi
bRebRcbRobLobLgbLobLobRcbRobLobLibLobLobLobLobLebRcbLobLobRibLebLcbReb
RebLobLobRebLobRobRobLibRebLobLobRcbRebLcbLgbLcbRobLobLobLsbRcbRebLgbR
obRibRjbLebRebLebLcbLcbRibRobLebLgbRebRcbLsbLobRobLobLobLobLobRcbLobRe
bLgbRebRobLobLebRcbLebLebLobRebRebRobRgbLobLcbRcbRobLcbLcbLcbLcbLobRcb
LobLebLjbLobRibLebLobRobLgbLobLcbRebLobLobRebLobLobRobLebLcbRobLebLebR
obRcbRobLebRebRebLobLibLcbRobLebRsbLobRebRobRcbLjbRobLobLebLebRebLhbRo
bRobRibRsbRobRibRobRsbRcbRebLebRebLcbRibRobRobRebRcbRhbRibLobRobLcbReb
LobRgbRobRcbRobLcbLcbLsbRebRcbLebRebLobRgbLobRgbLjbLobLebLebLgbLibRcbR
obLobLobRebLibLobLobLebLibLobRebLcbLobRcbLobRobLobLjbLobLebRcbLcbRobLc
bRsbRobLebRobRobRebLhbRgbLebRobLobRgbRebLobRobRebLebLcbRsbRibRebRhbReb
RebLobRobLebRebRibLobRcbLgbRcbLjbLsbLobLobRobRobLcbRebLebRcbLebRebRobR
ebRgbRgbRobLibLibLgbRcbLsbRebRebRebLobLhbRobRobRobLobLibLgbRebLebLcbRe
bLibRebRcbRobRcbLcbLebRcbRobLobRobLcbRebRobLcbLebRcbLobLebRobRobRobRcb
LsbLcbLebLobRebRibLobLjbRebLebLibRobLcbLobRcbRobRobLcbRcbLcbRobRsbLobL
ebRobLebRobLobRcbLobLcbRobRjbLgbRcbRebLobLebRsbRcbLcbRebRcbRebLsbRsbLo
bRjbRebLcbLobLebRebLobLobLobLobLebRhbLcbLibRgbLobLebRebLebRcbLcbLobLob
RobRobLcbLobLebLobLcbRcbRebRobLobLobRebRobRcbLebRibRebRibLobLobRebRobL
ebLibRibLcbRsbRobLebRebRobLebRcbLebRobLcbLobLobLsbRobLcbLobRebRjbRobLo
bRobRobRebRebLobLobLebLobLobRobLobLebRobLobRobRobRgbLobRgbRobLobRjbLob
LobRobRebLobRobRebRgbRobRibRobRebLibLcbLgbRebRcbLgbLebRibRebLsbRebRebR
obLebLobRcbRobRebRibLcbRobRobLjbLcbLobLsbLebRobRibLsbRobLobLobRobLobRe
bLebRcbRibRobRcbRebLjbRgbLebRebLebRobLibRsbLebLobRobLebLobRebRebLcbRcb
RebRibRobLobLcbLcbRcbLibRebRibRcbRibRcbRobLgbRebRebLobLobRobLobLibRcbR
cbLebRobLobLobLobLobRebLebLobLobLobLobRcbLobLsbRibRcbRebLcbLobRcbLcbLo
bRobLcbRcbRobLobLebLobRobLobRobLebLcbLgbLebLebLcbLcbLebRgbRgbLcbRobLib
LebRibLebRgbRebRobRibLjbRcbLebRhbRebRobRobLobRcbLobLsbLcbLobLebRobLebR
ebRobRibRibLobLebLibLebLobLcbLebRebRebLibRobRobRcbLcbLcbRcbRebRobLsbLe
bRobLcbRobLebLebRebLebLobRobRsbLcbRobLobLcbLobLebLcbRjbRsbRobRcbLcbLcb
RhbRobRgbLcbRhbRobRobLhbRobRobRobRebLebRcbRcbLobRibLcbLebLcbRibLgbRobL
ebLobRcbRebRobRobRjbRgbLcbRobRobLebRsbLcbRibRobRcbRobRobRebRcbLebLibRg
bLebRobRebLobLebRobRsbLebRcbLobLobLebLobRobLebRcbLebLobLobRsbLebLibLcb
RjbRobRobRebLsbLebLobRobLobRibLobLgbLobLgbRobRibRebRcbRebLebRjbRcbRobL
obRcbRhbRgbLibRebRebLcbRgbLebLebRobRobLibLobLebLobRobLcbRcbRobRobLobLe
bLebLebLebRebLhbRebRcbLebLebRjbLibRsbRibLebRebRibRobLobRobRobLcbRobLib
RcbRobLjbRobRobRebRobLobRibLebLcbRobRebRcbLibLibLcbRebLsbLsbRibRebRebL
obRsbRgbLobLobRebRcbRobLobLobRobRobLobRebRebRobLgbRcbRobRobLobLebLsbLo
bRebRibRobRobRobLgbRobRobRcbLobRibLebLcbRobLebRobLobLgbRobRobLebRobRcb
LobLibLobLibRobRobLobRgbRgbRcbLobLcbLibLcbLebRhbRcbLsbRobRobLcbRcbLobR
ebLebRsbLobRgbLhbRebRcbLebLebLgbRobLgbRobLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bsbLibLebLibRibRibRcbLgbRibRibRsRsmbRebLsbLhbLgbLgbRgbReRgRsmbRibRiRsR
imbRhbRiLsbRibRgbRgbRgbRibRobLjbLibRjbLsbRiRsmbRgbRsbRebLebLibRcbLibLi
bRgbLhbRjbLsbLsbLibLgLsLsLimbLibLibLebRibRgRebRhbRsRibRsRsmbRgbLjbLibL
ebLibLgbLgLhbLibRibRcbRgbRhLsbRibRibRsRsmbRgbRgRsmbRhbRhbLibLibLebLgbL
ebLsbLibLoLsmbRibRiLsbRibRgbRgbLibRhbRcbRibRibRgbRgLsbRgbRibRibRibLgbL
gbLibLibLibRgbLgbLibLibRsbLibLhbLsbLibLiLsbLgbLibLgbRibLsbRcbRibRibRgR
smbLjbLibLibLgbLgbLibRcbRhbRibRgRsRgmbRgbLjbLiRsbLgbRjbLebLibRsRebRcbR
ibLibLgbLebLgbLgbLibLsbLgbRjbLjbLobLsbLjbLibLibRcRsRsmmbLsbRibRgbRibRi
RcbRibRcbRgbRgRsmbRhbRhbLebLibLgbLgbLebLibLgbRsRibRibRibRibRiRsmbRibRg
bRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bsbReRsmbRibLsbLsbLgbLiLobRiLiLiLsLeLgbLjbRoRsRsmmbRiLsLsmbLgbLcbLeLiL
sbLibsbRibRgbRgbRgbRgbRiRsmbRibRibRgbRgbRibRibRibLiLibLibLgbLgbLgLsLsm
bLibLibLhLgbLjbLiLsbLibLgbLibLibLgbLhLcbLibLgbLsbLgbLgbLgbLsbLsbLsbLsR
sbLebLiLsLsLsmmbLgbLgbLibRgbRcRiReRsmbRiRsmbRgbRgbRcbRgLsbRgRsRsmmbRcb
RgbRiRsmbRgRhbRibRgbRgbLjbLhRsbRgbLhLsbRjbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bLsLsLsLsLsmmmmbRsbLsbLibRsbLsbLsLsmbLsLsmbLsbRobRgbLgLsbLgLsbLibRebLg
bRsbRgbRgbRcRsmbRibLibRsbLibRsbLibRgbLibLibRsbLgRsLsbLgLsbLgbLsbLsbLsL
smbLgbLsLsLsmmbLsbLibRgRsmbLibRcbRsbLjbRhbRsbRgbRgbRgRsmbRsRsmbRgRgbRs
RsmbRsbLsbRsRsmbRsbRiRsmbRcbLgbLgbLsbLgbLsbLsLsmbLsLsLsLgmmbLsLsmbLgbL
gbRcbRibLsbRcbRgbLsbRhbRsbRsRsRsRgRsmmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bLibLjbLibLgbLsbLgLsLsmbLibLhbLgbLibLibLgbLgbLibLgbLibLiLsbLeLsLgLebLe
bRcRgbRsRsmbRjbRcLsbLgbLiLsLsmbRjbRcbRgbLjbRgbRsRsRsmmbRibRsbRgbRsbRgL
sbRgbRgbsbRsbRgRsRsRgmmbRsbRgRsmbRsbRgbRhbLsbRibRgbRgbRebRsbRhbRibRgbR
eRibRibRhbRibRiLsbRibLiLsbLcbLiLeLsbLgbRcbLibRsLjLsmbLcbLibLgbLgbLebLs
bLgbRsLsRjbRcRsmbRibRcbRgbLibLgbLiLsbLiLsbLiLsbLibLibRibRibRhbRhRiRibR
gRsmbRsRgbRsbRgbRgbRgRgbRjLsLsmbLsbLibLibLcbLsbLibLcbLgbLgbLsbRiRsRsmm
bLjbRjRsmbRgRsRsRsmmmbLsbLibLibLgbLibLsbLgbRsbLibLsbRgbRsRsmbRgRsRsRsR
gmmmbRsRsRsmmbRsRsmbRgRsLsmbRsRsmbLsbLibLibLgbLgbLsLsLsmmbLgbLsLsLsmmb
LgLsbLgLsbLgLsbLibRjbLibRsbRjbRoRsRsmmbRibRsbLjbLhbLiLsbRhbLibRibLsbRs
bRsbRgbRibLibRibLjbRhbRgbRsbLibRsbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bLgbRibRibRiRsmbRibRiRiRsRsmmbRibRgbRgbRgbRsRsmbRibRibRgbRibRebRiRsmbR
gRsmbRsbRsbRibRgRsmbLsbRsbRibRsRsRsmmbRibRibRebRiRsmbRibRgbRcbRibRiReR
ibRcbRsbRhbRgbRebRgbRcbRibRgbRibRhbRhbRgLsbRibRibRsbRgbRiRiRgbRsbLsRcb
LhbRhbRiRgRsmbRgbRsbRsRsmbRgRsmbRgRsRsmmbLgbLjbLiLsbLgbRsbLsbLsLiLsbRs
bLsbLibLsLsmbLgbLsbLsbLgbLsLsRsmbLsRsbLibLgLsbLhbLebLibLibLgbLibLhbLcL
ibLcLebLibLibLibLibLibLibLgbLgbLcbLjbLgLsRsbLgbRcbRebRhbLsRsbLsRsRibRg
bLiLsLgbLsLsmbLibRsbRhbRjRsRsmmbRiRsRsRsmmmbRebRebRjbsbReRsmbRjbRsbLjL
ibRcbRsRhbLgLjLsmbRjbRibRgbRgbRjbRibRgbRcbRebLiLsbLjbLsbRiRsmbLcbRsbLj
bLgbRsRsmbLiRsbLibLgLsbLibLgbLgbRgbLiLsbRsbRsbLsbsbLgbLsLsmbLsbLsLsLgm
bLsbLsLsLsLsmmmbLsLsmbLgLsRsbLsbLeRsbLsLsmbLebLgLsLgLsbLgLsbLhLiLsbLib
LebLgbLjLsmbRsLibLibRsbLgLsLsmbLsbLgbLibLgbRsbLgbLsLsmbLsbLsLgbLgbLsLs
mbLsbLibRgbLsLsmbLsRsbRsRsmbRsbLsbLsbLjLgbLjLsmbLsbRsbLibLgbLsLsmbRsbR
ibLgbLgLsbLiLsbRgLsbLibsbRsbRebLsLgbLhbLgbRsbLhLsbRsbLsLsmbLsbLgLsbLsb
LsLsmbLsbRiRsRsmmbRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bRebLobLcRsbReRsmbRhRsmbRiRsmbRibRibRebReRsmbRhbRgbRgbRebRsRsmbRsbRsLs
bRebRsbRsbRgRsmbRibRsRhbRgbRibRibRibRgLsbRgbRgbRibRibRgbRiRsmbRgRgbLsb
RibRibRibReRsRsRsmmmbRgbRgbRiRsmbRiRsmbRgbRgbRsbRsbRibRgbRibRibLsbLjbL
gbLsbLsbRjbRgRsmbRgbRibReRsmbRsLsbRsbRibRiRsmbRgRsRsmmbLgbRiLsbRgRsmbR
cbLjbLjLsmbLcbLebLiLsbLsbRebRibRgbRebLcbRjbLjLsmbRhbLibLsbRgbRgRgbRgRs
mbRsRgbRgRsmbRgbRgRgRgbRsbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bRebsbRibLhbLcbLibLiLsbLhbRcbRibRibRhbRcbLcLsmbLibLibLiLsbLibLiLsbLibR
jRhbRhbRibRebRhbRiRibRhbLebLibLgLsLsmbLsLsmbLibLiLsbLgLsbLiLsLsmbRjRsR
smmbLgLsbRjRsmbRsbRgRsRsLsmmbLcbLhbLibLhbLsbLiLsbLiLibLeRsbRsLsbLgbLsR
sbLiRsLsbLhbLibLcbRcbRjbRibRhRsRimbRibRhbRebRibRoLsbRiRsmbRgbRibLsbRob
RibRibLjbLhbLibLiLsbLgLsbLgLsbRsLsbLiLsLsmbLgbLgbRsLsbLgbRsbRsLsLsLsmm
bsbRsbLiLsLsmbLsLsmbLsbLcLsmbLibLibLobRobRebRibRiRibRibRoRsmbRcbRiRsmb
RibRcbRibRgbLsLibLeLsLsmbLiLsbLebLhbLibLcbRibRiRsmbRhLsbRsbLhLsbLibLgb
LgbLsLsLgmbLebLibRjbLhbRjbRhbRcbRebRibLeLsbLiLsbLibLibLibLibLibRiRsmbL
obLiLsbLgbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
bRoLsbRgLsLsmbLibLgRsbLibRcbRcRebRibLibLibLebRcbRibRibRgbRhRhLsbRebLeb
LsRsbLjbLiLgLsbLgbLiLsbLgbLcbRibRcbRcbRhbLebLjbLcbRebRhbRoRsmbRebRsbLs
bRibRcbRgbLobLiLsbLsbLgLsbLgbLgbLsbLsbLobLebLsRsbLebLiLgbRhbRhRsRhmbRc
bRebLebLebRgbLhbLgbLibLiRsbRibRebRebLcbLibLibLcbLgLebLjbLibLgbRobRibRi
RgRsRimbRgbRgbRibRibRebRhRsmbLcLsLsmmbLibLsbLiLsbLiLeLebLgbLgLsbLibLib
LibLgbLiLsbLgLsbLgbLgbLiLsbLibLgbLgbRjbLjbRjbLibLgbRibLjbRhbRhbRibRgbR
jbLsbLjbLiLsLsLsmmbLsbLibLibRsbLgbLgbLgbRgbRsRsRsmmbLsbRibRibRsbRgLsbL
gbRiLsbLgbRgbRgRsmbRiLsbRibRsbRhbRibRgbLibLiLsbLibLgbLibLgLsbLgbLiLsbL
gbRjbRibRibRgbLsRsbRibRsbRsbLibRsRsmbRibRiRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bRjbLgbRibRsbLjbRhbRgRsmbRsRsmbRgRsmbRsRhRsmbLibRhbLibLobLcbLibRgbRjbL
jbLibLgbRgbRjbRcbLsbRgbRjRhRsmbRhbRhbRsLhbLibLsLsmbLsbLhbLgLsLsmbRhRsm
bRibRgRsmbRibRjRebRcbLibLibRhbRcRsmbRgbRcbLibRgRgbLiRsbLhLsbLibRcbRcbR
hbRcbRcbRsRsmbRiLsbRcRsmbLiLsbLiRsbLiRsbLibRebRcLsbLibRcRsmbRhbRgbLgbR
eRsmbRjbRcbRcbRhbRibLobLcbLebLgbLsbRjRjbRsbRhRsRsmmbRsRsmbRiRsmbRibRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
bsbsbsbRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
bLgRsbRsRsLsmbRibLhbRiRgRsmbRcbReRsmbRcbRibLsbRsbLcbReRibReRsRsmmbRsbR
sbRgRsmbRsRsmbRsbRgbRhbRibRebRebRsbRgbRsbRsbRibReRibRebRebRiRsmbRhbRhL
sbRcbRebRgbRhRebRhRibRcbRebLhbLibLebLsLsmbLhLsRsbLsLiRsbLgLsbLebsbLiRs
RsRsmmbLcbLibLiLsbLgbLibLgbRjbRcRsRsmmbRgLsRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bLsbRgbLsbRsbRgbLsbRsbRibLcbLibLibLibLibLibLgLsbLgLsLsmbLibLgbLgbLsbLc
bLhbLobLgbLcbLhbLgbLibLgbLiLibRsbLsLcLsmbLibLibLibLcbRcRsmbRhbRgbRibRi
RsmbRhbRiRsmbRibRiRsmbRiRsmbRibLsRsbRsbRsbRibRiRsmbRhbRgbRibRsLsbRobLs
bLibLibLiLhLsbLhbLibLgbLgbLgbLibLibLebLgbLgbLgbLibLgLsbLibLibLibLgbLib
LgbRjbRcbRiRsmbRibRsRsmbRibRibLibLhbLibLibLgbLebLibLebLgLsbLgbLgbLgbLg
bLibRgLsbLibLibLibLibLgLsbLgbLgRsbLibLebLibLgbLibLiLsbRgbLgbRibRgRsmbR
ibRgbRgLsbRibLgbRgbRcbRibRebRibRgbRgbRgRsmbRgbRibLsbRgbLcbLcbLibLhbLiL
sbLibLgbLsbLibLebLebLibLgbLgbLibLibRibLiRsbLibLibLgbLibLiLibLebLgbLibL
gLsLsmbLibLgbLgbLgbRhbRcbRcbRgbRgRibRgbRgbRgbRgbRgRsmbRgbLjbRsbLcbLibL
hbLibLgbLibLebLsLsmbLgbLgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bLsbLsRsbRsbLsLsmbLsbLsbRsbRsLsbLsLsmbLsbLsbLsbLsbLsbRgRsmbRjbRebLsbRs
bRsRsmbRsbRsRsmbLcbLsbRobLobRsRobRobLsbLebLsbLsRsRsmbLsbLobLsbRsbLsbLs
bRebRsbRjbRobRebLebRebRsbLsbRsbLobLobRsbLeRsbLebRsbLsLebLebLobRebRebRj
LsbRobRobLsLobRsRsLsmbRsbLsLsmbLjbLebLjbRsbRsbRebRobRobLsbRsbRsLsbRsbL
sbLsbRsLebLobRsbLsLsRoLombLobRsbLsLsRsmbRobLsRcbLoRsbLjRsbRsbLsLsmbLsb
LjbRebLobRsbRsbLsbLobReLsbLsbRsbRjbRobRebRsbLsbLebRjbRoRcbLsbLjbRsbLeb
RsbRsbLsLobLcbLsbLsRebRebLjbLsbLsbRibLobLjbLobRcbLobLobLsbRebLebRcbReb
RsbRobLobRebLebRobRcbRobRobRobLobRobLebRobRebLcbRebRsbLgbRobLibLobLobR
gbLebLibLobLobRebRibLhbRgbLebLebLibLcbLebLgbRcbLcbLsbRcbLhbRebLhbRgbRg
bLobRibRebRebRobRobLobLgbRebRebRobLibLebLobLcbRgbRebLebLebRobRsbLebReb
RobLcbRibLebRcbLhbRebRebLcbLgbRobLebRgbLibRebRgbLgbRgbRsbRebLobRobLobL
cbLibLobRebRibRsbLgbLsbRcbRobLcbRobLebRgbLobLobRobLebLsbRgbLebLobLibRs
bLobRcbLebRobRobLsbRebLobRcbLcbLebLebRcbLebRobLebLobRobLibRcbLebLsbLob
RobRobRcbLobLobRcbLobLibRgbLobLobRobLibLobRobLcbLobLhbRgbRibRgbRebLebL
obRobLobRsbRebLcbLobRjbLgbRebLhbLcbLobRebLobLobRobLobRebLebLcbRobLobRo
bLobLgbLobLcbRobLebRcbLsbLgbRcbLobLebLobRsbRgbRobLobLobRebLobRobRobLib
RobLobLobLsbRobRebRcbLgbLebLibLobLgbRobRebRsbRobLibLobLobRcbLobLgbRobR
obLobLibLebLobLobRebLebLebRebLibRobRobLgbLibLobLebLobRcbRebRcbLebLibRo
bRobRcbRobLobLcbRgbRibRsbLcbLcbRobLibRebRobRobRgbLebLibRobRebLobRgbLeb
RebLcbLobRobLcbLobLsbLobRcbRobLobRobLibRibRebRcbRobLgbRibLebRsbRobLobL
obLobLebLcbLebLebRobRibLcbLebRobRobRhbLebLobRsbRobRebLobRobRobLgbRcbLc
bRgbRobRcbRgbLobRsbRebRobRcbLebLobLebLobLobRobRgbLobRgbLhbRobRcbLebReb
LobLebLcbLebLgbRebRcbLebRebLhbRobRibLcbLobRobRobLobRebLobLobLobLebLsbL
gbLebRobRhbRgbRebLebLobLgbLobLebLibLebRgbRobLgbRobLobLebRebRobLibRebRs
bLobLobRobRebLobRcbRobRibRobRcbRebLobLebLobRobRobRobLebLgbRobRobRobRcb
RcbRjbLobRcbLobRobRobRsbRobRcbLgbRobRcbRcbLibRobLcbRobLgbLibLgbRcbRebR
obLjbRibLcbRebRebRobRebRebLhbRebLgbRobRobLobLibRsbRobLcbRobLcbRebLcbLo
bLebRebLobRebRobRcbRcbLobLobRebLobLobLobRgbRebRibRebLcbLgbLibLobLibLob
RobRobRsbLibRcbRobLcbLobLobRebLibLsbRhbRibLebLobRebLcbRobLobRcbLobLobR
ibLebRcbLobRcbRsbRobLobLobLcbRobLobLobLobRsbRobRcbRebRobLebLibRcbLobLc
bRobRobRibLebRobRcbLcbRebRobLebRebLcbRcbRibRobLcbRebLhbRebLgbLcbRobRob
LsbLobRcbRebRebRobRobLobLobRcbLebLcbRebLobRebLobLgbLebRebLobLobRobRebL
obLgbRcbRobRobRebLcbRgbRobRcbLebLobLobRobLobLebRcbRobRobLobLobRebLebLe
bLcbLibRobLjbRobRsbRcbRgbLobLgbLcbRobLobLebRebRibLobRebLhbRhbRcbLibRib
RebRebLcbLebLebLobLobLcbRebRcbLebLibRobRobLcbRobRobLebLobLebLebRobRcbL
obRcbRebLgbRgbLebLobLobRebLobLobLcbRobRcbRcbLebRcbLebLobRcbLobLobLebRo
bLsbRibRcbLobRebRgbLebRebLobRobLobRobRcbRcbRibRobRebLobRcbRebRobRgbRcb
RibLsbRgbRsbRcbLebRebRebLebRcbLcbLgbRhbLobRobRebRebRobRobLobLcbLobLibL
cbLobRibLobLgbRsbRcbRgbRobLebRibLobLibRebLcbLebRobLobRgbRcbLebRobRebRe
bRebRobRob

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bRebRebRsRsmbRgbRsbRsbRgbRgbRgRsmbRhRsRsmmbRgbRiRsmbRibRgbRcbRgbRibRiR
smbRgRsmbRcbRebRcbLsbRcbRhRsmbRibRibRjRibRibRsbLibLcbLiLsbLibLgbLsbLgL
sbLibLgbLgbLgbLgbLgbLsbLgbLsbLsbLsbRjbRibRebRibLjbLebLibLsbRjbLjbLibLs
bLgbLibLiLsbLcbLebLiLsbLebLiLsbLiLsbLibLiLsbLgbLcbLibLgbLgbLsbLgLsbLgb
LsLhbLsbLgLsbLgRsbRsLgbLgbLebRsRhbLjbLibLgbLgbLsbLsbLibRsbLibLibRsbLhb
LgbLibLibLebLibLebLibLebLcbLcRsbLhbLibLhbLcbLeLebLibLgbLsbLgbLsbLsbLsb
RsbLsbLsbLsbLgbLgbLgRsbLsbLgRsbRsRsmbLsbLgbLsbLsbLsbLsbRsbLsbLsbLsLsmb
LgRsbLgbLsbRsbLsbLsbsbLsRsbRsbLgbLsLsmbLsbLsbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bRibRsRsRgmbLjLsLsmmbRsRgRgRsmbRhb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bRhbRgbRsLsbRsbRsRsmbRgbLgbRgRsRsRsRsmmmmbRsRsRsRsRsRgRgRsRsRsRsReRemm
mmmmmmbRgbRsbRgRgRsmbRsRsLsmbRiRsRgRsRsmmmbRgRsRsRsRsRsRsRsRsRsRgmmmmm
mmmmbRsbLjLsmbLgLsbLgLsLsmbLsbLsbRjbRibRsRsRsmmbRsRsRsRgRsRsRsRsRgmmmm
mmbRgRgRebRgbLcbLiLsLsmbRsRsmbRsRsRsRsRsRsRsRsRsRsReRsRimmmmmmmmmmbRgb
RsbsbRsRsmbLgbRibLgRsbRsRsRsRsmmmbRgRsmbRibRiRsRsmmbRebRsbRgbRsRsRsRsR
sRsRgmmmmmbRibRgRsRsmmbRsbRgbRsRsRgRsmmbRsRsRsmmbRgbRgRsRsmmbRsRsRsRsm
mmbRsbRsRsRsRsRsRsRsLsRsRiRsmmmmmmmbRiRiRibRsbRsRsRgRsRgRsRsmmmmbRsRgb
LsRgLsbRgbRgbLsbRgRsRsRsmmmbRsbRgRsRsRsRsRsRgRsRsRsmmmmmmmmbRhbRhRgbRe
bRgbLjbRsRsRsRgRsRgRgmmmbRsRiRsmbRgRebRebRiRebRsbRjbRgbRsbRgLsRgbRiRsm
bRsRebRebRgbLsbLebLiLsLgLsLsmbLiLsLgLibLebLeLsbLiLsLsLsmmbLibLebLeLsbL
gbLgLsLsmbLsbLiLsLebLebLibLibRsbLebLsLibLebRebRsbRsbRibRsbRsRsmbRsRgbR
sRsRsRsmmmbRsRsRsRimmbRsRsmbRsbRgbRgbRgbRsLsRsLsbRsRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 19; Drug: Control Apo 50 然
bRhbRhbRgRsmbRsRgbRibRgbRgLsbRibRgbRgbRiRsRsmmbRgRsmbRgLsbRgbRibRgbLcb
LgbLibLgbLgRsLibLibLgbLgbLgLsbLibLiLgLibLebRjbRibRgbRgbRgbRsbRibRgbRib
RgbRibRibRgRibRgbRgbLibLjLsmbLibLiRsbLebLibLhbRsRsmbLiLgLsbLsLsLsmmbRj
bLiLgLsbLgbRcbRibRibRgbRibRgbRsbRiRgbRgbRibRsLsbRiRsmbRgRsRsRsmmmbRibL
cRsbLebLibLgbLgbLiLgbLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 20; Drug: Control Apo 50 然
bLhbRiRibRibRiRsmbRibLhbLhbLgLsLsmbLibLsbLhbLgLsbLibLibRcbRiRsmbLsRsbR
sRgRgbLjbLhbLcbLsbLibLcLsmbLibLgbRjbRiRsRsmmbLjbLcLsLsmmbLiLsLsmbLibLi
bRsbRcRsRsRsmmmbLebLgLsLgLsbLibLhLibLiLsLsmbLsbRebLgbLibLibLgbLibLobRe
RsmbRgLsbRhRsRsLsmmbRhbLhbLiLsbRjbRsRsmbRiRsmbRsRsRembRcbLebLiLsbLcLsm
bLibLiLsbRsLsbRcbRiLsbRiRsmbRebRgbRebRibRiRgbReRsmbRsRsmbRibRhbRgRsmbR
sbReRsmbRebRiLsbLgbRibRiRsRsmmbRiRsmbRiRsmbRgRsmbRiRsmbLgReRsmbRgbRiRs
mbRibRiRsRsmmbRebRiRsmbRhbRgRgbRibRgRsmbRibRhRsmbRibRebRebRhbLebRsLibL
ebLibLgLsbRiLibLebLgbRsbLebLsbRebRibReRsmbRsbRiLcbRobRibRhRsmbRgbRhRsm
bLsbLebLibLebLgRsbLsbLibLgbLsbLebLibLeRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 21; Drug: Control Apo 50 然
bRcbLibLhbRjbRiRsRsmmbRsRsRsRsmmmbLsRsbRibRibLsRsRsmbRsRsmbRhbLcbLhbLh
LsRsLsbLgLsbLgLsLgbLgbLsbLgLsbRsLibLhbReRsmbRsRsRsmmbRgbRgbRsLsbRcbRib
LsLjbLibLsLsmbLsbLjLsLsmmbLgbLgbsbRsLsbRsbRebRgRsmbRgbRsbRiRsmbRebRebR
ibLsLsmbRebRebRhbLeLsLsmbLgbLcbLiLsRsbLhbLibLiLsbLibRsLsbRebRob

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 22; Drug: Control Apo 50 然
bRhbRiRsmbLsbRibRiRsmbLobLibRsbLgLsLsLsLsLsmmmmbLgLibLsLsmbReRsmbRebLe
bLcbRebRebRhRsmbRibRgbRibLcbLcbRcbLgbLgbLibLibRcbRjbLibLgbRebLcbLibRjb
RcbRebRibRcbRhRsmbLibLhbLebRebLibLhbLsbLibLsbLsbRsLebLiLsbRsbRsLsbLobL
hbLiLebLhLsbLebLgbLgbLsbLgbLobLgbLibLibRobRhbRhbRcbRobRebRobRobRibLobL
gbLgbLibLgLsbLjbRsRsmbRobLeLibRjbLibLiLsbLsbLgbLgbRibRobLhbLibRcbRibRg
RsmbRibLobLibRibLjbRgbRhbLsRsbRibRcbLcbLibLgbRhbRibRibRibRibRebRebRgbR
eRsmbReLsbRgbLebLgbRjbRobLebLgbLgbLgLsbRcbRibRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 23; Drug: Control Apo 50 然
bRsRsmbRibRgbLcbLsbLiLsbLsbLsbLsLgLsbLsLsLsLsmmmbLgLsbLgLsLsmbLobLiRsb
LibLgbLgRsbLibLibLgbLgbLibLgLsLgbLibLibLobRcbRcbRibRibRhbRibRhbRhbRibR
ibRibRibRobRjRsmbLjbLhLsbLibLiLsbLibLibRobRibRcbRiRsmbRhbRgRsmbRgRsmbR
gbRcbRhbRgbRibRgRgLsbRgbRibLgbLcbLiLsbLibLgbLgbLgbLgbLgRsRsmbLgLeLsbLh
bLibLgbLibLgLgbLgLgLsbLobLcbLibLsbLsLsmbLsLgbLgLsLgbLsbLgbRjbRhbRibRgb
RibRgbRgbsbRgbRibLjbLhbLgLsbLgbLsLsmbLgLsbLgLsLsmbLgbLibLibLibLgbLibLg
bLgLsbLibLgbLibRsbRhbRibRibRgRiRsmbRibRgbRgbRgbRcbRibRhbRsRgRsmbRibRcb
LgbRhbRibRiRsmbRibRgbRebRjRibLgbRgbLsRcbRibRebLhbLjbLhbRibRibRibLobLiL
sbLiLsLsmbLibLebLiLsbLgbLgbRsLsLsmbRsbRgbLibLibLgbLgbLsbLiLsbLgbLiLgRs
bLibLibRibRibRebRgbRebRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 24; Drug: Control Apo 50 然
bRgRsmbRgbRgbLjbRibRibRgbRgRsRsRsRsRsmmmmmbRsRsmbRgbRgbLsbRebRsbRgbRib
RgbRsbRgbRhRgbRgbRgbRibRgbRsbRgbLsbRibRgbLgbRsRsmbLjLsmbRiRsmbRgRibRgR
sRsRsRsRsRsmmmmmmbRiRsRsmmbRebRiRsmbRhbRibRgbRgRsmbRhbRebRibRiRsmbRgbR
ibRgbRgRsRsLsmmbReRsmbRgbRibRiRsmbRgRsmbRgRsmbRgbRgbRsbRgbRgRsmbRebRgR
smbRgbRgbRgbRgLsbRgbLjLgbRibReRsmbRgbRibRibReRsmbRiRsmbRsLsbRgbRiRiLsb
RebReRsmbRibRebRebRgRsmbRsRsmbRgbRgbRsbRibRsRsmbRgbLsbRiRsmbRgbRsbRgbR
gbRibLgRsbLsbRiRsmbRgbRgbRgRsmbRsbRgbRgbRhRsmbLgRsbRibLgbRgRsmbRgbRgbR
sbRgbRiRsRsRgmmbRgbRsbRgRsmbRibRgbLsLsmbRjbRibLgbRibRsLsbRiRsRgRgRgmbR
sbRhRsmbLsbRgbRibLgbRibRjLsLsmbLgLsRsRsRsmmbRibRgbRgRsmbReLsbRibRsbRsb
RibRgbRgbRsbRibRsbRgbRsbRgbRsbLsbLhbLjLibLgLsRsbLibRibRhbRibRgbRgbRibR
sRsmbRgbLsRsbLsRsbLgbLgRsbLeLsbLiLsbRsRsmbRsbLsbLgbLgbLsbLeLsbLiLsbLib
RgbRsbRibRibRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bRibLgbLgbRibRibLgbRgbLsbRgbRsRsmbRgbLsLsRsmbLsbRhbRgRsmbRgbRgbLibRgbL
jbRsbLibLgbLsbLgbLgbLgbLgbRsbLgLsLgbLgLsbRsbLgbLsbLsbLebRebRibRgbLsbLs
bRebLsbLibLgbLibLgbRebRebRsbRgbRgbRgbLsbRgbReRsmbLsbLibLgbLsbLsLsmbLgL
sbLgbLgbLgbLsbLsbLibLgRsbLiRsbLgbLgbLgbLgbLgbLgLsbLgLsbLgbLsbLgbLiLsbR
sbLgbRsbLsbRsbRsbRgbRsbRsbLsbRgbRsbRsbRgbLsRsbRgbRgbRibRgbRsbLsbRcbRgb
LsbLgbRsbRebRhbRsbLsbRibRgbRgbRsbLsbRgLsbRsbRsbRsbLsbRibRgbLgbRebLgbLg
Lgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
bRgbRgbRgbLsRsbReRsmbRgbRhRsmbReRsmbReRsmbRebRgbRiRsmbRibLsbRibRibLgbR
hbRibRsbLibLgLsbRjRsRsmmbReRsmbRgbRibRgbRgbRsbRgbRcRiRsRsmmbRibRgRsmbR
iRsmbLgbRibRgbRgbRsRsRsmmbRgRsRgmbRsbRibRgbRiRsmbLsRsbLgLsbLibLgLsbLsb
RibLibLibLibLsLsmbLgbLebLgbLsRsbLibsbLibLgbLsbRebRibRgbRibRgbRgRgbRsRs
mbRibRsbRsRsmbRgbRsbRibRgRsmbRgRsmbRsRsmbRgbLsbRsbRebRiRsmbLsbRsbRgbRi
bRsRsmbRsRsmbRgbRsRsmbLsbRibRibRibRibRgbLgbLjbRsbLjbRgbRiRibRibRsRsmbR
gbRgbRgbRibRgRsRsmmbRibRibRibRibRibRibRibReLsbRibRhbRsRsmbRibRgbLsRsbR
iRsmbRgbRsbRsRgbRsRsmbRsbRsbLsbRibRgbRsLsbRsbRebRebRhbRebRobLhLsbLgbLs
bRibRsbRsbRsbRsbRsbRsbRgbRsbRgRgbRibRibRgbRsbRgbRibRhbRsbLsbLoLsmbLgLi
LibLiLsbLibLcLsmbLsbLebLgLeLsbLgbLgLsbLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bLibLebRcLsbRjbRiRsmbRiLgLsbsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bLsLsmbRcRsmbRhbRsbRibRiRsmbRibRibRebRsbRgRcbRibRcbRibRcRebRebRcLsbLgb
LibLiRgbLibLcbLhbRebRcRgbRcRebRgbRgLoRsbRibRhRsmbLgbLsbLhbLiLebLiLsbLe
bLibLibLhbLeLhLebRsbLgLsbLgbRjbLebRiRsLsmbRibRgbRibRjbLobLebLiLcLeLsbL
ebLgRsLsbLebLsbLgbLibLgbLibRebRhbRibRsRhbRcbRiRcbReRsRimbRebRgbRebLgLe
bLebLibLibRebRcbRibRsbLibLibLgbLibRibRibRibLibRebRgRgRsmbRiRsmbRgbLsbR
ibLibLebLhbLibLhLobLcbLgbLibLibLiLsbsbLsbLsLsLsLhmmbLgbLsLgLsLsmbLsbLs
bLsLsLiLembLsLsLsRsmmbLsbLsbLsbLsbLsLsmbLsbLsLsLsmmbLsbLsbLsLsLsLsLsLs
LsmmmmmmbsbLsLsmbLsLsLsmmbLsbLsLsLsLsmmmbLsLsLsLsLsLsRsLsLsLsLsmmmmmmm
mbLsLsLsLsLsmmmmbsbRsLsLsLsRsLsmmbLsLsLsLsmmmbLsLsLsLsLsLsLsLsLsmmmmmm
mmbRsbLsLsLsLsLsLsLsLsLsLsLsmmmmmmmmmmbsbLsbLsLsLsLsmmmbRsLsLsLsLsLsLs
LsLsmmmmmmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
bRibRgbRibRibRhRhbRgRsRiRsmmbRcbRebRgbRsbLcbRcbLibLgbRgbRobRsbRibRibRg
bRibRiRsmbRsbLjbLibLgRsbLgbRsRsmbRjRgRgRsmbRibRgbRebRebLibRcbRhRsmbRib
RgRsmbRhbRibLhbLgLsLsmbLibLibLgbLibLibLibRgbRcRsmbRibRiRsmbRcbReRsmbRg
bRibRgLsbLsbRiLsbRibRsbRibRibRibRgbRhbRgbRgbRebRgRsmbRibRiRsmbRebRibRi
RsRsmmbRebLjbRsRsRsRsRsmmmmbRgRsRsRgRsmmmbReRsRembLgbLgbRhbRibRibRibLs
LsmbLsbLsRsRsRsmmbLsbLhbLibLgbRcbRgbRcbRgbRcRsmbRibLhLsLsLeRsmbLgbLibR
jbRjbLibRgbRgRsRsRsRsRsmmmmmbRebRgbRebRibRiRsmbRhLsbRebRibRebRibRibRib
RcbRsLsbLibRjbLcbLibLibLibLhLsbLiLsbLibRcbRibRibRgbRgbRibRibRgbRibRebR
gbRgbRgbRgRgbLgRsbLibLibLsLcbLibRjbLgbRcbRiRsmbRibRgRsmbRgbRibRebRgbRi
bRgbLjbRsbLjbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bLebRsbLhbLgbLsLibLhbLebLgbLsbLgbLsLsmbLibLgbLsbLebRsbLgbLsbsbsbLgbLsL
smbRcbLsbRgbRgRiRsmbRhRsmbRgbRibRibRsbRsRsmbRsRsmbRhbRgbRibRgbRgbRobLi
bLibRebRgRgbRibRsbRgbRsbRsbRsbLsbRgRsmbRebRgbRsbRsLsbRgbReRsmbRgbRebRg
bRsLjbRjbLibRgRsRiRsmmbRgbRsbRibRiRsLsmbRsRsmbRgbRsRsRsRsmmmbRgbRebReb
LcbLobRgbRibLjbLibLgbLhbRibRibRgRsmbRgLsbRgbRgbRgbRsbReRsmbRgLsbRibRgb
LgbLcbLibRsbLobLsRsbRgRsmbRiRsmbRibRsbLsbRgbRibRibRibRgbRebRgbRebReLsb
LjbRjbRsbLgRsbRgbRjbRjbLsbRgbRhbRibLgbRgLsbLsbLebLebLgbLjbLibLgLibLjbR
sbRsbRjbRibLjbLgbLgbLgbLsLsmbLjbLgbLsbLeLsbLgLsbLgLsbLsLsLsmmbLsbLhLsb
LgbLjbLsbLebLgbLebLgRsbLsbLjbLsbLsbLebLsbLgbLebLgbLiLsbLgbRgLsbLgLsbLi
bLgbLiLsbRebRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bRebRhLsbRsbLebLgbLibLibLcbLgbLhbLcbLibRgbRhbRibRjRhbRiRsmbRgbRsbRsbRc
RsmbLjbLgbLcbLcbLebLiLsbLibLsLsmbLgbRhbRgRibRgRgRsmbLgbRiRsmbRebRebRhb
RebRebLobLhLhbLcbLebLeLsLeLsbLgLsbRsbsbLsLsmbLgbRsbRibRebRhbRgbRibRiRs
mbRebRhbRebRhbRibLebLebsbsbLibLcbLcbLcbLebLhbLibLgLsbLibRsLsbLhbLibLcb
LibLcbRcRsmbRoRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bsbLebLgLibRsRsmbRsbLsLsLhmbLgLeLsbLcLsmbLobLibLibLibLibLhbLibLibLoLsm
bLiRsbLobLhbLiLsbLgbRhbRcbRgLsbRgbRgRsmbRobLibLiLsbLoRsLsbLcbLiLibLiLs
bLhbLibLobLhbLobLibLibLibLiRsbLibLebLiRsbRiRsLsmbRebRcRsmbRcbRebReRsRe
mbReRsRiReRgRembRibLoLcbRsbLjbLobLibLcbRsbLibLibLibLibLiLsbLibLiLsbLib
LhbLibLiLsbLobLjbRiLsbRibRsbLsbLsbLsbRebLsbRiRsmbRsRebRibLsbRiRsmbRibR
gbRgbLgbRiRsmbRibRiRsmbRibRgbLsbLibLibLibLgbLgbLgLsbLgbLibLibLibLcbLcb
LcRsbLgbLgbLibLgbLgbLgbLgbLgbLjRsbLsLsmbLgbLgbLgbLgbRgLsbLgLsbLgbLgbLg
bLgbLibLibLibLgbRsbLibLiLsbLgbLgLsbLgbRgbRjRgRsmbLsbRiRsmbRgRsmbRibRgb
RsRebRgbLiLsbLibLibLgbLgLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bRsbRhbRibLgbLjbLibLibRjbRjbRibRibRibLgRsbRibLgbRcbLibLgLsbLgbRsbLibRi
bLibLibRjbRhbRiRsmbRgbRgbRibRibRibRgbLsbRiRsmbRgbRibRgbRibLsLsmbRibRib
LsbRcbRgbRibRiLsbRgbLgbRibRibRhbRibRgbRibLgbRibRibRibLsbRiRsmbRsbRibRi
bRgLsbRibRibRgbRebRgbLgbRibRibLsbRibRibLgbRibRebRebRebRgbLsbLibLibLgbL
gbLgbRjbRgbRibRgbRibRgbRgbRibRibRgbRibLcbLiRsbLibLgbLgbLgbLgLsLsmbLsbL
gbRsbLibLibLsbRhbRibRgbRibRibLsbRibRgRsmbRibLjbLjbLibRsbLibLgLsbLgLsbL
iLsLsmbLgLsbLgbLgbLgLsbLgbRsbRcbRcbRibRgbRcbRgbLibLibLgbLiRsbLibRhRsmb
RibRgbLsbRibRibLsLsmbRjbRsRsmbRhbRibRgbLsbRibRsbRhbLgbLibLgbLiLsbLgbLg
bLgbLgbRgbLiLsbLgbLgbLibLgbLibRjbLiLsbLgbLiLsbLgbLiLsbLgbLibLibLgLsbLi
bLsbRcbRiRsmbLgbRcbRjbRibRibRsRsRimbRibRgbRibLgbLjbLibLgbLgbLgbRgbRjbR
cbRibRgbRsbLibRcbRhRsmbLsbRibRibLsbRiRsRsmmbRibRibRgbLsbRhbRibLsbRibLs
bLgbLiLsbLibLgLsbLgbRsbRcbRibLjbRobRibRgbRibRibRgbRgbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bRgbRsbRgRsmbRsRsmbRgbLgbRiRsmbRgbRsbRsbRibLibRgbRibRibRgRgbLsRsbRsRsR
gRsRsmmmbRgRsmbRiRsmbRebRiRsmbRibRgbRibLgbRibRibRsRcbRsbRgRsmbLibLgbLs
LsLgmbRsbLsLsLsLsmmmbLgbLgbLoRsbRgbRgbRcbLgbRhbLgbRiRsmbRebRgbRgbRgbRg
RsmbLsbLcbLibLsLsLsmmbLibLiLsLsLsLsLsmmmmbLibLgbLsRsLsLsmbLhLsbLgLsbRs
LsRsRsmbLobRiRsmbLibLiRsRsmbLgbRsLsLsmbRcbRsRsmbRgRsRsmmbRebRibRibRibL
sbRsRsmbRsRsmbRsbRgRsRsRgmmbRsRsRsRsRsmmmmbRgbLsbReRsmbRibRgbRibRgRsmb
RgRsmbReLsbLibLibRsbLgbRcbRiRsmbLgbRsRsRsRsmmmbRiRsmbRsbRsbRgRsRsRgRsm
mmbRibRgRsRsmmbRsRgRgbRgbRibRgbLsLsLsmmbRibLebLsLsLsmmbLhbRgbLhLsLsLsm
mbLiLsbLgbLibLebLgLgLsbLebLgbLgbLgLsbLgLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bLgbRcbLiLsbRsbRgbRjbRsRsmbLcRsbLiRsbRibRgbRcbRgbLcbRsRsmbRibRsRcbRhbL
ibRcbRcbLgbLobLibLgbLibRsbRobRcRsmbLgbRibRibRsbRsbRobLsbRobRgbRgRsLsmb
RgbRgbRgbRhRsmbRibRsbLibLibLgbLsbRibRhbRsbRibLgLsbLgbLibLibLgbLebRjbRh
bRibRsbRibRgbRgbRsbRibRgbRibLibRgRsmbRiRsmbRibRiRsmbRibLjbLjbLibLgbLib
RgbLibLgbLibLgbLgLsbLgbLibLgbLgbRsbLsbLibLgbLsbLiLsbLsbLsbLgbLibLsbLgb
LgbRjbRibRgbRibRgbLsbRgbRgbRgRsRsmmbRgRsmbRibRgRsmbRgbLibRibRiRsmbRgbR
sbRsbRgbRsRsRsmmbLgbRiRsmbRibLgbRcbRhbLhbLjbLibRsbLibLgLsbLgbLgbLgLsbL
gbLgbLgbLgbRiRsmbLobLsbLgLsbLgbLsbLibLgbLibLsLsmbLgbRsbLiLsbRgbLibLsbR
hbRcbRibLsbRibLgbRgbRibRgbLgbRebRgRsRsmmbRgbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bRhbRgbRibRibRgbLibRiRsRsRsRsRsmmmmmbRiLsRsbRsbRibLsLcLsmbLcLsmbRibRhb
RjRsmbRibLcbRibRhbLobLcLsLsmmbRobRhbRibRebRjbRgbRcbRcbRgRsmbRobRgbRhbR
ibRobRibRjbRibRiRsmbLsbRibRhbLsbLhbLjbLhbLhRsbRibLibLgbLiLsbLsLsmbLhbL
iLsbLibLgbLibLiLsbLgbRiRgbRgbRebLiRsbLibLebLsLsLsmmbRgbLsbRsLsbLsbRgbL
cbLoRsbRebRjbRsRsRsRsmmmbRiRsRsRsmmmbRsbLsLsRsLsRiRsmmbRjRgbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bLsbLgbLsbLsRsbLsLsmbLgbLsbLsRsbLsbLgLsbLsLsRsmbLsbLgLsbLsbLgRsbRsRsRs
mmbRsbLgbLiRsbRsbLgbLsbRsLsbLgRsbRsbLgbLgLsbLgbLsbLgbLgbLsLsLsmmbRsbLg
RsbLgLsbLgbLsbLsbLsbLsLsmbLgbLsRsRsmbLgbLgbLsbLsbLgbLgbLsbLgLsbRsLsbLs
LsmbLsLsmbLsbLsLsmbLgbLgbLsbLgbLgRsbRsRsmbLgLsLsmbLgbLsbLsbLibLsRsbRgb
LjLsmbLgbLsbLgbLsLsLsmmbLsbLsbLsbLsbLsLsmbLgLsbRsbLsLsmbLsbLgbLsbLsbLg
LsRsbLgbRsbLgLsbLsbLsbLsbLsLsmbLsbLgLsbLsbLsbLsbLsLsmbLsbLsbLibLgRsRsm
bRsbRgbLgLsLsmbLsLsLsmmbLgbLsLsmbRgLsbLgbLgbLgbLgbLebLiLsbLiLibLiRsbLj
RsbRgbRiRsmbReRhbRhRsmbRgbRibRgbRibRobLebLiLsbLiLsbLeLsbLibLhLsbLiLsbL
ibLibLiRsbLcbLcLebLebReRsmbRiRsmbRiRsmbRibRiRsmbRgbRgLsbRsbRiRsRsmmbRg
RsmbRgbRsRebRiLsbRibRibRibRgLsbRgbRhRsmbRiRsmbRebRebRgbRgbRgRibRibRibR
gRsmbRsbRgbRgbRgbRgLsbRibRibRhRsmbRiReRsmbReRsRiRsRsRcmmmbRgLsbRgRsmbR
ebRgbRibRgbRiLsbRibRgbLsbRibRibRgbRgbRgbRgbRsRsmbRgRsRsmmbRgbRibRebRgb
RiRsRsmmbRgRsmbRhbsbRiRsmbRgRsmbRiRsmbRibRgLsRsbRibRgRsmbRgbRgRsRsmmbL
sLsmbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bRgbRgbRsbRgbRsbRgRsRsmmbRsbRgRsRimbRgbRibRibRebRibRgbLgbRhbRiRsmbRhRs
mbRgRiRibRhbRhbRgbRibRsbRsbRgRsRsRsLsmmmbRibRiRsmbRebRebRiRsmbRibLcbRj
RsmbRhbRebRgbRgRsmbRgbRgbLsRsbRgbRgRsmbRibRgbRibLsLsmbRgbRsRsRgmbRhbRi
RsmbRibRgbRgbRebRhbRhbRhbRgbRibRgbRiRgbLiRsbRgRsmbRgRsRsmmbRibRhbRebRg
RsmbRcRsmbRgRsmbRsbRibRebRiRsRsmmbRebsbLsRsRsReRsmmbRibRebRgLsbRgbLibL
sLsLgmbLhbLeLsbLebLgbLgLsLgLiLsLgbLibLibLebLibLebLibLiLsbLgbLsLgbLiLsb
LebLeLsbRsLhbLeLsbRsbLgbRsbLsbLhLsbLebLiLgbLsLiLibLgLsLsRsmbLibLiLsbLs
LsLiLsLsLsmmmbLgLebLebLhbLibLsbLgLsbLebRsbRjbLebLsbLgbLeLsbLgbLgbLcLsm
bRsbLgLsbLebLsLgbLhLsbLgbLibLgbLsLsLsLsmmmbLebLhLsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
bRgRsLsmbRcbRebLjbLibLhbLobLgbLiRsbLibLhbRebLsbRebRebRcbLgbRcRsRsmmbRh
bRsbRibRcbRebRgbRgbRhbLgbRebRsbRsbRsbRgbRgbLjbLgbRcbLjbLiLgbRcRsRsmmbL
jbLjbRgbRhbLobRebRhLsbLobLhbRcbRebLjLsmbLcbLhbLjbLsRcRsmbLsRjbRgbLibRc
bRgbRibRgbLjLsmbLjbLjbRjbRjbLebLgRsbRgbLiRsbLebLiLsLgbLiLsbLgbLgbLibRg
bRsRcbLgRsRsRsLsmmbLcbLibLgLgbLiLsbRsLsbLsbLcLgbRhbRhRsmbLjLsmbLcLsmbL
ibLibLsLsmbRgbRcb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bRebRgbRebRibLsbRibLsLsmbRebReRsmbLebLebLiLsLsmbLsLsLsLgmmbLsbLgbLsbLg
bLibLgLsbLibLebLsbLsbLgbLsbLgbLgbLgRsbRgbRiRebLgbLibRsLsbRsbLiLgbLsLiL
sbLgbLebLiLsbLgLsbLebLgbLsLgLsbLebLebLgLsbLgbLebLeLsbLibLibLibLsLsLsmm
bLgbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
bLgbLibLibRsbLeLsbLgbLhbRgbLibLibLgLsRsbLgbLibLgbLibLsbLiLgbLgLsbLibLe
bRcbRgbRgRsmbRibRgbLsbLsbRebRsbRsRiRsmbLsbRibRgRsmbRgRsmbLsbRibLeLsbLg
bLgbLibLcbRibRibRiRibRgbRibRsRsmbLebLgLsbLgbLibRsLibRsbLibLsbLibLgbLib
LibRhbRebRgbRibRgbRibRgbRhbRgbRhbLgbLibLiRsbLgbLcbRsbRgRgbRjRsmbRgbRsb
RgbRsbRibRsbLsbRsbRibRcbLibRibRsbRibRibRgbRibRsbRgbLsbRibRgbRgbRgRsmbL
gbRiRsmbLsbRsbLjbLhbLibLgLsLsmbLgLsLsmbRebRsbRgbLjbsbLibLgLsbLiLiLsbLh
bLiLsLsmbLiLgbLgbLsbLebLhbLibLibLgbLibLibLebLibLhbLgbLibRsbLsbLcbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 43; Drug: Control Apo 50 然
bRebLsbRiLsbRibRgbLsLsmbLjbRsbLibRsRsmbRsRsRjmbRibRgbRibRebRiRsmbRgbRg
bRgbRgRsRimbRgbRibRibRibRiRsmbRgbRibRiRgbRsbRgbLsbRsbRiRsmbRhRgbRhRsmb
RibRsRebRgbRgRsmbRsRsmbRibRgbRibLgbRhbRibLsRibLjbRsRhbRgbRgbRcbRgRsmbR
ibRibRibRibLgbRibRgbRgbRebRsbRgRsmbRgbRgbRibRibRhbRsRsLsmbRgbRiRsRsmmb
RgRsmbLjbRebRgbLsRsbRhbRiLsbRiLsbRgbRibRsbRgbRibRsbRhLsbRgbRhbRgbLsRsb
RsbLsRsbRibRhbRibRgbRsbRgbRcbRsbRsbRibRibRibRebLsbRebRgbRsbLibLibLgbLi
bLsLsmbLibLsbRgbRcbRgRgRsmbRjLsbRgbRibRebLsbLiLibLgbLsbLibLgLibLgLiLsb
LiLsbLcbRobRhLsbRsRsLsmbRibRgbLsbLgbRibRibRgRgbLgbRhbRebRibRhbRibRhbLj
bRsbRebRcbRibRgbRibRgbRgbRibRibRibRebRebLsbRibRebLgbLgbLibLibRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 44; Drug: Control Apo 50 然
bRsbRibRebLgbRiRsRsmmbRgbRgbLebLhbLibLebLebLeLsbLcLsmbLibLsLsLsLsLsLsL
smmmmmmbLsbLibLhbLcbLcbLebLibLebRibRgbRibRgbRiRgbRiRsmbRsLsbRibLibLiLs
bLiLsLsmbLiLsbLebLhLsLhbLebLibRhbLjbLiLibRgbLsLsLgmbLebLhbLcbRsbRgRsRs
RsmmmbRgRsmbRiLsRsbLsbLjbLgbLebLhbLebLibRjbLeLsbLeLsLsmbLhbLcbLebLsLsL
sLgLimmbLiLiLgLsbLgbLibLgbLebLibLhbLgbRgbLhbLebLgLgbLhbLebRsLsLsmbLgLs
bRsLgLsLsLsmmbLsLgLsbLsLgLsLibLiLsbLiLsLsLsLsmmmbLiLsLebLsLsmbLgbLebLs
LsmbLgbLibRiRsmbRebRiRsRsmmbLebLibLebLibLibLeLgbLhbLsLsmbLgLsbLibLibLc
bLiLgLsbLebLiLsLsLimbLgbLibRsbLiLgLsLsLsmmbLsLgLsLsLimbRsbLibRgbLebLib
LjbLgLsbLiLsbLiLsbLjbLeLsLhbRibRiRsRsmmbRiRsRsRsmmmbRjbRgRsRsmmbRsRsRs
mmbRebRgbLsbLebLebRjRebRibReRsmbLsLsmbLibRibRebRebRebRgbLibRsRjbLhLsbL
hbLebLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 45; Drug: Control Apo 50 然
bRcRsmbLibLebLoRsbRibRcbRibLebLebLjbLobReb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 46; Drug: Control Apo 50 然
bRgbRebRiRsmbRsbRiRsRiRsmmbRibLsRebRsbRibReRsmbLsbRiRsmbLjbLcbLgbLibRc
bRibRibRibRgRsmbLsbRibRgbLjbLibLsbRiRsmbRibRebRgbRgbRgbRgbRgbRgbRgbLgR
sRsmbLjbRjbRgRebLsbRgbRsRgbLibLibRjRsmbRgbRgbRgbRgbRgbRgRsmbRgbRgbRgbR
gRsmbRgbRgbLibLjbLibRsbLibLgLsLsmbLibLgLsbLgLebLebLebLeLsLeLsLgLgbLhbL
sbLgLsLiLsLsLiLgmbLibLgbRsbRibRibRsbRgbLsLsmbRgbRgbRgbRcbRibRibRgRgRsm
bRgbLibLgbLgbLgbLsbLsRsbRibRebRiRsLsmbLgbRiRsmbReLsbRgbRgbRgbRiRsmbReb
LibLibLgbLgLsLsmbRgbRjbRibRsbRgRsmbRsbRgbRgbRhbLgbRgbRhbRibRiRsmbRibRg
bRgbRibRsbRibRgbRgRsmbRgRsmbRiRebLeLsbLgbLsbLsbLgLsbsbRsLsbLgLeLsbLibL
gbLsbRsbLibLibLibLsLsmbLsRsbLsLsmbLsbLgLsbRsbLgbLgbLiLsbLibLgbLsLgLsLs
mbLibLgLsbLsRsbLsbLibLgLsbLsLsmbLiLsbLgLsbLgbRsbLgRsLsbRsLsLsmbLsLsLsL
smmmbLiLsbLgLsbLsLsmbLgbLibLgLsRsbRsbLsbRsRsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 47; Drug: Control Apo 50 然
bLgRsbRsLsbLsLsmbLgLsLsmbLsLsmbLgbRsLsLsmbLgbLsbLsLsmbLiRsbRsbLsLsLsLg
mmbLgbLgbLeLsbLibLibLsbLgLeLsLcbLiLsRsbLibLiLsbLsbLsbRjbRhbRibRhRsmbRg
bRiRsmbRgbRgbRgLsbLiLsLgbLgbLgbLebLgLhbReRgbLeLsbLsLebRcLsbRcbReLsbRiR
smbRcRgLsbRibRibRsRsmbRsbRsbRsbLjbRibRibRgRgRsmbLebLgLsbLibLsbRsbRcbRi
bRsbLoLsmbLebLiLsbLibLgbLjRgbRjbsbsbsbRsbsbsbRsbRibRgLsbRsbRgRsmbRsbRg
bRiRsmbRhbLsbLibLiLsRsbRsbLsbLjLebRsbLibLibLgbLgLibLiLhbLebLsbLibRsbRe
bLjbRcRsRsmmbRgbLgbLeLsbLibLibLiLsbLebLsbRcbRhRibRhbRgRsmbRcRebRsbRgLs
bRibLsbRsbRsRsmbRsbRsbRsbRsbRsbRgRsmbRibLsbRsbLibLcbLeLsLebLsbLsRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121423; End: 121923;
Recording: 6-1; Individual: 48; Drug: Control Apo 50 然
bRebRibRibLjbLcbLsLsmbLebLgLsbLsLsmbLcbLhLsbRgbLcbLibRgbLebLhbLcbLebLi
bRhbLcbLebLebLibLcbLhbLibLcbRhbRiRsmbLgbLebLibLebRjLsbRjbLhLsbRjbLhbLe
LsbLhbLibLibLebLibLhbLcbRjbRsRibRibRgbRgbRgbRgbLsbRgRsmbRgRibRsbRobRib
LsbLiLsbLibLjbRobLcbRsbLebLjbRsbLeLsbLeLsbLiLsbLiLsRsbLcbLcbLebLibRibL
iLsLsmbLibRjbLcbLcbRgbLjbLhbRgbLiLsbRsbRsbLebLcbLebRgbLhLsbLeLgRsbRgbR
sbRgbRgbLebLibLibLebLcbLgbLgbLebRsbLcbLebLebLebLebRsbRgbLcbLcbLibLebLe
bLcbLebRcbRgbLgbRgbRibLjbLibRjbRibLjbRgbRhRsmbLjbRibLcbLibLsbLgbLeLsbR
sLiRsbLibLebLibRibRgbRsbRibRiRsmbRibRgRsmbRgbLebLebLibRsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
bRebRobRobLibRobLhbLebRibRobRobRobLobRibLsbRobRebRgbRcbLebRhbRcbLsbRob
RebRobLobLcbLobRobRibLsbLobRcbRibLsbRobLebRebLebRcbLebLgbLebLgbLebLobR
obLjbLobRebLobRibRgbRgbRcbRobLebRibRhbRebRcbLcbLgbRebLebRcbLibLebLobRo
bLebLebRibLobRcbRobRjbRobLebRsbLsbRgbRgbLobLobLobRcbRebLhbRgbLobRobLcb
LcbRebLobRobRgbRgbRibLsbLobRebLebRobLgbRobLebRebRgbRcbLebLobLobLobRebR
cbLcbRobLebLcbRibLcbLebLobRsbLsbLebLjbLobLcbRcbLobRcbRsbLebLsbLhbLcbLg
bLebLobRibLebRobLobRcbLebLobRobRgbRibLsbRobLsbRobLobRobRobRjbLebRibRob
LobRebLibLsbLobLgbLobLgbRcbRobLebLgbRebLobLebRcbLobRobLebRebLebLgbLobR
ibRobRobRebLobLcbLebLebRcbLsbRobLjbRebLcbRobLebLobLebLobRobRgbRebLebLo
bLobLobRcbRebRobLobRobLobRobLobRobLgbRebLebLebLebRebLobRebLobLebRobLib
RobRebRebRobRebRcbLobLobRcbRhbLobLibLobLebRebLebRobRebRsbLebLsbLcbLgbL
ebLobRebLsbLobLibLobLsbRebLcbLcbRebLobRsbLobRebLebRebRebRebLgbLobRsbLh
bLsbLobRgbLebLobRobLhbRibLcbLobLcbLobLobLcbRobRebLebLobLjbLgbLcbLobReb
LebLobRebRebLobLobRebRebLsbLsbRebLgbLobRebLcbLebRebRobRsbLobRibRgbLcbR
ebLjbRebRebLsbRcbLebRobRcbRobLgbLgbRobRcbLibRobLhbLebRobRobRsbLibRcbLo
bRebLobRebRsbLobLebRjbLobLsbLibLibRgbRgbRobLibRcbRibLobRobRebLobLibRcb
RebRcbRebRobRebRebRobLobRobRgbLobLgbLobLsbLsbLibLebRcbRcbLobLhbLobRebR
jbLebRobRcbLobLobRgbLobRcbRebLgbLobRobRobLobRobRobLgbRobLcbRjbLsbRebLc
bLebRsbLobRobRebRcbLsbLebLebRebRobRjbRsbLibRibLobRcbRibRebLcbLebRobLob
LobLebLobRsbRobRcbLhbLebLobLgbRcbRebLobRibLobRibLebRsbLobRebRobLgbRcbL
obLebLgbLebLebLebLsbRgbLebRgbRobRsbRebLebRibLcbLgbLsbLebRibRibRcbRgbRo
bRobRebRobLcbLebRcbLebRobRibLcbLobLebRsbLobRobLobLebRobRibLjbRibRgbLib
LobLebLibRcbRobLobLobLsbRcbRebLobRebLobLcbLgbRebLobLjbRcbLsbLobLobRebR
obRebLsbLobRcbRobLebRcbLobLebRobRobLobLcbLcbLjbLsbLebRebRcbRobRebRibLe
bLobRobLebRgbLcbLobLcbLcbRebRcbRcbLebRobRgbRebRebRobRgbRebRobRcbLobRob
RobLebLibLcbLcbLobLebLgbLobRobLebRobLebRobRsbRsbRobRhbRcbLgbLobLcbLobL
cbLebRobLebLobLcbRobRobRsbLjbRobRobRsbRjbRebRcbRebRgbRibRibLebLobLcbLo
bLibLgbRobLobLobLcbLgbRcbLobRobRcbLobRgbRibLibRobRebLobRcbLcbRebRobLob
LgbLobRebRobRcbRibLobLobRgbLebLebLobLobLobRebRobRebLibRebLhbRebRebLobR
obLobLibLebRebLobRjbLebRobRibLobLebLcbLebLgbRebLsbLgbRcbLcbLebRebRgbRe
bRobRcbLgbLobLebRobLsbLebRobRebRobRcbRobLobRobLobLgbRsbLhbLcbRobRebReb
LibLcbRobLebRcbRebRcbRebLobLsbLobRebLobLibRebLobLobRobLibLgbLsbLcbLobR
obRebRibRcbLebRobRobRhbLebRebRjbLsbRobRebRebRobLebLobLobLobRobRobLibLc
bLsbLobsbLsbRsRsmbRsRsmbRsbLsbRsbRsbRsbRsLsbRsbRobLobRsbLsRsbLsLsmbsbR
sbLsbLsbLsLsmbRsbRobLebRebLebLsLsmbLebRebRebLcbRebRebLebRobRsbRjbLgbLo
bRobRhbRebLebRobRebLobLsbRcbLobLjbRobLebRobRhbLobRobRcbLebRgbRebRsbLeb
LobLobLcbRobRebRsbLcbRobRgbRobLebLibLsbLobLobLebLobLobLebRebLobLcbRobR
sbRobLebLebLebRsbRibLgbRobRebRcbRjbRobLebRebLcbLobRcbRobLobLobLobLcbRg
bRibRebRcbRcbRebRobLobRibRsbLcbRhbLobRobLobLcbLebRcbRebRobLcbLebRsbLob
LcbLgbLebLcbLcbRebRobRibRobLobLebRebRjbLobRobRebRsbRebLebRobLcbRobRsbR
obRobLebRobLgbLobRsbLibRebRebLebLebLcbRsbLcbLjbRobRebRobLcbRgbLebLcbLo
bRebLobRebLebLebRobRgbRsbRebLobRobLcbRebLobRjbRcbRebLobLgbRgbRsbRebLob
RebLobRebRgbRebLibLebLobLibLcbRhbLibLobRobRobLibLebLcbLobLcbLibLebLobL
obLebRsbLobLsbLsbRcbLhbRgbLobLebRcbLobLjbLobLsbRcbRobLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bRebRgbLgbRebRebLjbLcbLcbRgbLcbRibRcbRibRhbRibRcbRgbLcbLibLibLcbLobLib
LhbLibLibRobRibRgbRgbRibRibRibRiRsmbRibRibRoRsmbLhbLibRibRcbLjbLcbLibL
gbLsbRobLgbRjbLgbRsbRibRgRsmbRibRibLsbRibRgbRhbRibRiRsmbRebRebRibRcbRe
bRgRsRsmmbRibRebRibRibRibRsbReRsmbLcbLibLibLsbRgbRibLjbLgbLibRjbLhbLeb
RebLebRhbRebRcbRibRhbRibLhbLgbLibRibRibRibRibRgbRgbRgRibLgbLibLcbLibLg
bRibRibRibRgbLsbRcbLibLebLgbLibLgbLgbLibRjbRhbRgbRibRgbRgbRibLibLibLeb
LibRgbLebLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bsbRsRsLsmbRsRsmbRsbRsbsbRsRsRsmmbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bRsbLsbRgbLsbRgRsmbRsRgRgbRcbLgRsbLsbRcRsmbRgbRsRsRsLsRimmbLsbRsbRebRs
bLgbLgLsbLgLsLsmbLsbRsbLgLsbLgbLgbRsbLgbLsLsmbLgLsLgbLgbLgLsbLibLgLsLs
mbLgLsbRsbRsLsbLsbLsLsRsLsLsmmbLgbLgLsbLgbLsLsmbRsLsLsmbLgbLgbLiLsLsmb
LsbLsbLgLsbLsbLgbLgLsbLgbLsbLsbRjbLibRgbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bLgLgLsLsLsmmbLgbLgbRsLsbRsRsRsRsRsmmmmbRgRgbRgRsRsRsRsRsRsRsRsRsmmmmm
mmmmbRjbLebRsRsRsRsmmmbRsRsRsmmbRibLcbLcbLhbLibRsbLibLsLhbRibLhbLhbLgb
LibLsRsbLibLgbLgbLgbRcbRibRgbRiRgbRiRsRsRsRsmmmmbRcbRibLjbLobRsbLcbLiL
eLgbLeLsbLhbRebRiRsRgmbRiRsmbLgbLjbLibLebLibLebLebLgLeLsbLgbLsLsmbRsLs
LsmbRsbLsbsbLsLsmbLsbLsbLgLsbLgbsbLsbLsbLsbLsbLsLsmbLsLsLsLsLsmmmmbLsL
smbLgLsbLsbLgLsbLgLsbLgLsbLgbRjbRebRebRibRibRibRhRiRibRgbRibRibRhbRoRs
mbRibReRsmbRebRibRgRsRiLsmbRgbRgbRgbRibRhbRiRsmbRiRsmbRiLsbLsRgRsmbLjb
RibLjbLobRjRsmbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsbLsbRgLsLsmbLibLibRebRgbLj
bLebLgbLgLsLsLsLsmmmbsbRsbRsRsRgRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmbRgR
smbRgbRsRsmbRhbRiLsbRgRsmbRgbRsbLebLsLsLsLsmmmbLsbLibLgbLiRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bRjRsmbLgbLiLsbLgbLgbLgLsbLsbLgLsLsLsmmbLgbLgbLsLsmbLjLsmbLgbLgLsbLgLs
bLiLsLsLsLsmmmbLgbLgLsLsmbLgLsLsLsRsmmbLgLsbsbLsbLgLsbRobRcbLsbLgLgLsb
LgLobLsLsmbLgbLsLsmbLgbLsLsLsLsmmmbLgbLsLsLsmmbLsbLsLsLsLsLsmmmmbLgbLs
LibLibLgbLebLibRcbRibRiLsRsbLsbRoRsmbLeLsbLgLsbLebLsLibLeLibLgbLgbLobL
jbLeLgLsbLibLgLgLsbLgLsbLsbLibLibLsbLibLibLsbLhbLobLgbLgbRsbLsbLibLgbL
gbRjbLgbRcbRibRiRsmbRiRsmbRibRgbRgbRhLgbRobLibRgLsbLcbRsbRsbLjLsmbLsLs
LsmmbLgLsLgLsbLsbLgLsbLsLsLsLsLsLsmmmmmbLsbLsLsLsmmbLsbLsbLsLsmbLsLsLs
mmbLgbLiLsbLeLsLsmbLgbLsLsmbRibLebLiLsLsmbLhbLsbLhbLsbLgbLgbLgbLgbLgbR
hbRobRibRgbLsLgLsbRjbLcLsmbLgLsLsmbLgbLsLsmbLgLsbRcbLsRsRsmbRgLsbLgbLs
LsmbLsLsLsLsmmmbLsbLgLsbLgbLgbLsLsLsLimmbRgRsmbLgLsLsmbLsLsLsLsLsmmmmb
LgLsLsLsLsLsLsLsLsLsRsLsmmmmmmmmbLsbLgbLgLsLsLsLsLsLsLsLsmmmmmmmbsbLsL
smbLsbLsLsmbLsbLgbLgbLsbLsLsmbLsLsmbRhbRhbLhbRobRgLsbLsbRibLgbRjRsRsmm
bRgRsRsmmbRsRsmbRgRsmbLsRsRsLsmbRgRsRgRsmmbLsRsRsRsmmbRsbRgRgRsRsRgmmb
LgbLjLsmbLgRsLsbLsLsmbLgbLeRsbLgLsbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bRsLsbRebRcbLsbRgbRsbRsbLjbReRgbRebRgRsmbLsLsmbRgbRiRsmbLsbLsbRibRebLs
bLcbRsbRebRibRgbRibRebRsbRibRsbRebRgbRibRgRsmbRgRsRsmmbRgbRibRgbRgRsRs
RsmmmbRibRgbRsbRgbRibRgbRgRgRsmbRsbRsbRgRsmbRgbRibRgbRgbRgRsmbRsbRgbRg
bRgbRsRgbRgbRgbRibRgbRsRsmbRsbRgbRsbRibRgbRgbRgbRibRgLsbRebRgbRgRsmbRg
RsmbRgRsRsRsmmmbRgbRsbLsbRgRsmbRibRiRsmbRgLsbRgbRgbLobRgbRgbRsbRsbRsbR
sbRsbRgbRsLsbRsbRgbRgbRsbRgbRebRsbRgbRsbRsbRibRgbRgRsmbRgbRgbRgbRgbRib
RgbRsbLsbRsbRgbRgbRgRgbRibRsbRgbRibRgRsmbRibRibRgbLsbRsbRsRsmbRgbRgbRg
RsmbRgbRsbRgbRgbRsbRgbRsbRsbRgbRgbRiRsRsmmbLsLsmbRgbRhbRibRgbRgbRsbRgR
smbRibLsRsbRgbRsRsRsLsmmbRgbLibLhbLcbLcbLebRiRibRibReRsmbLjbLcbLsbLsbL
eRsbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bLhbLebRhbRiRsmbRhbRibLcbLgbLibLiLsLsLgmbLibLgbLhbLibLibLsbLgLsbLeLsbR
obRgRsRsmmbRgRsmbRgLsbRjRgbLgRsbLsbRgRsmbRiRsmbRsLsbRsRsmbRsLsRsRsRsmm
bRgRsmbRgbRgRsmbLsLsmbLsbRsRsmbRsbRsbLcLsmbLcbLcbLobLiLsbRsLebLobRebRh
bRgbRobLsLsmbRibLsbRhbLjbLsLibLiLsbLgLhbLgbLcbLibRhbRibRgbLgbRsRiRsRim
bRibRibRibLsbRiLsRsbLgbLjbLiLiLsbLgbLibLibRcbRibRgbRebLeLibLgRsbLibLeb
LibLgbsbLsRsbLsLsmbLsLsLgLsmbLsbLgLsbRsbLsLsLsmmbLsLsLsmmbRsbLsbLsbsbL
sLsLsLsLgLsmmmbLsbLsLsLsmmbLsLsLsRsmmbLsLsLsmmbLiLsbLgLsbLhLsLsmbLgLsb
LiLsLsmbRjbRcRsmbRcRsmbRcbLebLhbLiLsbLgbLibRcRsmbRhbRiRsmbRgbRhbRiLsbR
hbLebLiLsbLgbLibLgbRcbRhRsRsmmbRiLsbLgbLibLibLibLibLgRsRsmbRcbRibRiLsb
LcbRjbLjbLgbLibRjRiRsmbRibLgbRibLsbRgbLgbLebLgLsLsLsmmbRsLsLsmbLgbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
bRoRsmbLobLjLibRcRibRsbRibRobLsRibRcbRgbRiRsmbRsbRhbRcbRcRgRiRgbLebRgR
smbRgRcbRobRsbRiLsRibReReRsRembReRsReRsmmbRibLibRhbRibRsRhbRgRsmbRgbRi
bReRsRsmmbRcRsRiReReRsRiRsmmmbRcRsmbRiRsRsmmbRhRibRgRsmbRsRsmbLcLsmbLe
bLgbLebLibLiLhRsLhbLebLebLgbRsbLibLibLibLsbLgbLibLgbLibLhbLsbRibRibRsR
smbRiLsLgRsbRibRibRcRcbReRebRibRcRsmbRgbRgRsmbRgRebRebRibRhbRgbRiRsRsm
mbRcbRiRsmbRsbRgRgbRiLsbRibRiRsmbRcbRiRsmbRiRsRiRsRemmbRgbRgbRebRibRhR
smbRgRsmbRgbLjbLibLhbLgbLiLsbLiLsbLibLibLiLsbLcbRjbRoRsmbRhb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
bLhbLiLsbLeLgLsLgLsbLgbRcbRhbRibLibLjbRhbRsbLjbLjbRgbRgLsbRsRsmbLgRsbR
ibRibLhbRgLsbRcbRgbRibLhbLibLsLsmbRjbRgbRgbRibRgbRgRgbLhbLgLsbLiRsbLib
LgbLgbLsbLibLgbLibLibLsbLgLsbLcbLeLsbRsbLgLsLsmbRsRsRsLsLsRsmmmbLibLib
LgLsbLsbLsbLibLibLsbLibLgLsLsmbLgLsbLgbLgbLiLsbLibLibLibLiLsbLebLebLeL
sbRcbRhLsbRiLsbRebLjbRiRsmbRsbLsRsRsRsmmbRsRsRgRsmmbRgbLjbLcbLgbRsbLcb
LebLhLsbRjbRiRsmbRgbLebLgbLhbLibLibRsbRcbRibRgbRgbRhbRsbRgRsmbRsbRibRi
bRiLsbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bRsRsmbRibRgRsmbRsbRgRsmbReRsRcmbRcbRcRsmbLibLhbLhbLhbLgbLebLgbLibRobR
cLsbRobLibLhbLhbLhbLibLhbLibLibLibLgLsbLgbLcbLoRsbLsRsbLibLgbLibLhbLiL
sbLhbLibRjbLhbLibLsLcbLgRobRibRoRsmbRibLibLgbLiLsbLgbLsbLibLgbRgbRibRj
RsRgmbRgRoLsbRgRsRsmmbRgbRsbRgRsmbRsbRibRhbRebLcbLibLhLsLsmbLiLsbLibRs
bLhbLibLibLibRsbReRsmbRibRibRsbLjbRhbLjbLobLhbLibLgbLobLhbLibLgLsbRjbL
ibLiLsbLgbLgbLiRsbLcbLgLsbRibRjbRibLgLsbLjLsmbRsbReRsmbLebLibRgbRibRib
RgRsmbRibLibRibLgbRiRsRsmmbRgbRhRsmbRiRsmbRebRhLsbRhbRcbLjbRiRsmbRiRsm
bLsbRhbRsRgbRibLsbLsRsbRibRsRsmbRgRsmbRiRsRsmmbRgbRcbRsbLjbLjbRibRgbRe
bRsbRgbRsbRiRsmbRsRsRembRsbLibRobLibLiLsbLiRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
bRibRgRsRsmmbRiRsmbRcRiRsmbRgbRibRsbLsbRcbRsbLhbLsLsLsmmbRobRibRsbLcbL
iLibLsRsbRebRgLsbRibReRsmbLoRsbRibRibRjLsbRebLiLsbLhbLobRjRibLeLgbLebL
jbLebLebLebLebLjbLebLhLsbLcbLibLhbLgbLcbLgbLgbLsLebLgbLjLcbLeLsbLjbRob
RiRsmbRebRhRiRsmbRibLiLsLibLgbLibLgbLgbRobRebReLebLhLhbLobLgbLiRsbLobR
jbRoRsmbRibLsRibRgbRibRgbRgbRibRhbRibRjbRobRsbRhbRibRgbRibRibRibRgbRib
RibLgbLgbLibLobLibLibRsRjbRcbRgbRibRibRibRibRgbLibLgbLgbRgbLgbLibLibLi
bLgbLibLsbLsRsbLsLsmbLsbRsbRsbRsbLgbLgbLgbLgbLgbLgbLibLgbLgbLsbRsbRhRs
RsmmbRsbRgbRgbRebRibLgbLgbLgbLsbLsbLiLsbLibRsbLgbRhbRibRgbRsbRibRgbLgb
RhbRibRsbRibRsbLsRsbRgbRsbLsbLhLsbRsbLsLsmbLsbLsLgbLgbLgbRjbRebRgbRibR
ibRibRsLsbLibLibRgbReRsmbRibRgRsmbRsbRibLsbRgbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bLsbLgLsbLgbLebLgbLibLgLgbLgbRsbLibLgbRsbLibRsbLgbRsbLcbLgbLibLgbLibLi
LsbRgbLgbLgbLibLibLgbLsbLhbLibLgbLibLibLiLsbLibRjbRibRgbRibRibRibLibLi
LsbLgbLibLgbLebLibLebLhbLibRiLsbRgbRibRibRcbRjRsmbLibLibLgbLgLsbLhbLjR
sRsmbRiRsmbLhbLebLgbRjbLibLibLibLgbLgbLgbRjbRibRibLsRgbRgbRgbRibRgLsbR
gbRibRgbLebLibLibLgbLgbLsLibLebLibLgbLgbLibLsLsmbRgbLcbLhbLebLgLibLsLs
mbLeLsbLgbRsbLgbLgLgLsbLgbLgbLibLgLsbLgbLibLgbRgbRebLhLsbLibLgRsbLgbLe
bLibLibLiLsbLgbLibLgbLebRcRsmbRibRibRgRsmbRiRsmbRgRibRibRcbRgbRgbRhRsm
bRibLibLibLeLibLibLgLibLebLibLgbLgbLgbRgbLibLebLebLgbRobRibRibRibRjRib
LibLgbLibLiRsbLcbLebLebLgbLcbRiLsbRgRsRsmmbRgbLsbLhbLibLgRsbLebLebLibL
gLsbLibLibRjbLiLsbLebLibLibLgLsbLibLibLebRgbLhbLgRsbLgbLibLeLsbRibRjbR
iRsmbRiRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bLsRsbRebRgbRgbReRgbLjLhbLiLsbRsRsmbLgRsbLiLsbLgbLsbLcbRgbLgLebLgLsLsm
bLibLibLgbLibLiLibLebLibLgLsbLhbLibLcLsmbLgLsbRsbRhbLcbRcbReRsmbRcRsmb
RebReRebRcRsRsmmbRgbLibLgbLiLsLebLibLhLebLhLeLeRsbLgbLhbLgbLsLgbRcbReR
smbRgLsbRibRiReLsbRibLcbReRsmbRibRibRsbLcLsmbRsbRhRsmbRobRgbRibRcbRgRe
bRibRiRcbLobRcbLjbLcbLgbLcbLhbLeLjbsbLebLiLsbLiLsbLsbRoRsLsmbRgbRiLebR
ibRhbRibRibRsbRgbRobRibRibRgRsmbLoLsmbLibLibLibReLsbRsbRgbRibRiRsRsmmb
RgbRgbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bRsbRsbLsRsbLsbLgRsbLsbRgbLibRsRgbLsbLsbLsbLsbLsbLgbLgbLsLsmbRsbRcbRib
RgRsRembReRsmbRgbRsRsmbRiRsRsmmbRcRsmbLeLgbReRsmbRgbLcLsmbLcbLsbLibLsb
LgbRcbRhRsmbRibRsbRebRhbRebRhbRibRiRsmbRibRibRibRsbRibRoRsRcRsmmbReReb
RebRgbRgbRgRsmbRsLsbRhbRibRibRgbRcRsRembRebRgRsmbLsbRibRibRgRsmbRgLsbR
gbRebLjLhLsbLgbLibLsbLsRsbsbLsRsbRebRiRebLcbLibLgbLgbLsbLhbLibLcbLibLc
bLgbLhbLiLsbLibLibRcRebRibRibRibRibRcbRebReRsmbRibRebRibRgRsmbRgbLsRib
RibRoLsbLibLibLsbRgRibLgLsbRsRsmbRiRsmbRsbRsRsmbRgRsmbRsbRsRgbRsbRibLs
bLgLsbLsbLgbLgbLsbRsbLsbRsbLsbLgbLgbRsbLsbLsbLsbLsLsmbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bLebRcbRebRcRibRebLcbLibLcbLiLsbLibLibRiRsmbRgbRgRsReRsmmbRsbRebRcbRiR
smbRibRgRibReRibRiRhbRgLsbLjLsmbLibLgbLsbLgbLsLsmbLsLsLsLgmmbLgbLgbLsb
LeLgbLgLsbLgbRsbLebLsLsmbLibLgbLebRgbLibLgbRjbLibLhbLibLgRsbRsLcbLhLsb
LeLsbLgbLebLgLsbRjbRsRiRsRsRemmbRgbLgbLebLibLgbLhbLgbLibLeLsbLhbLgbLib
LebLeLsbRjRsmbRgbRebRgbRibRhbRebRibRiRsmbRcRsmbRhbRcbRhbRibRgRsmbLebLc
LsmbLhLibLebLibRibRsbRsRgRsmbRgbRiRsLsmbLhbLgbLgbLibLgbLibRgbRgbLebLhL
sbLibLgbLebRjbRgbLsbLsLsmbLjbLhbLibLjbLhbLebRibLhbLibLgbLgRsbLsbLibLib
LgbLgbRsbsbReRsRsmmbRgbLibLeLsbLgLsbLiLsbLiLibLeLsbLgbLebRgRsmbLeLsbLi
bLibLiLsbLsLjbLsbLibLgbLiLibLibLhbLibLibLiLsRsbLibLiLgLsbLiLgbLhLsbLhb
LibLgbLcbLhbLibLibLsbLhbLiLsbLgbRjRhbReRgbRcRcbRebRiRsRsRsmmmbReb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bRsRsmbRsRsRgmbRgbRsRgbRsbRsbReRsmbRiRsmbRibLgbRgbRebRebRhRsmbRgbRgbRs
bRsbRsRsmbRsRsRsmmbRsRsRsmmbRsRsRsRsRsmmmmbRsRgLsbRsRsRsRsmmmbRsbRgbRg
bRsRsmbRsRsRsmmbRebRsRsmbLgbRjbRsRiRsRsmmbRsRsRsmmbRsbRsRsRsRsRsmmmmbR
sRsRsmmbLsRsRsRsmmbRsRsRsmmbRsbRjbRgbRsRsmbRsRsRsRhRsmmmbRebRgbRgbRgbR
ebRebRgRsmbRsbRgbRhLsbRibRebLebLsLsLsmmbLsbLsbLsLsLsmmbLgbLgbRsbLsLgLs
LsmbLgLsLsLsLsmmmbLgLiRsbLebLebLsbRcbRgRsmbRibRgRsmbRibRgbRebRebRsRsRe
LsmbRibRebRsRsRsmmbRsRsLsmbRsRsRimb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 19; Drug: Control Apo 50 然
bLsLebRsRsmbLibLsbLhbLibLhbRsRsmbLiLsbLsbRsbLsRsbRjRsmbRhbRgRgbRgRsmbR
hRsmbRebRgbRgbRhbLibLcbLeLsbLgbLgbRcLsbRibLsLsmbLjbLhbLsLsLsLsmmmbRsRs
mbRsRibRsRibRiRsmbRebRgbRgbRibLsRsbRgRsmbRibRgbRibLgbRgRsmbRgRsRsmmbLj
LsmbRebRiRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 20; Drug: Control Apo 50 然
bRjbRebRgRgRsRiRsmmbRiRgbRgbRebRiRsmbReRsmbRebRibRsRsRsRimmbRiRsmbLsbL
sLcbLebLcbLgbLebRsLsbLsLiRsbLeLsbLibLiLsbLebRobRibLcbLebLiLsLgbLibLgbL
iLsbLiLsbLsbRcbLcbRebRsRsmbRiRebLcbLjbLeLsbLgLsRsbLeLsbLgbLsLsmbLgLsbL
gLsbLgRsbLibLgLsRsbLhLsLgbLeLiLsbLebLhbLhLsbLibLgLsbLgLsLsLsmmbRgbRebR
ebRiRsmbRibRibRebRibLjbLibLiRsbLgRsLsbLibLiLsbLgLgbLiLsbRsLsLsmbLiLsbL
ebLebLgLeLsbLcbRibLhbLibLsbLgbRobRiRsRgmbRebRibRebRhRsRsmmbRebRhbRsRib
RiRsmbRibRgRsRsmmbRobRiRsmbRiRsmbRibRiRsmbRiRsmbRsRgRsmbRsLjbLebReRsRs
mmbRiRiRsmbRebRebRgRsmbRgbLsbReRgbRebReRsRsmmbRhbRibRhb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 21; Drug: Control Apo 50 然
bRgbsbsbRgbRgbRgRgReRsmbRebLebLibLsbLgbLibLsbLgRsbLsLsRsmbLsbRsLsbLsbs
bRsbsbLsbRsLsLsmbLgLsLsLsmmbLsLsLsLsmmmbLsbLgbRsbRsRsmbLsLsRsmbRsbsbRs
bLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 22; Drug: Control Apo 50 然
bLgbRgLsRsRsmbRgbRiRgRsmbRgbRibLcbLebLebLebLgbLibRcbRibRcbRebLibRhbRcb
RcbRebRebRsbLibLibLcbRsbRebRsRsmbRibLsRsRebRebLcbRibReRgbRibReRsmbRiRs
mbRibRiRsmbRibLgRsbRibLgRsbRebRiRsRsLsmmbLibLjbLhbLibLsLsmbLgLsbLibRob
LsbReRsmbLgbRibRibRibRhbRsbRgbRsRsRsmmbLjbLebLhLsbLhbLebLgbLebLgbRgbLi
LsLgbLibLgLsRsbLgbRjbLebRebRebRiRgbRibRsbRgbRebRcbLibLhbRebRcRsmbRibLj
bLibLgbRibRibRibRsRiRsmbRsRsmbLsRiLsbLobLhbLhbLebLibLjbRsbRibLcbLsbRib
RiRsmbRebRebRebReLsbRebRcbRibRhbLhbLjbLibLibRsbLcbLhLsbLebLsbLeLsbRcLs
bRsbRebRsRsmbRebLibLhbRhbRcbRgbRcRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 23; Drug: Control Apo 50 然
bRgbRibRibReRsmbRsbRgbRcLsbLgbLhbLgRsbLgLsbsbLgLibLiLsbLiLhbLibLsbRcbR
ibRiRsmbLcLsmbLsLsmbLiLsLsmbLgLsbLibLibRibLibLobLgLsbLsLibLibLibLgbLgL
sbLibLgbLgbLgLsbRebRibRibLgbRsbRhbRibRibRibLiRsbLgbLiLgbLgbLgbLibLgbLi
bLsbLibRsbLgLsLsLsLsLsmmmmbLsLsmbLsbLsLsmbLgLsbLsbLsLgbLgbRobRebRiRsmb
LsbRgbRibRibRgbRebRiRsmbRebLsbRgbRgRsmbRgRgbRgRsmbRsbRcbLgbRgbLsRsbLsb
LgbLgLsLsmbLsbLiLsbLibLgLsLsmbLibLgbLibRibLgbRibRgbLsbRsbRobLobLibLgbL
gLsbLgLgLsbLgLgLsbLibLibLibRsbLibLibRsRsmbLgbLgbLibLiRsbLibRsbLcbLgLsb
LsbLgLsLsLsmmbLgbLibLsRsRsmbLsLsLsmmbRgbRgbRsRsRsmmbRsRsmbRgbRsRsmbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 24; Drug: Control Apo 50 然
bLsRsbRgbRsRsmbRgbRgbRsRsmbRebRgbRibRibRibRibRibRgbRgbRsbRgRsmbRgRibRg
bRgbRibRsRsmbRgbRgbRgbReRgbRgbRgbRgbLsbRhbRsbRgRsRsLsmmbRgbRsRsmbRiRsm
bRgbRiRsmbRgbRsbRibRsRsmbRsbRgbRsbRgRsmbRgbRgRsmbRebRibRgRsmbRgbRsRsRs
RsRsmmmmbRgbRsRsmbRibRebRhbRgRsmbLsbRiRsmbRgRibRibRebRibRgbRebRgbRsRsm
bRgRibRgbRibRgbRgbRgRsmbRgRgbRgbRgRsRsmmbRibRibRsbRgbRgRsmbRhbRgbRiRsm
bReRsmbRgbRgRsmbRibRsbRgbRibRiRsmbRgRsmbRsbRgbRebRhbRibRebRhbRgbRgbRgb
RibRibRibRgRgbRhRsmbRgRsmbRgRsRsmmbRgRsRimbRiRgbsbsbRibRibRibRsbRgbRsb
RebRsRsRembRibRgbRgRsmbLsbRjbRgbRibRgRsmbRgRsmbRsbRibRibRsbRgbRgbRgbRg
bRibRsbRiRsmbLibLgbRibRgbRgRsmbRsRsmbRsbRsRsmbRgRgbRgRsRsmmbRgRsmbRgbR
gRsmbRgRgbRgbRsbRgRgbRgbRgbRgbRgRsmbRgRsmbLsRsRsRsmmbRhbRibRebLsbRsbRs
bRgbRgbRebRsbRsbRgbReRgbRgLsbRgbRgbRgbRiRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bLsLsmbLsLsmbLgbLibLiLsbLgbLgbLgbLgbLsLsmbLgRsbLsbLgbRsbLsLsmbLgLsbRsb
LibLgbLgbLibLgbLgbLibLgbRsLsbLgbLsbLsLsmbLgbLsbRsbRebLsbRgbLsRsbRsRsmb
RgbRgbRhbRibRibLsbRebRibRgbRebRibLebRcbLsbRgbLsbLjbLsbLgbLgbRsbRibRgbR
ebRsbRobLibLibLgbLebRebRiRgbRgbLsbRebRsbRibRiRsRsmmbRgbRibLgbRgbRsRsmb
RsbRsbRsRsmbRgbRebLsRsbRebRsRsRsmmbRibRsRsmbRsbRsbRsbRsbRgbRebRgbLhbLi
bLgbLsbLsbRsbLgbLgbLgbLgbLibRgbLibLgbRsbLgbLsbLsbLgbLsbLsLsmbLsbLsLsLs
mmbLsLsmbLgLsbLsbLsbLsbLsbLgRsbLhbLgbLibRsbLibRibLgbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
bLsLsLimbLiLsLsmbLgLsLsmbLgLsLsLgmbLsbLgbLgbLsLeLsbLhLsbLsLibLibRsbLgL
sbLibLibLibLgbLgLsbRjbRjbLhbRebRsbRsRsRsmmbRgbRsbRgRsmbRgRgbLgbRiRsmbL
sbRsbRgRgbRiRibLgbRgbRhbRsRgRsmbRibRgbRgRsmbRiRgbRgbRibLsbLgbRgbRebReb
RcbRibRgbRibRgbRibRgbRgbRgbRsbRgbLsRgbRgbRgbLgbRgbRibRgbRibRhRgbRsbLsb
LsbRibRibRgbRsbLgbLgbLgbLgLsLsLsLiLgmmbLgLibRebRobLsbLeLsLsmbLebLibRsL
sbLgbLgLsLsmbLibLsLsRsLsLimbLebLiLsbLeLsLsmbLsLsLgLgLgLsLimbLibLibLeLs
bLibLsLsLemb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bRsRsmbRsRsmbRsbLgbLibRcbLoLgLsbLiLsbLgbLiLiRsbLibLhLiLsbLhLgbLibLebLi
bLhLsbLgLsbLiLsbLgLgbLeLibLibLiLsbLgLsLeLebLgbLsbRjbReLsbLsbLebRsbRsbL
sbLsbLsbRcbRcbLjbLibLjLsmbLibLsLsmbRsRibRjRgbRcbLcbLibLhbLibLgbLgbLgbL
eLeLsbLoLsmbLjLiLsbReRsmbRhRsLsmbRobRibRibRcbRhbRsbRcbRgbRhbRibRgbRibL
ibLcbLibRgbLibLcLsmbLhbLibLgbLgbLsLibLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bLsbRsLsbLsLsmbLsbRsbLsbLsbsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
bRgbRcbRsbRibRgbReRsRsmmbLsRsbRiRsmbRgbRhbRhbRgbLgbRhbRhbRibRgRsmbRibR
gbRgbRibLjbLibRjbLsbLsbRgbRgbRebRgbRsbRebRgbRibRhbRibRgRsRsmmbRibRgbRs
RsLsRsmbRgLsbLibRsRibLsbRsbRgRgRsRsRsmmmbRiRsRsmmbRibRgRsmbLsbRibLsLsm
bLhbLhLsbRjbLcbRibRsRhbRibRgbRibRibRgbRebRebRebLibRsLsLsmbRsbLgLsbLsLs
LsLsmmmbLgLgbLiLsbRsbRibRcbRsbLibRgbLibLibLgbRhbRsbLhbLiLsLsmbRjbLibRc
RsRimbRiRsRsmmbRibRgbRebLibRibRibLgbRsRsRsmmbRsRsRsmmbRiRsmbRsbRiRsRsR
smmmbRibRgbRibRibRebRibRibRgbRsbRsbRibRgbLjbLjbRcbLjbRjbRgLsbRcbRsbRib
LcbRgbLiLsLhLiLsbLgLsbRjbLcLibRebRgRsmbRibRsbLsbRiRsmbLsLsmbRhbRsbRibL
gbLcbRgbRjbRsbRgRiRibReLsbRgbRibRgbRhbRhbLhbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bRsRgbRgRsLsmbLsLsRsmbRiRsmbRgbRhbRibLsbRsbRsbRgbRgRsmbRsbRgbLsRgbRgbR
sbRsbRsbRgbRgbRgbsbRebLsbRsbRsbRsbLibLebLgbRebRgRsmbRgbLjLsmbRgbRgRiRs
mbRibRibRgbLcbRsbRjbLebRjbRgbRgLsbLobLibLsLsmbLebLgbLebLgbLebLebLsbLib
RsbRjbRibRibRsbLgbLgbLibLiLsLhbLhbLibLoLsmbRgRsmbLhbLibLsbLebRsbLsbLsb
LebLsbLebLibRsbRgbLobLcbLsbLiLsLsLsmmbLgbLgbLsLsmbLsbLsbLgbLsbLsbLgbLe
bRibRibRibLsLsmbLgbRgbLgbLgbRsbRsbRibRsbRebRsRgbRgbRibLjbLibLibLgLsbLg
bLiLsbLebLsbLgLsbLjbLibLsbLgbLibLhbLgbLibLibRsbRobRibRsRsLsmbLjbLcbLeb
LsbLsbLgbLsLsmbLsRsbLsbLgbLsbLibLsbLsbLgbLgbRsbLsbLibLgbsbLgLsbLgbRsRs
mbLibLiLsLsmbLebLgLsbLgbLgbLibRjbRobRibRgbRgbRgbLiLsbLsbRsbRgbRibRsbRi
bLobsbRibRsbLobLobLsbRibRgRsmbRibRibRsbRgRsmbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bRcbLobLiLiLsbLjbLsLsmbLgbRcbRibRcbRibRcbRhRibRcRcRgbRcRebRhbRebRebLob
LibRjbRebRhLsbLibRcbRhbRibRsbRiRsmbRibRsbLsbLsLsmbRibLcLsmbLibLiLsbLgL
ebLgbLibLebLebRsbLoLeLiLsbLiLsbLiLsbLibLhbLsbRjbsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bLsbLgLsbLsbLiLsbLgLgbLsbLgbLgbRobLsbRibRibLgbLibLibLgbLgbLgbLgbLgbLgb
LsbLgbLgbLgbLgbRgbLibLgLsbLgLsbLgbLgbLgbLsbLgbLgbRsbRibRiRsmbRgbRgLsLs
mbRibRibRibRhLsbRiRsmbRsRgbLsbRgbLibLibRsLsLibLsLsLsmmbLgbLsLsLgmbLgbL
gLsbLibLsbLgLsbLsbLgbLsRsbRgbLiLsbLgLsbRsLsbLgbLgbLgRsbRgbLibRsLgbLgLs
bLsLsmbLsbRsLsLsLsLsLsLgmmmmbLgbLgbLgbLgbLgbLgbLgbLgLsbLgbLsbLsbLgbLgb
LgbLgbLgLsbLgbLgbLgbLgbLgbLsbLgbLgbLsbRhbRhRgbLsbLgbLjLgbLgbRsLsbLgbLg
bLibLgbLgbLgLsbLgbLibLgLsbLgbLsbLgbLgLsbLgbLsLsmbLgbLgbLgbLsLsmbLsLsLs
RsmmbLsLsLsLsLsLsLsmmmmmmbLgbLiLsbLgbLibLibLiLsbLgbLgbRgbLibLgbLgbLgbL
gbLsLsLsmmbLgLsbLgbLgbLgbLibLibRsbLgbLgLsbLsLsmbLgbRgbLsLibRjbLjbLibLg
LsLsmbLgbLgbLgbLgbLgLsbLgLsbLgbLgLsbLgRsbLiLsbLgLsbLibLgbLsbLgbLgLsbLi
bLiLsbLgLsbLgbLgbLibLsLsLgLsmbLsbLsLsmbLsbLiLsbLsLsLsLsLgmmmbLsLgbLsLs
LsmmbLgLgbLgLsbRsbLgLsLsLsLsLsLsLsLsmmmmmmmbLsbLsLsLgmbLgLsbLgbLgbLgbL
gbLsbLgbLibLgbLgbLgLsbLgbLgbLgbLgbLibLibLgbLsbLgbLsLsLsmmbLgLsbLsLsmbL
ibLgRsbLiLiLsbLebLsLsmbLebLibLebLebLebLibLeLsbLiLsLsmbLgLsbLsLgLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bLjbLibLibLgbLgbLgbLibRsLsLsmbLgbLiLsbRsbLhbLgbRjbRjbRibRibRiRsmbRgbRs
bRibRibRibLsLsmbRibLsRibRibLgbRgbRibRibLsbRgRsmbRibRibRsbRiRsmbRgbRibL
ibRibRibRebReRsmbLibLibLibLgLsbLibRgbRjbRgbRibRibLgbLibRjbLibRjbsbLjbL
ibLgLsbLhbLibLebLgRsbRsbLibLgbRsbLibRsbLgbLibLibLibLgbLgbLgbRsLgbRjbRe
RsmbRiRsmbRibRgbLgLsbLibLiLsLsmbLsbRiRibRibRcbLsLsmbRibLgbRgbRhLsbRibR
hbRgbLgbRhbRgbRgbRibRgbRsbRibRibRgbRibRibRiRsmbRjbRibRibRibRibLibLibRg
bLiLsbLsbRcbRiRsLsmbLgbRibRgbRsbRibRsbRibRibRibRsbLgbLibRsbLibLibLgbLg
bLgbRjbLibLgLsbLgbLgLsbLgbRsbLibLgLsbLsLsmbLgLsbRibLibLibLgbLgbLgbLgLs
bLgLgbLgbLibLgbLgbLgLsbLgbLsbLsbLgbLgbRibRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bLgLsbLibLgbLsLgLsbRgLsbLiLsbLsbLsLsmbLhbLiLsbLibLibLhbRgbRhRsmbRibLsL
sLsmmbRibRsRsmbRgRsRsmmbLsRsbLcbLgbRibRibRgRsmbRibRsbRiRgbRiRsmbRsbLsR
sRsRsRsmmmbRsbRgbRgbRgbRgRsRsRsRgmmmbRsRsmbRgRsRsmmbRgbRgRsmbRibRgbRhb
LgbRsbLjbLibLsbLsLcbLibRsbRsbLgLsbLsLsmbLgLsLsLsLsLsmmmmbLsbLgbLgbLgLs
LibLibLibLsLsmbRsRsmbLgLsbLgLsbLgLsbLgLiLsbLgbLgbLsbLibRsLsbReRsmbRibR
sRsmbRgRsRsRsmmmbRsRsRsRsRsmmmmbRgRsRgmbRgbLgbLsbLgbLcbRgRsmbRgbRgRsmb
RibRibRgbRsRsRsRsRgRsRsmmmmmbRsRsmbRgbRsbRsRgRsmbRibRhbRiLsbRsbRgbRibL
gbLgLsbLsLsmbLiLsLsmbLgbLgbLgLsbLgLsbLgbLgLsLsLgmbLgLsLgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bRiRsmbRcRsmbLsRsRsmbRgbLgbRcbRibRcbLsbLibRjbRsRibRsbRibRgbRjRsmbLgbRi
bRibRgbRgbRgbRiRsmbLiLsbRgbRibRibLcbLibLgLsbRsbRjbRebRgbRibRsbRibRgbRs
bRiRsmbLsbRgRsmbRsbReRsmbRcbRhbLgLsbRgRsmbRsRsRsmmbRgbRibRgRsmbRgRsRsR
smmmbRgRsmbRjbsbLgbRiLsbRgRsmbRgbRgbRgRsmbLgbRgRsmbRebRgbRgbRgbRgbRsbR
cbRsbRcbLibRjbLsbRsLsLsmbRsbRsbLgLsbRsLsLsmbLibRobRibLsbRebLibLsbRobRi
bLibRsbRcbRgbRcbRebLsbLjbLgRsbLsbRcbRebLsbRsbRibRgRsRsRgRsmmmbLgRsbRcR
smbLibRgbRebLsLsLsmmbRsRsmbRiRsmbRibLhbRgbRhbLibLgLsbLsRsbRgbRibRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bRgbRhbRhRsRsmmbRcRsmbRcbRhbLjbLcbLiLsbLgbRgbRcRsmbRibRhbRcbRjRsmbLsLg
bLsLsLsLsLsmmmmbLgRsRsLsmbRhbRhRsmbRiRsLsmbRoRsmbRcbRcRsmbLcbLcbLcbLcb
RcbRcbLhLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bRsLibLeLgLsLibLibLgLsRsbLibLebLgLsbLgbLgbRsbLibRgbRsRsmbLsbLgbLgbLsLs
LsmmbLsbRsbLsbLgbRsbLsLsLsmmbLsbLsbLsbLsLsmbLsbLsLsmbLsLsmbLgbLsRsbLsb
LgbLsbLsLsmbLsLsmbLsLsmbLsbLsLsmbLgLsbLsbLsbLsbLsbLsLsmbLsLsLsLsmmmbRs
bLgbLsbLsbLsLsmbLhLsbLgbLgbLgbRsRsmbLsLsLsLsLiLsmmmbLgbLgLsbLsbLsbLsLs
mbLgbLsbLsLsLsmmbLgbLsbLgbLgbLgbLsbLsLsmbLsbLgLsbLsbLsbRsbLsLsmbRsbRsL
sbLsLsmbLgbLgbLgbLgbLsbLsbRsLsbLsbLgLsbLsLsLsLsmmmbLsLsmbLsbLsbLgLsbLg
bLgbRebRebRobRgbRebLhbLcbLibLibLhbLiLsbLeLeLsRsbLebLebLebRcbRebRcRsmbR
eLsbRcbRcbRebRiRhbRgbRibRjbRgbRsLsbRibRibRgLsbRgbRgLsLsmbRgbRgbRgLsbRs
bRgRsmbRsRsRimbRibRgbRgbRiRsmbRibRgbRgLsbRgRsRsmmbRgbRgbRgbRgbRgLsbRgb
LsbRsbRhLsbRcRibRcbRebRhbRjRgbRibRibRgbRgbRiRsmbRiRsmbRiRsmbRiRsmbRgRs
mbRibRiRsmbRhRsRsmmbRgRsmbRibRiRsmbRsbRibRgRsmbRgbRgRgbRgbRgbRebRibRhb
RibRcbRibReRsmbRibRiRsmbRebRibRgbRibRgbRgRsmbRibRcbRhRsmbRhRsmbRebRhRs
mbRcbRhbRebRcRsmbRiRsRcmbReRcbRgRsRsmmbRibRibRgbLsbRsLsbRsRibLgbLcLgLs
bLgbLgbRiRebRsRsmbReRsmbRiRsmbRgbRgbRiRebRsRsmbRsRibLgbLcbLgbLgbLgbLiL
sbLgbLibLcbLhbLibRibRibsbRiRsmbRibRgbReRsmbRgRsmbRhRibRsRsmbsbRsbRiRsm
bRibRebRhbRgbRhLsbRibRiRsRcmbRhRsmbRsbRiRsRsmmbRgbRgbRgbRsRsmbRebLhbLg
bLiRsbLsbRobRhRsRsmmbRibRgbRiRsmbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bLgLsLsmbLiLsbLibLsbLgbLgbLibLebLeLsbLsbLgLsLsRsmbLgLgbLsbLiLsbLgLsbLs
LsmbLebLsLsLgLsmbLgbLsLsLsmmbLibLsbLebLsRsbLgLsbLiLsbLiLgbRsLsbLibLsbL
gbLiLsbLgLsbLibLgbLiLsbLgbLsLgLsbLibLgLiLgLibLsLsmbLeLeLsbLsLsmbLebRsL
sLsmbLgLsbLgbLsLsLsmmbLiLsLsmbLiLsbLebRsbRgRsmbRibRgRsmbRsRsRgLsmbRsbL
sLgbReRsmbRsbLebLebLibLgRsbLibLeLsLibLebRebRhbRibRsbRebLgLsbRibLibRsRs
mbRgbRsRsmbRsRsmbLsRibRibRgRsmbRgbRgbRgbRjbRsLsbRiRsmbRsbRgLsbRgbRgbLi
bRsRsmbRhbLsbRgRsmbRibRsLsbRibRgbRibRgbLsbRsbRgRsmbRibRsbRsbRiRsmbRgRs
mbRgRsmbRsRsRimbRgRsRsmmbRhbRebReb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
bRiRsmbRibLibRebRebRgbRibRjbRibLgbRjbReRsmbLcbLibLgbLhbLgbRibLebRjbLgb
LibLiRsbRiRsRsRsRsmmmmbLeLsbLgRsbRgbRjbRibLsbLebLjbRjbRcbLhLeLsbRsbLiR
sbLcbLibLhbRhbRhbRiRsRsmmbsbLgbRgbRhbRiRgbLjbLjbLjbLcLsRsmbLhbLibLibLi
LsbLgbLibRhbRibLjbRibRgbLibReRgbLeLsLibRjbLgLgbLiLsbRgRsRsRsmmmbLibRcb
LiRsbRcbLhbRcRsRsmmbRsRebRgbRgbLcb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bLgLsLebRjbLcbLhbLgbLgbLsbLgbLebLebLsbLibLgbLebLibLibLibRgbRjbRebRgbLi
bLebLebLebLiLsbRobReRsRcmbLgbLibRiRsmbLoLsmbRebReRsmbRjbRiRgbRhbLobLib
LcbLgbLjbRobLoRsbLsbRebRsbRibRsbRsRsLsmbRgbRgbRgbRebRgbRjbRebRgbLcbReb
LsRsbRiRgbRsRgbRebRsbLsbLgLgbLeLibReRibRgbRebRgbLebLebLobLib

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
bRsbLibLibLiLsbLibLsLsmbLgLsbLgbLibLgbLibLsLsmbLgbLsbLibLgbLgbLiRsbLgb
LgbLgbLsbLsLsmbLsLsmbLsLsmbLibLsbLibLgLsLsmbLsbLibLebLgbLobRebRebLebLh
bLibRjbRgbRibRhbLibLcbLcbLebRsbRibRgbLsbRibRibRgbLibLebLibLgbLgbLebRhb
RgbLiLibLebLcbLhbLgLsbRgbRgbRibRgbRsRgbRcbRgbRoLsbLeLsbLgbRjbRjbRhbRcb
RibRsbLsLsmbRsbRibRibRibRgbLgbRibRibRsbRgbRgbRgbLsRibRibRgbRgbLsbLsbRi
bRgbLgbLsbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 43; Drug: Control Apo 50 然
bLgbLgbLgLsLsLsmmbLgbLgbLgLsbLjbRsLsbLgbLsbLibRibLibLibLibLgbLgLgbLgbL
gbRsbLgbLibLsbLgbLibLsbLibLibRsbLsLsmbLibRibRsbsbRebRgbLcbRebRgbRebRgb
RibRhbRebRsReRgRsmbRgbRgRsmbLsbRebRibRibRibRibRibLgLsbLgbLebLgbLgbLgbL
gbLsLsmbLgbRsbLibRibLibLgbRjbLibLgbLibLgbRgbLhbLibLgbLgbLsbRebRcbRgbRs
bRgbRgRsmbRsbRsRsRsmmbRgbRgbRibRebReLsbLibReRgbRgRsmbRsbRebRebRgbRsbRs
RibRgbRgbRhbRibRibRsLsbRgbRjRibRibLgbRcbRibRsRsmbRgRsmbLsRsbRsRsRsRsRs
RsRsRsRsmmmmmmmmbRebRcbRgbRgbRhbRibRebRibRibRebRgbRgbRebRsbRebRgRsmbRg
bRsbRibLjbLsbLsbRebRibRibRsRsmbRibRsRib

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 44; Drug: Control Apo 50 然
bLibLebLcbLgbLibLsbLsLgLsbLgbLgbLibLebLsbLgbRsRsRsmmbLgLiLsLsmbLsbLsLs
LgLsLsmmbLibLgbLhLsbLcbRgRsmbRhbRibLjLgbLsbLhbRsLsbLsbRsLsbLsbLhbLebLi
bLgLsLgLibLebLsbLsbLeLsbLgbLgLsbLsLebLgbLhbLibLgLsbRsLsbLsLgbLgbLsLsmb
LgbLsbLsbRsbLibRcRsmbRgRsmbLsRsbLjbLhbLsLgbLibLgbLgLsLeLgLsbLebLgbRebR
gRsmbLibLhbLgLsLsmbLiLsbLgLebLiLsLsLsmmbLsLgbLsLsLsmmbLsbLsbLebLhbLibL
gLsLsmbLsbLgbLsLsLsLsLgmmmbLgbLgbLiLsbLibLebLsbLibLsLsmbLsLgLgLsLsmbLg
LsLsLimbLebLgLsLhbLeLebRsLiLsbLiRsbRgbLgbLgLebLcbLcLsmbLgRsLsbLcbLgLsL
smbLsLsLsLsRsmmmbLgLibLgbLibLibLiLsbLgbLgbRsbLibLiLhbLeLhbRibLgbRcbLgb
RsbRebLsLsmbLgbLjbRebLibLsbLjbRebLebLhbRibLgbLhbLgLibLsLsmbLgLsLsmbRgb
Rib

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 45; Drug: Control Apo 50 然
bRhbRoRsmbRcbReRsmbRiRobRcbRjRsmbRcbLsLobLibLsLcbLgbRhbRgRsmbLcRsbRiRs
mbRibRebRiLsbLsLsmbRobLsLobLgLsLsmbLgLgRsbLebRobRoRsmbRcbRsRsmbRhbRhRs
mbRgbRgbRiRsRsRcmmbReRibRibRebRobLibLhRiRsmbRjbRobLgbLcbRhRgbRibRibLiL
sRsRsmbRibLcbLibLiLsbLgbRcbLjbLgbRhbRibRobRibRcRibRibRhLsbRibRhRsRembR
obRsbLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 46; Drug: Control Apo 50 然
bLsLsLsmmbLsbLgbLsbRsbRsbLsbLsbLgbLgbLgbLiLsbLgLsbLibLcRsbRhRsmbRhRsmb
RebRibRiRgRebRiRcRsmbRhbRobLcbLibLibLgbLgbLgbLgbLgLsbLsbLgLsbLibLsbLeb
LsbRobRebRibRibRiRsRsRsmmmbRgbRsRgbRibRgbReRsmbRiRgbRsRsmbRibRcbRiRsmb
RibRgbRcbRhbLcbLgbLgbLibLsbLsLsmbLsLiLsLeLsbLibLiRsbLsbLebRsbRsbRsbLib
LsbLgLsbLsbLsbLsLsmbLgbLgbLebLgbLgbLsbLsbLsbLsbLgbLsbLhLsbLhbLiLsbLibL
gLsbLgbLiLsbLeLibLeRsbLobLobLibLibLsbLibLibLgbLibRgbRibRibRibRiRsmbRib
RibRgbRsbRgbRgbRgbRgbRibRgLsbRgbRgbRibRibRibLhbLibLibLiLsbRsbLibLgbLgL
gLebLibLebRjbRcbRibRibRgRsRsmmbRgRsmbRgbRebRgbLjbRibLjbLibLibLsLsmbLgb
LibRgbLgbLgbLiLsbLibRgbRibRibRgRsmbRsbRgbRgbRgbRgbRgbRgbRgbRibRibRebRe
bRsRebRibRgbLcbLgbLgbLibRsbRibRibLjbRibRebRibRiRsReRsmmbRibRgbRgbRebRi
bRhRsmbRebRibLgbRibRibRgbRgbRgRsRsmmbRgRsmbRhbRibRibRibRgbRgRsmbRibRib
RsbRgRsRsmmbRgRsmbLsbRibRsbRgbRgRsLsmbLsbRsLsbRibRgbRiRsRsmmbRibRibRsb
RsbRgLsRsbLsbRibLsbRebRebRiRsmbReRsmbRebRhbRsLsbRiRsmbRsbRibRebRhbRibR
sbLcb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 47; Drug: Control Apo 50 然
bLgRgbLibLiLsbRjbRebRgbRgbRcbRibLebLcbLiRsbLcbLibLgbLoLsmbLobLibLhLsbL
gbLgbRcRsmbRcbRsReRsRsmmbRsRsmbRsRsmbRibLiLcLsmbLgbLgLsbLibLiLgbLhbRob
sbsbsbLsbLsbsbLsLsLsmmbLsbRgbRibRgbRiLsRsbRgbRsRsmbRsRsmbRgbRgbRgbRebL
sRjbLeLhbLebLebLebLjbRsRsmbLsLgbRcbRcRsmbRebLsLgbRjbLcLsLgLsmbLsLsmbRs
bLjbLiLsbLibLibLibRibRibRhRsmbLebReRsmbLibLiLsRsbLgbLiRsbRoLsbRgbLsbRs
bRhLsbRsRsRsmmbRsbRgRebsbRsbRcRsLsmbLsbLebRjbLeRsbLhbRsRcbRibRgbRhLsRi
bRiRsRgmbRebRgRsmbRsRsRsRemmb

>ZF Recording 2016-03-22; tW: 300s; Start: 121925; End: 122425;
Recording: 7-1; Individual: 48; Drug: Control Apo 50 然
bRibLgLsbLsRsbRjbLebRhbRiLsbRgbRgbRgbLgbRsbRgbRgbRiRsRsmmbRsbRgbRgbRib
LhbLebLgbLcLsmbLibLibRgbLebLibLhLgLsLsLembLsbLiLsbLibLibRibRsRgbLsbLeb
LiLsLsmbLibLeLsbLhbLebLebLcbLebLgbLeLsbLgbLiLsLebRjbRjbLjbLibLibLibRib
RebLsLjbLebLebLgbLgbLibLeLsbLibLhbRsLsbLebLhbLebLeLsbLebLebLcbRgbLibLi
bLebLibLcbLebLcbLcbLibLiLsbLebLcbLebLcbRgbLcLsmbLgbLiLsbLebLebRsbRcbLc
bLjbLgbLebLjbLgbLebLsbLhbLebLgbLebLsLsmbLibLibLgbLsLebLebRgbLcbLibRhbL
ebLhbLebLebLebLcbLhbLhbRgbLeLsbLebRgbLhbLebLebRgbLeLsbLgbLebLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
bRebRjbLobLcLsmbLcbLjLibLcbLcbLcbLhLsbLiLsbLhLsbLcbLsLsmbRcbRiRibRgbRj
bRibRcbRcbRcbRjbLibLibLibLeLiLsLibLiLeLeLeLeLgbLgbLiLibLgLibRobRhRsmbR
gRsmbRibRsRsRgmbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bLcbLibLhbLibLcbRgbRobRibRiRsmbRhbRibRibRgbRcbRiRsmbRgbRgbLgLsbRgbLjbL
sLcbLgbRebRgbRgRsmbRsbRebReRsRsmmbRgbRsReRibLsbLsbLebLgbRgbRjbLebLobLc
bRebRsbRsbRcbRgLsbRhbRebsbLsbRebLibLcbLibLcRsbLibRibLjbLibLibLgbLibLib
RiRsRsmmbRebLcbRgbLjbRcbRibReb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bsbRsRsmbRsRsmbRsbsbRobRebRibRobRibLhbLiLiRsbLgbRsbLiLsbLiLsbLibLibLiL
sbLcLebRsLsbLiLibLiRsbLibRhbRgbRgbRibRibRebRibRgbRibRgbRibRibRibRobRib
RibRgbRibRsRiRsRgRsRsRgmmmbRebRsbLgLsbLibLcbLibLcbLibLgLsbRsbRsLsbLsbR
eRibRiRsLsmbRgRsLsmbRiRsmbRgbLjbLjbLiRsbLibLobLhbLcbRcbRgbRcbLibLibLjL
smbRjbRebRibRibRibLibLibRsRsmbRibRgbRgbLgbLcbLibLcbLibLhbLibLibRgbLcbR
gbRgbRsRsmbRgRsRiRsRsRsmmmmbsbsbsbLsRsbsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bLsbLsLsLsmmbLsbLobRiRsmbLgbRgbRgbRsRsRgRhmbRsRsmbRsRsmbRsRsmbRsbLsbRi
bLgbRsbRebLhbLsbLebLhbLgbLsLsmbLgbRibLibLibRsbLgLsbLhLhbLgbLgLibLsbLcb
RgbLsbLhbLgbLgbLgbLibLgLsbLibRsbLeLibLebLsbLgLsbLgbRsbLsbLobRsbRgbRgLs
bRgbRhbRiRsmbRgbRebRcbLgbLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bLsLsLsLsLsLsLsmmmmmmbLsLsLsLsLsmmmmbLsLsmbsbLgbLgbRgbLebLebLebLgbLibR
hbRibRebRibRibRgbLgbLibLgbLgLsLsLsmmbLiLsbLibLgbLhbLibLiRsLgLsLsmbLiLs
LsmbLibLibLsbRibRcbRibRgRsmbRsbRsbRgbRsbRgbRsbRgbRgbRibRgbRebRibRgbLsb
RgbRgbRgbRibRibRibRgbRsbRsbRsRsRsRsRsRsRsRsRsmmmmmmmmbRsbRgbRgRsRsRsRs
RsRsRsRsRsmmmmmmmmmbRsbRsbRgLsbLsLjbLibRsbLebLeLsbLiLsbLibLibLsbLgLsbL
sbLsLsLsmmbLsLsmbLgbLgbLebLgLsLgbLeLebLgLsbLgbLebLibLgbRgbLjbLibLibLib
LgbLsLsLsLsLsLsmmmmmbLsbLsLsRsLsLsLgmmbLgRsbLgbLgbLsbLibRsbLgbLgLsbLsL
sLsLsLsLsmmmmmbRsLsLsLsLsLsLsLsmmmmmmbLiLsLsmbRsbLibLibLibRsbRibRibRib
RgbRgbRsbRgbRhbRhbLsRsbLhbLgbLgLsbLgbLsbLsbLgbLgLsLsLsLsmmmbLgLsbRcbRg
bRgbRsbRgbRsRsmbRgbRsRsRsRsRsRsRsRsmmmmmmmbLsbRsbRgbLcbLibLgbLsLsmbLsL
sLsLsLgmmmbLgLsLgbLgLsLsmbLiLsbLgbLgbLibLsRsbLhbRsRsmbLibLgbLsbLgbLgbL
gbLeRsbLcbLgbRjbLgLsbLhbLsbLhbLibLibLibLeLebLgbLcbLgbLibLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bRcbLsRsRsmbLsbRiRsRsmmbRsbRsbRsRsmbRsLsbRgbLsbRsbLhLsbLebLgbRcbRgRibL
sbRgRsmbRgRgbRgRsRsRsRsRsmmmmmbRsLsbRsRsmbRsbRsRsRsmmbRsbLsRsRsmbRsbRs
bRsRsRsRsRsRsRsRsRsmmmmmmmmbRsRsmbRsbRsbRsRsRsRsRsRsRgRsmmmmmmbsbRgRsR
sReLsmmbsbRsbLebLgbLsLsmbLsLebLgbLiLsbLebLgLsbLgbLgbRjRsmbRcRsmbRibRib
RibRiRsmbRiRsRsRsRsRsRgmmmmmbRiRiRibRiRsmbRsbRsRsmbLsbLsRsRsRsRsRsRsRs
RgmmmmmmbRsRsRembRsRhbRibRsbRsbLsRsbsbsbLsbLsRsLsRsbLsRsbsbsbsbsbsbsbs
bRsbLsbRsRsmbRsRsRsmmbRsbRsbRsRsRsRsRsRsRsmmmmmmbRsRsmbsbRsRsRsmmbRsRs
RgRsRsRsmmmmbsbRsRsmbRsRsmbRsbLgbRibRsbRsbRhRsmbLsRibLibLgLsbLsLsmbLeb
LibLibLgLsbLgLibRhbRibRibRgRsRsRsRsmmmmbRebRgbLgbLcbLhbLibLibLeLsbLgbL
iRsbLibRgLsbRhbRcbRgLsbRibLgbRibLsRsRsmbRsbRsRsmbRsbLsbRsbRsRsmbRsRsRs
RsmmmbRsbRsRsRsmmbRsbRsbRsRsmbRsRgRsRsRsRsRsRsRsmmmmmmmbRsRsRsRsmmmbRs
RsRsRsRsRsRsRsmmmmmmmbRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsRsmmmmmmbRsRsmb
RsRsmbRsRsRsmmbRsRsRsRsRsRsRsLsmmmmmmbRsbsbsbLsRsbRgRsRsRsRsmmmmbLsRsb
RsRsRsRsRsRsRsRsRgRsRsRsRsRsmmmmmmmmmmmmbRgRsLsmbLsbRsbRsbRsRsmbsbRsbs
bRsbRsRsRsmmbLsLsmbsbLsbLsbRsRsmbRsRsmbRsRsRsLgmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bLgRsbLibLgbLgbLibLgbLgbLgbLebLiLsbLgbLsbLgbLgbLebLibLiLsbLgbLgbLgbLib
LgLsbLibLhbLgLsbLgLsbLsbLgbLgbLsLgbLgbLsLibLebLebLgbLgbLgbLiLsbLgbLgLs
bLibLgbLgbLgbLgbLgbLgbLgbLgbLibLgbLebRgRsmbRobRgbRjbLhbLiLsbLsbLgbLsLs
LimbLgLsLebLgbLgbLgLsbLebLgLsbLgbLsbLgbLsbLsbLsLsLsmmbLsLebLebLhbLsbLs
bLsbLsbLsLgbLsbLsbLsLsRsLsmbLsRsbLsLsLembRgLhbLiLsbLebLibLgbRiRsmbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bLsbLsLsLsLsLsLsLsmmmmmmbRsLsRsbLsbLsbLsLsmbRsLsbLsLsLsmmbLsbLsbRsLsbL
sLsLsmmbLsLsmbLsLsLsmmbLsLsmbLsbLsbLsLsLsLsLsmmmmbLsLsLsmmbLsLsLsmmbLs
LgLsLsLsLsLsmmmmbLsLsmbLsLsLsmmbLsLsmbLsRsLsLsmbLsLsLsLsLsLsRsRsmmmmmm
bLsRsbLsLsmbLgbLsLsRsmbLsbLsLsmbLsLsLsmmbLgLeLsbLeLsbLibLcbLcLsLsmmbLc
LsmbLeLsbLiLsbLsbLebLhbRcbRcbRibRhbRebLcLsmbLibLibLsbLgbLibLibLobRibRi
bRcRebRobRiRsRimbRcLsbLibLcbLibLgbLsRsbLgbRibRgRibLjbRhRsmbRibRgRibRib
RgbLsRsRsmbsbRebLgbLibRebRhbLsbRiRsmbRgbRiRibLibLibLibLibLiLsbLibLibRg
bLgbLsbLibLgLsbRjbRcbRgbRibLiLsbRgRsmbLgLsbRsRsmbRsRsmbRgbLsbRgRsmbRib
RgbRsRsRsRsRsLsmmmmbRsRsRsRsRsRsmmmmmbRsbRgbRgbRsRsRsRsRsLsmmmmbRsRsRs
mmbRsbRsbRgRsmbRgbRgLsbRgRsRsRsRsmmmmbRsbRsbRsbRsLsbRgbLsRsbRsbRgRsRgR
sRsRsLsRsLsRsmmmmbRgbRsbLsLsmbRsbRsbRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbRhbR
hbRcbRibLcbLibLibLibLibLebRcbRibRebRibRcbRibLjbLjbLibLibLibRcRsmbRibRe
bRcbRiRsmbRhRsmbRsbRhbLsLibLibLgLsbLgbLibLibRcRsmbRgRsmbRgbRobLgRsbLib
LgLgRsbLgbLgbLgbLgbLgbLcbRhbRgbRgbLsbLsbLibRjbRcbRiRsmbRiRsmbRsbRgbRsR
sLsmbRgRsRsRsRsRsLsRsRsRsmmmmmmmbRsbLsRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
bRiRsmbRibRibRcbRjbLhRsbLebLjLgbLibLcbLhRsbRibRebRibRibRebRibRgbRibRhb
RibLoRsbLibLgLibLibLgLsbLcbRcbRebRibRibLhbLibRibRjRsmbRgbRgbLiRsbLhbRj
bRhbRgbRhbRgbRibRjbLjLsmbRiRsRsmmbRiRgbRhbRibRhbRhbRgRsRsmmbRebRgbLcLs
mbLiRsbLgLsbLjLsmbLjLibRsbLhbLibLgLsbLsbLsRsbRgRsmbLgbRhbRiLsbRibLebLi
bRjRsmbRjbLsLsmbLhbLibLhbRgbLibRibLebLgLsbLibRibRjbRcbRibRsbRsbRhbRebR
hRsmbRibRhRsmbReRsmbLobLibLibLibLgbLgbLgbRcRsmbRibRsRiRsmbRibRibLibLib
LibLiLsbRsRgbLgbRibLjLsmbLgbLibRgbRcbLgbLibLibLgLgbRhbReRsmbRsRsmbRibR
hbRibLjLsmbRcRsmbLgbLgbRibRhbRgRsmbRibLsLsmbRibRebRjRsmbLjLsmbLjLsmbLg
bRiRsmbLhbLgbRgbLiLsbLibReRsmbRebRibRhbRgbRhbRgbRjbLsbLibLibLibRgbLgLs
bLgbLibRgbRibRcbRgbLjLgbLsbRhbRcbRcbRebRhRsmbRiRsmbRsRsmbRgbLibRibRhbL
jLsLsmmbLiLsbRiRsmbLibRcbLjLsmbLibLibLgLsbLsbLsbLgbLhbRebRebRhbRgRsmbR
hRsmbRhRsmbRgbRiRsmbLjbLebLgbRgbLcbLsbRhbRsbReRibRiRgRsmbRhbRhbRibRcbL
gbRcbRgbRebLsbRebRsRcRsmbRebRebLsbLgLsbLebLiLsbLibLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
bRsRsmbRgbRgbRsRsmbRibRiRsRgmbRsbRgbRsbRibRgbRsRsRsRsmmmbRsbRsLsLsLsRs
RsmmmbRibLsRsbRiRsRsmmbRgbRsLsbRsRsRsmmbRsRsRgmbRgRsRsmmbRgRsRsmmbRgRs
RsmmbRgbRsRsRsRsRsmmmmbLsRsRsRsRsRsRsmmmmmbRgRsRsmmbRgRsmbRibRhbRgbLgb
RhbLebLsLebLebLsLgLebLsbLsLsmbLeLsbLiLsbRjbRhbRibRibRibRibRibRibRibRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bLibLgbLgbRgLsRsbLgRsbRsbLsbLgbRsbRjRjbRobRoRsmbLhbRebLibLibLcLsmbRobR
cbLcbLcLsLsmmbLibRcbLibRoRsmbRcbRibRcbLibLhbLcbLgbLobLibLibLhLsbRsRebL
sRebLsRsbRiLsRsbRiRiRsmbRiRsmbRibLjbRiRsRgmbRgRsmbLjbRsbRhRsmbLibRibRh
RsRsmmbRsRsmbRsbRsRsRsmmbLgbRiRsmbRcbRsLiLsbRhbRebRibLgRsbRiRsmbRcbLiL
sbLsbLgbLebRebLibLgRsRsmbLjbLhbRiRsmbRhb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
bLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
bRgbRgRsmbRsRsmbRibRsbRsRsmbRgbRsRsRsRgRimmbRgbRgbLsbRcbRibLsLsmbLsbLs
bLgbRsbLsLsLsLsmmmbLobLhbLgbLibLibLsLsLsmmbLibLsbLsLsLsmmbLibLibLebLib
sbLsLsLsmmbLsbLgbLsLsmbLibRsbRcbRsRsmbRgbRibLsbLgbLsbRgbRgRsRsRsRsmmmm
bRsbRcbLsbLsRsLsbLiLsRsLsbRoLsbRibLsbRsbRsRsRsmmbRsRsmbRsRsRsmmbRibRsb
RsbRsbRsbRsRsmbRsRsLsmbRsbRsbRsbRiRsLsmbLgbRsbRcbRgbRibLgLsLsRsmbRsbRs
bRgRsmbRsRgbRsbRgRsRsmmbRgbRgRsmbRsbRgbRgbRsRsmbRgLsbRgLsbLsRsbRibLgbL
iRsbRsbRibLsRsbRgRsRsmmbRsRsRsmmbRsRsLsmbRgRsRsRsmmmbRiLsRsbRsRsmbRsRs
RsmmbRgbRgbRgbRgbRibRsbLsbRibRsRsRsRsRsmmmmbRgbRgRsmbLsRsRsRsRsRsmmmmb
RsbRgRsmbLsbRsRsRsmmbRgbRiRibLibRgbRgRsmbRsRsRgmbRsbRsbRsRsmbRsbRgbRsb
RsbRgbRgbRsRsLsRsRsRsmmmbRsbRsRsRsRsRsmmmmbRsRsLsmbRsbRsbLsbRjbRsRsmbR
gbRsbRgbRsbRsbRsbRgbRsRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bRsbRsbRsRsmbRgLsRsbLsRsbLhbLiLsbLgbLibLiLsbLibLibLibLibLibLgbLgbLibLi
bLibLibLsbLebRgbLhLsbLhbLgbLiRsbLgLsbLgbRibLibRibRibRibRibRgbRgbRibRib
RhbRibRibRgbRgRsmbRibLsbsbRsbRgRgRsmbRgbRgbRibRsbRsbRgRsmbLsbRgbLsbLsb
RgRsmbLsRsRsLsmbLsbRiRsmbRgbRiRsRsmmbRebRibRebRsbLeLibLibLebRsbLiLsbLe
bLgbRebLsLsmbRobRibRibRcbRiRsmbRiRsmbRgbRibRibLiLcbLhbLibLibLgLsbLhbRs
LsbRjbLcbLibLgbLiLsRsbLiLsbLgbLibLebRgbRjRsmbLibLibLibLiLsbLibLibLibLi
bLsbLibLgbLgbLibLgbLibLibLsbLgbRsbLgRsbLgbLibLibLsbLsLgbLsbLgbLibLibLg
bLgbLgLsRsbLgbLgbLibLibLgbLiLsbLgbLgLsbRgbLiLsbLgbLgRsbLgbLgbLibLgRsbL
gbLgbLgLsbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bLgbLobRsbRhbRgbRibRgbLsbLgbRobRibRgbRgbRsRsmbRibRibRsbLsbLsbLibLibLgb
LcbLgbLibLsbLcbLsbLibRcbRgbRgbLibLibLgLsbLjLsmbRibRsbRibRebRcRsmbRgbRi
bRgbRibRibRgbLsbRgbLibLcbRgbLhLsLsmbRjbRjbRibLhbRibLebLibLsbRsbLhbRgbR
gbRjbLiLgLsbRsbLsbLhbRsRsmbRibRcbRibRhbRibRibRiRsmbRibRibRsbRibRgbRobR
ibRgbLsbRibRsbRhbRibRcbRsLsLsmbRhbRibRibRibRhbRgbRibRjbRhbRgbRibRibRib
RgbRgbRgbRgbLibLibLcbLibLgRsbRgbLibLcbLiLsbLgbRgbRebRcbRhbRgbRibRgRsmb
RibRebRgbRgbRgbLcLsLsmmbLgbLibLgbLcbLcbLibLiLsbLhbLcbReReRebRebRebRibL
sb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bRsbRsbLgbLsbLgRsbRsRsmbLsbLsbRsLsbLsRsRsLsmbLsbLsbLsbLgbLibLcbLhbLebL
iLsbLebLcbLcbLeLsbLcLibLiLibLebLhbLcbLeLhLsLebRcbLoLsmbLsbLgbLibLibRcL
sbRibRibRiRsmbLibLobLibLibLibLibRcbRgbLcbLobRibRhbRcRsmbRiLsbLhbLjbLhb
RhRsLsmbRibRibRgbRiRsmbRibLgLsbRiRsmbRsRsmbRsbRsReLsbRsbRsbRebRsRibRgR
ebRsbRsRsmbRsbRgbRhRebRcbRibRgbRcbRibLhLsbRhbRsRibLjbLobLibLibLgLsbLib
LibLcbLibRhbRcbRhbLsbLobRcRsmbRsRcbRgbLsbRibLjbRsRibLsbRgbRgbRibLjbLiL
sbLgbRsbLhbRjbRcbRsbRibRibRsbLcbLibLibLibLibRibRiRsmbRibLjLiRsbLibRsbL
ibLibLibRcbRibRibRhbRsRibRibLcbLibLibRibLiLsbLsbRsbRjRiRgRsmbLgRsbRebL
sbLsbLhbLgbLgLebLsbRsbRgbRgRsmbReRebLcbLgbRebRgbRgRiLgRsbLgRsbLsbRebRs
bLjbLsLibLibRjbLibRsbLsbRhbRibRgbLjbLebLibRgbLebLibLibLibRibRibRcbRcbR
ibRhbRiRsmbRgbRibRgbRibRibRcbRibLobRibRsbRebRibRibRhbRgbLgbRibRebRcbRi
bLibRibRjbLhbLiLsbLgbLibRhRgbLebLibLibLibRgbRjbLibRebRibRgbLgbRibRgRsm
bRiRsmbRibLsRcbRibRsbRibLibRibRsRibRibRibLsbRjbLgbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bRhbLgLgbLeLsbLsbRebRebRebRhbRgbLjbLcbLibLiLsLsmbLgbLgbLcLcbLibLibLgbL
ibLgbLgbLibLgbLgRsbLebRjbLgLgRsRsRsmmbRsRebRibLjbLjbLebLjbLcbLgbLgbLgb
LibLjbLcbLgbLibLibLibLsbLgbLgbLebLgbLsLsmbsbRsRsLsLsmmbLsbLcbRgbRjbReb
RebRhbLjbLeLsbLobRgbLjbLobLibLgbLgbLibLiLsLsmbLgbLgbLibLiLibLibLsbLgbR
gRsmbRebLibLjbLiRsbRgbLjbLibRibRjbRgbRibRebRjbRgbRibRsbRebsbLjbRiRsmbL
ibRibRibLjbLibLibLibRiRsmbRibRibLjbRgRsmbLjbRhbReRsmbRebRib

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bReRsmbRebRgbRebReRsmbRgRsmbRebRgbRgbRgbRebRebRebRgRsmbRgRsmbRgbRsbRsb
RsRebLsbLibLibLebLsbRoRsmbRsbRgbRsReRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 19; Drug: Control Apo 50 然
bRebRebRsRsmbRibRiRsmbRibRebRgbRiRsmbLcbLebLjbLibLgLsbLgbLiRsbRhbRibRg
RsmbRiRsmbRsRiRsRsmmbLgbRibRgbRibLsLcbRhbRibRibRgbRgRsmbRsbRibRibRgbRg
bRgbLsbRibRibLsRsbRiRsmbRgbRgRsmbRiLsbLibLibLibLsbLsLsLsLsLsLsLsLsmmmm
mmmbLgLsLgLsLsmbLsLhLsbLgbRjbRsRsRsmmbRebsbRebRebLjLibReRsmbRgbRiRsmbR
ebRebRhbRebRgbRsRsRgmbRibLjLcbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 20; Drug: Control Apo 50 然
bRgbLjbLcbReRsmbRebRgRsmbRiRgbRibRsRgbRibRibRebRebRiRsRsRommbLhRsLsbLi
bLgbReRsmbRibRhbRibRsbRsbRiRsmbReRsRsmmbRhbRibRibLjbLebLebLebLhLsbLgbR
cbRiLsbRiRsmbRiRsmbRibRgRsmbRibLjbLcbLebLiLsbLiLgbLgLsLsmbLibLhbLiLsLs
LsmmbLsLsLsLsLgLsLsmmmmbLgLsLsmbLeRsbLeLibLibRsbLsRsbRiRsLsmbRsbRgbLeb
LsbLsbRcbRcbRibRebRhLsbRebRibRibLsbRgRgbRibRibReRgbRsRgbReRsmbRibRhbLs
RsRsmbReRsRiRsmmbRebRebRiReLsbRibRebLebLgbRcbLebLhLsbLebLgbLeLibRsbLgb
LsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 21; Drug: Control Apo 50 然
bRsLsbLsLsmbRsLsbLsbRsLsbRsLsLsmbLsLsRsmbRsLsbRsRsRsmmbRsLsbRsbLsbRsRs
mbsbLsLsmbLsbRsLsRsbLsRsbRsRsLsmbRsRsmbLsbRsRsmbLsbsbRsLsRsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 22; Drug: Control Apo 50 然
bRcbRsbRgbRobLgbLjbLebLgbLgbRcbLsbRibReRsmbRsRsRgmbLiLsbRgRsmbRibLibLi
bLebReRsRsmmbRiRsmbLgRsRsRsmmbRibRibLcbLsbLebRgbLsRsbRibRgbRgbLsbRgbRe
bRgbRsRebRgbRcLsbRsRsmbLcbLhbLgbRhbRcbRcbRibRgRsmbLcbLibLibRjbRgbRsbRi
RsmbRsRsmbRiRsmbLebRobRcbRcbRcbRhRsmbLcb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 23; Drug: Control Apo 50 然
bRgLsbLsRobRjLsbLgbRgRsmbRsbRgLsbRibLibLsLgbLsbLgbLsbLgbLgbLcbLibRsRsm
bRsbRgbRgbLibLiRsbLgbLgbLibLibLhbLgbLgbLibLgLsbLiRsbRhRsmbRhbRibLgbRgb
RgbRsRsmbRibRgbLsbLjbLjbLgLsLsLimbLgbLgRsbLibLibLibLsbLibLsLsLsLgLsmmb
LsLsmbLgbLgbLgbLoLsmbLsbLsbLibLsLsmbLgbLgbLgbLgbLgbLgLsbLcbLgbLgbLibLg
bLgbLgbLgbLgbLgbLgbLibLibLgbLsLsmbLgbLgbLgbLibLgbLsRsbLibLiLsbLgbLgbLs
bLsbLgbRgbLibLgbLgbLgbLibLgbLgLgbLsbLeLgbLibLibLhLsLsLgLgmbLibRjbRebRi
bRgbRiRsmbRgbRibLhbLebLibLgbLgbLgbLhbLgRsbRsbLgbLgbLgbLsbLgbRsbLsLgLsL
smbLsbLsbLgLsbLgbLgbLiLhbRsbLjLsmbLsbLsLsLsLsmmmbLsbLgRsbLsbLgbLsLgbLg
bLibLcbLsbLsbLgbLgbLgLsbLgbLsbLsLsLsmmbRgbRibRgbRgRsmbRgbRsbRsRsmbRgRs
mbRgbRibRsRsmbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 24; Drug: Control Apo 50 然
bRgbRgbRibRgbRgbRebRhbRhRsmbRgbRgbRibRgbRgbRibRibRgbRgLsbRgbRsbRsRsmbR
gbRibRebRebRibRsRsmbRgbRsbRgbRsbRgbRgbRgbRgbRsbRgLsbRgbRgbRgbRgbRgbReb
RebRgbRgbRgbRsRiRgbRgbRgbRgbRibRgRsmbRibRsbRsbRsbRhLsbLsbRgbRgbRsbRgbL
gbRgbRgbRgbRgbRgbRgRsmbRgbRsbRgbRiRsmbRibRgbRgRsRsRsmmmbRgbRgbRsbRsbRe
bLsbLsbRsRsRembRsbRibRgRsRsmmbRibRebLobLgbRgbRgbRgbRsRsmbRiRsmbRsbRgbR
ibRgbRgbRgRsmbRsbRebLsbRjbRibRebRgbRsbRgbRsbRgbRgbRgbRgbRgbRsbRibRgbRi
bRibRsbReRsmbRiRsmbRgbRsbRibRgbRgbRgbLsRsbRsbRgRsLsmbRhRsmbRsbRsbRsbRi
bRebRgbRhbRgbRgbRsbRgbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bLebRibLibRsbRgbLsbLhbLebRsbRebLgbLgbRsbLebLgbLibRgbRsbRebRsbLsbLsbRgb
RsbRgbLsbRgbRibRsbLgbLebLibRgbLgbRhbRsbRcbLibLgbLibLgbRcbLsbLsbRgbRgbR
iRsmbRgbRsbRgbRgbRgbRgbRgbRsbRibRibRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
bLsbLiLgLsLgbRsLsbRsbRcLobLsbLibLsbLgbLibLgLsbLgRsbLsLsLsmmbLgbLgLgbLg
LsbLgLsbLgbLsbLiLsbLsLsmbLgbLgbLsLsmbLsbLiLsbLibLebLibLebLgbLsbLiLsbLe
LsLsLsmmbLgLsbRsLsRsLsRsbLiLsbLgLsbLgLsLsmbLsLsmbLsLsLsmmbRebRgRsmbRib
RsRgbRibRgbRiRibRgbRgbRgbRsbRsbRgbRsbRgRsmbRsbRgbRsbRibRgRsRsmmbRibRsb
RgbRsbRsbRcbRobReRsmbLsbRebRjRgbLcbLibLeLobRgbLhLsLsRsmbLgRsbRsbLsbRgb
RgbRgbRsbRgbRgbRgRsmbRsRsmbRsbRibRgbRibRib

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bLebLhbLgbLgRsRibRhRsRsmmbRjRsmbRgRsmbLgbRiRsRgReRsRsmmmbRcbRcbRgbRobR
gbLibLcLsmbLibLsLibLsbLibLhLsbLhbLibLibLgbLgLsbLgLgLgLsLsmbLgbLgbLobLi
bLibLebLiLsbLcLsLiLimbLsLsmbLgbLibLiLibRjRebRiRsmbRiLsbRibRibLgbLgbLhb
LibLibLiLsbLiLibLhbRgbRjbRhbRiRhRhbRibLsbRgbReLibLibLcbRibRcbRobRjbRhb
RiRsmbRsbRgbRiRsmbRsRsmbLsbRebRiRebLgRsbRsbLhLsbLiLsbRjbLiLsbLjbRcRsRg
mbRgRsmbRiRgRsmbRibRsRcbLibLibLcbLibLgbLibLibLiLsbLibLibLhLibLhbLgbLib
LibLibLiLsbLsbLiLsbLibLibLgLgLebLiLebRjbRsbRgLsbLsRsbRiRsmbRgbLjbLcbLi
bLgbLgbLhLsLibLhbLibRjbRcbRhLgbLjbLibLgbLgbRgbRhbRiRsmbLhbRibRgRebLsbR
ebRsbLgLsbLjbRibRjRsmbRhbLjbLobRebLobLibRjbRibLhLebLebLcLsmbLibRjbRcRs
mbRibRibRobLhbLhbLibLhbLgbLsRibRibRsbRcbRebRibLibLibLgLibLibLcbLobLhLs
bLhbLibRibRibRibRibRgbRibRgbLgbRgbRgbRibRgbLgbRcbReRebLsbRgLsbRgLsLsmb
LibLhbLeLebReRsmbRgbRgbRgbRebRebLjLsLeRgLsmbRjbLibRsbLsbReRsRembRibRgb
LsbRgbRcRsmbRiRsmbRgbLjbRebRiRsmbRibRjbRiLsRsbLiLsbLsbLcbLibLhbLibLibR
hbRibRgbLgLsbRibRibLiLsbRebRibLjbLhbLibLiRsbLibLibLcbLibRjbRibLebLibLi
bLibLgbLibRgRgbRhbRjLsbRibRgbLibRgRsLsmbRibRibRibLgLsbLhbRibRibRibLgbL
ibLgbLibLibRibRcbRhbRibRgbLgbRhbRsbLibRcbRgbLgbRibRibRgbRgbRhbLgbRcbRi
bLgbRibRibRgbRibRibReb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bRobRgbRibRibRebRsLsRsbRebRjbLebLibLibRjbRibRibRsRgRsmbRcRsmbRsbRibRib
RebReb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
bLsbLsLsLgLsmbLiLsbLibLgbLgbLebRibRgbRsbRsRsmbRsLsbReRsmbRgRsmbRsbRgbR
gRsRsRsmmmbRgbRsRsmbRibRgRsRsmmbRgbRgbRgbRgbRsRsRsRsmmmbRsRsRsRimmbRgR
smbRsRsmbRsRgRsmbRgbRgbRsbRsRsmbRebRebRhbRsbLsRsbLsbLsbRsbRgbRgRsmbRsb
RsRgRsRsmmbRsbRsbRsRiRgbRsbRgbRgRsRsRsmmmbRgbRsbRcRsmbRcbRiRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bRsbRgRsmbRgRsRsRsRgmmmbRgbRjbsbRibRgbRgbRgbRgRgRsmbRhbRebRgRsRsmmbRhb
RibLhbLeLebLebRjbLjbLebLsbLeLsbLsbLebLsbLgbRsbLgLsbLebLgbLsbLgbLsbLgbL
hbLgbLebLgbLgbLgbRgbLsbLgLsbLgbLsLsLsmmbLibLibLibLsbLgbLobLebRsbLsbLsb
LibLsLsmbLsbLibLibRsbLibLsbLgRsbLsbLibLibLgbRsRsmbLsbRsbLibRsbLgbLgbLg
LsbLibLgbLsLsmbsbLjbLgLsbLsbRcbLebRjbRibRgbRgRsmbRsbRiRsmbRsbRsbRgbRsb
LsbRcbRibRibRgbRsbRgbRsbRibRgRsmbRibRibLcbRibRsbRsRsmbRibLsbRgbRjbRsbR
gbRibLsbRsbRgbRibRsbLjbLebLsbLibLgbLsbLsbLgbLsbRsbLsLsmbLsbLsbRobLsbLg
bLibRsLsbRsbRsbLsbLsbLsbLibLgLsbLjbLsbRsbRsbLgbLebLsLgbsbRjbRibRgLsbRo
bRgbLgLsbLgbLsbLebLsbLibLgbRsbLebLibLsRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bsbLobRsbRsbsbRcbRjbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bLgbLsbLgLgLibLgLebLgLiLsRsbLgbLsbLibLebLebLgbLsLsLsLgmmbLibLhLsbLibLg
LgLsbLgbLsbRsLsLsmbLsbLsLsLgmbLebLebLeLsbLibLiLsbLsbLgLsbLibLibLgLsbLe
bLgbLebLhbLhbLebLiLsLsmbLgbLibLsbRgLsLiLsLgLgbLhLsLsmbLsLsLsLsLimmmbLi
bLsLgbLebLiLgLgbLsbLsLsLsmmbRsLgbLgLibLebLgLsbLgbLibLgbLibLsbLibLgbLsL
gbLsLsmbRgRsRgmbLibLiLsbLibLgbLgbLgbLsRsbLiLsbRsLsLsLsmmbLgLgbLibLsLsL
smmbLgbLsbRgbRebRsLsRsbRebRebRgbRebRgLsbRsRgRsmbLsbLibLiLsbLgLsbLgbLgb
LgbLibLgbLsLsmbRsbLgLsLsmbLgLgLsbLeLsbLgbLibLsLsmbLgLsbLgbLgbLibLgbLib
LsLsLgmbLgLiLsbLsLsLembLibLsRsbRsbLsLsmbRsLebLgLsbLgLsbLibRibLibLibLgb
LgbLgLsbLgbLsLsLgmbLgbLibLgLgbLgbLebLgLsLgbLsbLgbLgLgbRsLebLsbLsLsLsLs
LgmmmbLgLgbLsLsLsmmbLgLsLhbLebLebLgLsLgbLsLsLimbLebLgbLgbLgLgbLgLeLsbL
gbLibLgbLsbRsLebLebLgbLhbLibLhbLgbLgbLgbLgLsLgbLgLsLgbLibLhLsbLiLhRsbL
ibLsbLsLebLiLsbLgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bRgbRibRsRibLsRgbRoLsLsmbRibLobReRsmbRebRebLsbRiRsmbRibRibLsbRgbRsRiLs
bLgbLsLhbLibLgbLgbRjbLgbRibRhbRgbRgbRsbRibRibRibLsbRibRibRgbRibLgbRibR
gbRgbRibRgbRgbLibRibRibRobRebRgRgbRhbRebLsbReRsmbRgbRgRsmbRibRgbRgbRgb
RgbRgbRgbRsRsRsmmbRgbRibLsbRgRsmbRgbRgbRsbRgRsmbRgbLsbRgbRgLsbLgbLjbLi
bLgLsbLgbLgbLgbLgLsbLgbLgbLgbLsbRcbRhbRsbRibRgbRgbRiRsmbRibRsbLsbLibLi
bRsbLibLgbLiLsbLgbLibRjbLibLiLsbLsbLiRsbLobRebLobRobRhbRgbRiRsmbRibRgb
LsbRibRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbRsRsmbLsbRibLsRsbLsRsbRibLsbRibReb
RgbRgbRsbRibRgbRsbRjbRsbLjbLjbLjbRjbRibRgbRgbRibRsRsmbLsbRibRibRgbRgbR
gbRsRgbRgbRgbRgbRgbRgRsmbRibRgRsRsmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bLgLsbLsLsmbLsLsmbLgLsbLgbLgbLibLgbLgLsLsmbLgbLsbLgLsbLiLsbLsbLibLgLsb
RsLsbLsbLibRsLsbLgbLgbLsLsRsLsLsLgmmbLibLsLsmbLgbLsbLgLsbLsbLgLsLsLsmm
bRsLsLsmbLgbLgbLiLgbLibLgLsLsmbLsLgbLgbLgLsbLgbLsbLsLgbLgbLiRsbRgbLgbL
gLsbLhLsLsRsLembLibLgbLibLsbLibLgLsbLibLsLsmbLgbLgbLibLsRsbLibRsbLgbLg
LsRsLsbLgbLgLsbLgLgbLibLebRsRsRsmmbLhLsbRsRibRgRsRsmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bRhbLibRibLcbLgbLgbRsRsmbLgLsLsLsmmbRsLsbRsbLcLsmbLhbLsLsLsLsmmmbLsbLs
LsLsmmbLsbLsLsLsmmbRsLsbLgLsbRgLsLsmbLsLsLsmmbLsbLsLsLsmmbLsbLsLsLsmmb
LibLobRcRsmbRcRsmbRcbLebLgLsLsmbLebLgLsbLsbLibLiLsLgbLibLibLgbLgbRcRsm
bRgRsRsmmbLsRsbRibRibRgbRebLcLsmbLgbLibRsbLibLibLgRsLsbLiLsbLgbLibLgbL
sLsmbLgbRsLgbLibLibLeLeLebRcbRebRiLsbLsLsmbLibLibRsbLgbLgbLgLsbLsLsmbL
sbLgLsbRsbLsLsmbLsLsmbLsLsmbLsLsLsmmbRsLsbLsbLsLsLsLsLgmmmbLsbLsbLsLsm
bRsLsLsLsLsLimmmbLsbLsLsLgLsLgLgLsmbLsLgLsbLgbLcLsmbLibLibLgbLibRhbLcb
RiRsmbRgRsmbRobLgbRsRsmbLiRsbLhbRgRsmbLebLibLgbLgbLgbLcRsbRsbLiRsbLhbL
sbLgbLgbLgLsbRobRebRiRsmbReRsmbRsRsmbRsbRsbRibLgbReRgRgRsRsmmbRibRibRe
bLgbRgbRgbRsRsmbLsRsbRgRsmbRsbRsbRgRsmbRsRsRsmmbRsbRhbRsbRibLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bRsbLeLsbRcRsmbLjbRiRsRgmbRsbLcLibRjbRjbLcbRjbRsbRiLsbLcLsmbRsbLcbRcLs
bRcRsmbRebRcbLcbLcRsLsbRebRibRhLsLsmbRibLhLsbRgbRiRsmbRsLsRsRgRsRsmmbR
sRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bsbRsRsRsmmbRsbsbRsRsmbRebRiRebRibRebLsLsmbRebRgbRibRsRsmbRsbRgbRibRsb
LjbRgRsRsmmbRgbRiRsmbRgbRiRsmbRebRgbRgRsRsRsmmmbRgRsmbReRgbLcLibLgbLob
LibLsLibLobLcbLiRsbLiLsbLibRjbLibLcbLgbRcbRebRhLsbRibRebRibLgbLgbLgbLg
bLcbRcbRebRibRibRibRebReRgbReRsmbRhbRibRhbLgbRhbRebRebRiRsmbLibLgbLgLs
bLiLsbLsLsmbLjbLibRhRsmbLsbLgLsbLgLsbRsLsbRsRsmbReRiRsmbReRsRsmmbRgRsm
bRibRibRsReRgbRgbRgbRgbRhbRiRsLsmbReRsmbRhRsRsmmbRebRcbRebRebLibLibRjb
RcRsmbRhbLhbLhLsbRjbRsRsmbRgRsmbRgRibRiRsmbRgRibRgRsmbRebRsRsRsmmbRsbR
sRgRebRgbRsbRibRibRgRsmbRsLsbRgbRgRsmbRgbRgRsmbRgbRgbRsRsmbRgbRgbRgRsm
bRgbRgbRgbRsbRsRsmbRgRsmbRgRibRibRibRgbRgRsmbRibRgbLobLebLjbLsLsmbLiLs
bRobRsbRgRsRsmmbRgbRhRsmbRebRobRebRibRibRhbRoRsmbRcbRcRsmbRjbRhbRibRjb
RhRsmbLsLsmbLibLgbLgbRjbLhbLhbLibLibLibLibRjbLgbRgbRiRsRgmbRsRgRsmbReb
RiRsLsmbRebRhbLsLsmbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bRibRiRsRsmmbRgbRiRsmbRgRsmbRibRgRsmbRgRsRsmmbRibRgbRibRibRibRgRsmbRgb
RsRsRgmbRibRibRiRsmbRibRebRsbRobRiLsRsbRibRiRsmbRibLsbLjLsmbRjbRjbRgRs
mbRgRsmbRsbLsRsRsmbRgbLsbLjbRgbRibRgRsRsRsRsRsmmmmmbRsRsRsRsmmmbRgRsmb
RsRsmbRsRsmbRgRsmbRgRgbRgbRgRgbRgbRibRsRsRsRsRsRsmmmmmbRgLsRsRsLsmbRib
RibRibRiRsmbRgRsRsmmbRgRgRsmbRgRsRsmmbRibRgbRgbRgbRgbRgbRsbRgbRgRsmbRg
bRibRsbRsbRgRsmbLsRsRgRsmbRgRgbRgRsmbRgRsmbRgRsmbRsRibRsbLsRsRsmbRsRsm
bLsRgRgRsRsRsRsRsRsRhmmmmmmbRiRsmbRsbRgRsRsmmbRgbRsRgbRiRsmbRgbRgbRgRs
mbRgbRsRsRsRsmmmbRgRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
bRjbRcbRibLobLgLgbLsbRjbRcRsmbRgbLebLcLsRsmbRgbLsLibRcbRhRsmbRsRsmbLjb
LgLsbLiRsLsbLibRgbRsbLiLsbLibLibLjRsbLgRsbLiLsbRebRgbRgRsRsRsmmmbRibRs
RsmbRebRebRsbLsLibRsLsbLebRgbLibRgbLsLibLibLhbLgbLjbRibLgLsLsLsLimmbLg
bLgbRgbLgbLibLgRsbRgbLiLsbRgbRsbLgbLibLiRsbLgbRibRiRsmbRsbRiLsbLsbLiLs
bLhbRibRcbReRsmbRsRgRsmbRibRsbLjbLhbLgbLibLibLjbLibLgRsbRgbRgbLsbRgbRc
bLgbLiLsLsmbRsRsLsmbLebLebLibRsRsmbLibLiLcbRhbLibLibLgbRibRebRibRgbLjb
RsLiLsbLsbLiLsLsmbLsbRebLiLsbRsLsLsLhmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bRibRgRsmbRsRsmbRgbRsbRgbReRsmbLsbLebRsbRgRsmbRebLgbRebRibRsbLebRebRgb
LobRoRsmbRsbRebLjbRobLgbLgbLgbLgbLeLsLsLsmmbLibLgbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
bRsbRgRsmbRgRsmbLsbRgbRebRsRibRhbRgbRibRibRgbLsbLjbLebLibRsRsmbLibLsLg
LsbLiLsLgbLeLibRgbRcbRsbLibLgLsbLgbLgbLebLgbLsLsmbLsLgbLibLsbLgbLibLhb
LibLgbLibLgbLibLgbLibRsbLhLgbLgbLhLgbLgLibLebLhbLcbLhbLgbLebRsbLebLibL
gbLgbLibLibLgLsbLiLgLgbLiLsbLibLsLsmbLsbRsbLhbLibLebLsbRobRobRebLhLgbR
sbLebLgLsbLibLgbLgbLsbLgLsbLibLibLebLgbLgbLibRsbLgbLgbLibLgbLibLgbLibL
gbLsbLgbLsbLgbRsbLibLibLebLgbLibLibLibLgbLiLsbLgbLibLiRsbLsLgbLobRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 43; Drug: Control Apo 50 然
bRhbRgbRgbReRsmbRgbLebLsbRsbLgbLsbLgbLgLsbLsbRsbLgbLgbLgbLgbRsbLgLgbLi
bLsbLgbRebLsbLiLsbLgbRhbRgbRiRsmbRgbRgbRcbLjbReRsmbRibRebRibRibRcbLhbL
gLsbLibRsbRjbRhbRebRebRhbRsbRibRsbRgRsmbRgbRhbRsbRgbLgRsbRebRibRsbLcbL
gbLgbLgbLhbLgbLsbLgbLgbLgbLibRibRibRsRiRsmbRhbRsRsmbRibRgbRgbRhbRibReb
RibRgbRsbLhbLibLgbRsLgbLgLsRsbLsLsRsLsLsmmbLibLgbRjbRhbRiRsmbRgRsmbRib
RgRgbRiRgbRibLsbRebRgRsmbRibRibRibRgbRgbLsbLgbLibLgbLgbLgbLibLgbRebRsb
RibRgRebRhbRgRgRsmbRgbRgbRiRsmbRibRibRibRiRsmbRhbReRsmbRgRebRgbRebRibR
ebRsbRgbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 44; Drug: Control Apo 50 然
bRsbRebLibRgbRibRibLeLiLgbRsRsmbLhbRsLsLebLibLgbLebLgLebLebLsbLsbLiLsL
smbLebLiLgbLebLjbRiRsmbLhbLibLibLiLsbLhLgLsbLsLgLeLsbLeLsbLsLsLembLsbL
sbLgbLgLgbLcbLibLcbLcbLgbRgbRhbLebLibLibLsbRebLebLhbLsbLibLsbReRgLsbLe
bLeLsbLeLebLibLhbLsbLcbLhbLcLsmbRjbRcRsmbRcbLcbLgLsbLiLsbLibRsbLgbLgbR
sbLgbLsbLhLsbLiLibRsLsLsLsmmbLebLiLsbLgbLibLoRsbLsRsLsbRibRibRiRsmbRgR
smbRsbRgbLsbRgbRgbLsRsRsmbRsbReRsmbRebLibLibLiLgbLibLgbLgLsbLhbLsLsmbL
sLsLsLemmbLjbLobRibLhbLgbLsbLsLsLsLsmmmbLsLsLsLsmmmbLeLsLsmbLsbLeLsbLi
bLebLebRgbRsbLsbLgbLibLgLsbLgLsbLgbLsLsmbLhbLgLsbLgbLibLibLsbLgbLsLsmb
LsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 45; Drug: Control Apo 50 然
bLibLibRcbRcRsmbRibRgbRgLsbRobLsRsbRebRgRsmbRcRgbRiRobRiRsmbRibRhbRgbR
cbRebRgRsmbRsRobRsbRgRsRsRhmmbLobLobLsbRobRiRsmbRgbRhRibRibRcbRibLgbLi
bLebLsLebLebLoRsRsmbLiRsbLobLgbLsbLhbRjbLhbLsbRhbRiRsmbRsbLcbRsbLhbRsR
smbRcbLcbRjbRcbLjbRhRsmbLcbLcbRhbRjRsmbRjbRebRibRjRsmbLcbLibRibRobLhbL
hbRjbLiLsLsLsmmbRsbLjbLgbRcRsmbLebLibLibLhbLhbLgLsbLobRcbLibRcbRibRgRs
mbLjbRcRsmbRhbRibRcRgbRsRsRsRsmmmbRiRsRsRsRsmmmmbRiRsLsRsmbLcbRsbRgRsL
smbLsRsbLibRobRcRsmbRhRsmbLsbLhbLgLsLsLsmmbLcbRcRsmbRcbLibRcRsRsmmbLjb
LiLsbRgbLjLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 46; Drug: Control Apo 50 然
bRhbRgRsmbRgbRibRibRgRsRembLsRgbRgbRsbRibRsbRibRsbRgbRibRgbRhbRgbRgbRc
bLsRsbRibRgbRgbRibRgbRebRsbRgRsmbRibLgRsbRiRsRsmmbRgbRgbRgRsmbRgbRgbRg
bRsbRgbRsbLsbRgbLgbLibRebRgRsRsRgmmbReLsbRebRgbRgbRebRsbRibRgRsLsmbRhb
RsRsmbRgbRgRsRsmmbLgbLjbLhLsbRibRsbRhbRsRsmbRebRgbRsbRhbRgRsmbRgbRibLj
bLcbLibRsbRhbRgRsmbRiLsbRgbRibRhRsmbRgbRgRsmbRiRsmbRsRgbRgRsmbLcbRsRcb
RebRiRsmbRebRgbLsbRhbRebRsbRebRcbLibRhbRgbRebRgbRgbRgRsmbRhbRgbRgbRibR
gbRgRsRsRsmmmbRhbRgRsmbRibRebRgbRhRsmbRebRebRgbReRsmbRebLsbRhbRibRebLs
bRibRgbRiRibRibRsbRgbRgbLsbRgRsmbRsbRhLsbRibReRsmbRgbRibRhbRibRgRsRemb
LsbRiRsmbRibLgbRgbLgbLjbLiRsbRibRebRsbRibRgRsmbRibRiRsmbRsbRgbLgbLjbRe
bRhRsmbRebRib

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 47; Drug: Control Apo 50 然
bRsbRhLsbLcbLgbLibLebLgLebLebLhLcbLebLibLebLiLsbLibLeLsbLibLgLsbRcbRgb
RcbRibRgbRgRsmbRibLcbLgbLsbLsLsmbLebLgbRsbRjbLibRebRgbRibRibRibRgLsbRi
LsRsbRgRsRsRsmmmbLebLhLsLsmbLeLsRsbLibLibLibLibLibLgbLibLibLibLebRhbRi
LsbRgbRsRhbRibsbRibRsRsRsmmbRsRibLsbRsRebLsbRgbRsRsmbRiRsmbRsbRsRsLsmb
RsRsRsRsRiRsmmmmbRsRsRimbRsRsmbRsRsmbLsRsbRsbLsRsbRsbsbLcbRcbRibRsRebR
gReRsmbRsLsbRiRsmbRgbRcRsmbRsbLibLgbLcbLhbLiLsbLebLgbLgbRsRsmbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 122427; End: 122927;
Recording: 8-1; Individual: 48; Drug: Control Apo 50 然
bLibRsbLiLsbLebLgbLibLeLsbLcbLebRgbLeLsbLebLebLcbLgbLibLeLsLibRgbRgbLe
bLebLebLebLgbLiLgbLibLcbLeLsbLsLsmbLeLsbLebLiLsbLebLebLcbLibLeLsbLibLh
bRsbLeLsbLebLeLsbLsbLsLsLsLsmmmbLibLsLibLibLebLibLeLsbRgLsbLebLeLsbLeb
LebRgbLcbLsbLcbLcbRibLhLsbLsLsmbLibLeLsbLiLsbLebLgbLsbLiLsbRsbLibLgbLe
bLcbLiLsLsmbLgLsbLiLhbLcbLeLsbLsLgbLebLjLgbLsbRsbLibLgbLebLhbLsLsmbRsb
LebLgbLhLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
bLeLiLiLiLsLiLiLsbLebLgbLgbLgbLebLebLebLebLibRgbRibLgLsbLjbLibLhbLgbRh
RsmbRebRebRebRebRibRgbRebLgLgbLibLgLibLcLiLeLgLebLgLsbLgLibLsbLjbLgLsb
LsbRgbRebRcRsmbRhRsmbLjbLcbLibLibLiLsbLgbLcbLeLiLgLsbLiLgbLibLgbLiLsbL
gbLgbLgbLgLibRgbLebLgbLgLsbLgbLgLsbLgbLgbLibLsRsbLibRsbLcRsbLcbLgbLibR
cbRibRobRcbRibRcbRibRcRsmbRcbRjRcbRhbLebLibLebLibLibLibLiLsbLgbLcbRibR
iRsRgRsRsmmmbRebRsbLcRsbRsbRebRsRsmbRcRsmbRjbRcbRcRsmbRsRhbRhbRjbRebRc
bRiRsLsmbLjbLibLibLiLgbLhbLiLibLgLgbLgbLgLgbLgbLgbLgbRhbRibRibRibLibRc
bRjRsmbRhbRgbLjLsmbLjbLjbLibLhbLibLsLibLebRjbLiLgbReRsmbLebLebLibLjbRh
bLiLsbRjbRjRsmbLjbLhbRcbRhbLibLcbLhRsbLibLibLiLsbLebLibLsbLhLsbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bReRsmbLobLibLiRsbLgbLsLsLsmmbLsbRjbRgbRgbRobLibLebLiLsbLsbLeLsbLeLsbL
gbLibRcbRibRcbRibRebRibRgRibRsbRibRibRibLgbLsLibRjbRcbLibLgbLebRgbLeLg
bRcbRgbReRsLsRsmbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bRjRsmbRibRgbRsRgRsRsRsmmmbRiRsRsmmbRgbRgRsRsmmbRgbLsbRsRsmbRibReRgRiR
smbRiRsmbRibRibRoRsmbRibRobRibRibRiRsmbRcLsbRiRsmbRgbRiRgRsmbLcbLibLhb
LibLibLebLibLibLsRsbRcbLjbLcbLgbLgLgbLoLgbLibLgbLgbLgbLcbLibLibLhbLgbL
ibRhbRebRibRibRibRgbRibRgRsmbRgbRsLsbRibRibRgbRsbRsbLsLjbLibLibLibLgLs
bLgbLhLgbLibRgbLsbLjLsmbLsLsmbLibRibRgbRsbLibRibRibRibLcbRsbLsLsLiLimb
LsLeLsbLcbLibLcbLibLibRibRiRsmbRgbRibRgbRibRiRsmbRibRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bLebLibLgbLgbRsbLgbRsbLhbLsLebLsbLsbLibLgbLgbLsbLsbLsbLibLibLsbLsbRsbL
gbLgbLgbLgbLibLsbLebLgbLgbLibLgbLgbLsbLsbLgbsbRsbLgbLibRsbLsbLibLibLgb
LgbsbLgbLsbLgRsbLibLsbRsbLsbLsbRsbRgbRsbRgbRsbRsbRsbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bLsbRsLsLsLgmbLgbLsbLgbLgbLhbLgbLibLgbLsbLgLsLsLsLgLsLsmmmbLsLsmbLsLsL
sRsmmbLgbLsbLsbLibLgbLgbLgbLgLiLsbLgbLgbLgLsLgbLsLsmbLsbLgbLgbLgbLibLe
bRiRsmbRgbRsRsmbRgbRgbRsbRebLgbRsbRsbRsRsRsRsmmmbRsbRsbRsbRsRsmbRsbRsR
sRsmmbRsbRsbRibRgbRibRibRgbRsRgbRsRsRsRsRsRsmmmmmbRsRsLsmbRsRsRsmmbLsb
RcbLsbLjbRibRibRsRgbRgRsRgmbRsRsmbRibLjbLiLsbLibLsbLsbLgLsLsLsLsmmmbLs
LsmbLgbLsLsmbLsLibLiLsbLcbRsbLibLhLsbRsbLibLibRcbRibRgbRgbRgRsRsLsmmbL
sbRsRsRimbRsbRgLsbRsbRgbRibRebRibRgbRgbRgRsRsRgLsmmbRsbRsRsmbLsbRgbRsb
RgbRgRsmbRgbRebRsbRgRsRsmmbLjbRsbLgbLgLsLsLsLsLsLgmmmmbLsLsmbLgbLgbLsL
smbLsLsmbLsbLsbLgbRhRsmbRsbRibRibLsRibLsbLjbRsbLgbLgbLgbLsbLsbLsbLsLsm
bLgbLgbLsbLsbLgbRjRsmbRcbRibRgbRgbLhbLibLsbLibLgbLibLgbRsbLsbLgLsLgLsb
LgbLsRsbLgbLgbRhbRgbRgbRgbRgbRgbRsbLsRsRsRsmmbRsRsmbRsRgbRsbRsLsbRsbRg
bRiRsRcmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bRgbLjbLebsbLibLebLhbLibLcbLibLhbLsLsLsmmbLsLsmbLebLgbLcbLeLsbLsLgLsbL
gLsbLsLsmbLiLgbLgbLebRibRsRsRsRsRsRsRsmmmmmmbRsRsmbRsRsmbRsRsRsRsRgmmm
bLsRsRsRsmmbRsbRsRsLsmbLsbLjbLsLsLsmmbLgLsLsLsLsLsLsLsmmmmmmbLgLsLsLsL
sLsmmmmbLsLsRsLsLsLsLsLsmmmmmbLsLsLsLsLsmmmmbLsLsLsLsLsLsLsLsLsLsLsLsm
mmmmmmmmmmbLsbLgLsLsLsmmbLgbsbRsLsLsLsLsLsLsLsLsmmmmmmmbLsbLgLsbLgbLgb
LsbLgbLibLebLeLsbRgbRcRsRsmmbRibRibRiRsmbRgRgbRsRsRsRsRsmmmmbRsRsmbRsR
sRsRsLsmmmbRsbRsbRsbRsRsRsmmbLsRsRsRsRsmmmbLsRsRsmbRsRsRsRsmmmbRsRsmbL
sbRsbRgRsRsmmbRebRibLsbRgRsRsRsRsmmmmbRsRsRsRsRsRgRsRsRsRsRsRsRsRsRsRs
RsRgmmmmmmmmmmmmmmmbLsbRibLsRsbRgbRsRsRsRsmmmbRsRsRsRsRgRimmmbRsRsRsRs
RsRgRsRsRsmmmmmmmbRsRgbLsbLjLgLsLsLsmmbLebLgLgLsLsLsLsLsRsLsmmmmbLsbLs
LsLsLsLsLsLsmmmmmmbLiLsLsmbRsLsLsLsRsmmbLsRsbLsLsmbRsLsLgLsLsLsLsLsmmm
mbLsLsLsLsLsmmmmbLsLgLsLsLsLsLsmmmmbLsLsLsLsLsLgLsLsmmmmmbLgLsLsLsLsmm
mbLgLsLsLgLsLsmmbRsbLeLsbLiLsLsmbLgLsbRsbReRsmbRiLsRsRsmbRsRsmbLgLsLsm
bLsLsLsLsLsLgLsLsLsmmmmmmbLgLsLsLsLsLsmmmmbLsbLibLgLsLsLsmmbRsRsLsLsLs
LsLsLsmmmmmmbLiLsbLgbLsbLsbLgbLgLsLgLsLgLsLsLsLsLsmmmmbLgLsbLeLsbLhLgL
gLsbLgbRiRsRsRiRsRsRsRsmmmmmmbRgbRsRsmbRgLsRsRsRsRsmmmbRcbRgbRgRgbRsLs
bRsbLsbLsLsLsLsmmmbLibLgbLgLsLsLsmmbLgbLhLsbLhLsbLebLiLgLgLsbLsbLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bRsRsRsRsRemmmbRgbRebRgbRibRebRgbLgbLcbLsbLsbLsbRebRsbRsbRsbRiRsRiRsmm
bRsbRgbRebRobRibRgbRibRibRsbRgbRibRgbRgbRgbRgRsmbRgRsmbRibRgbRsbRgbRsb
RgbRgbRiRsmbRebRgbRsbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRsRsmbRgbRgbR
ebRsbRgbRgbRsLsbRgbRibRsbRiRsmbRebRiRsmbRgbRsRsmbRgbRgbRibRgRsmbRgbRiR
sRsmmbRgbRgbRibRibRgbRsbRgbRebRebRgRsmbRsbRgbRiRsmbRhbRiRsmbRgbRgbRgbR
sbRgbRsbRebRibRgLsbLgbRhbRgLsbRibRibRebRgbRibRibRsbRgbRgbReLsbRibRsbRs
bRibRsbRsbRgbRgbRgbRgbRgRsmbRibRgRsmbRhbLsbLsbRibRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bRsbRsRsmbRsRsmbRsbRsRsRsRsRsRsRsRsmmmmmmmbRsRsLsmbRsbRsRsmbsbRsbRgRsR
sRsRsRsRsLsRimmmmmmbRsRsLsmbRsRsmbRgRsmbRsRsRsLsmmbLsRsRiRsRgmbRsbLsRs
bRsbLsRsLsbRgRsmbRgRsmbRgRsRgRsmmbRgRsRgmbRsRsmbRsRsLsRsmbRsRsRsRsmmmb
RsRsmbRsRsRsRsLsmmmbRsRgRsRsRsRsRsRsRsRsRsmmmmmmmmmbRgbRgRsRsRsmmmbRsR
smbRgRsRsRsRsRsmmmmmbRebRcbRibLgLsbLoRibLibsbLibLcbLiLsbLiRsbLhbRhbRcb
RhRsmbRebLeLsbLgbRjLcbReRhRgbRibLebLgLibLibLgbRcbRibRgbRsbRiRsmbLgbRib
RiRgbRsbRhbLsbLsbLcbLgbLsLsLgmbLgbLibLgbLgbLgbRcbRgRsmbRiRsmbRibRgRsRg
mbRsRsRsRsRsmmmmbRsLsbRsRsmbRsRsRsRsRsRsRsmmmmmmbRsbLsRgRsRsRsRsmmmmbR
sRsRsmmbRgbRiRsRsmmbRsRsRgRembLsLsmbRsbRsbRsRsmbRsRsmbRgLsRsRsRsRsRsRs
RsRsRsRsmmmmmmmmmbRsRsRsRsRiRsRsRsRsRgmmmmmmmbRsRsRsLsRsRsRsRsRsRsmmmm
mmmbRsRsmbRsRsRsRsRsRsRsRsRsRsRsLsRsRsRsRsmmmmmmmmmmmmmbRgRsRsmmbRsbLs
bLsRsRsRsmmbLsbRsbRsbRsRsRsmmbRsbRsRgbRiRgRsRsRsmmmbRsRsmbLsRsRsRsRsRs
RsRsRsRsRsRsLsRsmmmmmmmmmmbLsbRsRsRsRsRsmmmmbRsRsmbRsRsRsRsmmmbRgRsmbR
sRsRsRsRsRsRsLsmmmmmmbRsLsRsbLsRsRsmbRsbLsRsRsmbLsRsRiRsRsmmbRgRsmbLsR
ib

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
bRsbRsbRiRsmbRibRhRsmbRcbRcbRcbRcRsmbRibRcbReRsRsmmbRcbRhbRiRhRsmbRcbR
hRsmbRibRcbRebRibRibReRsRsmmbLebLhbLgbLgbLiLebLgbLsbRsLsbLgbLibLibLsbL
ibLibLgbRjbRcbRibLgbLgbLcbRsbLibLhLsbLsLsmbLiLsbLgbRcRibRibRibLibRebRh
bLibReRsmbRgRhbRibRibRhbRcRsmbLibLgbLgbLibLgbLgbLgbLgRsbLsbLibLgbLjbLi
bLjLsLsmmbLibLjLsmbRibRibRcbRgbRjbLsbLibRgbRhRsmbRibLsLsRsmbRsbLsLibLs
bRjbRsRhRsmbRsRsmbRhRsmbLgbsbLibLgLsbLebLgbLibLsbRobRibLebRcbLcbLhLsbL
ibRjbRebRiRsLsmbLsRsbRsbRgRsmbRsRsmbRibRgRsmbRgRsmbRibLsLsmbLgbLebRebR
ibRebRibRibRibRgbRhbRcbLgbLhbLjbLsbLibLsbLgbLgLsbRibLsbRsRsmbRebRiRsmb
LsbRsRsRsmmbRgbRsRgRsRsmmbRiRsmbRsbRibLgRsbRibLsbRsbRsRsmbRsRsRsmmbRsR
gbRgRsRsRsmmmbRgRsmbLsbRsbRsbRsRsmbRgLsbRsRsmbRsbReRsmbReRsmbRibLgRsbR
sbRgRsRsmmbRsRsRsRsmmmbRhbRgbLgbLjLsLsmmbRiRsmbRiRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
bRhRsmbRsbLcbLiLsLgbLibLgLsbLibLgLsbLsLsmbsbLsLsLsmmbRsLsLsmbLiLsbLiLi
bLibLebRibRibRgRsmbRiRsmbRibLgbLjbLiLsbLcbLgbLibRsbLhbLgLsbLiLsLsmbLiL
ebLgLsLsmbLsLsLsmmbLsbLsbLsbRsbRsbRsbLsRsbLsbLsbRsbRsbLsLsLsmmbLsRsbRs
bRsbLsbLsbRsbRsbRsbRsbRsbLsLsRsmbRsbLebLiLsbLsRsLsbLiLsbLgbLgbLsbLibLs
bLsbLgLsbLibRebRibRgRsmbRsbRiRsmbRibRibRibRibRibRgbRcbRsbLgbLhbLibLgbL
gbLjbLgbLgbLgbLsRibRibRibRibLsbRiRsmbReRsmbsbRsRsRsmmbRhRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bRjRhbLibRgbRoRsmbLibRcbLibRcbLibLibRsbRibRgRgRgRgbLgbRjbLebLibRjbLjbL
gbRiRsmbRhbRgRsRgRsmmbRsRcbLgRsbRibLgRsRsRsRsmmmbLsRsLsbLhbLebRibLibLg
bRhbReRsRsRsmmmbRhbRgLsbRgbRiRsmbLgRsbRhbLiRsRsRsmmbReRsRsmmbLsbRsbRgb
LgbRhRsRsRsmmmbRgRsRsmmbRhRsmbLgbRsRsmbRsbRgRsRsRsRsRsRsmmmmmmbRiRgbRs
bRibLsbRsbReb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
bLsbRcbRcRsmbLibRcbRibRibRebRcbRebRsReRsmbRibLgbRgRsmbRgbRebRebLgbRgbR
sbRgbsbsbsbLsRsbLsbLsbLsbLsbRsRsLsRsRsLsmmbRsLsRsLsLsmbLsLsmbLsRsbsbsb
LcLsmbLcLsmbLsbRsbRibRcbRcRsmbRcRsmbRgbRibRsbRcLsbRoLsRsRgRsmbRgLsbRib
RebRebRiRsmbRsbRcbLebLhbLiLsbLsRsbLsRsbLiRsbLsLsmbLibLsbLibLhbLcbLhbLi
bLgbLibLsLsmbRsbLsLsmbLiLsbLibLcbLjbLibLibLsbLgbLobRgRsmbLjbRcbRcbRibL
hbLjbLcLsmbLjLibLhbLhbRhbRcbRgbRcbRgbRhbRibRgbRgbRhbRgbRebRsLsbRhbRibR
ib

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
bRsRsmbRsbRsbRsRsmbLsbRsbLsbRgbLgbRgRsRsRgmmbRsRsRgRsRgRsmmmbRsbRsRsmb
LsRiRsmbRgbRgbRsbRsRsRsRgmmbRgRsmbRsRgbRsRsmbRsbRsRsmbRsRsRimbRgbRebRs
bRsbRsbRgbRsRgbLsbReRibLsbLebLhbLsLsmbLibLsLsmbLiLsbLgbRsLsLsmbLgbLiLs
LsLsLgLsLgmmbLsLsLsLsmmmbsbRsLsbRsLsbLhLsbLsLsLsLsLsLsmmmmmbLsLgbLsLsL
gmbLgLgbLsLsmbLsLsmbLgLsbLibLiLsbLgLibLgLsbLgbLsLsLhLimbLebLsLsmbLsbLs
bLsLsLsmmbLsbLebLibLibLgLsbLgLiLsbLgLibLgbLgbLsLsmbLsbLgLsbLibLgLsbLgL
ibLsbLsLgLsbLibLsLsmbLsLsmbLsLsRsmbLsLsLsLgLsmmbLgbLgLsbLgLsLibLgbLgLs
bLsLgbLibLibLibLsLsmbLgbLgLsbLsLsLgmbLgLsLsLgmbLsLsmbLsLiLsbLsLsmbLgLg
bLibLgLgbLeLsbLgLsLsLsLimmbLgLsbLgbLgbLgbLgbLibLibLgbLgLsbLgbLgbLibLib
LgLsbLgbLgbLgbLgbLsbLsbLgbLibLgbLgLsbLgRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bLibLsLsmbLgbLibLgbLgbLgbLgbLgbLsbLiLsbLibLgbLibRsLsLsLgmbLibLgbLibLgb
LibLgbLgbLgLsLgbLgbLgbLsbLgbLgbLgbLgLsbLgbLgbLibLiLsbLgbLgbLgbLgbLgbLs
bLgLsbLgbLgbLgbLgbLgbLgbLgbLgbLgLsbLgbLgbLgbLhLsbLgbLgbLiLsLsmbRsLsbLg
LsbLgRsbRgLsbLgLsbLibLgRsRsRsLsLiLsLsmmmbLiLsbLibLgbLgbLgbLgbLgLsLgbLs
bLgLsbLgbLibLgbLgbLgbLgRsLsbLibRgbLsLgLebRsLibLiLsbLgbLibLgbLsbLhbLhbL
cbLhbLiLsbLibLibRgbReRsmbLgbLjbLhbLibLgRsbRsRsmbLgLsRsbLgbLgLsbLgLsbLg
bLibLgbLgLsbLebRsbLibLebLibLibLibRjbLsbLibLibLsbLibLeLsbLsLsLhmbLhbLiL
sbLebLebRebRcbLibRibRibRgLsbRibRgbRibLgbRibLibLjbLibLgbLgbLgbLgbLibLeb
LgbLeLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bRhbLsbLhRsbLiLsLsmbLcbLsbLibLgbLhbLgbLcbLebLhbLebLcRsbRiRiLsbRiRsRemb
RgbRjbLgLsbRobReRebRibLsbLebLiLsbLgbRgbRobRjbRebLibLgRsbLcbLeLsbLeRsbL
eLcbLgLsLsmbLgbRsbLibLgbLgbLgbLgbLhbLibLibLgbLgbLgbLobLsbLobLgbLibLgbL
gbLgbLhbLgbLgbLsbLsbLgbLibLibLibLibLgbLhbRjbRhRsmbRgbRebRgbRsbLcbLsLsm
bLiRsbLhbLsbRsbLsbRgbRsbRgRsLsmbRgbRhbRgbLgbLsRsbLsbLgbLhbLgbLibLgbRhb
RsbRsbLjbLcbLebLgbLsbLhbLsRsbLcbRsbRsbLsbRsRsmbRsbLgbLibLibLibLgbLhbRi
bLhbLsLsmbsbLibRibRgbRgRsmbRibRsbRsbRsRgbRcbRsRsmbLibLcbLibLiLsbLsbLcb
sbLsbRsRibRsbRibRgRsRembLibRibRgRsmbRibRibRgbRgbRgbLibLjLsmbLhbLsbLcbL
gbLebLibRgRsmbRhRsmbRibRgbRsRsmbRgbRgbRgbRsbRibRgbRgbRibRsbRgbRsbRsbRs
bRsRsRimbRibRsbLsRsbLcLsmbLsRsbRcbRgbRgbRsRsmbRsbRgRsRsRgRimmbRgbRibRg
LsbRgbLeLsbRgbRiRsmbLsLsRsLsmbLgLsLsmbRjRsmbRhRgbRgbRibRsbRibRibRgbRgR
smbRgbRsRsmbRgRsmbRsRsmbRsbRsRsmbRsbRsRsRsRsRemmmbRsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bLibLsbLibRebLjbRhRsmbRibRibRgRgbLsbRsbRhbRebRebRsRgRsmbRiRsmbRibRibLs
RgRsmbRiRgbRibRgbRgbRsRsmbRibLjbRhbLiRsbRhRgbLibRjbRsbRsRgRsmbRgRsRsmm
bRgbRibLibRsRsmbRhbRibLgbRibRsbLsbRebRiRgbRibLgbRsbRsRsmbRgRsmbRibRibR
gbLibRibLgRsRsmbRsRsRsmmbRgbRibLgRsRgbRgbLibRsbRibRibRibRsbRsbRiRsRgmb
LsRsbRsbReRgbLsReRsmbRgbRibLsRsRsmbLgbRhbLibRibRgbRebRibRebRhRsmbLgbLe
bRjbRsRebLsbRsbRsRsmbRsRsRimbRebRgbLgbRsRsRsmmbRgbRiRsRsmmbRibRsbRiRgb
RgRsRgmbRibRibRgbRebRibRsRebRebRsbRebRgbRsbRgbReRsmbRgbRgbRibRgbRgRsRs
mmbRsbRebRsbRsbRsbRsbRsbRjRgbRoRsmbRhbRebLgbRsbLibRebLibLibRhbRgbRsbLc
bLiRsbRsbReRsmbRhbRgbRsbRebLsbRsRsmbRhbRibRgbRgRsmbRsbsbRiRsmbRgRsmbRs
bRgbRhbRhbLgbLgbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bLibLiLsbRjbLibRjbLibRcbLhbRjbLibLibLibLjbLibRhRsmbLibLhbLhbLsbRibRebR
ibRhbRiLsbRibLibLibLibRsbRhbRibReRsRsmmbRgbRjbLgbLjbLsbLhbLgbRjbRgbReb
RibRgRsmbRgRsmbRjRsRsmmbRibRebLibLjbRibRsbRiRsmbLjbRibLsbRhbRibRibRsbR
sbRjbRebLjLcbRcbRhbLgbRibLhbLgbRiRsmbLjbLjbLibLjbLjbLcbLcbLgbLsLsmbLgb
LebRhbRhbRebRibRiRsRcmbRibLibLibLgbLsbLgbLiLsbLibLgbLgLsbLgbLibLibLsbL
gLgbLibLibLgLsbLgLsLeLsLebLgbLjLsLsmmbRhb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bLsbRgbRsbLcbLibLsbLsLeRsbLebLcbsbRcRsmbRhbRsbLjbRgbRibRsRgRgbRsbRgRsR
smmbRhbRsbRibRgRiRsmbRibLoLsmbLebLgbLebLiLsbLgbLgbLsbLgRsbLibLebLsLsLh
mbLibLgbRjb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 19; Drug: Control Apo 50 然
bRcbLeLsbLgRsbLibLibLgbLhbLibLsLsLsLsLsLsLsLsLgLsmmmmmmmbLsLsLiLsmbLgL
sbLiLsbRibRgRsRgmbRsRgbRiRsmbReRsReRsmmbRibRibRibRgbRgbLjbLcbLgbLgbLib
LibRibRgbRgbRgbRgbRibRgbLgbRebRibRgbLgbRibRgbRgRsmbRgbLjbLebLgbLgbLgLs
bLibLgbLibRsLsbRsbLibRjbRhbRgbRibRsbRgbRgRsmbRgbLsbRsRsmbRebRsRgRsmbRc
bRgLsbRiRgbRsRsmbLhbRgbLebLcbLibLgLibLsbLgbLhbLgbRjbRhbRgbRgbRgbRgRsmb
RgRsmbRsbLebLibLsbLgLsbLgbLgbLibRsbRiRsmbRcbLsRsbRebRsbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 20; Drug: Control Apo 50 然
bLgbLhbLsLsmbLhbLebLebLgbLibLgbLsbLgbLiLsbLgbLgLsbLibLeRsbLeLsbRsbRoRs
mbRsbRsbLgbLibLsLebRebRgbRgbRobRebRsbRibRibRebLcbRjbRibRhbRibRsbRgbRgb
Rsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 21; Drug: Control Apo 50 然
bLsbRsbsbRsLsbRsRsRsmmbLsbRsbRsRsLsmbRsbRsLsLsRsmbLsRsbRsbRsLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 22; Drug: Control Apo 50 然
bRsbRgbReRsRsmmbRhbRgbRsRsmbRiRsmbRibLgbLebLsbLibLsbLgLsbRebLsbRsbRcbR
iRsRsmmbRhbRcRsmbRsbRsLsLebLsLsmbLibLibRcbRhRsmbRgbRgRsmbRgbRgbLsbRhRs
LsmbRcbRibRcbLibLibRebRgbRebRcbRgbRgRsmbLcLgbLsbRhbRebRobLibRebRcbRgbR
sbLibLgbLebRcb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 23; Drug: Control Apo 50 然
bRebRibRsLsbLsLsLsLsLsmmmmbLsLgbLsLsmbLsLsLsmmbLgLsLsLsmmbLibLibLiLsbL
gbLsbRjbRibRiLsbRsbRibRcbLsbRcbRebRibRibRebLgbRsbLibRsbLhRsbLibRsbRjbR
hbRibRibRibRibRcRsmbLibLjbLgRsbRsbLobLibLiLsbRibRjbRhbRebRibRebRibLsbL
jbLhbLgbLsbLgLsbLsbLgLsbLgLsbLgbLgbLgbRsLibLgbLgbLiLgbLsbLsbLobLgbRibR
hbRgbRibRsRsRsmmbRibLgbLgbLsLgbLsbLsLsmbLsbLgbLgLsbLgbLiRsbLsbLibLsbLs
bLsbLgbLsLsLsmmbLgbLgbLgbLibRibRjbRibRibRsbRgRsmbRsbRgbRgbRgbRibRsbReb
RgbRgbRgbRgbRgbRgbRgbLcbLgLsbLgbLgbLsbLgLgbLgbLgbLsbRsLsbLgbLgbLgbLibR
gbLiRsbRsbLsbLsbLgbLgbLgbLgbLgbLgLsbLgbLgbLsLsmbRebRiLsbRsbRebRibRgbRi
bRebRgbRsbRgbRsbRgbRgRsmbLgbRsbLgbLsbLsbLgbLibRebRib

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 24; Drug: Control Apo 50 然
bRgbRgbRibRibRgbRibRgRsmbRgbRsbRgbRsbRibRgbRgbRgbRgbRgbRgbRsbLsbRsRsmb
RsLsbLsbRsbRsbRibRsRsmbRibRsbRsbRgbRgbRgbRgbRsbsbRjbLsbRsbRgbRsbRsbRib
RsbRsbRsbRsbRsbRgbRgRsRsmmbRgbRgRsmbLsbLgbRjbRsbRsbRgbRibRsbRgbRgbRebR
ibLsbLsbLsbLsbsbsbRsbLibLgbLgbLsbLgbLsbRjbLsbLsbLsbLibRjbRibRsbRsbRsbR
sRsmbRgbRgbRgbRsbLsbRsbRsbsbRjbLsbRsbRsbRgbRsbRjbRjbLobRibLjbLsbRjbLeb
RsRsmbLsbLsbRsbRsbRsbRsbsbsbRsbLsbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bLsLsmbLgbLgbLebLibLobLsbRsbLgbRebRsbRjbLgbRjbRobLgbLgbRebRjbLgbLgbLsb
RsbLsbRsbRobLsbRebLibReReRsmbRobLcbLsbLcbRcRibRsRgbRsbRgRsmbRsbRsbLsbL
sbRgbRsbLsbRsbLsbRsbLsbRsbRsbLsbRgbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
bRgReRsRsmmbRgbRgbRibRgbRsbRibRiRsmbRibRgbRgbRsbRgbLsRgbRgbRibRsbRiRsm
bRibLsRsbRibRebRsbRsbLibLgbLiLsbLgbLsRsbLsbLgbLsbLsLsmbLeLgLiLsbLgLsbL
gbLgbsbLiLsLsmbLgbLibLsLsmbLibLsbLiLsbLeLsbLgbLibLsLsLsLsLgmmmbLgbLgbL
gLsbLgbLgbLsLgbLibLgbLgbLsbLsbLgLgLsLsmbLsbLsLsmbLcLsLsLgmmbLsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bRsbRebRibRhRiRebReRsmbLcLsLhLsmbRcbRiRsmbLhbLcbLgbRjRsmbRibRibLgbLjbL
cbRsbRebRibRgbRgbRhbLebLjLsmbRibLhbLiLsRsbLgbLcbLibRgbRcbRibRibLibLcbR
cbRibRgbRjbLhbRjRsmbRibLiLgbLcbLiLsbLibLsbLibLibLhLibRjbLcbLgbLibLibLg
bRibRhbRibRgbRgbRjbLhbLjbLibLibRjbRcbLcbLhbLiLsbLhbLibRibRibLsLibLibLg
bLsbRsbLgbLsbRebRibLjbRibRcbLibLjbLibRibLibRgbLgbLibRibRsRsmbRgbLcbLgb
LhbLibLgbRsbLcbLibLgbRgbRcbRibRebRibRgbLjbLjbLibRsbRcbLibRibRibRibLibL
ibLcbRgbLcbLgbLgbLgbLsbLibLibLeLibRgRiRsmbRhbRgbRibRgbRsLsbRibRibRhbRe
bRgbLjbLcbLgLsbLibLibLgbRibRcbRhbRibRcbLsbLjbLibRjbLibLebLibLibLgbLibL
ibLgbRgLsbReRsmbRibRgbLibLgbRjbRhbRibLgbRibRsRibLgLgbLebLibLibLgbRsbLg
bRjRsmbRjRsRsmmbRibRsbLibLibLcbLcbReRsmbRibRsbLcRsbRcbRibRcbRsbLhbLgbL
cbRjbLibLibLibLsbLibLibRiRsmbLibLcbLibLibLgbLsbLsbLgbRjbRibLcbLjbRibRs
bRibLgbLsbRhbRgbRibLgbLibLhLibLibLibRjbLcbLgbLiLsbLhbLgbLibLibLgbLgbRc
bRgRsmbRjRgbLjbRibRiRsmbRsbLgbLgbLibLebLibLgbRebRgbRibRibRcRibLsbRibRe
bRcRebReRgbRgRsmbRgbLsbRgbRgbRgbRgbLsbLsbRsbRgbRgbRgbRgbRibLgbLebRiRsm
bRibRib

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bRgbRgLsbRgLgbRsRebRsbRebRgLgbRcbRcbRebRibLsbLjLsmbRebLibLcbLgbLibLjbL
hbLibLcLhbLhbLebLeLsLsmbLgbRgbLebLibsbRgRibLibRjbRhbRgbLgbRhbRibRibRib
RibRiRgbRgbRgbRebRsRsmbRgbRebLsbRoLsLsmbRsLsbLsRsbRjRhbRsLsbLsRebRebRs
bsbRsbRsbRsRsmbRsRsRsmmbRsRsReRgmbsbRsRsmbRsbRsRsRsmmbRgRsmbLsbRsRsRgR
gmbRsbRsRsLsmbRsbRsRsmbsbRsbRsRsmbRsbRsRsRgRsRsRsRsRsmmmmmmbRsbRsbRsRe
bRgRsmbLsbLoRsbLgbLibRsbRobsbRibRibRgbRibLebLgLsLsmbLhbRjbRhbRibRibLiL
sbLsLhLsbLsbLjbRsbLgbLcbLcbLibRjbRsbRgbRibRgbRjbLcLsmbRobRgbRsbRsRsRsR
emmbLsRsRsReLsmbRgRgRsRgmbRsRsRsRsRiReRimmmbReRgbRibRgbRebRibRsLobLibL
cbLjbRhbReRsmbRoLsbRebLhbsbLsLsLsLemmbRsbLiLibLgbLjbRsbLcLsmbLiLsbRiRs
mbRibLsbRjbRcbRibLjbLoLsmbLiLsbLgbLsLebLibRibRiRsmbLibLjbLgbLgbLsLsmbL
sbRsbRsbRgbLibRsLsRsbLsbLsLsRsLsLsmmbLsLsLsLsLsLsLemmmmmbRgbRibRsRebRs
RsRsRsRgRgmmmbRsRsmbRebRsRebRsRsRgRsRsRsmmmmbRsLsbRsRgbRsRsRsRgRsReRgm
mmbRsRsRgRimbRsRsRsRsRsmmmmbRsbRsbRsLsbRsRsmbRsbRsbRsRsRsRsRsRsmmmmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
bRgbRsbRcbRibLsRsbRgbRsRsmbRgRsmbRsRsRsRsmmmbRgbRgbRibLgbLibLcbRgbReRg
RsRsmmbRibLsbLsbsbRgRsRsRsmmmbRcbRgRsLsmbRsbRgRsmbRgLsbRsRsmbRgbRgRsmb
LsbRsRsRsmmbRgbRsbRgRibLgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bLgbLebLibLgbLoLsmbLibRgbLhLsLsmbLgbLibLgbLgbLsbLsbLsbLgbLibLsbLibLgbL
sbLhRsRsmbLgbRiLsbLebLgbLebLsbLibLibLeLsbRcbRhbLgbLibLhbLgbLsbsbLebLeb
RsbsbLsLsmbRsbLsbLsRsbLsLsmbLsbRgbLebRobRcbLgbRgbLibLebLsbLgbLsbLibLgb
LsbLgLsbRjbLsbLibRsbLgbLsbLgbLgbLsbLiLsbLgbLsLsmbLsbLgbLiLsbLibLibLgbL
gLsbRibLeRsbLibLebLsbLsbsbRjbLsbsbLibLgLsbLibLsLsmbLebLgbRsLsLsLimbRsb
LeLsbLebsbLibLgbRgLsbRgbLjbLibRsbLeRsbLsbLhbLiRsbLgbLgbLibLibRgRsmbLib
RsbLgbLsbLeRsbLgbLhbLibLgLsbLgLsbLgLsLgbLibRsLebLsbLsbLgbLiRsbLgbLgbLs
bLiLsbsbLsRsbLgbLgbLsbLsLsmbLsbLsbLgbLsRsbsbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bRsLsbRebRebRcbRgbLiLsbLcLsLsmmbLibLhLsbLiLsbLibLiLibLibRebRsbRcbRiRsm
bLsbLsbRsLsbLsLsRsmbRsbsbsbRsbsbsbRsbsbsbRsbLsbLsbsbsbsbsbsbsbsbRsbRsR
sLsmbsbsbRsbsbRsLsbRsbsbsbsbsbsbRsRsmbRsRsmbRsbRsbLsLsmbRgbRcRsmbRcbLo
bLiLsbLebLgLsLsmbLgbLgbLebLgRsbLsLgbLgbRjbRcRsmbRiRgbRibRsbRcbRibRcRsm
bLgbLibLsLsmbLgbLibLibLibLebLhLsLiLiLsLebLebLsbsbsbsbsbsbsbRsbLsbLsbLs
LsmbLsbLgLsLsLsLhmmbLiLsLsmbLgbsbRsbsbsbsbsbsbsbRsbRsbLsbLsLsmbLsbLsbL
sbLgLibLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bLibLhLgbLhbLgbLsbLgLibLhbLgLgbLsLsmbLgLibLgLsbLeLsbLgbLsLsmbLebLibLhb
LgLsbRsbLibRsLgbLhbLgbLsbLsbLsLgLsLsLsLsmmmbLebLebLsLibLiLsbLibLeLsbLg
LibLgLgbLgLsbLsLsmbLibLgbLebLebLsLsmbLgLgLsbLebLeLsLibLebLgLgbLgbLgbLi
LsLgLgbLsbLibLeLsbLibLgLebLgbLsbLsLsLgLimbLgbLgLsbLsLgLsbLibLgbLsLsmbL
gLgbLebLhbLebLibLsLsmbLsLgLsbLebLhLsbLgbLsLibLgbLebLiLgLsbLgbLebLgbLsb
LgbLhbLsLebLgbLhLsbLibLebLebLibLsbLibLhbLhbLgLgbLebLsbLebLgLsbLebLhbLs
bLsbLeLsbLhbLhbLibLibLibLgLgbLiLsbLgbLhLsbLiLsbLebLibLsLsmbLsLgbLibLeb
LhbLeLsbLibLiLgbLibLhbLsLsmbLeLsbLibLebLsLsmbLsbLebLsLsLimbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bRsRsRsmmbRgbRibRibRgbLgbLsRsRhRsmbLsbRgRsmbRibRgbRcRsmbLibLibLgLgbLib
RibRebRibRgbRsbRgbRgbRgbRgbRibRibLgbLibLiLsbLgbRcRsmbRibLibLgbLgLsbLgb
LgbLgbLgbRgbRjbLgbRgbRiRsRsmmbRgbRgRsmbRgbLsbRgbRgbRgRsmbRibRgbRgbRgbR
ibRgbRgbRgbRgbRgbRgRsmbRibRgbRgbRibRsRsmbRiLsbRibRibRsbRgRsmbRgbLsbRib
RgbRgRgbRgbRsbRibRsbRgbRgRgbRibRibLibLobRebRgbRgbRgbRsbLsbLsRsbLsbRibR
gbRgbRgbRsbRgbRgbRgbRibRsbRiRsmbRgbRsbRibRibRgbRgRsmbRsbRgbRibRibRsbLs
bRibRsbRgbRgbRibRgbLgbRsbRsbRibLsbRsbRsbRibLsbRgbRgbRgRsmbRgbRgbRsbLsR
sbRibRgbRibRgbRsbRgbRsRsmbRibRgbLgRsbRibRsbRibRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bRiRsmbLjbLcbLsbLibRebRcRgbRsbRiRsmbRsRsmbRgRsmbRibRebLiRsbLhbLgbLcLsm
bLsbReLsbRgRsRsmmbRsRsRgmbRibRiRsmbLsLsmbRebLgLsLsmbLsbLsLsLsLsmmmbLgb
LsbLsbLiLsbLgbLgbLgbLgbLhbLhbLgbRsbLgbLiLsbLebLgLsbLgLsLsmbLgbLgbLsbLg
bLgLsbLsLgbLgbLgbLgbLgbLgbLsLsLsmmbLibLsbLgLsbLgbLgLsLgLsbLibLibLgbLgb
LgbLgbLgbLgbLsLsLsmmbLgbLebLibLibLsLsmbLgbLgbLgbLgbLgLsbLgbLibLiLsbLcb
LgbRhbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bRibLsRsRsmbLsRsRsRsmmbRsRgRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRgbRgbRgRgbR
sRsRsmmbRobLgbRibRgbRsRsRsmmbLsRsbRgbLsRsbRgbRgbRsRsmbRgRsmbRgbRiRebLs
bLsbsbLeLsLsmbLsbLsLsmbLsLsLsLsLsLsLiLsmmmmmbLsLsmbLsLsLsmmbLgbLgLsLsm
bRcbRcRsRsmmbRiRsRsmmbRgRsRsRgmmbRsbRsRsmbRibLgbRgbRcRsmbLgLsbRsbRsbRi
bLsRsbRiRsmbLsbRgbsbRsRsRsRsmmmbRsRsmbRsRsRsmmbRsRsmbRiRsmbLsLsmbLjbRc
bRgRsmbRsbLsRsbLgLsbRobRsRsLsmbRsLsRsbRsRsmbRgRsmbRhRsmbRiLsbLsRsRsLgm
bRcbRsRsRsRsRsRsRsmmmmmmbRsRgbRgRsRsLsmmbLsRsRsLsmbRsRsRsmmbRsRsRsRsmm
mbRsbRsRsmbRsRsRsRsmmmbRibRsRsRsRsRsmmmmbRsRsRsRsmmmbLibLibLibRsLgbLsL
sLsLsmmmbLgbLsLgbLsbLsLsmbLsLsLsLsLsmmmmbRsLsLsLsmmbLsLsmbLsLgbLgbRsbL
iLsbLhbRsbLibLibLiLsbLsLsLsmmbLsLsLsmmbLsLsLsLsLsLimmmmbLgLsbRsbLsbLsb
LsLsLsmmbLsbLsLsLsLsmmmbLgLsbLsLsLsLsLgLsLsmmmmbLgLsLsLsLimmbLsLsLsLsL
sLsmmmmmbLsLsLsLsmmmbLgLsbLsbLgLsbLgLgLibLgLsLsLgLsLgmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bRgbLiLsbLsLsLsmmbLgLsLsmbLsLsLsmmbLsLsmbLsLsmbRcbLcLsmbLgLsLsmbsbRjbR
gbLibRibRhRsmbLhLsbRgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bRsRsRsRsRgRsRgRsRemmmmmbRebRiRsmbRebRibRsbRsbRgbRgRibRiRsmbLgbRiRsRim
bRgbRsRsmbRsRibRibRiRsmbReRsmbRebRhRgbRebRsbRgbLjbRhRsRsmmbLibLjLsmbLc
bLgbRebRhbReRsmbRiRsReRsmmbRebRebRibRebLjLsmbRebRsRsmbRibRibRibRebRibR
ibRibRebRebRgbRgRebLjbLibLsLsLsLsmmmbLsLsmbLsLgRsbLsbRebRebRhbRibRebRg
bLsbRibRebLsbRsRsRsmmbRsRsRsmmbRgRsRimbRibRebRibRebRibRibLcbLibLhbRcbR
cbReRsmbRgRsRgmbRebRhbRebRgbRgbReLsbLgbRcRsRsmmbLeLsbRsbRgRsRsmmbRsRsR
smmbReRsmbRebRsRiRsRsmmbRebRebRibRibRebRebRebRgRsmbRsbRebRgbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bRsbRsRgbRsbRsbRgbLsRsRsRsRsmmmbRsRsRsRsRsmmmmbRgbLsRsRsRsRsRsRsRsRsmm
mmmmmbRsbRsbRsRsmbRsRsRsmmbRsRsRsmmbRsbLsRiRsmbRgbRgbLsRsRsmbRgbRsRsRs
mmbRsRsmbRgbRgRgbRgRsRsRgmmbRgRsmbRgRsmbLsRsRsRsmmbRgbRgRsLsmbRsbRgRsm
bRsbRgRsRsRsmmmbRgRsmbRgbRsRsRsmmbRgbRsRsRsmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
bRsLsbLibLeLsLsmbLibLjbRibRibRibRjbRiRsmbRebLiRsbRgRsmbLgLsbRcbRebRibR
gbLcLsmbLsbRjbRcbRsRsmbRebLsbRiRgbRgbRgbRgbRibRgbLibLiLsbRsLsLsLsLsLsm
mmmbLibLjbLjbRebRibLgbLgbLibLibRgbRsbLibLibLgRsLsLsmbLibLjbLebRebRsRsR
imbRebRgbRiLsbLjbLhbLiRsbLiLiLsbRsLsbRsLsRsLsbLsLebRgRsmbLsbRobRgbLebR
jbRcbRgbRibRibLjRsbRcbRibLiLgLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bRibRcbLebLebLgRsbLgbLgbRibRebRibRgbRebLgbRgbRibRsbRiReRsmbLebLibLgbRs
RsmbRsbLebLgbLgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
bRsbRgRsmbLsbRibRgbRgLsbRibRsbRgbLibLgbLiLsLsmbLgLsbLgLsLsLgLsmbLgbLsb
LibLiRsbLibLebLgbLgbLsbLiLibLibLgbLgbLiLgbLgbLgbLibLhbLgbLgbLsbLgbRsbL
gbLsbLgbLgbRsbLgbLgLsbLgbLgbLsbLgbLgbLsLebLsbRsbRgbRgbRsbRgbRgbRibRsbR
sbRoLsLsmbRsRgbLgbLgbLgbLibLgRsbLgbLgbLgbLgbLsLsmbLgbLgbLgbLgbLgbLsbLs
bLsbLsbLsbLgbLgbLgbLsbLsbLhLsRsRobLgbLgbLsbLibLgbLgbRgbRsLsbLsbRsLsbRs
bRsbLsbLsLsmbRgbLsbRgbRgbRsbRgRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 43; Drug: Control Apo 50 然
bRgRibRibRibRibRibRibLsRsbRhbRsbLebLgbLgbLgbLgLsbLgbLgbLgRsbLgbLibRsbL
sbLgbRebRgbRhbRsRebRiRibRgbRebRgRsmbRgbRibRgbRsbRibRibRibRgbRibRgbRebR
hbRgbRebRhbRebRgRgbLgbRsbRebRibRibRhbRibRgbRibRhbRgRgbRiRsmbRgbRgbRgRs
mbRibRiRsmbRgbRibRsRsmbRsRgbRgbRhbRibRgbRgRsRsmmbRgRsmbRiRsmbRsRsmbRsR
ibRsRsmbRsbLibLsbLiLsLsmbLgLsbLobRebRiRsmbRgbRebRiRsmbRibRibRibLsbRebL
gbLebLsbLgbLgbRjbRgbRebRibLsbRsRsmbRibRcRsmbRibLgbLibLgbRsbLgbRgbLgLsb
LgLsLiLsbRsbRhbRibRsbLgbLsbRsbLsLsLsmmbLibRjbRebRgRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 44; Drug: Control Apo 50 然
bLibLsLsLsmmbLgLsLgbLebLebLibLgbLiLsbLibLebLebRsLsbLsLsmbLebLgbLibLibL
ebLebRsLsbLsLibLgbLibLibLebLebLsbLsbLsbLebLibLebLgLsLebLebLebLibLibRib
LjbLcbLibLgbLgbLsbLebLebLhbLibLgbLsbLsbRebRobRsbLebLgbRgbRgbLsRsbRgbRs
RgbRebRgbLgbLgbLeLibLgRsbLhbRsbLeLsbLgLsbLebLebLebLebLebLibRsbRsbRsbRj
bRgbRsbRebRebRibLobRibRsRsRsmmbRgbLsbLsbLebLebLibLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 45; Drug: Control Apo 50 然
bLibRhbRiRsmbLibLoLsmbRgRgRsmbRgbLcbLibLjbLhRsbLhLsbLgLsRsbLgLsbsbRgRs
RsLsRsmmbLobLoRsbRebRgbRgbRsReRsRsRsmmmbRgbRibRcRsmbRgLsbLgbRjbRsRhbRi
bLgRsRsmbRgRsRsmmbRsRsmbRgRgRsmbLsLsLsmmbLgbRibRcbRcbRcRsRsmmbRobRcbRh
bRhbRiRsmbLcbReRsmbRcbRcbRcRsmbLhbRiRsRsmmbLebRiRsmbLgbLibReRsRgmbLcbR
sRsmbLibLebLobLhbLcLsmbLcbLsRsLsRsLsLsmbRjReRsRsmmbRiRsmbRgRsRsmmbRcbR
gbRhbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 46; Drug: Control Apo 50 然
bRsbRgbRgbRgRsRsRsmmmbReLebRhbReRsmbRsbRiRsmbLjbLibRibRhbRibRiRsmbRibR
gbRgbRibRsbRgbRgRsmbLsbLobLsRhbRgbRcLsbLsbRebRebRgbRsbLebLgbLsbRcbRebR
ebRibRsbRgLsbLgbLjbLhbRgbLgbLibLebLebRgbRsLibRgbLgbRgbRgLsbRobLsbRibRi
bRibRebRibRgbRgbRsbRibRgbRsbRhbRhbRgbRgbRgbRjbRsbRgbRgbLgbRgbRgbRcbRgb
LgbRibRgbRhbReRsmbRebRibRibRgbLsbLsRebRsRsmbRsbRgbLsbRgbLebLibRgbRsbRg
bLsbRgbRibRobLsbLgbLsbLebLsbRobRibRebLoLsmbLibLibRsbLibRcbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 47; Drug: Control Apo 50 然
bRgRsmbRibRiRsmbRgbRsbRibLjbRgbLsLebLgLsbLgbRjbRcRsmbRiRsmbRibRiRsmbRi
bRibRiRsmbRibRgbRebRgbRibRibRgbRhbRsRsRsmmbLsbLjbLgbLsLgLgbLsRsbLsbLsb
sbLgbLsLsLsmmbLsLsmbLgbLsbLsLsmbLsLsmbLsLsmbLsLsmbLsRsbLsRsLsbRsbLsRsL
sbLgLsbLgLgLgLsbLsbLgbLsbLsLeLsbsbRsbLsLiLsLgbLhLsbLgbLebLgbLjbLeLsbRi
bRsbRsbReRsmbRibRgbRsbRsRgbRibRsRsmbRsbRsbRgbRebRsLsbRgbRibRgRebRsbRgR
iRebLjbRgbRsRsmbRgRibReRsmbRsbRsRsmbRgbRgbRsbLsRsbRjRibLgLsbLibLibLcbL
jbLiLsbLcbLsbLhbLibRibLhLsbLebRibRiRsmbRibRgbLgbLjbLcbLibLgRsbLibRhbLg
bLhLsbRibLgbLsbLgbLsbRsLsbLgLiRsLsbLgbLgLsbLebLgLsLsmbLgbLsbLgbLsLsmbL
hbLibLsbLiLsbLgbLsbLgbLsbLgbLgbLgbLgLsbLsbLgLsRsbLibLhRsbLgbLgbLsLsmbL
sbLgbLsbLsbLsbLiLsbLsbLibLgbLsbLgbLgbLgLsbLgbLgLsbRsbLiLsbLsbLgbLgbLsL
smbLgbRsLsRsbLsbLsLsmbLgbLgbRsRsmbLgbLgRsbLsbLgbLibLgbLgbRsbLsLgLgLgbL
gbLsbLgbLgbLsLsmbLsLsmbLgLsbLhbLgLgbLgLsbLsbLibLgLsbLgbLsbLgLgbLsbLsbR
jbLsbLsbLebLiRsbLgbLibLebLgbLibLiLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 122928; End: 123428;
Recording: 9-1; Individual: 48; Drug: Control Apo 50 然
bLebLiLsbLebRgbRibLsbRgLsbRsbRsbRibLsbLebLeLsbLeLsbLibLgbLsbLeLgbRgbRj
bRibLjbLebLcbLcbLcbLhbLeLsbLebLebLibLebLebRsbLebLgLsbLebLhbLebRsLsbLeb
LebRjbRibRgbRsbLjbLebLeLsbLebLsbLeLibLhLsbLebLgbLebRibRgbRgbRgbRsbLjbL
ebLebLebRsbRgRsRsmmbRsRsRsRsRsmmmmbLeLsLibLiLsbLebLebLibLhbRibLeLsbLeb
RsLsLsmbLiLsbRsbLebLeLsLsmbRsLsbLgbLgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
bRcbRebRibRjbLhbRjbLibLcbLibRjbLhLsbRcbLebLibRjRsmbRjbRebLibLebLcbLebL
ibLibLcbLhLsbLhbLhbLsbLiLiRsbLgbLiLhbLibLibLeLsbLgbRibRhbRgLsbLgLgLsbL
iRsbLhLsbLebLgRsLebLhbLeRsbReb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bLgRibRobRcbRcbRhbRcbLgbLcbLibLgbLobLcbLgbLgbRhbLhbRgbRcbLjbRobRibRgbR
gbRgbLibLibLibLgbLsbRcbRhbRgbRgbRibRibLcbRjbLjbLhbLiLsbLsLsmbRsbLiLsbL
ibLgbLgLibRsbLiLsbLebLibLibRcbRgbRebRibLebLhbLsLsmbRcbRhbRibRibRibRgbR
gbRgbRgbRibRgRsmbRibRsbRibRgbLsbRibLgbLhbLibLibLibLiLgbLsbLgbLibLsLsmb
RjbRsbRebReRsmbRgbRsbRgRgbRgbRgbRsbRibRsRibRgbReRsmbRgbRibRebRebRebReb
ReRebLgbReRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bRgbRgbRgbRiRsmbRsRsRsRsRsmmmmbsbRsbRsRsRsmmbRjRsRsmmbRsLsLsRsmbRsbRsb
RsRsRsRsmmmbRsRsmbRsbLjbRibRiRsmbRgbRgbRobRsbLgLeLibRgbLsLsmbLiLsbRiRs
mbRgbsbRsbRibRgbRgbRgbRgRiRsmbRgRsRsRsRsmmmmbRgRebRsRsRsmmbLsbRsbLobLs
bLebLebRibRgRgbRgRsRsRsLsRsRsmmmmbRgbsbRgRsRsRsRsmmmmbLsRsbRsRsRsmmbRs
RsmbRsbRibRsRsmbRsRsRsRsRsmmmmbRsRgbRsbRgbLiRsbLcLsmbLebLibLgbLcbLcbRi
bRcbRibRgbLebRjbLhbRsbLjLgbLibRgbRsbLibLsLsLsLgmmbRsRsLsmbRibRcbRgbRgb
RsbRgbRgRsmbRibRibRiRgbRgbLsbRsbLsbLsbLgbsbRsRsRsRsmmmbRsRsmbRgRibRibR
hbLgbRsbRcbLebRgbRgbLcbLgbLibLgLsbLjbLibLcbLiLsbLgbLibLebLsbLgbRsLiLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bLibRsbRobLgbLgbLsbLsbLsbLgbLsbLgbLsbLgbLsbLsbLsbLsbLgbLgbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bRhbRsRsmbRgbRiRsmbLsRsbRgbRsRsmbLsbRsRsmbRsbRsbRsRsmbRsbRsbRgbRgbRsRg
RibRsbLsbRsbRgRgbRgbRsbRgbRgbRsbRibLgbRiRsmbLsbLgbLgbLsbLsbLsLsmbLsbLs
bLgbLsLsmbLsbLsLsmbLsbLhLgLgLsLgbLgbLsLgbLsbLsbRcbRgbRibRsbRsbLsbRsbRs
bRgbRsbRgbRsRsmbRsbRsbLjbLcbLsbLsLsmbRsbLsbLsLsLgmbLibLsbRebRebRsRsmbR
sbLgRsbRsbLsbLgRsLsLsmbLsLsmbRsbLsbLsbRcLsbRsLsbLsRsbRgbLibLsbLsLsmbLs
bLsbLgbRsbLibLibLsbLhbLgbLsbLiLsbLgbLsbLsbRhRsmbRibRsbLsRsbRsbLsbRsbRs
LsbRsRsRsRsmmmbRsRsRsRsRsRsmmmmmbLsbRsRsmbRgbRsbRgbRgRsmbRibLcbLgbLibL
gbLsbLsLgbLgLsbLsLgRsbLgbLsbLsbLsbLsbLhbRsbRgbRsbRhbRgLsbRibRibRsbLsbL
ebLibLebLgbLgbLibRsLsbLibLgLsLsLsLsLsLsmmmmmbLgbLgbLebLgbLebLebLebLibL
ibLgbLgbLhLsbRsbRibLcbLgbLgbLsLsmbRsLsbLsLsmbLsLsLsLsLsRsLsLsLsLsLgmmm
mmmmbLibLsbLsbLsbLsbLgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bLsLsmbLsLsLsLsLsmmmmbRsbLsbLsbLgLsbLsbLgLsLsmbLiLsbLiRsbLsbLsbLiLsbLg
bLgLsbLibLgbRsLsLsmbLsbLgbLgLsLsmbLgLsbLsLsmbRgbLsbLgbLsLsLsLsLsLsmmmm
mbLsLsmbLsbRsbRsbLsLsLsLsLsLsmmmmmbLgLsRsLsLsLsLsLsmmmmbRsLsbLsLsmbLsL
gLsLsLsmmbLgLsLsLsmmbLsLgLsLgbLibLgLsLsmbLgLsbLgLsLsLsLsLsmmmmbLgLsbLs
bLsLsLgLgLsLsmmbLgbLgLsLsmbLgbRsbRsRsmbLgbLgLsLsLsmmbLgbLsLsLsmmbLsLsL
sLsLsmmmmbLibLiLsLsLsLsRsmmmbLgbLgLgbLsLsLsLsLsLsLsmmmmmmbLgLsbRsLsLsL
sLsLsmmmmbLgbLgLsbLgbLebRgbRibReRsmbLsbRgbRsRsmbRsRgRsmbRsRgRsRsRsLsmm
mbRsbRsRsRsLsRsRsRsLsRsRsRsRsRsRsmmmmmmmmmbRsRsRsmmbRgRsmbRsRsRsRsRsmm
mmbRsbRsRsRsRsmmmbLsRsRsmbLgbLsRsbLsbRsbRsbLsbLsbLsbLsbsbLgbLsLsLsLsLs
mmmmbLgLsLsLsLsmmmbsbLsbsbsbsbLgLsLsLsLimmbRsbLsbRebRibRibLgRsbRsbRsbR
sRsRsRsmmmbRsRsRsRsRsmmmmbRsRgRsmbRgRsRsmmbRgRsmbRsLsRsRsRsmmbRgbLgbRs
bLjbRebRsRsmbRsRsRsmmbLsRsLsRsbRsRgRsRsRsLsRsRsLsLsmmmmmbRsRsRsmmbRgRs
RsRgmmbRsRsRsmmbLsRgbRibRebLsbRgbRgRsRsRsmmmbRsRsRsRgRsmmmbRgRsRsmmbRs
RhbRgRgRgRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bRgbRsbRsbLsbRgRsmbRiRsmbRsbRgbRhbRibRgbRsbLsbRsbRsbRsbRsbLgbRsbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bRsbLsLsmbRsRsmbRsRsRsRiRsmmmbLsRsRgLsbRsbRsRsRsRsmmmbRsbRsRsmbRgRsmbR
gReRsmbLebReLsbLcbLiLsLsmbLcbLebLgbRcbRhRsRsRsmmmbRcRsmbLobLcbLibLgLib
LobLibRgbRcRcRsRsmmbReRsmbRcRgbRgbRcbLibLcbLgRsbLiLsbRebLibLgLsbLgbLgb
RjbRjbLibLgbRcbRibRgRsmbRiRsRsmmbReLsbRiRgRsmbRiRsLsmbRibRsRsLsmbRsRsR
gRsRsmmmbRsRsRsRgRgRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmbRsbRsRsRsmmbRsR
smbRibRgRsmbRgLsbRgRsRsmmbLsLsRsmbRsRsRsRsRsmmmmbRgRsRsRsRsRiRsmmmmmbR
hLsbRgRsmbRsRsmbRgRsLsmbRgRsRgRsmmbRsLsRsRsLsmbRgRsRsRsmmmbRebRgbLobLc
RsbLibLgLsbLsbLibLgbRcbRsbLcbLgbLgbRcbRebRibRibLgbLjbLibLibLgbLibRcbRi
bRibRiRgbRgbRiRsmbRibRebRsbLcbLiLsbLgbLgbLgbLibLibLgbLsbRsbLgLsbLgbRsb
LgLsLsmbLgbLibLsLsmbLgbLgbLsbLhbRebLebRgbLgbLgLsbRjbLibLgbRsbLgbLgbLsb
LsbLsbRsbLgbLgLsLsmbLgbLgLsbLgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
bRsRsRsRsRgRsmmmmbRgbRiLsbRgRsmbLibRcbLiLgbLgbLgLsbLgbLgRsLsbRsRcbLhbL
jLsLsmmbRgRsmbRjbRjRsmbLsRsbRsRsmbRsRsRsRsmmmbRgRsmbRgRsRsmmbLsbRiRsmb
LsbRsbRsRsmbRsRsRsmmbRibLsRsbLsbRgbRgRsRsRgmmbRsRsmbRsbRsbRsbLsRsLsbRe
RsmbRsRgbRgRsRimbRgbLiRsbLebRcRsmbRsbRsbRsbRgRsmbRcbLjLsmbLgLsbsbLgLsb
LibRgLsbLjLsLsmmbLgLsLsLsLsmmmbLsLsmbLebRgbRcRsmbRsRsRsRsRsRsRsRsRsRgR
smmmmmmmmmbRgRgRsmbRsRibRcbRcbRibRiRsmbLiLsbLebRebRhbLibRebReRsRsmmbLg
RsbRebRgbRiRsmbRgRebRiRsLsmbRebRiRebRibRibRgbRiRsRsmmbRgbRgbRibRsRgbLs
RsRsLsmbLsbRgRsRsmmbRgRsmbRiRsRsmmbRgbRibRgbRgbRsRsRsmmbRsbLsbRiRsRsmm
bLsRsbLsLsLsmmbLgbLibRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
bRebRsReRsmbRsRsRsmmbRgRgbLsRsbRebLgbLobLcbRcbRibRsbRgbRsRibLiLsbRhbRc
bRibRibLibLibLiLsbLeLsbLgbLgbLgbLibRgbRhRsmbRgLsbLgbLcbLhbLsbLiLsbRsbL
gLsbLibLjRsbLgbRgbLibLgbLibLgbLgLsbRjbRjbRibRgbRgLsbRgbLjLgbLiLgLsbLib
LsbRsLgLeLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bRgRsmbRsbRgbRgbRebLcbLcbRibLhbRjbRhRsRsRsmmmbsbRgRsRsRsRsRsRsRsRsRsmm
mmmmmmmbRsRsRsRsmmmbRcRsmbLgRsbRsbRgRsmbRcbRsRsRsmmbLebRcbLgbRibRiRsmb
RgRsRimbRsbRgRgRgRsmbLgbRebRhbRgRsmbRsRsRsRsRsmmmmbRibLjbRcbRsRhbRcbRs
RsmbRgbReRsmbLsRsRgRsmbRibRiRsmbRibRgbLsbRsbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
bRgLsbRhbRcbLibRhbRibLebLjLsmbLeLsbRgbRibRibRibRibLjbLjbLsbLgbLcbRibLi
bLgbRsbLhbLgbRibRhbRibRibLsbLjbRibLsRsRsLsmbRsRcbRgbLcbLgbLcbLgbLibLgb
LcbLcbLsbLsLsRsmbRjbRhbRsbRibRgbRcbRgbLibRgRsmbRibLibLebLcbLiRsbLgbRcR
smbRsbLjLsmbLgbRsRsLsmbLsbLjRsbLhbLibLibRcRsmbRcbRibRgbRsRibRgbRsbLcbL
iLgbLsRsbLsLsmbLiLsbLiLsbLgLsbLiLgbLhbLsbLjLsRsmbLsbRsRsLsLsmmbLebLjbL
cbRsbLsLsmbLjLcLsmbRjRsmbRgbLsRsbRoRibRiLsbLgbRhRsmbRsRibLcbRgLsbRcbRi
bLobLiLsLsmbLsLsLsLsLsLgmmmmbLgbLgbLcLsLgLsmbLibLib

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
bLeLsbLebLgbLibLibLibLgLiLsbLgbLibLibLgbLgbLgbLgbLgbLsbLibLgbLsbLgbLib
LgbRsbLsbLgbLgbLibLhLsbLibLsLsmbLgbLsbLgbLsbLsbLsbLsbLgbLgbLibLsbLsbLg
bLgLsbLgbLsLsmbLgbLgbLgbLsbLsRsbLsbLsbRsbLsbLgbLsbLsbLgbLsbLsbRsLibLhL
sbLebLgLsLsmbLgbLsbRsbLsbLgbLeLiLsbLiLsbLsbLgbLsbLsbLgLsLibLgbLsbLgbLs
bLsbLsbLgbLsbLgbLgbLsLsmbLsbLsbLsLsmbLsbLsbLsbLsbLsbLsbLsbRsbLgbLsbRsb
LsbLsbLgbLsbLsbRsbLsbLgLsbLsbLgbLsbLsbLsLsmbLsbLsbLgbLsbLgbLgbLsbRsbLg
bLsbLsbLsbLsbLsbLsbLsbLibLsbRsbLsbLsbLgbLsLsmbLsbLsbLsbLsbLsbLsbLsbLgb
LibLgLsbLsbLsbLsRsbLsLgbLsbLgbLsbLgbLsbLsbLsLsmbLsbRsbLsbLsLsmbLsLsmbL
sbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsLsLsmmbLsbLsbLsbLsbLsbLsbLsbLsbLsbLs
bLsbLsbLsbLsbLsbLsbLsbLgLgbLsLsRsLsmbLsLsLsmmbLgbLsbLgbLsLsmbLsbLgRsbL
sbLgLgbLsbLsbLsbLsbLsbLsbLsbLsbLsbRsLsLsRsmbLsLsLsLsLsLsLsLsmmmmmmmbLs
bLsRsbLgbLsLsLsLsLgLsLsmmmmbLsLgLsbLgbLsbLsbLsbLsbLsbLsbLsRsLsbLsbLsbL
sb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bRebRibRgbLjLsmbLsLsLsmmbLibLgbLibLcbLebRgbLiLsbLibLebLgbLgbLgbLibLgbL
gbLgRsbLgbLibLibLiLsbLebRsRsmbLsbLjbLibLibLgbLgbLgbLiLsbLgLsbLgbLibReb
LobLiLsbLgLsbLibLhbLibLibLgbLebLebLgLsbLibLgbLhbLibLibLgLibLibRibRebLg
bLgbLibLibLgRsbLhbLibLgbLebRibRibRgbRibRibRibRibRibRibRgbRhRsmbRibRibL
sbRibRibRiRsmbRgbRgbRgbLsLsmbRgRsmbRibLsLhbLibLgbLibLgLsbLgLsbLsLsmbLi
bLgbLiLsbLiLsbLibRsRsmbRcbRibLjbLhbLibLgbLibRibLsbRebRibRgbRibLsRsbRgR
smbRibRsRiRsRsmmbRibRgbRsbRsRsRsmmbRiRsmbRgRsmbLcbLibLibLibLhbLgRsbLiL
sbRsbRjbRibRgbRibRgRsmbRgbRibRibLgbRibRgbRiRsmbRgbLcbLhLsbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bRgRsmbLebLgbRgbLsbLgbLsbLcbLgbLiLsbLjLsmbLibLsbLsbLsLsLsmmbLsLsLsmmbL
sLsmbLsbLsLgLsbRgbRsRsmbRgbRsbRsbRibRibRgbLsRsbLeLsbRibRibRgRsmbLsbLsL
smbRgRsmbRebRibLhbsbLsLsRsRsRsmmmbRsRebRgbRebRibLsbRgbRiRsmbRgRsmbRgLs
bRgRsmbRibRibRibRgRsmbLgRsbLgbsbLsLsmbLgbRsRsmbLsLsmbLsbLsLsmbLsLsmbRs
LsbLgLsbRjbReRsmbRibRibRsbRhbLsbLgbLsRsbRsbLgbRibRibsbRsRsRsRsRemmmbRg
RsmbLsbRgbRsbRsRsmbRgbRsRsmbRsbRcRsmbLsbLibRgRsmbRgRsmbRibRsLsbRsRgRsR
imbLsRsbRgbRsbRiRsmbRibLibRsbLibRsRgbRsbLsbLjbRgRsRsRsmmmbReRsmbRsbRgL
sbRhbLsLsLsmmbRsbRsLsRsbRgRsRsRsRsRgmmmmbRgbRsRsLsRsmbRsRsRsmmbRgbsbRs
bRgbLsRsbLsRsRsmbRsRgbRsRgRibRsbRgbRgRsmbRgRgbRgbRgbRsbRgbRgRsRsRsmmmb
RgRgRsmbRsRsmbRgbRgbRsRsRsmmbRibRgbRgRsmbLsbRibRgRsmbRgRsRsRgmmbRsRsLs
mbRiRsmbRgbRgbRgbRsRsmbRsRsRsmmbRgbRibLsLsmbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bRibRebRsRsmbRibRgRsRsRsmmmbRsRsRgmbRgbRgbRibRsbRibRgbLsbRgbRgbRsRsmbR
gbRsbRsbRgbLsbRgbRsbLobRgbRgbRsbRsbRsRgbRgbRsbRebRebRgbRibRibRibRsbRgb
RgbLgRsbRsbLsbLsbRsbRgbRsbRcbRsbLsbRsbRjbLsbLebRsbRebLgbRgRgbRgbLsRsbL
sbRibRhbRsbRsbRsbRsbRgbRsbRibRiRsmbRibRgbRsbRebRebRgbRsbRsbRsbRsbRgbRg
bRebRibRsbRsRgbRibRibLgRsbRgbLgbRsbRjbRgbRibRibRsbRgbRgbLsbRibRibRsbRs
bLsRsbRsRsmbRsbRsbRgbRgbLsbRgbRsbRgbRgbRgbRibRgbRibRhbRibRsbRgbRgbRsbR
ibRsbRgbRgbRiLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bRebRibRhbLgbLebLibLibLgbLibLibLibRibLibRsbLjbRgbLsbLgbLgbLibLgbRjbRhb
LjbRibRibRibRibLiLsbLgbLgbRgbRhbRjbRgLsbRibRibLjbLibRsbRsbRsbLibRibLib
LsbRgbRibLibRibLjbRgRsmbRgbLjbRhbRhbLsbRhbLhbLibLsbRibLcbRjbRcbLjbRibL
cbLsbLiLgbLgbLgbRcbRhbRebRebRgbRibReRsmbRsbLibRhbRebRibRiRsmbLibRhRsmb
RsbRibLsbRsbRsbRiRsmbRsRsRsRemmbRcbRebRcRibRgbRcbRebRiRsmbRgRgRsmbRibR
ibRibRibLibLhbLcbLgbLgLsbLibLsbLibLsbLibLibRebRgRsmbRsRsmbRgRsmbRibRib
RsRsmbRibRsbRsbRibRsRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bRsbRgbRgbLgbRoRsmbLsLgbLsbRsRsLimbLgbLibRsbRibRsbRgbRsRsmbRgbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 19; Drug: Control Apo 50 然
bRgbRiRsmbRebRibRebRebRgbRibRgbRiRsmbRebLjbLebLiLgRsbLgbLibLgbLgbLiLsR
sbLgbRsbLibLiLgLsbRsbLiLibRgLsLsmbLcbLiLsbLhbLsbLiLebLiLsbRgbRsRebRgbR
sbRsRsmbRgRsmbRgRgbRsRsmbRgbRhbRgRgbRcRsmbRgbLjbLebLgbLsbLibLgbLibLhbL
gbLebRsbLibLgbLgbLgbRebRhbRgbRibRiRsmbRsRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 20; Drug: Control Apo 50 然
bRgbRsbRgbRibRsbRgbRgbRgbRibRsbRsbRgbRebLobRsbRsbRgbRsbRgbRgbRsbRgbRgb
LjbRebsbRebRgbRgbRebRiRsmbRgbLgbRgbRgbRsbRsbRgbRgbRgbRsbRgbRsbRgbRgbRi
bLsbLsbLgbLibRobLibLgbLsbLsbLsbLgbLsbLibLsbLibLgbLgbLsbLsbRsbLgbLsbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 21; Drug: Control Apo 50 然
bsbRsbRsLsRsLsbRsLsbLsbRsbLsLsmbLsbLsbLsLsmbsbRsbRsbRsbRsbRsbRibRsbLsb
LsbRsbRsbLsbLsbsbsbRsbRsbLsbRsbLgbRsbRsLsbRsbLsbRsbsbRsbsbLsbRsbLsLsmb
RsbsbsbLsbRsbsbsbRsLsbRsbsbRsbLgbRsbLgbRsbRsLsbsbsbLsbsbLsbLsRsLsbLsRs
bRsbRsbRsbRsbRsRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 22; Drug: Control Apo 50 然
bRibRcLsbRebRhbLsbLjbRibRibRcbLsbRsbLsbLsbLgbLsbLibLgbRjbRobLibLhbLebR
ebLsbLjbLebLobRjb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 23; Drug: Control Apo 50 然
bRgbLsbRgbRsbRgRsmbRhbLiRsbLobLibLibLsLsmbLsLsmbLsbLgLsbLgbLgbLgbLgbLi
bRsbLhbRsRsmbLibRsLsbLsLsmbLsbLsLsmbLgbRsLsLsmbLgRsbLgLsLsmbLsbLgLsbLg
bLibLibLgbLsbLsbLsLgbLsLgbLgbLgbLgLsbLgbLgbLgbLiLsbLsbRgbLibRhbRgbRobR
sbLibLibLibLgbLgbRhbReLsbLgbLgbLgbLgRsbLsbLgbLgbLibLibLgbRsbRibRjbRibR
ibRibRebRgbRibRgbRgbRgbRebLjbRibRebRibRcbLgbLiLsbLgbLibLgbLgLsLsmbLibL
gbLgbLgbLgbLsbLsLsmbLibLgbLgbLgbRgbRgbRsRsmbRgbRsbRgbRgbRsbRsbRgRgbRgb
LjbLgbLibLgbLgbLgLsLsLsmmbLgbLgbLgbRjbRibRsbLsbRsbRgbRsRsmbRgbLsbRsRsm
bRsbRgbRgbLcbLgLsbLgbLgbRsbLgbLgLsLsLsmmbRsRsmbLibRsbRsbRsbRgbRgbRibRg
LsbRcbRgbRibLgbRibRibRebLsbRibReRsmbRgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 24; Drug: Control Apo 50 然
bRjbLsbLsbRobRsLsbLsbRsbRsbsbRgbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bRgbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
bLgbLsbLgRsbLsbRibLsbRobLobLgLsbLsbLgbLgbLsLsmbLsbLsLsLsLsmmmbLsLsLsRs
mmbRsbRebRgbRsbRsbRcRsmbLsbLibRibLsRsbRobRsbRcRsRsmmbLcbRibLoRsbLhbRhb
RibRgbLsRsbRsbRsLsbRibRhbReRgbRgRhRsmbLsbRgbRgRsmbLibRob

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bRgbRsbLibLiLsbRsRiRsmbRgbRgbRibRgbLgbRiLsbRibRsbRgbRibRibRgbRibRibRgb
RibRibRibRibRgbRibRibRgbRgbLhbRjbRjbRibRgbLibRjbRebRibRibLibRibLsbRhbL
hbLiLsbLgbLibLibLibLibLibRebRgbRibRibLgbRjbLgLsbLibRgbRibRjbRibLiLsbLi
bLgbLgbLgbLgbRsbLgbLiLsbRsbLibLibLgbLibLibLgbLibLibLgbLhbLibLgbRebRibR
ibRiRsmbRibRibRebRibLcbLibLgbLgbLiLgbLibLibRibLjbLjbRjbRibLjLsLsmmbLcb
LgbRibRgbRgbRibRsRsmbLjbLibLgbRsbLgbLgbLjbRjbRiRsmbRgbRsbRgbRsbRiLsbLe
bRgbLibLibRgbReRsRgmbRgRsmbRibLsbLjbRhbRhbRcbRhbRibRgbRgbRibRibRhbLhbR
sbLibLibLibRgbLgbLsbLgbRiRsmbLgbRibRiRsmbRibRgLsRsbLgbLjLebLgbRjbLiLsb
LgbRsbRgbLhbLgbLebLebLibRibRibRibRibLhbLibLibLgbLsbRcbRibLjbLhbRibLibL
gbLgbRjbLhbLgbLgbLgbRibRhbRibRsbRgbRsbRibRgLsbRsbRcbLibLebLibLsbRjbLgL
sbRjbLsbLgbRibRgLsLsmbLjbLebLibLgbRjbLibLgbLgbLgbRjbRhbRibLibRhbLgbRgb
RibRibRgbRibRibRibRsbRebLcbLibLgbRibRibRibLibLibLgbLcbLibRibLiLibLgbLi
bLgbLebLiLsLibLgbLibRcbLhLsbRjbLebRjRsmbLcbLjLgbRgbLgLsbLgbLsLsLsRsmmb
RjbRcbRibRebRgbRgbRgbRibRibLibLiLsbRiRhbRgbRgbRibRgbLsbRjRgbRibLhbRsbL
sbLgLsbLibLebRgbLibsbRibRebRhbLebRibLsbRibRibLsbRcbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bLsRsbLsRsbLeLsbLibLgbLgbLcbLhLsbLiLsbLiLsbLgbLjLsmbRsbRcRibRcbRgRsmbR
gbRiRsmbRibRgbRsbLebLibLibLgLsbLibLibLeLsbLibLgbLcbLibLibRhbLcRsbRcbRs
bRsLsbRsRsRsmmbRgbRsbRsRsmbRsbRsRsRsRsRsRemmmmbRsRsRgRsRsRgmmmbRsRgbRs
RsRsRemmbRgbRebLobLhbLibLhbRgbRibRhbRcbRebRibRjbRiLsbRgbRiLsbRgLsbLsbR
sRebRibLjLcLibLibLiRsbLibLibLibLibLgbRibRibRiRsmbRebRibLjbLhRsbLibLgbR
ibRobRgbRgRsLsmbLgLsLsRsmbRsbRebLjbLibLibLebLsbLgbLibLgbLsbLcbRsbRjRib
LjLsmbLgLsLsmbLsLsmbLsLsLsLsLsLsLsLemmmmmmbLgbLsLsLsLsLsLgLsLgLgmmmmbL
ebLgLsbRjbRjbRjLsbRibRibRsRsLsmbRiRsmbRgRsRsmmbRgbRsRsRsmmbRebRibLgLgL
sLgLsbLgLsbRsLsLsLsLsLsLsLsLemmmmmmbLebRebRgbLjbRjbRsRsRsRsRsRsRsRsRgR
sRsmmmmmmmmmbRsRsRsRgRsRsmmmmbLgRsRgRsRsmmbLsRgRgReRibRsbsbLsbRgRsRsRs
RgRsRsmmmmmbRgRibRibReRsmbRsRsmbLjbLjbLcbLhbLiRsLsRsbLhbLgbLsbLcbRsbLh
LsLsmbLibLibLcbLjbLhbRsbLiLsbRibRsRsRsRsRsmmmmbRsbLsRsbRsRsRsmmbRsRsRs
RsmmmbRsRsmbRjbLsbRebRibLiLsLsmbLhRsbLgLgbLsbLsLsLgLsLgmbLsLgLgLgbLsLs
LsLsLsLsmmmmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
bRebRsRsRsmmbRgbLobLgbLobLebRgbRcbRcbLeLsbLiLsbLebLibLsbRibRgbRiLsbRgb
ReRgbRhbRcbLobLobLgbLibLsbLibLsbLsbLgbLsbRsbLsbLgbLcbLgbLgbLsbLsbLgbLs
bLsbLibRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bRsbLgLsbRcbRibLsLsmbRgLjbLjbRjbLjbLgLgLsbLebLgbLsbLsbLibRobRsLsbLebLg
RsbRsbLibRsLsbLgLsbLibLgbLsbsbLibLeLsbLibLsbLibLgbLibLgbLgLsbLsbRsbLib
LgbLsbLsbLsRsbLjbLsbRsbLibRsbLsbLgRsbLibLgbLibLgbRibRjbLjbLebLgbLsbLgb
LgbLsLsmbLibLgbLgbLgbLgbLeLsbLibLcbLcbRibLsbRgbRgLsbRibLgbRsbLgbRsbRgb
RgbRgbRgbsbRgbRgbRsbRgbLsRsbRebLsbRsbLsbRgRsRsmmbRsbRsbLsbLsbRsbRibRib
RgbRgbRhbLsbLsbRsbLsLsmbLibLibLgbLibLebLsbRsbsbLgbRibLcbLsbLhbLiLsbLgb
RgLsbLebLiLsbLibLebLhbLgbLgbLiLsbLibLebLsbLsbLsbLsbLsbLhbLgLsbLhbLibLg
bRsbLgbLebLgbLgbRgbLcbLebLgbLibLgbLeLsbLsbsbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bLsbLsbLsLsmbLgLsbLsbLsbLsLgLibLsbLsbLiLsbLgbLibLobLcbLebLcbLgLsbLgbLo
LsmbRibLhbLeLsbLibLhbLgbLgbRsbRhbRobLsbRhbRgbLsbRgbRcbRiLgbLhLsbLiLgbL
ibLhbLsbRobReRgbRibRhbRsbRoLsbRsLibLobLgbLhbRjRsmbRibLsRsLsbRsRsRsRsRg
mmmbRsbRsRsRhmbRgbRgRsmbRsbRsRsRimbRsbRgRsmbLsRsbsbRsRgRsRsRsRsmmmmbRs
bRsRsRimbRsbRsbRsRsRgmbRsbRsRsRgRgRimbRsRsRembRsRsLsmbRsbsbRsRsmbRsbRs
bRsbRsbRsbRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bLebLgbLgLgbLsbLebLgLiRsbLhbLibLhLsbLhLsbLsLsLgLsmbLebLibLebLiLhbLebLi
bLebLgbLhLibLibLsbLhLsbLebLhbLibLsbLebLhLsbLgLsbLeLsbLgLsbLebLebLeLsbL
ibLebLebLeLsbLebLeLsbLhbLebLgbLiLsbLiLsbLcbLcbLebLgLsbLsLsmbLibLgLibLe
bLibLebLebLebLgbLhbLgbLgLgbLibLsbLibLebLibLebLebLhbLhbLiLsbLebLebLeLsb
LebLebLebLeLsbLeLsbLeLsbLibLebLeLsbLeLsbLebLebLeLsbLiLsLsmbLeRsbLeLsbL
ebLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bRgbRgbRobLsbRgbRgbLsbRgbRgbRgbRibRgbRsbRsbRibRgbRgbRsbRsbRgbRibRgbRsR
smbRibRgbRgbRsbRsbRsbLobLiRsbRibLgbLsbLsbLgbLgbLgbLgbLsbLibLsbLgLsbLgb
LsbLibLgbRsbLgbLgbLgLsbLsLsmbLsbLgbLsbLgbLgbRcbRgbLebLobRoRsmbLibRsRgb
RsbRsbRgbLgbRjbRgbRgbRgbRibLgbLcbLebLsbLsLsmbRobRsLsLsLgmbLgbLibLgbLgL
sRsLsbLgLsLsmbLiLgbLgbRsbLgLsLsLsLsmmmbLgLsLsmbLsLgLsRsLsbLiLsLsLsmmbL
sLsmbLsLsLsLgLsmmbLgLsbLgLsLsmbLgLsLsmbLsbLsLsmbLebRoLcbLiLsbLebLibLsb
LsbLsbLgbRsbRsbLsbLsbRsbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bRebLsbLsbLsLsLsLsmmmbLsbLsLsLsmmbLibLsLsmbLiLsbLsbLsRsLsLsmbLgLsbLibL
gbLsLsmbRcbRobRsbRebRhbRsRsmbRgbRebRibLibLgbLibLgbLibLiLsbLgbLsbLgbLsL
smbLgbLeLsbLgbLibLgbLibLgbLeLsbLebRsbLgbLibLibRgbRebRibRgbRsbRebLgbLhb
RgbRibRgbLoLcbRebRgbLsbRiRsmbRgbLobLgLsbRebRebLsbLibLiRobLgbLsRsbRgbRo
bRebLsRhbLsbRcbReRsRgRsmmbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bLsLsLsLsLsLsLsLemmmmmmbLhbLsbLsbLgbLobLgbRsbLibLibLgLgLsLgbLgbLgbLsLs
LsRsmmbLsLsLsLsLsmmmmbLsbLgbLgbLibRgbLgbRsbRsLsbLgLibLgbLsbLgLsbLsLsLs
LsLemmmbLiLsbLebLibLebLibLcbRgbLhbLibLgbLgLsbLibLibLgLgLsLsmbLsLsLgLsm
bLebLibLiLsbLiLsbLgbLhbLgLsLsmbLgLsbLsLsLiLsmbLebLibLgLebLhbLibLgbLsLs
LsmmbLgLsbLgbLsLeLibLibRsLsbLgLsbLgbLibLgbLsLsmbLsLebLsbLgRsbLiLsbLebL
ebLibLibLsLsmbLibLebRsbLibLgbLsLsLsmmbLsLgbLibLsbLsLsLgLgmbLibLsbLebLs
bLgbLsbLsLibLibLgbLgLgbLgbLgbLsLsLsmmbLsbLsLgbLsbLsLsmbLibLsLsLgmbLgLs
bRsLsbLibLib

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bLsbLsbRhbLcbRjbRgbLjbRjbLcLsmbRcbRibLcbLebRjbLibRjbRcbRibRibLcbLgbLcb
RibLhLsbLiLsbLcbRebRhbLsRiLsRsbRibRgbRgbRiRgbRibReLsbLcbLcLsmbLebLgbLh
bLgbRsbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bRebLgbsbsbRebLibLibLsbReRsmbRebRgbRibRgbRebRgRsmbRebRebRibRibRiRsRgRi
RsRsmmmbRiRsmbRebRebRgbRebRgbRebRebRgbLsLsmbRcbRsbLgLsbReRiRsmbRibRgRs
mbReLsbRebLsbRsRibRibRebRgbRebRebRebRgbRgLsbRgbRhbLgbLsLsmbRgRsRgRsmmb
RsReRsmbRgbLsRiRsRgmbRebReRsmbRibRgRsmbRebRibRgbRgbRebRibRgbRebRgbRebR
gbRgbRgbRsRgbReRsmbRibRebRebRibRibRsbRgbRebRebRgbRibRgRsmbRibRebRibRhR
smbRebRhbRiRsmbRibRebRebRiLsbRsbRebRgRsmbReLsbRhRibLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bRsbRsRsmbRsRsRsRsRgRsmmmmbRgRsRsRsmmmbRgRsmbLsRsRsRsRsRsRsRgRsRsmmmmm
mmbLsRsbsbRgRsmbLsRsLsbRibRgbLobLgRsbLgbLgRsbLibLoRsbLgLsbRcbRgbRgbLsL
smbRhbRiRsmbLhbLeRsbLgbLiRsbRsbLibLcbLgRsbRsbRiRsmbRgbRgbRibRsbRgbRgbR
gbRibRiLsbRgbLcbLhLsbLibLgbLgbLibRgbLibRsbRcbRgbRsRsmbRgLsbRsbLsbRsbLg
bLgLsLsLsmmbLsbRsbLibLiLsbLgLsLsmbLsLsLsLsLsLgmmmmbLiLsbLibLsLsLsLsLim
mmbLgbLgbLobRsbRhbRibRiRsmbRhbRgRsmbRgbRibRibRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
bRjbRobRsRgRsmbRebRgRsmbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bLsbLsbLsbLsbLebRsbLibLobLeRobLsbRsbLsLsmbLsbRjbRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
bRhbRsbRsbRsbRsbRsbLsbRcbRsbLsbLsbRsbLsbRsbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 43; Drug: Control Apo 50 然
bRgbRgbRgbRgbRebRibRgbRsbRebRsbRibLibLgbLibLgbLsbLibRebLgbLebLebLgbLib
LgbLsbRgbRsbLgbLibLgbLibLgbRsbRgbRcRibRgRsmbRibRibRibRebRgbRebRgRsmbRi
bRibRibRgbRibRgbRgbRsbRiRsRsmmbRgRebRibLebLsbLebLeLsbLiLgbLsLebLgbLebL
sLsLgLsmbLgbLgbRebRhbRibRgbRibRebRibRibRibRibRibRibRgbRhbRebRibLibRebR
gbRgbRibRibRsRsmbRiRgbRgRsmbRgRsmbRgbRgbRsbRebLsbRiRsmbRgbRebRibRebLib
LsbRsRsmbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 44; Drug: Control Apo 50 然
bLgbLibRsbLgbLcbRgbLgbLcbLiLsRsbLsbRsbRibRhbRgRsmbRgRsmbRibRgbRsbRsRsR
smmbRgbRsRsRsmmbRibRibRiRsRsmmbRebRiRsmbRgRsLsmbRsbRsbRgRsmbRebRiRgbRs
RgbRgbRibRebRgbRhbRgbRebRgbLsbReRsmbRibRsRgbRgbRgbRibRebRibRgbRsbRgbLc
b

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 45; Drug: Control Apo 50 然
bRgRgRsRsRsmmmbRsbLiLsLsmbLgbLsRsLsRsLsbReRsRsmmbReLsbRobRsRsmbRcbLibR
iRsRsRsRsLsLsmmmmmbLeLsbLebLibRjbRhRsmbLsRsbRobRibLcbLcbLcbRcbRiRsmbRi
bLjbLcbLibRcRsmbRibRcbRgbLebLcbLgbRjRsRsmmbRiRsmbRhbRgbRcbRobLhLsLsmbR
gRsmbLsLsmbRiRsRsmmbLsLcbsbRgbRiRsRsRsRsRsRsmmmmmmbRgRsmbRsbRsRsRsRsmm
mbRgbRsRsRsRsRsRsRsRsmmmmmmmbLsbRhbLcbLcRsbLebReRsRsRsmmmbLebLcbReRsmb
LebLeLsbRibRcRsRsRsRsmmmmbRcbLibLebRsRsmbLeLsLsmbLiRsbRhRsRsmmbLgbLobL
cbRgRsmbReRsRsmmbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 46; Drug: Control Apo 50 然
bRhbRsbRsbRgbRsRhRsmbRebLgbRibRsbRgbLibRebRsbRgbLsbRibRgbRgbRgbRsbRgbL
sbRibRsbRgbRebLcbRsbRhbRgbRsbRsbLgbRiRgbRsbLsbRsRgbRgbRgbRgbRgbRgbRsbR
gbLsbRhbRsbRibRhbLgbRibRgbRsbRgbRsRsmbRgbLsbRgbRsRsmbRibRsbRiRsmbRhbRi
bRgbRibRibRsRsmbRsbRgbLgbLobLgbRsbLgbLiLsbRsbLibLsbLsbLgbLgLsbLsbLibLg
bRgbLjbLjbLgbLsbLsLsmbLsbLgbRjbLebRgbRiRsmbRibRsbRgbLsbRgbRsbRsbRgbRsb
RsbRsbRgbRgbRibLsRhRsmbLgbRibRgbLsbRibRsbRgbLgbRgbRgbRsbRgbRibLgbRgbRg
bLsbRgbRibRibRibReb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 47; Drug: Control Apo 50 然
bLibLgLgbsbLsLsLsmmbLgbLibLsbLhLsbLsLsmbLgbLsbLsLsLsmmbLgbLgLgbLsLsmbL
sLsmbLiLsbLgbLhbLebLgbLgLsbLgbLibLibLgbLiRsbLsbLsbLebLsLsmbLsLsLsmmbLs
LsRsmbLgbLgbLgbLibLsbLgbLibLgRsbLibLsLsmbLsLsmbLgbLsLsmbRsLsLsmbLsbLgb
LibLhbLsbRsbLsLsmbLgbLgLsbLsbLsLsLsmmbLgbLgbLsbLsbLgLsbLsbLebLibLgbLgb
LgbLibLgbLsbLsbLsbLsbLsRsbLgbLsbLsbLsLsmbLgbLsbLgbLsLsmbLsLsLsmmbLgbLg
bLgbLgbLgbLgbLibLgbLsbLsLsmbLsbLsbLgLsbLibLgbLgbLsLgbRsbLgLsbLgbLgbLeb
LgLsLsmbLgbLsLgbLgLebLgbLgbLgbLsbLgbLgbLibLgbLsbLgbLcbRgbRgbRsbRgbRgbR
gbRgRsmbRsbLobLsbLibRgbLcbLiLsbLhLsbLiRsbLjLcLsmbLeLsbLiLsbLgbLsbLeLsb
LsbLgLsbLiLsbLgLsbLibLgbLgbLgbLsbLsLsmbLgbLgbLsbLgbLsLsmbLgRsbRsbLjLgb
RgbLebLgbLsLsRsmbLsbLsLsmbRsbLgbLsLgLsbLibLgLsbLgbLgbLibLgbLiLsbLgbLgb
LgbLibLsbLsbLsbLsLsmbLsbRsbLsbLsRsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLgbLsbRs
bLsbRsbLsbLsbLsLsmbLsbLsbLsbLsbLsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123430; End: 123930;
Recording: 10-1; Individual: 48; Drug: Control Apo 50 然
bLsLsLsmmbLeLsbLeLsbLcbLebLcLsLsmmbLcbLjLibLebLebLebLebLebLebLgLsbLebL
ebLebLibLebLgLgbLhLsbLsLebLebLebLebRgbRsbLcbLebLeLebRsbRsLsbLebLgbLibL
ebLebLeLgbLebLebLebLibLibLibRsbRibRgbLhLsbLibLhbLebLibLebLeLsbLsbLgbLi
bLibLgbLibLibLebLgbLebLeRsbLsLebLibLibLgLgbLibLgLsbLibLebLebLgbRgbLebL
sbLibLebLibLsRibLebLibLibLgbLibLhbLibLhLsbRsbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
bLibLsbRebLgbRebLeLsbLcbLhbLibLsLhbLibLsbLibLhbLsLsLimbLgbLibLgbLgbLgb
LibLibLibRcbRibRgbRibRgbRibLjbLcbLeLgLsLgLgbLsbLgbLgLsbRsLgbLgbLsLsmbL
gbLgLsbRgbLhbRibLoLiLsbRebRiLsbRibRebLsRgRsmbRsRsRsRemmbLcbRoLsLsmbLgb
LibLjLgbLcbRgbRsbLjbLgbLgbLsbRibLsLjbRibRgbRsRsmbRibRcbLibRgbRibRibRib
RgbLibLcbLgbLgbLgbLgbLgLgLsbLgbLgbLebRjbLgbLebLsbLiLsbLjLsmbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bRebRebRebRebLibLoLsmbLsbLgbLsbRsbRgbLsbRsbLsbLsLibLgbLibLgbLibLgbLgbL
sbLgbLsbLsbLgbLsLgbLgbLgbLibLgbRsLsbLgbLebLibLcRgbsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bLsLgbLiRsLsRsbRobRobRibLibRsbLobRoRsmbRjbLcbLibLsbLgRsbLcLsmbLgbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bRgbRgbRsbLsbRsRsmbLsbRgbRsbRsbRsbLsbRsbLsbLsbRsbRsbRsbRsbRsbLsRsbRsbR
cLgbLebRgbLsbLsbLsbLsLsmbLgbLsbLsbLsbLgbLsbLsLsmbLgbLsbRsbLsbLsbLobLsb
RjbLobLebLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bRsbLsbLhbLsLsmbLsLsLsLgLsLsLsLsmmmmmbLgLsLgbLgLsLgLsLsmbLibRcbRibRgbR
gbLsbRgbRgbRgbsbLsbRgbRgbRsbRsRsmbRsRsmbRsLsRsbRsbRgbRiRsmbRgbLgbRiRsm
bLsbRgbRiRsmbLsbRgRgbRsbRsbRsRsmbRsRsmbRsbRsbRgLsbRsbRsbRsbRsbLsbLsbRg
bRibRibLsbLsRsbRibRsbRibLsLsmbLgbLgbLgbLsbRsLsbLgbLsbLsbLgbLgbLgbRcbRi
bRgbRgbRgbLsRsbRsbRgbRsRgbRebRsbLsbLhbLcbLsRsbLgbRsbRsRsmbRsRgRsmbLjbR
obLhbLibLcbLcLsmbLsbLhbRobRibRcbRebRebRcbRgbRgLsbReRebLsbRibLsRsbRsbRs
bRsbRsRsmbRgbRsbRgbRsbLcbLgbLgbLgbRgRsmbLsbLhbLsbLsbLgbLgbRsbRsbLsbLgL
sbRsbLsbLibLgLgLgbLibRsLsbRebRgbRhbRsbLsLsmbLjbRgbRsbRgbRsRsRsRsRgmmmb
RiRsmbRebRcbLsbLcbLgbLsbRsbLgbLgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bRgRsRsmmbRsRgRsRsRsRsRsRsRgmmmmmmbRsRiRsmbRebRgRsmbReRsmbRiRhRsmbRebR
iRiRsLsmbRebRibRibLsRsbRgbRebRibRiRsmbRsbRgbRibReRsmbRiRsmbRibRgRgbReR
smbRhbRebRebReRibRebRibRebReRsmbReLsbLsReRsmbRebReRhbRebRgRhbReRsmbRiR
smbReRsmbRebRebRsbRebReRsmbRhbRebRebRebRibRibRibRgbRibRiRsmbRebRgbRibR
hbReRsmbRibRhRsmbRgbRebRhLsbRhbReRsmbRsbLsbRsbRhRsmbRhbRsbRibRebRibRhb
RibReRsRsmmbRebRebRibRebRibRsRsRembRebReLsbRebRsbRibRibRibRibRgRsmbRsR
ebRgbRgbRsbRibRgbRsbRibRibLgRgbRibRibRiLsbRiRsmbRibRgbRsRsRsmmbRgbRhLs
bRebRgbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bRjbLoRsbLibLibLsbLsbLgbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bLibRsRsmbsbLsbLsbLsbLebLebLibLgRsbLsLsmbLgbLgbLgbLgbLsbLibLibLgbLsbLs
RsbLiRsbLibLibLibLgbLiLsbRgLsbLgLsbRgbLebLgbLsbLsRsbLsbLsbsbRsbRsbLsbL
gbLsbLsLsmbLsbLgbLgbLsLsmbLsbLsbLsbLsbRsbLgLsbRsbLsbLsbLsbLsbLsbLsbLgb
LsbLgbLsbLsbLsbLsbLgbLsbLibRjbLjbLibLsbLsbLgbRsbRsbLsbRgbLsbLsbRsbRsbL
gbRgbLsbLsbRjbLjbLgbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
bLhbLgLsLsLgmbLgLsbRcbRhRsRsmmbRcbLebLgLgLsLsmbLsLsmbLgbRsbLsbLgLsbRsL
sLsmbLgbLsbLsbLiRsLgLsbRsLsbLsbLiLsbLiLsbRgLsbLhbLgLsbLiRsRsmbLsRsbLgL
sbLsbLgLsbsbRjRcbLsbLjbLebLsbRjbLhLsbLiRsbRgbReRsmbRhRsmbLsRgbRgbRebRs
RsRsRsRgmmmbRebRgRsRsRsmmmbRsbRsRsRsRsmmmbLgRsbRsRgRgbLsbLeLsLsLsmmbRc
RsmbRsRsRgRgRsmmbRgRsmbRsRiLsbRibRgRsRsmmbRgRsmbLsRsbRgbLsRsRgRsmbRiRg
bRsRebRjRgbRgRsRsmmbRebRsbRsRhRsmbRgRsmbRsRsRsRgRsRsmmmmbRebRibRgRsRsR
sRsRsRsRsmmmmmmmbLsRgRsLsRsRsRsRsmmmmbLsRsRiRsmbRsRsRgmbRiRsmbRgRsRsRi
RsRsmmmmbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
bRsbRsLsLsLsmmbLeLsbRsbRcRsmbRibRibRhbLsbRibRgRsmbRsRsmbLsLcbLebLsLeRs
bLebLeLsbRsbRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bLsbReRsmbRebRcRsmbLsbLsLsmbRsLsbsbRsbRsRsmbRsRsRsmmbRsRsmbRsbRsRsmbRs
RsmbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
bLsbLsLsmbLgbLibRgLsRsLsbLjLsLgmbLcbRgRsmbLjbLiLsLgLgLsbLhRsbLcbLhbLgL
sbLgLsbRgRsmbLgbLcbLibLoLsmbRsbLibRsbLgbLgbLibLiLsbLsRsLsbLgLsbLgbLgLs
LsmbLgbLsLsmbLibLcbLobRhbLcLsLsmmbLsbLsLsRsmbRsLsLsLsLsLsmmmmbRsLsbsbL
sLsLsLsmmmbLsLsLsmmbLsbLibLsbLiLsbLsbRobLebLsLsmbLsLsmbLsLsLsRsmmbLsLs
LsLsLsLsLsLsLsLsLsLsLsRsmmmmmmmmmmmmbLsbLgLsbRsbLibRgbRobRibRsbRgRsRsR
smmmbLsbRsbRsRiRiRsRsmmbRsRsRsRsmmmbRsLsbLsRsRsmbRsbLcbLhbLhbRsbRjbRjR
gRsRsRsRsRsRgmmmmmbLsRsRgbLjbLcbLsbRibLgbLgLsLsmbLsLsLsLsmmmbLsbLsLsLs
LsLsLsmmmmmbsbLsLsLsLsLsLsLgLsLsLsLsLsLsmmmmmmmmmmbLsLgLgbLhLsbLebLsbL
sbRsRgRsmbRsRgRsRsRsmmmbLsLjbRjbLsLsLsmmbLsLsLsLsmmmbLsbLsRsbLgLsbLjbL
ibLobRebRhbRibRiRsmbRibRibRoRsmbLjbLebLebLgLibLib

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
bLsbLsbLsbLsbLsbRsLsbLsbLsbLsbLsbRsLsLsLsLsmmmbLsLsmbLsbLsbLsbLsbRsLsb
LsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbLsbRsbLsRsbLsbLsbRsbLsLsmbLsbLsbLgbLs
bRsbLsbLsbLsbLsbLsbLsbRsLsbLsbLsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsLsmbL
sbLsbLsbRsbLsbLsbLsbLsbLsbLsRsbLsbLsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLsbLsb
LsbLsbLsLsmbLsbLsbLsLsmbLsLsmbLsbLsbLsbLsbLsbLgbLsbLsbLsbRsbLsbLsbRsRs
mbLsbLsbLgbLsbLsLsmbRsbLsbLsbLsLsmbLsbLsLgLsRsbLsLgbLgbLgLsbLsbLsbLsbR
sbLsLsmbLibLsLsLsLgLsLsmmmbLsbLgbLgbLsLsmbLgbLsbLsbLibLgbLsbLsbLsbLgbL
gbLgbLsbLgbLgbLibLibLgbLsbLsbLgbLsbLsbLgbLgbLgbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bLgbLgbLgbRgRsmbLsLiLsLiLsbLibRsbRjbRhbRibRgRsmbRgbRibRgRsmbRsbRsRsRsm
mbRsRsmbRiRsmbRibLjbLebLebLgbLibLgbLgbLgbLgbLgLsLsLgLsLsmmbLgbLgbLibLi
bLibLgbLiLsbLebLeLsbLgbLgbLhLsbLgbLsbLibLsbLibLsRsbLgbLiLsbLibLibLsbLg
LsbLibLibLiLsbLhbLibLgbLgbLgRsbLsbLgbLsbLgbLibLsLsLsLsmmmbLgLsbLibLgbL
ibLibRsLsbLgLgbLibLgbLsbLsbRjbLibLibLgbLgbLiLsbLgbLgLgLsbLibLgbLiLsbLs
bLibLibLibLgLsLgLsRsbLgbLsbLsbLibLibsbLgLgbLgLsbLgbLgbLiLebRgbLgbRjbRg
bRgRsmbRibRibLsbRsRibLsbLibLebLebLibLgbLsbLsLgbLeLsbLibLibLebLgLsbRgbR
ebLsbRibLibLibRsbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bRsbRsbRsbLsbRgbRsbRiRsmbRibRgbRgRsmbRsRsmbRsRgbRsbRibRsbRgbRsRibRibRi
RsmbRsRsRgmbRgbRgRsmbRgLsbRsRsRsmmbRgbRgRgbRgbRgbRgbRgbRgbRsbRgbRsRsRh
mbRsRsmbRibRgbRgbRgbRgbRebLsbRsRsmbRiRsmbRibRgbRsbRgbRsbRsbRebRsbRsbRg
bRibLsbRibRibRgLsbRibRgbRsbRgbLsRsRsRsRgmmbRsbRsbRsbRsbRsbRgbRiRsmbRsR
sRimbRsbRsbRsbRgbRsbRgbRsRsmbRiRsRsmmbRgbRgbRibRsbRgbRgbRsRsLsmbRiRsmb
LsbRgRibRsbRgbRsbLsbRebRgbRgbRsRsRgmbRsRsmbRgbRgbLsLsmbRgRibRsbRhbRsbL
sbRgbRibLsbRiRsRsRsmmmbRgRsmbRgbRgbRsbRsRsRsmmbLsRebRibRgbRsRsmbRgbRgb
RsbRsbRsbRsbRiRsRsRgmmbRsbRgbRgbRsRgbRsbRsRsRsmmbRibLsRsbRgbRsbRsRsRgR
gmbRsbRsRsRimbRibLsbRgbRsbRibRsbRgbRsbRgbRsbRsRgbRsbRgbRgbRgbLsbRsbRsb
RibRsbRsbRgbRsbRsbRibRsbRgRsmbRsLsbRsRsmbLsbLsRsbLsbRsbRsbRebRsbRsbRgb
RsbRsbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bRsbRsbRsbRibRsbLobRsbLgbLsbLgbLgbLgLsbLibLgbsbLgbLgLgLsbLiLebRsbLgbLg
LhbLsLgbLsbLsbLebLgLgRsbLebLiLhbLebLgbLgbLsLsmbLsbLsbLsbLsLsmbLsbLsbLs
bLsbLsbLgbLsbLgbLsbLsbLsbLgbLsbLsbLgLiLsbLibLgbLsbLsbLsbRebRgbRgbRgbRg
bRsbLsbRcbRhbRibRsbRgbRibLsbLgbRhbLgbRhbLobRsbRsbRgbLobRobRsbLsbLsbLgb
LgbLgbLibLgLiLsbLebLsbLhRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bRsbRgRsmbRgRsRsmmbRgRgRsmbRibRgbRsbLsLibRjbRibRhbRsbRsbRibRgbRgbRiRsm
bRhbReReReRsmbRgRsmbRsLsbRebReLsbRgbRsbReRgbLhLebLsbLsbRsbLsbLibLibLgL
sbLibLsbRibReRsmbRsRsRgRgRsmmbRiRsmbRebsbRsRsRsLsmmbRsbRsRsRimbLsbRibL
jbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bLcbLgbLsbLsbLgbLsbRobLcb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 19; Drug: Control Apo 50 然
bRsLsbRcRsmbLiLsLibLgbLgbRjbRhbRsRgbRibRibRgbRgbRsRgbRhbLgbLibLibLhbRs
bRcRsmbRsRibRgRsmbRsRsmbRibRgbRgbRsbRibRibRgbRebRibRgbRebRiLsbRibRgbRg
bLsbRsbRgbLsbLcLgbRgRsmbRebLsbRgbLgbRibRebRgbLgbLgbLgbLgbLgbLibLgbLgbL
gbLibRsbLibLsbLcbLgbLgbLgbLgbRhbRibRgbRibRsbRibRgbRsbRsbRobLgbLebLebLi
bLgbRsbLgbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 20; Drug: Control Apo 50 然
bLsbLsbLgbRsbLsbRsbLsbRsbLgbLgbLgbLsbLsbRsbLsbRsbLsbRsbLsbLsbLsbLsbRsb
LsbLsbLsbLsbLsbRsbRsbLsbLgbLsbLgbLsbRsbLsbRsbLsbLsbLgbRsbLsbLsbRsbLsbR
sbRsbLjbLsbLjbLsbLibRsbLsbRibReRsmbRgbRibRsbRgbRibRgbRiRsmbLjbRgbLgbRg
b

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 21; Drug: Control Apo 50 然
bRsbsbsbRsbRsbRebRsbRgbRcbLsLsmbRobRcbLebLebLsLibLgbRebRobRcbRoRsmbRsR
sRsmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 22; Drug: Control Apo 50 然
bRgbRgbRsbLsbLgbLsbLgbRgbRsbRsbRgbLsbRgRsRsLsRsmmbRebRjbRjbRjbRsbLsbLs
bRsbsbRsLsbRsbsbRebLjbLgbLsbLsbRgLsbLebRobRsbLsRgbRsbRibRsbRgbRgbRebLe
LsbLsbRsRsRgRimbRsRsmbRgbRebLgRsbRsRsRsmmbLsbLobRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 23; Drug: Control Apo 50 然
bLsbLgRsbRsbRgRsmbRsbLsRsbRgbRgbRcbRgbRgbRibLgbRsLsbRsbLhbLibLgbLibLib
LgLsbLsbLgbLgbLsbLsLsLgRsLsmbRsLsLsmbLgbLibRebRebRiRsmbRsbRgRgbLsRsbRg
bRsbLsbRgbRgbRgbLjbLibLiLsbLgbLsLibLgbLgbLibLibLibLsbLgLsRsbLgbLgbLsbL
sbLgLsbLsLsmbLgbLsbRebRsbRibRhbRgbRhbRebRgbLsbLgbLsbLgLgbLsbLsLsLsLsLs
RsmmmmbLgbLsbLgbLgbLgbRjbRcbRiRsmbRgbRgRsmbRgbRsRsmbRgbLsbRgbLsRsbRgbR
gbLjbRcbLibLgLsbLibLsbLgbLgbLgbLsbRgbLibLgbRsbLgbLgbLsbLsbRsbLgLsLsmbL
gbLgbLsbLgLsLsmbLsbLgLsbLgbLgbRibRebReb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 24; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bRsbRsLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
bRhbRiRsRsRsmmmbRsbRibRibReRiRsRsmmbRgRsmbLsbRgbRgbRsbRgbRsbRsRibRsbRs
bRsbRgbRsbRsbsbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bRsRsmbRiRsmbRsbRgbRgbRgbLjbLcbLibRsLgbRebLibLiLsbRjbRcbRgRsRsmmbLcbRg
RsmbLibRibRiRsRgmbRibRgbRebRebRebRsbRsbRiRsmbRgbRgbRcbLgbLiRsbRjbRhbLi
bLgbLgbLgbLgbRgbLibLibRibRibLibLibRsRcbRibRgbRgbRibRsbRibRgbLibRibRgbL
gbRiRsmbRsbRsbRsLsbRsRibRibRibRibRgbRjLsbRsbsbRgRsmbRgRsRsmmbRsRsmbRiR
ebRibRhbRgbLgbRjbRibRjRsmbRibRibRibLibLgbRibLgbRgbRibRgbLsLsmbRiRibReb
RgbRgbRgbRgbLiRsbLgbLsbLgbLebLibLibRebRebRgbRibLgbLibLhLsLsLgLgmbLgLgb
RgLgbLebRjbRjbRcbRebLhbLibLiLsbLgbRhbRibRcbLgbRsRsmbLgLsLsmbRhbLsLsmbL
sbLsLsLsLsmmmbLibLiLiLsLsmbLebLgbLgbRsLsLsLsLsLsmmmmbLsLibLiLsLsmbRobL
ibLibRibRhbLiLsbLsLsLsmmbLsLgLsbLibLgLsbLibLsbLgbLgbLgbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bLsLsLsLsLsLsLemmmmmbLsLsLsLsLsLsLsLsLsLsLsLsLsLsLgLiLsmmmmmmmmmmmmmbL
sLsLsLsmmmbLgLsLsLgmbRsLsLgbLgLsLgLsbLsLsLiLgLembRsLsLsLsLsmmmbLsLsmbL
sbLsLsLgmbLgLsLsLsLsLsmmmmbLgLsbLgRsbLsbLsLsLsLsLsLsLiLsLsLgLgRsmmmmmm
bLsLsLsLsLsLsLsLsLgLsLsLsLsLsmmmmmmmmmmmbLsLsLsLgLsmmbLgLsLsLgLsmbLsLs
LgLgLsLgmbRsLsLsLsLsLsLsLsLemmmmmmbLgbLsbLgLsLsLsLsLsLsmmmmmbLsLgLgbLs
LhbLsLsLsLsLsLsLsLsmmmmmmmbLsLsmbLebLibLebLgbLibLgLsLsmbLobLhbLebLiLgb
RjbRibRibRibRgbRibRibReLsbRibLhbLibLgbLsbLgbLgLsLsmbLsLsmbLsLsmbLsbLiL
ibLsbLebLsLsmbLgbRsbRjbRhRsmbRibRiLgbLibLgbLhbRebRibLsbRibLsbLiLsbLibL
sbLsbLsLsLsmmbLsbLsLsLsLsLsLsLgLsmmmmmbLiLsbLgLsLsLsLgLsmmbLsLibLsRsLs
LsLsmmbLsbLsLsLgLsLeLsLsmmbLiLsLiLsLsLsmmbLsLsLgLsLsLsLgLsLgmmmbLibLsL
sLsLsLsLsLsLimmmmmmbLgLgLgLsbLibLsLsmbLsLsLsLsmmmbLsLgLsbLsLsLsLsLgLsm
mmbLsLsRsmbLeLibLgbLsLgbLsLgLeLsLebLgLsbLebLhbLgLsbLhbLebLibRsbLsbLebL
jbLibLiLgbLhbLcbLibLgLsbRgbRgRsRsmmbRjLsbRgRsLsmbLgbLebLebLiLibLiLsLiL
sLeLebLgbLgLsbLsbLsbLsbLsLgLsbLsbLibLiLgbLeLsbRgbLgLsbRibLgRsRsmbRsRgb
RcbRgbRibRjbRebRsbLibLebLibLgLsbLebLgbLgbLgbLgbRebRibRgRsmbRsRsmbRgbRg
RsmbRgRsRgRgRhmbRsbRsRsRsRsRgRsmmmmbRebRsRhRsRsLsmmbRgbRsRgRgRgbRsRsRe
mbRsRgRsRsmmbRebReb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bRgbLibLgbLgbLgbLgbLebLebRsbRgbLsbLgbRsbLgbLibLgbLibLgbLgbLgbLebLgbLeb
LsbLebLgbLsbLibLgbLsLsmbLibLibLibLibRsbLgbLibLibLibLgLsbLibLsbLgbLebLh
bLsbLsbLgbLgbLgbLgbLebLibRsbsbLibLsbLgbLgbLsbLgbLgbLsbLgbLibLibLsbRsbL
gbLibLsbLebLibLgbLgbLgbLgbLgbLsbLgbLgbRebLsbLgbRgbRibRgbRibReLsbLsbRsb
LgbLsbRgbRgbRsbRibRgbRsbRsbRsRsmbRsbRsbRgbLsbRsbLsbRsbRgbRsbRsbRsbRsbR
iRsmbRibRibLsbLsbRsbLsbRsbRsbLsbLsbRsbRsbRebRsRgbRgbRsbRsbLsbLsbRjbLsb
RsbLsbRsbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bsbLsRsbLsRsLgbLibLobLgLsbLcbLhbLibLibLcbLcbLgLiLsbLibLsbRhbRibRiRsLsm
bRibRiRsmbRhbRjbRibLhLsbLibLgLibLeLiLibLgbLsLsmbRjbRgbsbRsRsmbsbRsbRsb
LsbRsRsmbRsbLsRsRsmbRsbRsRsmbRsRsmbRsRsRsRsRgRsRsRsRsRsRsmmmmmmmmmbRsb
RsRsmbRsRsRsRsRsmmmmbRsbsbLsbLsRsRsRsmmbRsbRsbRsRsRsRgLsmmbRsbLsRsbsbL
sbRsbRsbsbLsRsRsmbLsRsRsRsmmbRsbRsbRsRsRsRsRsRsLsmmmmmbRsRsmbRsRiRsRsR
gRsmmmbRsbRsbRsRsRsRsmmmbLsRsRsmbRsbRsRsRsRsRsmmmmbRsRsRsRsRsRsRsRsmmm
mmmmbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bLeLsLsmbLgLsbLgLsbLebLeLsbLibLibLhbLibLebLhLsbLebLibLebLebLeLsLsmbLib
LiLibLiLsbLebLgbLiLibLebLebLeLsbLebLebLiRsLsbLeLsbLiLsbLebLgbLebLebLcL
smbLgbLgbLsbLgbLsLsmbLiLsbLebLebLibLibLebLhbLebLhbLibLibLiLsbLhbLibLib
LebLibLhbLibLibLsbLgLcbRjbLsbLiLsbLhbLebLhLsbLibLgbLeLhbLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bLgbRsbLsbRsbRsbLsbRsbLgbLsbLgbLsbLsbLgbLcbLgbLibLibLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bRgbRsbRibRsbRgbRgbRjbRibRjbRsLsbRgbRgbRgbLgbRiRsmbRgbRsbRgbLgbRgbLiRs
LsRsRsLsmbRsbRgbRiRsmbLsLsmbLsbLsLsLsLsLsmmmmbRsbLsbLsbLsLsmbLgbLibLsb
RobLsRsbRcbLibRsbRebRgbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bLgLsbLgbLsbLgRsbLgbLgbLeLebLgbLibLebLibLsbLebLsLgbLsbLibLgRsLsbLgbLgb
LsbLsLgbLgbLgbLsbLsbLsbLsbLgbLibRsbLebLgbLsLgbLibLgbLgbLibLsbLebLsbLsb
LgbLibLebLsbLgbLgbLgLgbLiLsbLibLgbLibLiLsbLgbLibLebRsRsmbRgbRsbRgbRgbR
hbRebRsbRsRsmbLsbLgbLsbLibLsRsbLgbLsbLgbLgbLgbLibLibLibLibLgbLibLgLsLs
LsmmbLgbLsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bLgRsRsmbsbsbRjbLhLsbLcbLcbRebLhLsbRjbLgbRsLsbRjbLcbRobRhbLcbRsRcbRibR
hbRibRjbRibLiLsbLiLsLsmbRgbRhbRiRsmbRibRibRibRib

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bRibRibRebRibRebRgbRibRebRebRebRcbRcRsRsRsmmmbRcbRcbRcRsRsmmbRebLhbLiL
sbLibLibLgbLibLeLsbLsbLiLsbLebLsbLibLgbLebLibLgbLgbLebLgbLibLgbLibLcbR
cRsmbRcbLebLcbLibLibLibLgLsbLiRsbLgbRebRhRgbRgRsmbRgRsmbRgbRebRebRebRe
bLcbLiRsbLcbLgbLiRsbLgRsbRibRebRibRibRibRhbRhbReRsmbRebRibRgbRgbRgbRgb
RgbRgbRibRebRgbRhbLobLibLsbLgRsbRgRsmbLsRsbLgRsbLsbRebRibRsbsbLsbRebRh
bRibRibLsRgbRgbRibLsbLgbRibRgbRiRgbRebLsbRsbLsbLibLebLgbLsbLsRsbLebLhb
LibLibLgbRsbLgbsbLibLibLsbLgbLgbLibLgLsbLgbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bRibRgbRcbLsbRiLsRsRsmbRgbLcbLgLsbRsLsbsbRjbRhbRgbRgbRgbRibRobRsbRgbLc
bLsbLcbLibLsLsmbLsbRibRgRsmbRsbLsbRgRsmbRsLsLsmbRgRsmbRibRgbRgbRgbRgbR
gbRgRsmbRgbRiRsmbRsLsRsRsRsRsmmmbRsRsmbRsbRgbRgbLgbLgLsbLiLsbLsbLsLsLi
mbRsLsbLsLsLsLgLsmmbLibRsLgLsbLgLsbLsLsLsLsLsLgmmmmbLibLgLsLgLsbLgLsbL
sLsLsmmbLiLsbLsLsLsmmbLsLgLsbLhbLsbRcbRibRgbRgbRgbRgbRibLsbRibLsbRgbRg
LsLsmbRgRsmbRgbRsbRgbRgbRgbRgbLgbRsRsmbRgRsmbRibRsbRsLsbRsRgbRibLsbRsb
RgbRgbRgRsmbRgbRsRsmbRsRsmbRgbRsbRgbRsbRibRibRgRsRsmmbRgbRsbLsbRsRsmbR
gbRgLsRsRsRsRsmmmbRgbRgRsmbRgRsmbRgbRsbRgbRgbRsbRebRgbRsbRsbRsbsbRsbRs
bRsLsRsRsmbsbRgbRsRsRsRsRgmmmbRiRsRsRsmmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
bLsbLsRsLsbLsLsmbRiReRsmbRiRibRgbRsbRgbRgbRsbLcbLhbLiLib

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bRjbRgbRsbLsbLsbLsbLsbRjbLsbLsbRsbLsbLsbLjbLsbLgbRsbRsbRsbsbLsbLsRsbLs
bRsbLsbLsbLsbLsbRsLsbLsbRjb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
bLebLjbLjbRjbRebRob

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 43; Drug: Control Apo 50 然
bLibsbLibLiLsbLiLsLsmbRsLsbLsLsmbLgLsbLgLsbLgLsbLsbLhbLebRebRebRibRsbR
gbRibReLsbRibRgbRibRsbRibRiLsRsbRebRgbRhbRgbRgRgRsRiRsmmbRibRibRibRibR
gbRgbRsbRgbRgRgRsmbRgbRibRibLgbLebLsbLibLgbRsbRsbRsbLgLsbRsLsbRsbLsbLg
LsbLgbLsLsmbLibLeLsbRibRebRibRebRiRsmbRibRibRebRgRsmbRiRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 44; Drug: Control Apo 50 然
bLibLgbLebRgbRsbRsbRsbLibReRsmbLoLgLsLsmbLcbRcbRebRgbRgbRgbLgbRebRsbRs
bRobRgbLcbLgbRibRobRgLsbLgbRjbRjbRgbLobLgbLebLebLgbLsbLsbLsbLsbLsbLsbR
sbsbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 45; Drug: Control Apo 50 然
bRsbLgLsbLibLgbLgLsLsLsLsLgLgmmmbLhbLcbRhRgbRcbRibRebLibLobRgLgbsbsbsb
RsbLsbLsLsmbLsbRsbLsLsLsLsmmmbLsLsLembRsbRjbLeLsbLobReRsRsmmbRcLsbRcbR
sRcRsmbRsbLsbLsRsLsbLhbLebLiLsbLsLsmbLcRsbRibRiRsmbRcbRiRsmbLsLeLsbRsR
sRsmmbRcbRcRsmbLcbRsbLiLsbRiRsRsmmbLgbRibRobLibLgLsLsmbRjbRobRhbRcbLgL
sLgLsbRgbReRsmbRhbRibLibRebRcbLiRsbRsRsRsmmbRgbLeLsbLiLsRsbRibRebRibRs
RsmbRibRibRgbLebLibLibRsRsmbRcbRibRibsbsbRebLeLsbLebLibLsRsbLsRsbLibRi
bReRsmbRibLgRsRsmbRgRsRsmmbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 46; Drug: Control Apo 50 然
bRsbRibRibLsbLsbRiRsmbRibRibRebLiLsbsbRsbLsbLsbLobRsbLibRibRibRebLsbLi
bRgbRgbRsbRgbLsbLgbRgbRsbRgbRgbRgbRsbLgbLgbLgbLob

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 47; Drug: Control Apo 50 然
bLgbLebRgbLjbLibLsbLsLsmbLsbLsbRebLibLsbLsbLgbLibLgLsbLsbLgbLibLgbLsbL
gbLsbLgLiLsbLebLgbLebLgbLgLsLsmbLsbLgbLsLsLsmmbLsbLsbLibLibLsbLsLgRsbL
gbLgbLgbLgbLgbLsbLsbLsbLsbLsbLsbLsbLsbLgbRsbLsbLgbLsbLsbLgLsbRsbLgbLsb
LgbLiLsbLhbLibLgbLgbRsbLsbLgbLsbLibLsbLsbLsbLgbLsbLgbLgbRsbLsbLsbRsbRs
bLsbLsbLsbLsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 123932; End: 124432;
Recording: 11-1; Individual: 48; Drug: Control Apo 50 然
bLebLhRsbLsbLgLsbLgbRsbLsbLibLibLsbLibLebLgbLebLsLsmbLebLsbLgbLibLebLi
bLebLibLsbLsLsLsLsLsmmmmbLgLgbLibLebLgbLsLsmbRsbLebLsbLebLeLsbLibLsLsL
gLsLsmmbLhLsbLsbLgbLebLiLsbLgbLebLebLsbLhbLsLsmbLiLsbLebRsRsmbLsbLebLe
bLebLebLhRsbLibLebLebLebLsbsbLgLsLsLsLsmmmbLebLebLebLgLsbLsbRsLsLsmbLe
bLsbRjbRebLsbRiRsmbRhbRsbLibRsLsbLibLgLsbRsLsbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
bRobRobLibLhRsbLjbRsRjbLibRjbLhbRjbRebRhRsmbLcbLibLgRsbLjbRsRebRibLebR
hbLsLcbLcbLibLgbLiLsbLgbLibLgbLiRsbLgbLgLibLgLsbLibLgLsbLibsbLiLsbLsbL
gbLgLiLibLgbLibLiLsbLibLibLibRsbLibLebLgbRibRibReb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bRsbRsbRjbRsbReLsbRibRsbRgbRobLjbLebRjbRebRjbLcbLobLebLebRgbLsbRsRgbRi
bRjbRgbRsbRibRsbRobRsbLsbLsbLgbRjbLsbRsbRgbRgbRhbRgbRhLsbRsbLjbRsbRgbL
sbRsbRsbsbRiRsmbLsbLsbRgbRsbRgbLjbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bReRsRsmmbRhbRcRsmbRcbRsbRibRgRsmbLebLsLcbLsRsLsbRgbRebReRsRsmmbLsRobR
cbRgbRgbRgbRgbRgbRiRsRsmmbRiRsmbRibRsRsmbRibRibRsLsbRsbLsbLcbLibLgRsLs
bLsLsLsRsLsLsLsmmmmbLgbRsbRsLsbLsLsmbLsLsLsLsRsLsmmmbLsLsLsmmbLcLsLimb
LgbLhbLibLgLibRcRsmbRibRebRgbLsRiRsmbRsRsmbRibRsbRibRsbRibRgbRsbLibLsb
LgbLibLibLgbLgRsbLgbRsbLsLibRsbLsLgLebRsLsLsRsmbLgbRiRsReRsmmbRebRobRh
bRcbRgbRibLjbLcbLibLiLsbLibLgbRsLsRsbLibLibLgbLjbLibRibRibRibRiRsmbRiR
smbRiRsmbRsRsRsmmbRgbRgRsmbRgbRgbRsRibRgLsRsbRsRgRsmbRsbRiRgbRgRsmbRsR
sRimbRgRsmbRgRsmbRsRgRibRsRgbRebRgRsRgmbRsRiRsRsRsmmmb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bLsbLgbReb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bRsbLsbLgbRsRjbRjbRebRgRgRsmbRgRsmbRgRgReRgbRgbRiRsmbRsbRsbRhbRibRsLsb
RsbRsLsRsLsbRsbRibRsbRebRsRsmbLebLcbLhbLgbRsRsmbLgbLgbLsbLsbLsbLsbLgbL
sbLgbLsLsmbLgLsbLgbRebRsbLsbRgbLsbLsbLsbRsbRsbRsbRsbRgbLsbRsbRgbRsbRgb
RgbLsbRsbRgbRebRsbLsbRgbRgbLsbRibRgbLsbLgRsbRcbRcbRgRebRgbRgbRebRibRsb
RsbRibRgbRsbLsbRibRebRsbRebRgbRsbRsbRsbRsbRsbRsbRgbRgRsmbRebRobLibLgbR
gbRibRibLgbLibLibRsbRgbLsbRsbRhbRgbRgbLsbRsbRebRcbRgbLsbRsbRcbRgbRibRs
bRgbRjbRebLibLgbRebLjbLgbLjbLibRsbRgbRsbLhbLibLsbLcbLgbRsbRhbReb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bRibRgbRgbRgbRsbRgRsmbRsLsbRsbRsRsmbLsbRsbRsbRgbRgbRgbRgbRgLsbRgbRsbRs
bRebRgRsRimbRiRsmbRsbRgRgbReRsmbRgbRiRsmbRiRsmbRsbRsbRsbLsbRsbRsRsmbRs
bLsLsmbRsbRgbRgbRebReLsbRibRgbLsbRgbRgbLsRgbRsbRsbRgRsmbRsbLgbRgbReRsm
bRgbRibRgbRsbRsbLgbRebRsbRsbLsbLsbLgbLsLsmbLgLsLsmbLgbRsLsbLgLsLsRsmbL
sLsmbRsbRsbLgLsLsLsmmbRsLsLsmbLgbLsLsmbLsbLsbLgbLsLsmbLsbRsbLsbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bLgbRsbLgbRobRsbLsbLgbLsbLibRsbLsbLsbLgbLjbRgbLcbRobRjbLjbLobLobRobLob
RsbLoLsmbRjbLcbRcbLgbLgRsbLgbRsbLgbLsLsmbLsbLsbLsbLgbLsLgRsbLsbLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bLibRsbLsbRebRobRsbRsbRsbRgbRsbRsbLsbLsbRsbRgbRsbRsbRsbRsbLobLsbRsbReb
RsbLsbLobRsbLsbLjbRsbRjbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
bRgbRsRsRsRsRsRsmmmmmbRsRsRgRsRsmmmbRsRsmbLgbsbRsRsRsmmbRsRsRsRsmmmbLs
bRhbLgLsbRgbRibRibRgRsRsmmbRibRgRsRsmmbLgbLsRsRsRsRsRsRsmmmmmbRgRibRiR
smbRibRibLsbLgbLebLsbLgbLgLgLsbLiRsbRhbRibRebRiRsmbLgbLsRsRsRsRsRsRgmm
mmbRebRibRgbRgRiRsmbRgRsRgmbRsRgRebRgRsmbRiRsRsmmbRgRsRsmmbRgbRgRsRsRe
mmbRibsbRebRebRgbLsbRebLebLiLsbLibLgLsbLgLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
bLebLcLsLsLgLsmmbLibRhbRgbRgbRibRsLsbLcbLgbLhbRgbRebRibLsbRgbLibRiRsmb
RgLsbRgbRgbRgbRgRsRsmmbRsRsmbRibLebLebLgbLsLsmbLgbLsbLsbsbsbLsbsbRsLsR
sbsbsbsbsbsbsbLsLebRebLcLsmbLcbRcRibLgbRibRibRebRhbLjbLhbLibLibLgbLhbs
bLsLhbLibLibLhbLgbRibRcbRgbRibRiRsRgmbRebRsbRsRsRsmmbRsReb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bLibRhbRobLcbLibRcbLobLcbLibRobRcRsmbLebLgbRcRsmbRjRcbLiLsRsbLcbLebLgb
RcbRebRiRgRgbRgbRibRgRiRsRsmmbRiRsmbLebLibLobRibRcbLebLibLcbLgbLhbLebR
cbRgRsmbLobRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
bLibLgLsRsbLsbRhbLcbLgLgLgbLgbLgbLhbRibLcLgbRcRsmbRgRsmbRibLgbLjbLhbRs
RsmbLsbLhbRsRsmbRhbLgLsbRjbRibLjbLgbLsbLsLsLsLsLsmmmmbLsbLsbRsbLsLsLsL
gLsLgLsLsLsLsLsmmmmmmbsbLsLsmbLgLsLsLgLsmbLcbLibLsbLgbRsLsLsmbLsbsbLsL
smbRhbRgbRsRsRsmmbRsRgRsRsRsRsRsRgRsRsRgRsmmmmmmmmbRsRsRsRsmmmbLjLjbLe
bLcbLsRgbLebLgLsbLgRsbLgbLjRsbRsLsRsLsRsLsLsLsmmbLsLsLgLsmbLsLsLsLsLsm
mmmbLgbLhbLeRsbLsLsLsLsmmmbLgLsLsLsLsmmmbLibLgLsbLhbLgbLgbRjbLsbLsbRhb
LjbLeLsbLeLibLhbLcbLsbRjbRhbRibRoRsmbRcbLcbLsbLjbLibLgbLsbLibLibLcbLgb
LgbRibLhbRsLsLsLgmbLsLsLsLsmmmbLgRsbLhbLibRsRsmbRsRsmbRsRibRcbLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
bLsbLsbLsbLibLcbLgbRgbLgbLsbRibLibRsbLgbLsbRsbLibLsbLsbRsbLibLgbRsbLsL
smbLgLsLsmbRsbRsbLsbLsbLsbLsbsbLsbLsbLsbRsbLgbLsRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bLibLgLsbLgbLibLibRsbLiLsbLibLgbLsRsbLgbLibLgbRsbLsbRsbRcbRgbRibRsbRiR
smbLsRsRsRsmmbRibLsRsRsmbRsRsRsRsRimmmbRibRsRsmbRgRsRgRsRiRsRemmmbLsLi
bRcbReRsmbRibRibsbLcRgbLebLibRsLeLsbRebRsbRgRsmbRibRibRibLsRgbRibRsbRg
bRgbLsbLjbLgRsbRsbLiLsbLsbLibLebLebLibLiLsbRsbRjbRhbLsbRibLsRsbLcbLsbL
ibLibLgbLsbLibLgbLibLibRsbRsbLgLsbLibLiLsRsLebLibLiLsbLgLgbLibLiLsLsmb
RsbRjbLgbLhbLibLibLibLibLsLgbLgbRgbRebRcbLibRgLsbLibLiLsbLiLsbLgbLhbLe
LsbLebLgbLgLgbLgbRsbLgbRjbRebRgRsmbRgbRgbRsRsmbRebRgbRiRsmbRgRsRsmmbRg
bRsRsmbRiRsmbRgRsmbRiRgbRibRhbLgbLcbLsLgbRcbRgRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bRgRibRsbRsbRgbRsbRsbRsbRgbRsbRsbLsbRhbRsbRibRsbRgLsbLsbRsbRgRsRsRsmmm
bRgLsbRibRgbRsbLsbRsbLsbLgbRgbRgbRgRsmbRibRsbRgbRibRsbRsbRgbRgbRgbLsLs
mbRsRgbRgbLsbRjbRibRsbRebRsbRgbRsbRsbRgbRsbRsbRgbRsbLobRsRibRgbRgbRsbR
sbRsbRgbRsbRoRsmbLsbRsbLebRsbLsbLcbLgbLgbRsbRebLsbRebRsbLibRgbRsRsmbRs
bLsbLsbRsbRgbRsbLsbRgbRgbRibRsbRsbRsbRsbRgbRibRibRsbRsbLsbLsbRgbRsbLob
LebRsbLsbLhbLjbLsbLsbLgbLsbLgbRsbLsRsbLgbLsbLgbLgbLsbLsbLsbLsbLsbLgbsb
LsLsmbLsbLgbLgbRsbLsbLsbLsbLsLsmbLib

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bLsbLsLsmbLgLsbLibLsLsLsLsmmmbRsbLsbLebLgbLibLgbLsbRsbLsbLsbLsbLsbRsbL
gbLsbLibLsbLsbLsbLcbLobRobRibLsbLobLgbRobLsbLsbRsbLebRobRebLoLsmbRobRg
bLobLjbLobRibRobLebLsbLsbRibRsRsmbRsbRgbRsbRjbLjbRgbLsbLob

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bRsbLjbLgbLibRjbLcLsmbRcbLebLsRsbRgRsmbRsRsRsRsRsRsmmmmmbRhbRgbRgbRcbL
hbRebRgbRebRsbRibLcbRebRgbRgbLebRsbRsRsRgRimbRibLsRsRsmbRgbRgbLjbRibRg
bRibRgbLhbRibLcbLgbLgbRiRsmbRsRsmbRibLiRsbRibRcbRhbRebRiRsmbRsbLibLjbR
gbRibRibRibLgbLcbLibLgbRibRhbRibRibRsbRgbRgRibRsbRgbRsRsmbRibRgbRsbLsR
sbRibRiLsbRibRgbRiRsmbRgLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bRjbRebRobRsbLebLsbLibRsRsmbRobRgbLsLsLsmmbLsRsbLibLgLibLgbLgbRobLibsb
LobLibLibLgbLgLsbLgbRsLsbLgbLgbLibLgLsbRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 19; Drug: Control Apo 50 然
bLgbRsbLebLgRsbLibLsbLgbLgbLgbLsbLsbLgbLgbLibLibLgbLibLsbLsbRsbLsbLsbL
gbLgbLhbLsbLobRsbRebLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 20; Drug: Control Apo 50 然
bRgbRgbRgbRsbRsbRgbRgbRsbRsbRsbRsbRgbRsbRgbRsRsmbRsbRsbRsbLsbLsbRhRsmb
RsbRsbRsbRsbRgRgbRsbLsRsRgRsmbRsRgRsmbRgRibRiRgRgbRsRsmbRsbRgRsmbRsbLs
RsbRgbRgRsmbRgRgRsRgmbRsRsRsmmbRsRsRsmmbRgRsmbLgbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 21; Drug: Control Apo 50 然
bLsbReRsmbRcbRiRsmbLcLsmbLjbRsbLjbLibLibRebRsbReRsRsmmbRgRsRsmmbLebLob
RebLiRsLsbLsbRibRobLiLsbLsbLiLsbLcLsmbLibRoRgRsmbRiRsmbLgbLoLsLgmbLgLs
LgbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 22; Drug: Control Apo 50 然
bRobLjbRibRsbLobRebRobLobRsbRibRebLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 23; Drug: Control Apo 50 然
bRsbLibLgbRsbLgbLgbLsbLibLibLgbLsLebLibLibRsRsmbRebRhbRibRgbRiRsmbLgbL
sbLgbRsbRibRsRsmbRgbLsbRgbRgRsmbRgbRebRhRgbRsbLsbLibRsbLsbLsbLgbRsbLsb
RjbLoLsmbRcbRcbRebRebRebRiRsmbRiRsmbRcbRebRibRgbRebRebRsRcbRgbRsbLgbLg
bLsbLsLsmbLsLsLsmmbLgbLsbLsbLsLsmbLgbRjbRgbRgbRgbRsbLsbRibRsbRgbRibRgR
smbRsRcbLsRsbLsbLsRsLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 24; Drug: Control Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bRgLsbLibRgbLsbLsbRsbLsLsmbsbLgLsLsLsLsmmmbLgbLsbLibLgbRibLibLibLhLsbL
sbRcbLiLgbLsLsLsLsLsLsLsLsmmmmmmmbLsLsLsRsLsRsLsLsmmmbLibLibLhbLcbLgbL
hbLsbLibRibRcbRebRibRgRsmbRiRsLsmbRsRgLsRsbLibLcbLgbLgbLibLibLgbLibLib
LibRjbLeLgbLgLsLsLsLsLsLsmmmmmbLsLsmbLsLgbRsbLsbLgbLibLgbLgbLibLgbLgbR
sbLgbRsLsLgLgLsbLgbLiLsLsmbLsLsLsLsLsLeLsLsLgLgmmmmmbLiLsLgLgLgbRsLsLi
LiLsLgLeLgbLsbLgbLgbLgbLgbLgbLebLgbLgbLgbLibRsbLhLsLsmbLibRiLsbRsbRsbL
sbRibLjbLiRsbLibLsbLsbLgLsLsLsLsLsmmmmbLgLgbLgbLgbLgbLibLgbLibLhbRsbLg
bRcbRiLsbLsbRsbLgbLgbLsLsLeLgmbLibLebLgbRgbLcbLebRjbLcbLibLebLebLibLgb
LgbLgbLibLibLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bsbRsRibRiRsmbRebRebRebLjLcbLeLsbLiLgbLgbLgLgbLsbLsLsLembLsLiLsLsmbLsL
eLgLebLsRsLsbLebLsLgLsbLsLsLsLsLemmmbLgLebLiLsbRsLebLsLsmbLiLsbLiLsbLg
bLsLeLhLsbLsLsLsmmbLebRsLsLebLsbLibLgbLibLcbLhbLsbLibLcbLibLgLsLsmbLib
LjRsbLgbLibLgRsbRgbRibRibRsbRibRgbRsbLgbRgbRibRibRgbRiLsbLsLsmbRjLsbLh
bLhbLhbLsbLgLsbLgbLsLsmbLiLsbLsLgLsLgbLsbLebLebLebLsbLsbLsLsmbLebLebLs
bLsbLgRsbLsbLsbLebLgLsbLcbLiLsbLgbLsLsLsLsLsmmmmbLsLebLebLebRsbLibRsbR
jbRgbRibRgbRgLsbLjLsmbLebLhbLebLebLebRsbLsbLebLebRsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bLsbLebLjbRgbLjbRsbLebLsbLobLsbRjbRsbRgbRsbRsbRsbLjbRsbLsbLsbLsbRjbRsb
RsRsmbRsRsmbLsbLsbLsbLsLsmbRjbLsbRebLjbRebRjbLcbLobRsbRobLsbRsbRobRobR
ibRjbLjbRjbLebRsbLjbLobRjbRjbLobLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bLsRsLsbRsbLsbLsRsbsbLsRsRsmbRsbRsRsRsmmbRgRsRgmbRgbRsRsmbRgbRsRsmbRsb
RsRsRgmbRsbRsRsRsRsRsRsRsmmmmmmbRsRsRgLsmbRsbRsbRsbRsRsRsmmbLsbRsbRsRs
mbRsRsmbRsbRsRsmbRsbRsbRsbsbRsRsRsRsRsRsRsRgRsRsRsmmmmmmmmmbRsRsmbRsRs
RsRsRsRsRsRsmmmmmmmbRgRsmbRsRsmbRsbRsRsRsRsRsRsRsmmmmmmbLsRsRsRsmmbRsR
smbRsRsRsmmbRsRsLsRsRsmmbRgRsRsmmbRgbLsbLsRsRsmbLgRsRsmbRsRsmbLsRsRsRs
RsRsRsRsmmmmmmbRsRsRsmmbRsRsmbRsbRsbsbRsRsmbsbRsRsRsRsmmmbRsRsmbRsRsRs
RsRsRsRsmmmmmmbRsRsRsRsmmmbLsRsRsRsRsRsLsRsRsmmmmmbRgRsmbRsRsmbLsbRsLs
bLsRsRsRsRsmmmbRsRsRsRsmmmbLsRsRsLsRsmbRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmm
mmmmbRsRsRsRsRsRsRsRsRsRsRsRsRsLsmmmmmmmmmmmmbRsbRgRsmbRsRsRsRsRsRsRsR
sRsRsRsmmmmmmmmmmbRsRsRsRsmmmbLsRsbRsRsmbsbRsRsmbLsbsbRsRsRsRsRsRsRsmm
mmmmbRgRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmbRsbRsRsRsRsRsRsmmmmmbRsRsRsmm
bRsRsRsmmbRsRsRsRsRsmmmmbRsRsRsRsRsRsRsRsRsRsRgRgLsmmmmmmmmmbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
bRibRcReRsLsmbLjbLgbLobLcbLcRsLsbLebLeb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bLebLhLsLsmbLebLeLsbLebLeLsbLeLsbLebLhbLebLebLgLsLiLsbLebLibLebLebLgLs
bLibLeLsbLsLibLgLsbLsLsLsmmbLsLsmbLiLgRsbLhbLebLibLebLhLibLebLebLebLeb
LiLsbLibLgbLgLsbLeLsbLiLsbLebLgbLsbLsLsLsmmbLgbLgbLibLsLgLsbLgbLibRibR
sbRgbLibLgbRsLsLsmbRsbLsbLibLgbLgbRsLsbLgbLgbRsLgLsbLgbLgLsbLgbLsbLgbL
gbLebLgbLgbLgbLsbLsLsmbLsbLgbLsbLsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bLgbLsbLsbLsbLgLsbLsbLsbLsbLsbLsbLsbLgbRsbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
bRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bLsbLsbLgbLgLsbLgbLgbLgLsbLsbLibLgbLebRsLeRgRgbRsbLgbLgLsbLsLsRsmbLsLg
LibLgLgLsbLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bRiLsbLsRsbRibLsbLhbRjbLcLsmbLcbLcbRcbLobLcbRibRjbRcbLcbLebLibRsRsmbRi
bRhbRibRibRsbLibLcbRgbLgbRjbRebRgbRiRsmbRsbRcbRiRsmbRsbLsRsRgbLsRsbsbL
sbLsLsmbLsLsmbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bLgbLgbRsLgbLgbLgbLgbLgbLgbLgbLgLsLsmbLibLhbLgbLgbLgbLgbLsbLgbLgbLgbLi
bLibLibLgbLsbLibLgbLgbLgbLgbLgbLgLsRsLsbLibLgbLsbLgLsbLibLgbLibLgbLsLs
LimbLgLsbLebLebLgLsbLgbLibLiLsbLibLgLsbLibLiRsbLibLiLsbLgbLgLsbLgbLgRs
bLgbLibLeLsbLhLsbLgbRsbRjbRobRebRhbRcbRcbLhbLgbLgLsbLgbLobRebRibRibRgb
RsbRebRiRsmbRibRhbRibRibRibRibRiRgbRgbRibRgbRibRibLebLebLeLgLhLsLgbLib
LgbLgbLebLsbLgLgLsLgbLgRsbLeLgbLgbLgLsLsmbLsbLsLsLsLsmmmbLgbLhbLgbLgbL
gbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bsbsbRsRsRsmmbRsRgbRhbRgRsmbLgLsbLgbLibLcbRhbRcbRcbRgRsmbRgRsmbRiRsmbL
jbRgbRibRibRgbLibLhbLsbLebLgLsbLiLsLibLgbLcbRcbRhRsmbRibRsbRgbsbsbsbRs
RsmbRgbRgbRgbRsbRsbRgRsmbRsbRgbRgbRsRsmbRsbRsLsbRgRsmbRsRsRsRsmmmbRsbR
sRsRsmmbRsRsRsRgmmbRsbRsLsbRsRsmbRgbRsRsRsRsRsRsRsmmmmmmbRgRsRsmmbRgbR
gRsLsRsmbLsbRibRsRsmbRsbRgbRsbRsbRgbRsRsRsmmbRgbRgRgRgbRgbRibRibRiRsmb
RgRsmbRibRsbRsbRibRebRgbRiRsmbRgRsmbRsRsmbLsRsbRibRgRsRsmmbRibLsRsRsmb
RsbRsbRsRsmbRsLsRsbRsbRsRsmbLsRsRgbRsRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
bRcbRgbLjbLcbLhbRibRgbLjbLhbLsbRjbRibRebRibRebRibLgbRibRgbRgbRgLsbLebL
iRsbLibRsbRgbRsbLebLhbRgbLcbRgbRgbLebRsbRibLjLsLimbLibLsLgbLgbLsbRcbRg
RsLsmbRibRgbLsbRebRsbRiRsmbLeLsbRjbLeLsbLsLsmbLhLsbLcbLcbRiRsLsmbLgLsR
sbLcbLcbRgLsRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
bRcbLsbRsbRebLobRobRcbRobRobRobRobLebRobLjbRobLobRjbLibLobLebLobRobRob
LobRgbRobRobRebRobRebRobLcbLebRobRjbLibLobRobLgbRobRobLobLcbRobRebLobR
ibRobRobRsbLcbLsbLobLcbLobLcbRcbRebRobRsbLobRobRobRsbRibLcLobLobLgbReb
RebLobRsbRsbLobLobRobLsbRobRobLcRebLsbRgbLsbLobRobLsbLcbRsbLobLobRebRe
bLobRsbLsbLeLebLobRobRsbLobRsbLebLsbLsbRsbRsbRobRobRsbRobRobRsbLebRobL
sbRcLebLobLhbRebLsbLebRobRebRsbLobRibRobLobLcbLsbLsbRsLsbRiLebRsbRobLc
LebLsbLobLobRebRobRobRobRsbRcbLsLsmbRebRibLobRjbLjbRobRobRsbRebLobRobL
obRobRcbRebRebLhbLobRebRcbLcbLsbRobRgbRcbLobRhbLebRibRcbLobLobRobLcbRe
bLsbRobRebLebLobRobRobRgbLebLobRobLebLcbRobLgbRobRobRobLobLobLobRgbLob
RebRcbLebLgbLobLobLobLsbLibRobRobLibLobRobLsbRobLobRcbLebRobRgbLibRcbL
hbLobRgbRsbLjbLobRobLobLobLsbRobLgbRsbLgbLobLcbRcbRebLsbRobRcbRobLobRo
bLobLcbLebLcbLobRobLibLcbLebLebRibLcbLobRobRibLobRobRcbRsbRobRcbRibRob
RibRobLobLobLobLibRsbRsbLhbRobLobLebLsbRobRibLsbRobLebLcbLebLobRgbRgbL
sbLibRebRobRibRobLobRcbRobRobLebLobLobLcbRobLebRebRobLcbLobLobRibRebRo
bLobLobLobRgbRgbLebRsbLsbLobRgbRobRcbRobRobRobLjbRebRobLobRobRobLibLgb
LgbRobLebRobRobRebRibRobRebRcbLcbRebRsbRgbLebLobLobLobRcbRcbRcbLebRsbR
obLcbLibLobRebRebRcbRebRcbLobLcbRobRobRobLgbLgbLibLobRgbRebLobRibRobLc
bRgbLobLibRobLsbLsbRobLebLjbLobRobLsbLgbRobLibLobLcbLjbLgbLobRobLcbLjb
LcbLcbRebLobRobRobRcbLcbLobLobRobLcbRobRobLebRgbRebLobRgbLibRobRobLobR
obLhbLibRobLcbRebRebLsbLebLobRcbRobLobRobRgbLobRebLobRobRobRsbRobRsbRc
bRobRobRobRobRobLobLjbLibRobRebRobLobLjbLjbLsbRobRobLobRobLobLobRsbRib
RgbLsbRjbRobRsbRobRsbLobLsbLobRobRjbRsbLobRobRgbLobRobLobLebRobLcbLsbR
obRobLobRobLobLebRcbRobRcbRobLsbLgbRobLcbRsbRebLobRobRobRebRsbLcbLobRg
bLobRcbRobLjbLcbRobLsbLobLebLobRebRsbLsbLcbLobRsbLebLhbLibLebRibRcbLgb
LobRobLobLcbRobRobLebRebLobRebLebRobLebRobLcbLobRcbLobRobLcbLibRebLobL
sbLebLebLobRcbRobRebRobRobLobLgbRgbLjbRebLsbRobRebRobLobRebLobLobRobRe
bLobRebRgbRebLobRibLsbRebRsbRobLobLebRebLsbLsbRebLibLobRobLobLebLobLob
RobLgbLcbRobLgbLebRobLcbRobRobRsbLcbRobLobRobLibRobRobLsbRsbLobLobRobL
ibRobLobLibLsbLgbRjbLibLobRcbLobRobRobLebLcbLobRobLobRobRobRgbLebRobRo
bLcbLsbRsbRcbLobLsbLobRobRobRobRobLobRebRobRsbRgbLsbRobLcbRibLobLebRob
LjbRobLobRcbRobLobLebRobLebLobRjbRsbLibRobRobRsbRhbRobLgbRsbLebRsbRobL
ebLobRebRsbRobRsbRibLobLobLibLobRsbLcbLcbRibRsbLobLsbRobLobRobLobLsbLo
bLobRobRebRobRobLobRsbRsbLobLjbLoLebLobLobLobLcbRsbLobLebLgbRobLcbRsbL
ebLsbRobLcbLebRobRsbRsbLebRebRsbLebLsbRsLebLjbLsbLebRobLebRsbLsbRobLsb
RebLebLjbLsRsbLsRsbRsbLsbLibRobRsbRobRobRsbRobLsbRsbRobRsbRsbRgbLsbRsb
LsbRsbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 43; Drug: Control Apo 50 然
bRsRibRebRebRgbRsbRsRsRsRimmbRgRsmbRebRibRebRiRebLsRsbLgbLgbRsbLsbsbsb
LgbReRsmbRebRcbRibRebRgbRibLsbRebRhbRcbRiLsRsbRgRsmbRsRsmbRgRebRibLsRi
RsmbRibLibLgbLgbLhbLgbLhbRebRibRgbRgbLebLgbLibLgbLiLsbLsLsLsLsmmmbLgbL
ibLeLgbLsbLgLsLsmbLsLsmbLgLsbLsbLsLsLgmbLgLsLsmbRsLsbLsbLgLsbRsbLsbLeb
RebRgbRibRibRebLhbLibRgbLibLgbLsbRebRgbRebRibLebLibLgbRjbRebRibLebLsbL
gbLgbLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 44; Drug: Control Apo 50 然
bRibLsbRsRsmbRsLsLsmbRsLsbRgbRsbRobRobRgbLjbRgbRsbLsbRsLgbRsbLsbRobRcb
RsRsmbLhLsLsLsLsLsLsRcRsRsRcmmmmmmmbRsbRgRsmbRgbRgRjbLibLgbLhbRsbLgbLj
bLsbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 45; Drug: Control Apo 50 然
bRiRsmbRiRsRsmmbRgRsRgRsRsRsRsRsRgmmmmmmbLsRsRgRsRsRsmmmbRsRgbRgbRsbRg
RsRsmmbRiRsmbReRsmbRibLgbRgRsmbRibLgbRhbReRsmbRsbLgLsbRebRcLsbLgbRebRg
bRiRsmbRgbRsbRibLobLgbRhbRiRsRsmmbRgLsbLobLcbLgbLgbLgbsbRebRebLibRgbRh
bRibLibRhbLgbRibLgbLcbLgbLgbLhbRiRsmbLibReRsmbRcbRibLebRiRsmbRgbReRsLs
mbRcbRcbLibRebLgbRebRebLsbLibLibRsRcbLsbRsbRsRsRsRsRsRsmmmmmbRcbRsbRsL
sbRibRib

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 46; Drug: Control Apo 50 然
bRebsbRsbLibLsbLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 47; Drug: Control Apo 50 然
bLgbLsbLgbLsbRobLsbLgbLeRcbRebRjbLeLsbLeLsbLoRsbLeLjbRhRsLsmbRsbRsRhRc
bReRsReRcmbLobRhRiLcbRsLiLsLeLsRoLsbLcbLiLsLgLsbLjbLoRsRgRcLsbRiRsRsmm
bLgbRobRsbRsRsmbLsbLcbLsbLiLsLsmbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124434; End: 124934;
Recording: 12-1; Individual: 48; Drug: Control Apo 50 然
bLiLibRsRsLsLsRsmmbLibLebLebLcbLsbLgbRjbLsbLibRiRsmbLcbLiLsbLiLsbLsbLe
bLgLsbLiLsbLsbLgbLhbLiLsbLibRsLebLhbLsbLebLgLsbRgbLcbRsLsbLeLsbLebLgbL
ebLeLgLsbLgbLgbLsbLgbLgbLebLibLsbLsbLsbLsbLgRsbRsLsbLebLsLsLsmmbLgbLsb
LebLsbLgbLgLhbLgbLgbLgRsbLibLibLsbLebLgbLsLsmbLebLeLsbLsbLibRsbLgbLgbL
gLsbLgbLsbLebLsbLibLhbLsbLibLgbLgbLibLgbLsbLhbLsbLsbLebLibLsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 1; Drug: CNO 10 然 Apo 50 然
bLiRsbRjbLhbLjLhbRibLebLibRebRjbRcbLjbLsbRcbLhb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 2; Drug: CNO 10 然 Apo 50 然
bRjbLsbLsbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 3; Drug: CNO 10 然 Apo 50 然
bRgRsmbRsRsRsRsmmmbRgRsmbRsbLsbLsRsRsRsmmbLsRibRsRiRsmbLsbsbLcbLiLsbLi
LsbLobLgbLibRjbRcRsmbRibRibRibRgRgLsbRgbLsLsRsmbRsbsbRsLsLsRsmbRsRsRsR
smmmbRibRsbRgbRsRsRsRemmbRebRgRsRsmmbRsbRsRsmbRgbRebRibLibLcbLebLgLsbL
sLsLgLiLsmbLeLsRsbLebLsbLgbLsLgbLsbLgRsbRsbLebLgbRgbRsbLsbLibsbLibLgbL
gLebRibRgbRgbRsbRsbLsbRgbRsbRsbRsbRhbRibRgbRjbLjbLsbRgbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 4; Drug: CNO 10 然 Apo 50 然
bLsbLsbLsbLsbLsbRsbLsbRsbLsbLsbLsbRsbLjbRsbRsbRjbLsbRsbLjbRsbRsRsmbRsb
LsbRsbLsbRsbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 5; Drug: CNO 10 然 Apo 50 然
bRgbRebLsbRgbLsbLobRsbRsbLsbLsRsLsbLsbLsbRsbLsbLsLsmbLebLsbLibLgbRsbRs
bLsbLsbLhbLibLgbRsRsmbLsbRsbRgbLsbRsbRsbLebLeLgLsLsLsmmbLgLsLsmbLsbRsb
LgbRsbLgLsLsmbLsbRsbLgbRsbLsbLsbRsbRsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 6; Drug: CNO 10 然 Apo 50 然
bRsLgbLsLsmbLgbLsbLsbLsbRsbLsbLsbLgbLsbLsbLibRsbLsbRsbRsLsbRsbsbsbRsbL
sbRebRsbRgbRsbRsbRgbRsbRsbRibLsRsbLsLsmbRebRsbRsbRsbLsbLsbLsbRsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 7; Drug: CNO 3 然 Apo 50 然
bLobRibRjbRebRebLgbLcbLjbRobRjbRjbLobRsbLcbRobLjbLcbRjbLjbLobLjbLsLjbL
cbLgbRobLebRebLcbRobRobLebRobRsbLsbRjbRjRsmbLebRebRsbRjbRgbLjbRebLobRj
bRebRobLobLsbLsbRjbRobLsbLobLibRjbRsbLsbRsbRjbLsbRsbRsbLsbLjbRsbRsbLsb
LsbRsbLsbLsbLsbRsbLsbRsRebRsbRsbLsbLjbLsLsmbRobLsbRobsbRjbRsLsbRjbRsLs
bRjbLsbLobRsbLsbLsbRebLsbLsLsmbLsbLsbRsbLsbRsbLsbRsRjbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 8; Drug: CNO 3 然 Apo 50 然
bLsLsmbRsbRsbRsbLsbRsbRsbRsbLgbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 9; Drug: CNO 3 然 Apo 50 然
bLebRsbRcbLcbLcbRsLibLhLeLsbRebRibRgbRgbRhbLibRgbLgbRgRhbRsbLsbRgRsmbR
gRsRsmmbRgRsmbRgbRebRgbRsbRgbLgbLsbLiLsbLebLgLgbLiLsbLgbLebLgbLebLibLi
bLgLibLibLgbLibLgbLgbLibLsbLibLgbLgbLebLebLgbLsbLibLgbRebRsbRhbLgbLgbR
sRsRimbRebRcbRgbRebRiRsRsmmbRebRgbRebRebRgbLibRsbRcbRcbRibReRsmbLgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 10; Drug: CNO 3 然 Apo 50 然
bLsLsRgmbRgbRsbLsbLjbLcbLiLsbLiLsbLibLibLibRcbRgRsRimb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 11; Drug: CNO 3 然 Apo 50 然
bRsbRsbRsbRsLgLsbRebRobLcbLcbRhRsmbLcbRibLsRsbRibRibLsbRebLsbLsbsbLsbR
sbLsbLsbRsLsbRsbsbRobRob

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 12; Drug: CNO 3 然 Apo 50 然
bLhbLjbLibLsLsLsLsmmmbLgLsbLsLgbLgRsbLgLgLgLsbLsLsLsLsLsLsmmmmmbLsLsLs
LsmmmbLsLsmbLsbLsLgLiLsLsLsmmbLsbLgbLibLgbLsbRsbLebLgLgLgLsLsLembLebLh
bLgLgLgbLgbRjbRcbLcLsmbLiRsLsLsRsmbLhbRsLsbRgbLgbLcLsLgLsmbLsLsLsLsLsL
sLsLgLsLsLgLemmmmmmmbLeLsbLgLsLsLsLgLsLsLsLsLsmmmmmmbLsbsbRsRsRsmmbRsR
smb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 13; Drug: CNO 1 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 14; Drug: CNO 1 然 Apo 50 然
bRsbRsLsbRhbRebRhbRebRhbRgbRgbLsbLgbRcRsmbLsbRsbRgRsRgRsmmbRiRsmbRhbRe
bRhbReRsmbRhbRiRsmbRhRsmbRhRsmbRgRsmbRibRebRibRgRsmbRibRhbRebReRsmbRib
RgbRibRsbReRsmbRhbRgbRsbRgbRgbRebRebRebRebRsbRibRgRsmbRgRibRsbRgbLgbRi
bRcbLsbLsbLsbRgbRibRibRebRebRhbRgbLjbRsbLibLcbLsbLgbRgbLibLebLibLibLgb
LibLgbLibLgbLibRsbLgbsbLibLibLhbLibLibLibLibLibLgLsbLgbLibLibLibLhbLhb
LiLsbLebLebLibLebLgLsbLibLgbLibLibLibLgbLibLgbLgbLgbLgbLgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 15; Drug: CNO 1 然 Apo 50 然
bLgbLiLsbLsbLgbLgLsbLgbLgbLsbLibLgbLsbLgbLsLsmbLsbLgbLsbLsbLsbLsbLsbLs
bLsbLgbLgbLsbLgbLibLsbLgbLsbLsbLgbLsbLsbLsbLsbLgbLsbLsbLsbLsbLsbLsbLsb
LgbLsbLgbLsbLsbLsbLsbLsbLsbLsbLsbLsbLgbLsbLsbLsbLsbLgbLsbLgbLsbLsbLsbL
sbLsbLgbLgbLsbLgbRsbLgbRsbLsbRsbLsbLgbLsbLgbLsbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 16; Drug: CNO 1 然 Apo 50 然
bLobRgbLjbLsbLcbLjbRsbRjbLebLebLjbRsbRsbRobLobRjbLobRebLjbLcbLsbRcbLjb
RgbRjbRsbRibRibsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 17; Drug: CNO 1 然 Apo 50 然
bLjbRiRgRsmbRibRgRsmbRibRsRsRsmmbRgRgRsmbRgRsRsmmbRsRsRgmbRsbRsbRsRsmb
RibRsRsRsmmbRiRsmbRiRsmbLobLibLjbRhbRgbRsbRibRibRibRibRibRhbRibRhRsmbR
hbRgbLgbLibRjbRiRsmbRiRsmbRibRibRibRgbRibLgbRiRsmbRibRsRsmbRsLsbRsbRsb
RgbLgbRibRgbRgbLsbLjbRibRibRgbLjbRibRsbRibRsRsRsmmbLsbRgbRsRsmbRsRsmbL
sRgbRibRibRgbRsbLjbRibRibRgbRgbRsRsmbLgbLhbLiRsbLgbRjbRgbRgLsbRibLsbLe
bLibLgbLgbRjbRibRiRsmbRgRsmbLsbRgRgRsmbRgRsmbRebRsRsRsRhmmbsbRgRsmbRgb
RibRibRgRsmbRibLsbLcbLibLgbLgbLjRgbRibRebLgbLgbLibLgbLgbRsbRibLsbRgbLs
bRsbRgbRgbRsbRcbRgbLibLgbRgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 18; Drug: CNO 1 然 Apo 50 然
bLsRsbRsbLsbLsbLsbLsbRgbLjbRsRsmbRsbRsLjb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 19; Drug: Control Apo 50 然
bLsbLsbsbLsbRgRgbRsbRgbRgbRsbRobRjbRobRobLobLcbLcbLjbLobLgbRsbRcbRobLo
bRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 20; Drug: Control Apo 50 然
bRsRsmbRsbRsbRsbRsbLebRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 21; Drug: Control Apo 50 然
bLgbRgbReRgRsRsmmbRcbRebLcbLobLebRobRcbLobLhbLibLhbLibLcbRjRsmbLcLsmbL
hbLgbLsbLibLhLibLgbRgbLhbLibLiLsbLibLgbRobLsbRcbRebRobRibLcLsLsmmbLibL
gbRgbLhbLiLebLiLgbLibLgbLgLiLiLgbRgbRcbRgLsbRsbRsbRgRsmbRsbRebRebRjbLs
bLsbRebLgbLcbLhbLsbLebLsbLjRsLsbLjbLsbRsbLsRsLsbRobRsbRgbLebLiLsbLiLsb
RsbLibLsLgRsbLibLgbLibRsbLgbLibRsbLsLsmbRsLsLibRsbLsLsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 22; Drug: Control Apo 50 然
bsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 23; Drug: Control Apo 50 然
bRibRibsbLgbRsbRsbLsbLsbLsbLsbRsbRoRsLsmbLibLgLgLsLsmbLsbLsbsbLgbLgbRs
bLebRcbRebRobRgbLcbLcbLibLobLibLgbLibLsbLgbLibLgbRsbRgbRcRsmbRhbRibRsb
RsbRsLsbLsLsmbRsbRgbRgbRibLjLsmbRsbRgbLsbRgbRibRsbLsbRibRibLsbRibRibRg
bLsbLjbLhLhbLgRsbLebLibLebLibRebRibRibRgbRgRsLsmbLsbRsRsmbRsRsmbRibRsb
RibRibRsbRsbRgRsmbLsbLsbRgbRgLsbLsRsbRgbRgbRgbRgRgbRsRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 24; Drug: Control Apo 50 然
bsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 25; Drug: CNO 10 然 Apo 50 然
bLsbLsbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 26; Drug: CNO 10 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 27; Drug: CNO 10 然 Apo 50 然
bLsbRgbLsbRibLjbRebRgbRsbRgRsRsLsmmbRgRsmbRgRsLsRsLsmbLsLsRsmbRsbRibLg
bRgRsmbLsLgbLgbLibLgbLgbLgbLibLeLgbLhbRgbRibRibRiRsmbRgbRgbRgbRibLgbLj
LsmbRibRsbRgRgRsRsRsmmmbRsRsmbLsRsRsRgRsRsRsRsRsmmmmmmbRsbRsRsRsRsRsRs
RsRsRsRsRsRsRgmmmmmmmmmmmbRiRibRgbRibRibLsbLjbLibRgbLhbLibLhbLgbLeLiRs
bRcRsmbRsbLeRsbRgbRhbLgbLjbRsbRibRibLjbRjbRebRgbLgbLjbLsbRhbRjbRsbRibR
gbLsbRibRgbLgbRebRgbRibRgbLsbLebLiLsbLgbRgbLibLibLgbLebLebLibLhbLebLib
LebLhbLibLsbLeLsbLeLsbLebRgbRsbRebLgbLebLebLebLsLsmbLebLgbLibLgbRgbLsb
RebLsbRebRebRebLsbReb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 28; Drug: CNO 10 然 Apo 50 然
bLsbLsLsmbLebLgLsbLeLebLgbLsLibLebLsLsmbLibLsbLsbLiLsLsmbLsLgLsLibLsLs
mbLsbLsLsLgmbLibLiLsbLsbLebLsbLsLsLimbLsLsLsmmbLibLeLsLgbLebRobLsLsmbR
sbLgbLsbLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 29; Drug: CNO 10 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 30; Drug: CNO 10 然 Apo 50 然
bRjbRsbLsbLjbLibRsbLsLsmbRsbLsbLobLsbRobLjbLsRsbLjbRsbLgbLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 31; Drug: CNO 3 然 Apo 50 然
bLsRsRsRsRsRsRsRsmmmmmmbRsbLsbLsbRsRsRsmmbRsbRsRsRsRsRsmmmmbRsbRsRsRsR
sRsRsLsmmmmmbRgbRgbRsRsmbRgRsRsRsRsRsRsRsRsRgRgmmmmmmmmbRgbRsRsRsRsRsR
sRsmmmmmmbsbLsRsbRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmbRgRsRsRgmmbRgRsmbRsb
LsbRsbRsbRsbRsRsRgmbRgRsRsRsmmmbRsRsRsRsRsRsLsmmmmmbRsbRsbRsRsRsRsmmmb
LsRsLsRsRsRsRsRsRsRsmmmmmmbRsRsRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmmbR
sRsRsLsRsRsRsmmmmbRsbRsRsRsmmbRsbRsRsRsRsRsRsmmmmmbRsRsRsRsRgRsRsRsmmm
mmmbLsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmbLsRsRsRsLsLsRsRsRsmmmmmbRsRsRsRsRs
mmmmbRsRsRsRsRgmmmbRsRsRsRgRsRsmmmmbRsbLsRsRsmbLsRsRsRsRsRsRsLsRsRsRsR
sRsRsRsmmmmmmmmmmmbRsRsRsmmbLsRgRsRsRsRsRsmmmmmbRsRsRsmmbRsRsRsRsRsmmm
mbRsRsRsRsmmmbRsbRsbRsRsRsmmbRgRsRsRsRsRsRsRsRsRsRsRsRsmmmmmmmmmmmmbsb
RsRsRsRsRsmmmmbRsbRsbRsbRsRsmbRsbLsbLsRsRsRsRsmmmbLsRsRsRsRsRsRsmmmmmb
RsbLsRsRsRsRsRsRsmmmmmbLsRsRsRsRsRsRsLsmmmmmbLsRsRsRsRsRsRsRsRsRsRsRsR
gRgRsLsmmmmmmmmmmmbRgbRsbRsRsRsRsRsRsmmmmmbLsRsRsRsRsRsRsRsRsRsRgmmmmm
mmmbLsRsRsRgmbLobLebLgbLgLsbLibLebLebLebRobLobLsbLgbLobLgbLebRhbRcbRgb
LobLhLcbLeLeLgLsbLgbLgbLsLsmbRsRsmb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 32; Drug: CNO 3 然 Apo 50 然
bRcbRoRsmbLgbLebLeLsLsmbLcbRhbRebRgRsmbRcbRebRebReRsRsmmbRgbRobLhbLibL
cLsLsmmbLhLsRsbLsLsmbLobLhbRebRibRsRsmbRsbLhbLebLebRobRcbRibLcLgbLcLsm
bLeLsRsLgbLiLsbLgbRebRhbRcbRsbRib

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 33; Drug: CNO 3 然 Apo 50 然
bLgbLibLgbLsbRsbLsbLgbLgbLsbLsbLsbLibLsbLsbLsbLsbLsbLibLgbLgbLsbLsbLsb
LsbLgbLgbLgbLsbLsbLgbLsbLgbLgbLsbLgbLsbLgbLibLgbRsbLsbLsbLsbLgbLsbLsbL
sbLsbLsbLgbLsbLsbLgbLsbLsbLgbLsbLsbLgbLgbLsbLsbLsbLsbLsbLsbLgbLsbRsbLg
bLgbLsbLgbLsbLsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLibRibLsbLsbLsbLsbLsbRsbLsb
RsbLsbRsbLsbRsbLsbLsbLsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 34; Drug: CNO 3 然 Apo 50 然
bRsRsmbsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 35; Drug: CNO 3 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 36; Drug: CNO 3 然 Apo 50 然
bRgbLebLsbRjb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 37; Drug: CNO 1 然 Apo 50 然
bLsLsLsLsmmmbRsLsRsbRgRsmbRsbLcbLcLsmbLobRgbRibRiRsmbRibLhRsbLhbLibLgb
RsLsbLgbLgbRsbLibRgbLibLsRjbLsbLgbRsbRjb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 38; Drug: CNO 1 然 Apo 50 然
bLsLsLsmmbLgbLgbLsbLsbLgLsbLsbLgbRgbRjbRgbRebRgbRsbRgbRsbRsbRsbRgbRgbR
sbRsbRibRsbRgbRsbRsbRgbRgbsbRjRgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 39; Drug: CNO 1 然 Apo 50 然
bLsRsRsRsmmbRsRsmbLsbRsbRsbRgbRsbRsRsRsmmbRgbRibRsbLsRgbRgbRcbLgbRjbLg
bLsbLgbLsbLebLgbLgbLsbLsbLsbLsbLgbLgbLgbLgbLgbLgbLgbLgbLsbLsbRsbLgbLsb
LcLsmbLsbLgbLsbLsbLsbLgbLsbLibLsbLsbRsbLgbLgbLsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 40; Drug: CNO 1 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 41; Drug: CNO 1 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 42; Drug: CNO 1 然 Apo 50 然
b

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 43; Drug: Control Apo 50 然
bRsLibLgbLgLsbLibLgbLsbLebLibLhbLsbLsbLgbLsLgbLgbLebRsbRebRsbRgbRgbLsb
RsbRhbRsbRsbRibRsRgbRsbRgbLsbRibRgbRibRgbRgbRsRgbRgbRibLsbRsRebRibLgbR
gbRsLebLhLsbLsLsmbsbsbLibLgbLsbLgbLsbLibLgbLgbLsbLgb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 44; Drug: Control Apo 50 然
bRcbReRsmbRhbRibRsbRsbRgbRebRjbRibRsbRiRsmbRsbLobRsbLobLiLsbLjbLebLgbR
gbRgbRsbRgbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 45; Drug: Control Apo 50 然
bLsbRgRsmbLsbRsbRsRsRsRgmmbRsRsmbRgbRgRsmbRgRsmbRebRsbLsbLcbLsbLebRgbR
gbRsbRgbRobRsbRgbRebRgbRsbRsRsRsmmbRsbRibRsRsRsmmbRhbRsbRhbLsbLsbRgbRi
bRibLsRgbRsbRgbLsbRhbLibRhbLsbRgRebRsbRsbLsbLgbLsbLgbRsbRsbLgbLsLsmbLs
bLsbLgbLgbLibRsbRcbRjbRibRhbRgbRsbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 46; Drug: Control Apo 50 然
bRsbLsbRsbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 47; Drug: Control Apo 50 然
bRsbLsbRjRsmbLsbRsbRjbLsbLsbLcLsmbLibLoLgLsbRcbLebLcLsmbLgRsbLsbLsbRgb
LobLcLsmbLsRsbLsbLhbLcbRsb

>ZF Recording 2016-03-22; tW: 300s; Start: 124936; End: 125436;
Recording: 13-1; Individual: 48; Drug: Control Apo 50 然
bLsbLgbLibLsLsmbLebLibLsbLsbLgbLgbRsLsbLsbLgbLiLgbLsLsmbLsbLgbLgbLgbLg
bLgbLsLibLsbLibLsbLebLibLgbLsbLsbLsLsmbLgbLsbLgbLgbLgbLibLsbLsbLhbLgbL
sbLibLibLgbLsbLgbLsbRsbLgbRsbLsbLsbLsbLgbLsbLsbRsbLsbLsbLsbRsbLsbLsbLs
bLsbRsbLsbLsbLsb

